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ABSTRACT 
LILIAN PEDROSA HEFFERNAN: Absorptive capacity for Global Fund grants: Lessons to the 
International Community 
 (Under the direction of Dr. Bryan Weinner) 
 
This study explores the concept of absorptive capacity of aid programs in health by focusing 
specifically on Global Fund grants. Based on the findings of the literature review, the main 
hypothesis of this study is that the absorptive capacity for Global Fund grants (dependent variable) 
is influenced by the level of governance, the overall level of funding for health, the level of 
development, the type of implementer, the disease component of grant, the number of grants 
managed by the recipient, the round of funding (year when grant was awarded) and the burden of 
disease in the recipient country (independent variables). 
This study also aims to investigate the effect of each of the independent variables on the 
level of funding absorption. These factors are analyzed individually and in various combinations, for 
example disease component (HIV/AIDS, Tuberculosis or Malaria). This study use a novel analytic 
method—qualitative comparative analysis—to analyze  if, and to what degree, the absorptive 
capacity for Global Fund grants are influenced by the following factors: the level of governance, the 
overall level of funding for health, the level of development, the type of implementer and the 
burden of disease in the recipient country. 
The results of this study confirmed the complexity of absorptive capacity by demonstrating 
that there are multiple pathways to high and low absorptive capacity.  The results are also surprising 
as it challenges the findings of the Literature Review related to factors associated with high and low 
absorptive capacity. 
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CHAPTER 1: INTRODUCTION 
The history of development has been defined by the transfer of resources from developed 
countries and multilateral organizations to developing countries with the noble objective of 
reducing poverty, expanding infrastructure, improving health, education and social systems and 
fostering social justice. It is estimated that over $ 2.2 trillion has been invested in development since 
1960 (Organization for Economic Co-operation and Development). 
Despite important and undeniable achievements, there is a growing criticism of the impact 
and success rates of development aid. More and more authors and critics point out disappointing 
results and argue that the failures of development aid outweigh its successes. There is a group of 
researchers and authors that continue to defend the success of aid and advocate for its increase. As 
a result, a contentious debate is now taking place:  one side argues that only a massive increase in 
funding would be able push developing countries out of poverty while the other side argues that 
additional funding not only will not bring significant improvement but might even have detrimental 
effects to the economies and development of countries. 
Of course the fight to reduce poverty and improve the lives of millions in the developing 
world must continue. The debate is not about the need for aid but rather how to transfer and to 
implement aid in the most effective way.  The outcome of the current debate will shape the future 
of aid as it seeks to answer fundamental questions: Should the donor community continue to 
provide funding in the face of the severe difficulties to deliver expected results? Should the 
organizations continue to manage and disburse funding despite the evidence of bottlenecks and 
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absorptive capacity issues? How can we better evaluate the impact of aid? How can we ensure that 
aid contributions are reaching people who need it most? 
The international community’s commitment to reduce poverty and achieve the Millennium 
Development Goals (MDGs), combined with the increasing and persistent burden of diseases in the 
developing world, have put Global Health at the forefront of the international policy agenda. The aid 
allocation for health has dramatically increased in the last decade and many new organizations are 
providing additional funding for health. Recipient countries have also made commitments to 
increase their state budget allocation for health. This represents a great opportunity and a major 
challenge for all stakeholders involved in Global Health. 
It is clear that resources alone will not lead to better results unless the challenges faced by 
aid effectiveness in general and by internationally funded health programs in particular are 
addressed.  Despite recent improvements in access to health care services resulting from global 
programs, recent experience in scaling-up programs revealed many bottlenecks that hindered the 
effectiveness of these efforts. 
Since 2000, the emergence of new partnerships has changed the landscape of international 
public health methods by which donors provide assistance. These partnerships provide funding to 
combat a small number of diseases that disproportionally affect low and middle income countries. 
More importantly, these new partnerships represent a concerted response from the international 
community that has leveraged additional funding and technical resources.  
From the 1990s until 2009, funding for the fight against HIV/AIDS dramatically increased. In 
2008, an estimated $15.6 billion was spent on HIV/AIDS compared to $300 million in 1996. In 2007 
alone, the Global Fund and GAVI Alliance donated USD 2.16 billion and The U.S. President's 
Emergency Plan for AIDS Relief (PEPFAR) donated USD 5.4 billion. According to the Global Fund and 
Partner’s report, Global Fund, PEPFAR and World Bank’s Multi-Country HIV/AIDS Program (MAP) 
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contribute more than two-thirds of all external funding to fight HIV/AIDS and Malaria in developing 
countries.  
The Global Fund to Fight AIDS, Tuberculosis and Malaria (referred to hereafter as The Global 
Fund) was created in 2002 as a public-private partnership that would attract and disburse additional 
resources to prevent and treat HIV/AIDs, Tuberculosis and Malaria.  This partnership between 
governments, civil society, the private sector and affected communities represents a new approach 
to international health financing. It has since become the main source of finance for programs to 
fight AIDS, Tuberculosis and Malaria, with approved funding of US$ 19.3 billion for more than 572 
programs in 144 countries. It provides a quarter of all international financing for AIDS globally, two-
thirds for Tuberculosis and three quarters for Malaria. 
The creation of the Global Fund sparked considerable debate regarding the capacity of 
developing countries to spend substantial additional resources for health effectively. This debate 
has not subsided with the rapid growth of the Global Fund. On the contrary, the creation of new 
partnerships and global health initiatives has continued to fuel this debate. The recent findings of 
corruption and misuse of funding have contributed to the doubts about the efficiency of this model. 
On one side there is the argument that countries can absorb a substantial increase of 
funding in health, given the massive needs to improve health systems, retain human resources and 
scale-up the fight against the three diseases (HIV, TB and Malaria) and other diseases related to low 
health and economic status. On the other side, there is the argument that countries cannot absorb 
additional resources due to the weaknesses in the systems (i.e. weak distribution chain, insufficient 
number of health workers, lack of qualified expertise, lack of necessary laboratories etc). Critics 
point out that increased resources for health would not translate into increased delivery of health 
programs and ultimately would not translate into increased health for beneficiaries. 
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This study aims at contributing to the current debate by studying the factors associated with 
absorptive capacity. The literature review explores the definitions of the absorptive capacity and the 
main factors associated with high and low absorptive capacity. Based on the literature review, this 
study hypothesizes that the absorptive capacity for Global Fund grants (dependent variable) is 
influenced by the level of governance, the overall level of funding for health, the level of 
development, type of implementer, disease component of the grant (HIV/AIDS, Tuberculosis or 
Malaria), number of grants managed by implementer, round of funding and the development and 
burden of disease in the recipient country (independent variables). 
This study uses a novel analytic method—qualitative comparative analysis—to analyze if, 
and to what degree, the absorptive capacity for Global Fund grants are influenced by the 
independent variables. The method analyzes how the independent variables contribute, individually 
and in combination, to the outcome of high and low absorptive capacity. 
By analyzing the specific data on Global Fund grants, this study contributes to a broader 
discussion on (1) criteria for allocation of additional resources for health and (2) potential strategies 
and policies that could improve the absorption capacity of aid funding.    
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CHAPTER 2:  LITERATURE REVIEW 
Chapter II provides an overview of the literature review.  It is organized into seven major 
sections. The first section focuses on the concept of development and how it evolved over time.  It 
explores the different discourses, theories and applications of development aid from the 1950s to 
the present. The second section focuses on the current debate around the barriers to the effective 
utilization of aid, common bottlenecks faced by countries and the degree of impact that results from 
increasing aid to health. The third section focuses on the concept of absorptive capacity and how it 
figures in the current debate as a central argument.   
 The fourth section explores the link between development and public health in the context 
of globalization. It focuses on the emergence of the Global Fund and its institutional design. The fifth 
section explores the concept of Performance-Based Funding (PBF) and how it is applied as a 
decision-making tool for funding for Global Fund grants. The sixth section provides an overview of 
the changes and challenges faced by the Global Fund over the last decade and how it affected its 
operational model and application of PBF 
 The last section explores the links between factors associated with absorptive capacity 
identified in the Literature Review and elements of the Global Fund grants. It depicts the process 
applied to select the dependent and indepent variables for this study.   
 
THE CONCEPT AND HISTORY OF DEVELOPMENT 
There is an abundance of definitions of the concept of development and interminable 
discussions and contradictory opinions on each definition. As a complex concept that encompasses 
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ideas associated with progress, well-being, social justice, human rights and economic growth, the 
definition of development has been modified and colored with different political and ideological 
theories. This study adopts the definition crafted by Rist (1997) in an attempt to remove political 
and ideological views: “Development consists of a set of practices, sometimes appearing in conflict 
with one another, which require—for the reproduction of society—the general transformation and 
destruction of the natural environment and of social relations. Its aim is to increase the production 
of commodities (goods and services) geared, by way of exchange, to effective demand” (Rist, 1997, 
p.13). 
The definition of development aid or development cooperation is much less controversial 
and it can be easily defined as aid (monetary transfer and in-kind) given by governments and 
agencies to support the economic, environmental, social and political development of a society. It is 
distinguished from humanitarian aid by focusing on alleviating poverty in the long term, rather than 
a short term response to an emergency situation caused by war, internal conflict or natural disaster. 
The term development cooperation is also widely used by multilateral organizations to express the 
idea that a partnership should exist between donor and recipient. Most development aid comes 
from the Western industrialized countries but some poorer countries also contribute aid to 
neighboring countries. Aid may be bilateral or multilateral. Bilateral aid is given from one country 
directly to another while multilateral aid is given by the donor country to an international 
organization such as the World Bank or the United Nations Agencies which then distributes it among 
the developing countries.  
In general, there are two types of aid: the Official Development Finance (ODF) and the 
Official Development Assistance (ODA). The ODA is targeted at the poorest countries and consists of 
grants and concessional loans containing at least a 25 percent grant component. The ODF covers all 
inflows of finance to developing countries disbursed by donor countries and multilateral agencies.  
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Although always present in the history of humankind, the modern concept of development 
dates to the colonial era, when philanthropic and humanitarian ideals were marshaled to support 
invasions, exploitations and colonization. However, the origin of development as we now know it 
dates from the end of World War I, when the Covenant of the League of Nations created the first 
permanent international political institution with the objective of promoting development.  
The end of World War II marks a pivotal moment in the history of international 
development. Many authors point to the Bretton Woods conference as the birth of modern 
development. During the first three weeks of July in 1947, 700 delegates from 44 countries met to 
discuss a new framework for a global system of financial and monetary management (Moyo, 2010). 
It is from these discussions that a plan to rebuild post war Europe emerged and defined the future 
of development. It was also during the Bretton Woods conference that the foundations of three key 
world institutions were laid: The International Bank for Reconstruction and Development (World 
Bank), The International Monetary Fund (IMF) and The International Trade Organization.  
In June 1947, George C. Marshall, the U.S.’s foreign minister at the time, proposed a bold 
plan to reconstruct Europe. The U.S. offered $20 billion (equivalent to over $100 billion today) in 
what was eventually known as the Marshall Plan. The plan was later formalized by President Truman 
in the Act for International Development (1950). 
The Marshall Plan is considered a success. The large amounts of funding, coordinated by key 
institutions, succeeded in restoring infrastructure and bringing political and economic stability. It 
soon became the standard emulated in many parts of the world. The success of the Marshall Plan is 
evidence that financial capital and investment are critical for economic growth (Rist 1997; Moyo, 
2010). 
The pioneers of international development in the 1950s, Regnar Nurkse, Paul Rosenstein-
Rodan, Albert Hirschman, Sir Arthur Lewis and Walt Whitman Rostow, were all influenced by the 
    8 
works of the English economist John Maynard Keynes and agree with the assumption that poor 
economic performance reflects a lack of aggregate demand of resources. Keynesian theory 
postulates that un unregulated capitalist economy is susceptible to depression  and that 
government spending on welfare works as a safety net to save economies from collapsing due to 
unpredictable market forces. His theory subverted the neoclassical theories and developed a 
twofold strategy for active government intervention: (1) macro-management of economy to ensure 
growth, and; (2) implementation of a range of social policies to ensure that the fruits of economic 
growth can reach the entire population.  
An economist working in development, inspired by Keynes, would consider capital 
accumulation as the motor of economic growth and the assistance during this period took the form 
of large infrastructure projects (roads, dams, ports etc). In the 1960s, however, the dissatisfaction 
with development strategy grew as there were few signs of trickle down effects coming from 
modern technology. Large infrastructure projects did not yield the expected results as they were not 
adaptable to local cultures and there were no local maintenance and management capacities. As a 
result, knowledge and skill transfer were also recognized as growth engines and development 
programs started to include social infrastructure (schools and universities) and technical assistance 
(Cypher and Deitz, 1997).  
The aid strategy adopted in the 1970s was shaped by the rapidly widening gap between 
poor and rich countries and had poverty reduction as the key goal. Development programs aimed to 
fulfill the basic needs of a country’s population and focused mainly on rural development and 
involved local administrations to ensure that the capacity to manage programs is installed. 
Unfortunately, the result of this aid strategy was a large amount of aid funding being siphoned off 
by local authorities and ruling elites (Easterly 2007). 
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In the early-1980s, a severe world wide debt crisis pushed countries to increase foreign aid 
and debt relief. Inspired by the success of the ‘Asian Tigers’ countries, the IMF and WB launched the 
economic restructuring programs that targeted developing countries. These programs aimed at 
reducing inflation, correcting government deficits and removing trade barriers. As a result of this 
strategy, the dominant paradigm was top-down planning. The structural adjustments and 
stabilization policies did not yield the expected results and by the early 1990s, the field started 
recognizing the need for sound institutions, good governance and democratic accountability as keys 
for positive aid results (Pitman and al 2005). 
The discourse of development is greatly influenced by economic political ideology. As one 
can note from the difference in aid strategy from the 1960s and 1970s to the1980s, the Keynesian 
school was challenged by the Chicago school, founded by Milton Friedman. This shift towards 
neoliberalism was anchored in the assumption that the scope of government should be limited and 
its functions should be restricted to preserve law and order, to enforce private contracts and to 
foster competitive markets (Ellerman 2005) 
The critiques of0 the neoliberalism approach to development grew louder and louder in the 
1990s, influencing a shift to greater development aid and more integration of recipient countries in 
the planning and implementation process. Additionally, the flourishing of civil society and new large 
public-private partnerships brought new actors, and more funding, to the field of development 
(Dichter 2003). 
Development is now accepted to be a complex phenomenon that occurs as a result of 
complicated interactions between several factors over a period of time. This includes ‘public capital’ 
(political, legal and economic institutions), infrastructure, physical and human capital, and ‘cultural 
and social capital’ (beliefs, values and social institutions) (Dichter, 2003). Consequently, different 
combinations of these factors in recipient countries will result in different results of aid across 
    10 
countries and over time. This understanding translates into both a call for additional aid and a call 
for additional selectivity in allocating aid as both sides of the debate apply different combinations of 
factors in recipient countries to advocate for an increase of aid and stricter rules for aid transfer. 
 
CURRENT DEBATE ON AID 
After 60 years, development continues to be a part of today’s agenda. Governments 
continue to set bilateral agencies to channel funding and in-kind, multilateral organizations continue 
to grow as new actors join the field. After more than 60 years, we are still confronted with shocking 
poverty, dismal inequality in access to health and education, and a lack of basic infrastructure in 
many parts of the world. It is understandable that so many scholars are pondering the question 
“Where did all the aid go?”  A fair question considering it is estimated that from 1960 to the present, 
over $ 2.2 trillion of official development aid has been transferred to developing countries (Easterly, 
1997). Over $ 1 trillion was transferred to Africa alone (Hebert, 2004; Erixon, 2005) and some 
African countries are poorer today than they were fifty years ago (Moyo, 201). 
Since the 1960s, the volume of aid has increased in real terms, excluding a period of decline 
in 1990s, and the plan is to reach a massive increase by 2015. Jeffrey Sachs, professor at Columbia 
University and chief advisor of the United Nations Millennium Development Project called for a ‘Big 
Push’  doubling the amount of aid immediately (in 2005) and then doubling it again by 2015, in order 
for countries to meet the MDGs. The view that countries need a massive increase in aid to escape 
poverty is supported by many multilateral agencies, Governments and influential pop culture 
personalities like singer Bono, Brad Pitt, Angelina Jolie and Penelope Cruz to name a few. 
Comparing the amount of financial investment and the results obtained, many authors and 
scholars view the results of aid in the last fifty years as disappointing. Of course there have been 
great successes: the eradication of smallpox and the dramatic decrease of blindness cases due to the 
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Onchocerciasis Control Program (both WHO led initiatives). Severe and moderate malnutrition has 
been greatly reduced in parts of Africa and there is no doubt that development assistance can play a 
significant role in improving water, sanitation, school enrolment and  child mortality rates. 
Some countries are hailed as proof that development aid can lift countries out of poverty. 
There are many articles on the development successes of Korea, Taiwan, Uganda, Tanzania and 
Vietnam (World Bank 1998, Devarajan et al. 2001, Bourguignon and Leipziger, 2006).  
Despite the success cases, there are a growing number of authors that focus on aid 
ineffectiveness.  They examine the reasons for ‘disappointing’ results and question the way aid is 
distributed and managed. Aid ineffectiveness can be defined as the low performance of aid in 
promoting economic growth, reducing poverty and improving health and education systems. The 
debate on aid ineffectiveness has been going on for decades and has generated a vast and many 
times controversial body of literature. The literature review showed many attempts to understand 
the reasons for the apparent lack of results in foreign aid assistance. Overall, the explanations can 
be divided in three categories: shortcomings of recipient country, shortcomings of donor agencies 
and shortcomings of the way aid is managed and delivered (shortcoming of agencies and 
organization that deliver aid). 
The first explanation holds that issues like corruption, bad governance, political instability 
and weak institutions often explain the low performance of aid (World Bank 1998, Lancaster 1999, 
Easterly 2006 b). The literature in this first category is by far the largest and it examines in detail the 
characteristics of the recipient countries that are associated with successes and failures related to 
aid.  
 Zambia is often cited as a country that did not fully benefit from aid when compared to 
other countries in the region. From 1980 to 1994, Zambia experienced inflation above 40 per cent 
every year except two from 1985 to 1996, despite 12 adjustment loans. Similarly, Pakistan had a 
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budget deficit of 7 per cent of GDP between 1970 and 1997 in spite of 22 adjustment loans 
throughout this period. 
 A number of empirical studies have supported the argument that causes of aid 
ineffectiveness lie in the country. In 1996, Boone published a controversial paper that showed the 
majority of aid was used for wasteful public consumption instead of financing investment and 
growth, regardless of political regime. Subsequently, Burnside and Dollar (2000) expanded on 
Boone’s paper and found that aid has a positive impact on growth in a good policy environment 
(good fiscal, monetary and trade policies). This was the beginning of numerous contradictions in the 
empirical literature on aid performance. Collier and Dollar (2002), using a broader measure of policy 
environment (World Bank’s Country Policy and Institutional Assessment) and a larger sample of 
countries, confirmed Burnside and Dollar’s results. Svensson (1999) showed that foreign aid 
positively affects long-run growth in democratic countries. 
These studies fall in the camp that defend the idea that aid does spur economic growth but 
only under specific conditions (Burnside and Dollar 2000; Hansen and Tarp 2000, 2001; Collier and 
Dollar 2002; Clemens et al. 2004; Moreira 2005). 
The issue of absorptive capacity has been frequently raised in the aid development 
literature, illustrating that there might be diminishing returns to aid in certain countries. In other 
words, because of developing countries’ characteristics mentioned above, there might be a certain 
level of aid inflows after which poor countries would have some difficulty to effectively absorb 
additional amounts of aid (Burnside and Dollar 2000; Collier and Dollar 2002; Clemens and Radelet 
2003). It is an undeniable truth that over the years, a certain amount of official development 
assistance has been wasted by the ill-managed machinery of recipient countries. Despite the strong 
arguments that the characteristics of the recipient countries play a role in aid effectiveness, it is also 
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clear that there are numerous factors in the aid delivery network with multifaceted interactions and 
relationships among them.  
Another important approach to improving the absorptive capacity of health areas is adopted 
by Mooney and Houston (2004). They incorporate the concept of ‘capacity to benefit’ to understand 
the potential for absorption at the recipient level. The ‘capacity to benefit’ is defined as the extent 
to which heath areas can take full advantage of resources allocated to them. This concept is linked 
to what the authors define as ‘Management Economic Social and Human (MESH) Infrastructure’. 
The authors explain that health service jurisdictions differ in terms of their capacities to produce 
results for three main reasons: (i) the health level of the population, (ii) the type of typical health 
problems; and (iii) the capacity of local health system. In situations where both the health levels and 
the health problems are similar, one health service may be better placed or better equipped to 
benefit its population than the other. In this case, the capacity to benefit is inhibited because it lacks 
the necessary MESH infrastructure to deliver health benefits to its population. This approach differs 
from traditional approach that measures the health needs and focuses on the benefits sought in 
allocating resources.  
The second, and much smaller, category of explanations found in the literature emphasizes 
issues related to the donors’ side. This category includes studies that point out these donor 
countries strategic interests and the aid allocation criteria used by aid agencies are often not what it 
is necessary for the development of a recipient country. This seems to be more prominent in 
bilateral agreements as donor countries favour former colonies and political allies. An exception 
seems to be small countries, such as the Netherlands and the Scandinavian countries that provide 
aid according to economic necessity and sound management criteria (Maizels and Nissanke, 1984; 
Fleck and Kilby 2005 b, Allen 2006). 
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Ostrom et al (2001) points out that the holding this many actors accountable for the results 
is the main reason for aid ineffectiveness. For instance, the richest countries in the world (such as 
the U.S., France, Germany, United Kingdom and Japan) with the largest decision-making power in 
international organizations are also the ones influencing and formulating aid policies. They also have 
influence over the selection of recipient countries (Clements 2005) and in the design and 
implementation of projects (Tendler 1975; Dichter 2003). For instance, Lancaster (1999) depicts the 
appearance of ‘donor-driven’ countries and links it to the weakness of national institutions. The 
former President of Nigeria, Mr. Olusegun Obasanjo made a declaration that illustrates this point 
well: “In education and in industrialization, we have used borrowed ideas, utilized borrowed 
experiences and funds and engaged borrowed hands. In our development programmes and 
strategies, not much, if anything, is ours.” (Lancaster 1999). 
The third set of explanations, also related to the donors’ side of the equation, postulates 
that international institutions involved in providing aid and implementing development programs 
are also a source of aid ineffectiveness.  For example, part of the problem of aid ineffectiveness can 
be due to the fact that the largest part of aid transferred may not reach the beneficiaries. Cudjoe 
(2006) estimates that out of every dollar given to Africa, 16% goes into consultant fees, 26% in 
emergency aid and relief and 14% in debt servicing, leaving less than 50% for program 
implementation. 
A potential cause for aid ineffectiveness from the donor side is the ‘Money-Moving 
Syndrome’, a term coined by Monkam (1998) to explain the pressure on donor agencies to disburse 
money.  This syndrome is observed when the quantity of aid committed or disbursed becomes, in 
itself, a key objective like effectiveness of aid. It can be a major handicap for aid effectiveness as it 
shapes other incentives at macro and micro levels of the aid delivery chain. This idea is based on the 
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principal-agent theory and explores the institutional incentives that affect the characteristics of an 
optimal and efficient contract.  
The explanations and insight found in the literature review point to a complex phenomenon 
where different factors are influencing the effectiveness of aid. Apart from ocassional success 
stories, the overall impact of aid on macroeconomic variables evidenced in the literature remains 
weak and ambiguous (Gibson et al. 2005; Bourguignon and Sundberg 2007). Mosley (1986) calls the 
co-existence of ambiguous macro-economic outcomes with successful projects the “micro-macro” 
paradox. 
Doucouliagos and Paldam (2005) report that until 01 January 2005, the aid effectiveness 
literature consisted of 97 studies, using one of the three aforementioned approaches. The authors 
applied meta-analysis techniques and found that despite a great variation in the findings, 
aggregated results showed that the average effect of aid is positive, but small and statistically non 
significant.   
Aid has also been negatively associated with growth in developing countries; however, this 
association does not prove that aid caused the decrease in growth. Easterly (2003) points out that in 
many cases aid has not been able to halt the deterioration of growth or that success could occur 
without foreign assistance.  
Although it is not possible to assess the change of aid effectiveness across agencies and over 
time, changes in the development discourses and in recipient countries can shed some light on the 
analysis of aid. Recent studies based on new approaches to selectivity shows that aid’s impact on 
growth is dependent on the quality of recipient countries’ institutions and policies (Burnside and 
Dollar 2004). Clemens and Radelet (2004) have also found that a particular type of aid, ‘short-impact 
aid’ which includes budget support, investments in infrastructure and aid to productive sectors have 
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a much stronger impact than aid as a whole. This result does not depend on levels of income, 
strength of institutions or quality of its policies. 
Despite controversial results in aid literature, there are clear indications that aid has 
diminishing returns. Most studies reviewed in the literature point out that an ‘aid saturation point’ 
could be reached anywhere between 15% to 45% of Gross Domestic Product (GDP), beyond which 
the benefits of additional aid inflows become negative (De Rezio 2005). This finding poses important 
questions to the development community as a bigger and faster increase in funding could 
potentially lead to faster diminishing returns.  
What are the possible factors that cause the diminishing return? A small but growing 
literature identifies absorptive capacity as the main obstacle and key factor responsible for limited 
aid effectiveness and decline in marginal returns.  
 
THE CONCEPT OF ABSORPTIVE CAPACITY 
The concept of absorptive capacity is receiving increasing attention in the past few years. 
The on-going debate on a potential increase in aid and the bottlenecks to the scaling up of 
development and health programs have brought the concept of absorptive capacity to the center 
stage of several theories and arguments.  
 Despite its aura of novelty, the concept of absorptive capacity in development has been 
used for over 50 years. The literature review traces the origin of this concept to a proposal made by 
Millikan and Rostow in 1957 to allocate aid according to the absorptive capacity of the recipient 
country. Rosenstein-Rodan presented in 1961 a very comprehensive use of the concept to measure 
the capital needs in a country.  
Nurkse (1953), together with Rosenstein-Rodan, were the first advocates for the ‘Big Push’ 
and they referred to the limitations of absorptive capacity of aid for investments. It might seem 
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contradictory that these authors were referring to absorptive capacity while advocating for the ‘Big 
Push’. However, as pointed out by Guillaumont and Jeanneney (2007), both concepts rely on the 
idea that low income countries face structural obstacles for growth, which are reflected in the 
absorptive capacity, and increasing aid is a way to overcome this. It is, however, important to put 
this discussion in a historical context. The concept of absorptive capacity was used 50 years ago as a 
way to mobilize aid rather than criteria to limit aid, as it is discussed presently.  
Nevertheless, absorptive capacity remains an ambiguous concept that is applied by different 
schools in the development community and it continues to be used to advocate for both more and 
less funding for aid.  
Gottret and Schieber (2006) discuss absorptive capacity in relation to whether countries are 
able to spend effectively those new resources for health made available by donors. However, the 
authors point out that absorptive capacity is not exclusively a problem of donor aid but also affects 
domestic expenditure. Absorptive capacity is defined as follows: “Absorptive capacity includes the 
ability of the public sector to design, disburse, coordinate, control, and monitor public spending. 
This coordination is both vertical (between central and local governments) and horizontal (between 
line ministries at any given level). The question is whether governments or even institutions such as 
health ministries have the capacity to manage a large increase in real expenditures beyond a usual 
trend” (Gottret and Schieber 2006, p. 239). 
Absorptive Capacity is now mostly being considered in heath areas to express concerns that 
massive increases in funding will not lead to improved results in health indicators. Clements and 
Redelet (2003) observe that both large amounts of funds and demand for quick results can create 
bottlenecks by placing increased demands on weak systems.  Bhagwati (2005) goes even further and 
warns that a significant increase in aid can become problematic as countries will spent it 
counterproductively. 
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These concerns contrast greatly with the international efforts and advocacy campaigns to 
mobilize funding to meet the MDGs. However, quick and substantial increase in aid funding does not 
necessarily mean that funds will be wasted or misused. Some authors suggest that countries in a 
post-conflict phase are more able to utilise large amount of funds effectively (Clemens and Radelet 
2003, Mackinnon et al. 2003). 
The findings of the literature review on absorptive capacity can be summarized in four main 
categories of constraints:  
- Macroeconomic 
- Institutional and Policy 
- Technical and Managerial  
- Donors’ Practices 
Macroeconomic Constraints 
A large and sudden increase in aid inflows in the form of foreign currency provokes a ‘Dutch 
Disease’ effect, causing an appreciation of the exchange rate and therefore harming the export 
sector. When aid flows in the form of loans, it can raise concerns about debt sustainability. Aid flows 
can also be unpredictable and volatile, which can negatively influence the macro-economic stability 
by causing inflation and interest-rate and exchange-rate volatility. This is often the case when aid 
comes in the form of budget support. Additionally, aid increases can cause labour market pressure 
for skilled workers. 
IMF and WB authors produced many articles on the risk of a real exchange rate appreciation 
following a scaling up of aid flow (Arelano et al. 2005, Heller 2005, Gupta et al. 2006, Rajan and 
Subramaniam 2005, WB and IMF 2005 and 2006). On the other hand, there are authors that argue 
that in the long term, an increase in productivity is likely to compensate for the effect of a possible 
rise of non-tradable prices on competitiveness. These authors refer to the Balassa-Samuelson 
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theorem to postulate that there cannot be a ‘Big Push’ without real appreciation: if aid succeeds to 
support a big push, it should make the real value of the currency appreciate. 
Institutional and Policy Constraints 
Recent research has confirmed the importance of strong institutions for development. The 
capacity to generate sound policies, the transparency and efficiency of budget systems, and the 
degree of decentralization are some key institutional issues that can have an impact on absorption 
capacity.  In many countries, the existing systems cannot absorb large increases of resources 
without increasing waste and fuelling corruption (De Rezio, 2005). High dependency on aid, in turn, 
can have negative incentives for reforms and a negative impact on accountability. 
Technical and Managerial Constraints 
Lack of qualified human resources remains a serious problem in many developing countries 
with serious consequences for the health sector. In some countries this is compounded by the 
effects of the HIV/AIDS pandemic. Moreover, the lack of adequate infrastructure and equipment 
prevents access to goods and services. 
Although an increase in aid can address some of these constraints, like hiring additional staff 
and providing training, the lack of qualified human resources in key technical and managerial areas 
of the sector is a significant challenge for the efficient implementation and scale up of health 
projects (De Rezio 2005). 
Constraints generated by donor practices 
The organization of the aid system can also be a source of absorptive capacity constraints. In 
general, aid is delivered in a fragmented manner which forces recipient countries to deal with a 
plethora of donors and their individual set of requirements.  There is no doubt that such 
fragmentation imposes heavy transaction costs on scarce government capacity. Recent shifts 
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towards sector and general supports are trying to address this issue but the results so far are not 
clear. (De Rezio 2005). 
Finally, the lack of certainty and predictability of aid flows can seriously hamper a 
government’s efforts to plan and implement programs. The Paris Declaration on Aid Effectiveness 
(2005) aims at improving donor coordination and predictability of funding to recipient countries by 
the harmonization and alignment of donors practices, requirements and performance indicators. 
Absorptive capacity constraints can take many forms and have different impacts on the 
short and long-term. The table below, adapted from De Renzio 2005, depicts its main constraints. 
Table 2.1 Absorptive Capacity Constraints  
Category of Constraints Short-Term Constraints Long-Term Constraints 
Macro-economic ‘Dutch Disease’ effects Level of aid-dependency on aid 
debt sustainability 
Institutional and Policy -Inadequate public 
expenditure management 
systems;  
-Perverse incentives in public 
officials’ performance 
-Major deficiencies in institutions 
and policy process; 
-Social/Cultural factors 
determining the demand for 
services 
Technical and 
Managerial 
Lack of adequate 
infrastructure and 
equipment 
Technical and managerial skills of 
public officials 
Donor Behaviour Uncoordinated donor 
interventions 
Difficulties in full donor shift to 
improved practices 
 
Diarra (2010) combines the constraints at recipient and donor sides and examines 
absorptive capacity from a ‘pipeline approach’. The aid pipeline represents the amount of aid 
pledged by donors but not yet disbursed. This waiting stock can be cancelled or postponed 
depending on the country situation and the policy of the donor agency. The main assumption is that 
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the pipeline level is influenced by the magnitude of bottlenecks and constraints. Also, it can provide 
a good indication of the recipient country’s capacity to manage and report on aid programs.  
The limited literature on disbursement delays shows conflicting results. Some authors 
(Svensson, 2000, 2006; Kanbur 2000) state that there are inadequate quick disbursements because 
donors are caught in moral dilemmas or because donors fall victim to the ‘Money-Moving 
Syndrome’.  Both are classic problems of agency theory where the existence of many principals and 
the asymmetric information contribute to large and inefficient disbursements. (Easterly 2000, 
Leandro et al. 1999, Hagen 2006, Pedersen 2001). 
Other authors (Odedokun 2003; Leurs 2005; Deutscher and Fyson 2008; Celasun and 
WAlliser 2008; OECD-DAC 2008; Bulir Hamman 2006, Bluir Lane 2002 and Roodman, 2006) affirm 
that the slow rhythm and long delays in aid disbursement are negatively impacting the recipient 
countries.  
Despite being used by both sides of the debate, the issue of absorptive capacity is not 
receiving concerted attention. The UN Millennium Project simply states that “scaling up needs to be 
carefully planned and overseen to ensure successful and sustainable implementation” (2005: 31). 
The Commission for Africa also underplays the importance of absorptive capacity as it argues that it 
is not a stringent obstacle to delivering development benefits, provided that there are (a) continuing 
policy and governance improvements within Africa, (b) better allocation of aid resources, and (c) 
better quality of assistance. 
The rich literature on absorptive capacity shows that it is a key concept essential in 
understanding the effectiveness of development projects and aid funding.  Unfortunate, as shown in 
the literature review, there is a lack of empirical studies that focus on absorptive capacity. 
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PUBLIC HEALTH ON A GLOBALIZED WORLD 
Public Health is a field of political struggle, historically cantered on the tensions between 
individual liberties and government’s rights and obligations to protect the health of the community 
(Turnock, 2008). When there is an occurrence of a disease, Public Health address three fundamental 
issues: First, whose problem is it? Second, how should the problems be brought under control? And, 
whose responsibility is it to do so? Szlezák (2008) observes that while addressing these issues, the 
disease is circumscribed and the boundary is created between those affected by the disease and 
those who are not. This boundary, however, is created as a result of the discourses of Public Health 
officials and has significantly changed over time. 
The second half of the 20th century brought rapid development to the field of Public Health 
and many changes to the way diseases are understood and perceived (Rosen, 1993). In general, the 
literature agrees that the representations of health and diseases changed in four major ways. First, 
the biomedical view was increasingly challenged and the concepts of diseases and health expanded 
to include cross-cutting economic, social, behavioural and political issues.  
Second, there was a shift in the way health and diseases are distributed in the world. The 
concept of epidemiological transition shows that with rising standards of living, developing countries 
will no longer be seriously affected by infectious disease but will face increasing rates of non- 
communicable diseases. 
Third, development theorists and economist began to realize that health is a means to 
increase the economic production of society rather than purely a consequence of it. As a result, 
health was brought to the forefront of the development discourse and resulting programs. In 1993, 
the World Bank launched the ‘Investing in Health’ report that called developing governments to 
invest in health as a way to increase their economic development. In 2001, WHO launched the 
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Commission on Macroeconomics and Health, which was responsible for producing research and 
studies on this new perspective. 
Fourth, the relationship between health and state has also recently transformed as health 
and diseases are understood to be transnational. The rapid spread of infectious diseases, like 
HIV/AIDS, bird flu, Sever Acute Respiratory Syndrome (SARS) etc, collectively confirmed that the 
transmission of diseases does not stop at country borders. 
The changes in the health and disease concepts were accompanied by changes in the Public 
Health landscape. The field that was until then dominated by state and the World Health 
Organization (WHO) increased to include the participation of multiple actors, including non-
governmental organizations, private-public partnership, community-based organizations and new 
multidisciplinary initiatives (Widdus, 2001). Reinicke (1997) captures the essence of these changes 
by stating that health became a global public good.  
This shift towards partnership marks the underlying reassignment of responsibilities away 
from nation state onto multiple actors (Buse and Walt, 2000a, 2000b). Szlezák (2008) explains that if 
disease is no longer a simple biomedical issue but rather a matter of economics, politics, society and 
culture, and now has the potential to affect the entire globe, then governments and multilateral 
organizations can no longer be the only ones to provide solutions. 
The launch of The Global Fund to Fight AIDS, Tuberculosis and Malaria (hereafter referred as 
The Global Fund) marked an important moment in the history of global health, not only for the 
enormous increase in funding for the three diseases but also for its innovative institutional design. 
The emergence of The Global Fund is the result of intense political struggles over the responsibility 
for the provision of antiretroviral therapy (ARVs) for patients in developing countries. It reflects the 
shift in the focus of responsibility away from state and multilateral organization towards 
partnerships and diverse actors. The Global Fund was created to address the plight of HIV/AIDS and 
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it was after being launched that Tuberculosis and Malaria were integrated as part of the mission 
(Macro International Inc., 2008). 
Despite the alarming increase in number of people living with HIV and AIDS in the 1990s, 
and the certainty that many countries would be severely affected by the disease, the provision of 
ARVs for developing countries was not considered feasible for three main reasons. First, the ARVs 
were very expensive, reaching more than USD 10,000 per year per patient (Gellman, 2000d) and 
they were not considered to be as cost-efficient as prevention campaigns. Second, the international 
donors believed that the provision of ARVs in developing countries was technically not possible as it 
required sophisticated machinery in health care facilities, highly trained doctors, and patients able 
to follow complicated drug intake schedules (Gellman, 2000d). Lastly, many governments continued 
to deny the existence of HIV and the presence of AIDS in their countries, which would impede any 
program implementation. 
The discovery of triple therapy in 1995-1996 brought new hopes that it would be possible to 
control the disease, that it may no longer be viewed as a ‘death sentence’. This   contributed to the 
further widening of the gap between patients in the developed and developing world, making it 
more difficult for donors to legitimize on-going HIV/AIDS prevention campaigns but no treatment. 
“Access to Treatment” became the new motto to many NGOs and activists and soon their attention 
turned to the pharmaceutical industry and the high prices of ARVs treatment (Macro International 
Inc., 2009 a) 
The South African Medicines Act approved in 1998 allowed for compulsory licensing and 
parallel importing of a variety of patent protected medicines, including ARVs. This augmented the 
pressure on the pharmaceutical industry. The negotiations between UNAIDS and the pharmaceutical 
industry resumed with the objective being a workable solution for both parties. In May 2000, backed 
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by President Clinton, a price reduction of 85% to 90% of ARV drugs for the developing world was 
announced (Szlezák, 2008). This is known as the Accelerating Access Initiative. 
The drop in prices of ARV treatment and the rising global concerns with HIV/AIDS brought 
the question of providing ARVs drugs to the developing world back to the discussion. However, 
donors continue to have concerns that the lack of personnel and technology needed to roll out an 
AIDS treatment would make the endeavour impossible. Additionally, donors were also concerned 
that the low level of education would prevent patients from correctly following treatment 
instructions. 
In an attempt to counter these arguments, some NGOs and academic professors started 
running ARV treatment in Cape Town shanty towns (Levy, Miksad et al. 2005) and in rural Haiti 
(Farmer, L. et al. 2001a, 2001b; Behforouz, Farmer et al. 2004). Paul Farmer, as the head of Partners 
in Health, demonstrated that administrating and adherence to the triple therapy could be achieved 
by training local lay people to accompany patients and supervise the intake of ARV drugs. They also 
succeed in showing that ‘low-tech’ parameters could be used in place of sophisticated machines to 
monitor treatment success (Koening, Leandre et al 2004). 
Paul Farmer’s findings were further substantiated by many other studies and in 2001 
professor Jeffrey Sachs put forward a proposal for the international donors to finance treatment in 
developing countries. The proposal stated that $4.2 billion would be needed for the first 5 years and 
it called for the setup of a new independent mechanism to raise and distribute resources. In April 
2001, Kofi Annan proposed the creation of a Global Fund dedicated to HIV/AIDS and other infectious 
diseases (Crossette 2001; Copson and Salaam 2005). Annan estimated that between $ 7 to 10 billion 
would be needed annually and in June 2001, the United Nations endorsed the creation of The Global 
Fund. 
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In a G-8 summit in Genoa, it was decided that The Global Fund would be created as a public-
private partnership. A Transitional Working Group (TWG) was charged with the operationalization of 
the Global Fund (Copson and Salaam 2005) and in March 2002, the first round of funding was 
announced (Ramsay 2002). 
The creation of the Global Fund introduced innovations that increased expectations that a 
donor organization could be faster, more transparent and less bureaucratic. The founding principles 
reflected the urgency of the mission and hopes for effective management of grants.  
Table 2.2 The Founding Principles of the Global Fund 
Founding Principles of the Global 
Fund 
Operationalization of Principles  
I. Operateas a financial instrument, 
not an implementing entity 
 
The Global Fund's purpose is to attract, manage and 
disburse resources to fight AIDS, TB and Malaria. It does not 
implement programs directly, relying instead on a broad 
network of partnerships with other development 
organizations on the ground to supply local knowledge and 
technical assistance where required.  
 
II. Make available and leverage 
additional financial resources 
 
The Global Fund is charged with raising large sums of 
money which neither replace nor reduce other resources to 
fight AIDS, TB and Malaria. It addresses gaps in country 
efforts to fight the three diseases and strengthen 
underlying health systems by financing programs that 
complement those of other donors, and seeks to use its 
own grants to stimulate further investment by both donors 
and recipients. 
 
III. Support programs that evolve 
from national plans and priorities 
 
The innovative Global Fund model finances programs 
developed by the recipient countries themselves in line 
with national strategic health plans and priorities. The 
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requirement that all areas of society with a stake in public 
health be involved in the development process, including 
civil society and private sector, ensures strong and 
comprehensive programs. 
 
IV. Operate in a balanced manner in 
terms of different regions, diseases 
and interventions 
 
The Global Fund gives priority to financing programs from 
countries with low income and high disease burden, though 
it will also consider programs from countries in the higher 
World Bank income brackets. While it finances the fight 
against AIDS, TB and Malaria worldwide, the Global Fund's 
demand-driven approach ensures that the money is going 
where it is most needed. 
 
V. Pursue an integrated and balanced 
approach to prevention and 
treatment. 
 
The Global Fund takes a comprehensive approach to AIDS, 
TB and Malaria, funding both prevention and treatment 
based on locally determined needs. 
 
VI. Evaluate proposals through 
independent review processes. 
 
The Global Fund's use of an independent Technical Review 
Panel ensures that limited resources are invested in 
technically sound programs with the greatest chances of 
success. The panel includes disease experts, as well as 
experts in the field of development who are able to assess 
how proposed programs complement ongoing health and 
poverty reduction efforts at the country level 
VII. Operate with transparency and 
accountability. 
 
The Global Fund holds its recipients accountable to strict 
standards that require programs to reach specific targets 
throughout the life of the grant. The public can track the 
progress of all grants via this website, which also publishes 
independent evaluations of the organization’s own 
performance and shares the documents discussed at Board 
meetings. 
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The significant amount of funding created expectations that a measurable impact in the 
fight against the three diseases would be attained in a short time. Additionally, there was strong 
political commitment to increase the participation of NGOs and the private sector and to address 
gender inequalities in access to treatment of the three diseases.  
The design of The Global Fund was formulated to catalyse additional funding and disburse it 
more rapidly and effectively than existing organizations (Brugha and Walt 2001). During the 
consultation process led by the TWG with representatives from 38 countries (developed and 
developing) and organizations, it was decided that the organization should be vertical and it should 
focuses on the three biggest fatal infectious diseases in the developing world: HIV/AIDS, 
Tuberculosis and Malaria. 
It was also decided that priority should be given to countries with the greatest diseases 
burden (The Global Fund 2002a). The institutional framework then detailed a combination of 
economic, epidemiological and political criteria for eligibility. The Global Fund envisions a new way 
of conducting development aid (Richards 2001) and it broke away from ‘business as usual’ by 
rearranging the relationships between actors in the field: states, multilateral organizations, donors 
and recipient countries and civil society (Mallipeddi 2007). Therefore, its governance model aims at 
crafting an organization that can respond efficiently to countries needs and produces observable 
results that satisfy donors (Poku 2002). 
The figure below depicts the organizational structure of the Global Fund. 
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Figure 2.1. The Global Fund Core Structure1  
 
 
                                                        
1
 Figure retrieved from The Global Fund website (htpp://www.theglobalfund.org) 
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The innovations of The Global Fund’s institutional design are based on 4 main pillars. The 
first pillar is Science. It emphasizes that scientific approaches and expertise are central to effective 
public health actions. The Technical Review Panel embodies this pillar as they are responsible for 
evaluating all funding proposals received on their technical merits.  
The second pillar of innovation is based on local ownership. In contrast to other large donors 
and multilateral organizations, all grants are locally initiated, designed and implemented. As an 
institution, the Global Fund does not dictate scope of projects, key interventions or how grants 
should be implemented. All decisions are agreed in country.  
A third pillar in the institutional design is The Country Coordinating Mechanism (CCM), 
which is an  obligatory stakeholder that serves to ensure that multiple local actors, including civil 
society and organizations representing patients, actively take part in the design of the proposal and 
the oversight of grant implementation. The operational guidelines stipulate that the CCM must be 
composed of no more than 50 per cent of its members from the Government. There are 6 minimum 
requirements that the CCM must adopt in order to be eligible for funding. 
The CCM is a fundamental piece of The Global Fund architecture as it is also responsible for 
nominating the Principal Recipient (PR), the organization or government institution that is 
responsible for the implementation of the grants. The CCM embodies both local ownership and 
participatory decision-making, both key values of the organization. 
The forth pillar of the institutional design is the Technical Review Panel (TRP), an 
independent body responsible for the technical review of proposals received from CCMs and 
resource allocation procedures. The TRP is made up of 26 health and development specialists 
appointed by the Global Fund’s board.  
The Global Fund Board consists of 20 voting members, representing developing countries, 
donors, civil society, private sector and people living or affected by the three diseases. The Board 
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can only approve or reject categories of proposal, not individual proposals. This is a mechanism to 
ensure that technical merit is the only criteria for approval and to ‘depoliticizing’ the funding 
decisions. The fact that Iran, North Korea and Myanmar are recipients of Global Fund grants show 
that The Global Fund have succeeded in keeping politics out of funding decisions. 
The Global Fund relies on technical agencies (i.e. WHO, UNAIDS, USAID, DFID etc) at the 
global and local level. At the global level, the technical agencies provide the standards and best 
practices in public health; and at the local level, they provide support for proposal development and 
grant implementation. 
The Global Fund design represents a bold move to change the way development aid works. 
It proposes to move away from donor-driven to locally designed and implemented programs while 
redistributing the responsibilities for global health among governments, multilateral agencies, 
private sector, civil society and people living or affected by the diseases. A new dynamic between 
these actors is created and reinforced by a new financing mechanism.  
The institutional design of The Global Fund was created to balance the principle of 
accountability at two levels. On one hand The Global Fund must be accountable to its donors and on 
the other hand, it must empower local actors.  Slezak (2008) argues that The Global Fund reached 
this balance by combining the inclusion of stakeholders at the local level and a scientific institution 
at the global level.   
The Global Fund’s innovations in its institutional design were translated into operating 
principles, policies and grant cycles. As discussed in the previous section, The Global Fund operates 
with 6 key structures: The Board, the Global Fund Secretariat, the Technical Review Panel, the 
Country Coordinating Mechanism, the Principal Recipient (grantee) and the Local Fund Agent. 
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The Global Fund Secretariat, based in Geneva, manages the grant portfolio, including 
screening submitted proposals, issuing instructions to disburse money to grant recipients and 
implementing performance-based funding of grants. 
The Global Fund signs a legal grant agreement with a Principal Recipient (PR), which is 
designated by the CCM. The PR receives Global Fund financing directly, and then uses it to 
implement prevention, care and treatment programs or passes it on to other organizations (sub-
recipients) who provide those services. The PR also makes regular requests for additional 
disbursements from the Global Fund based on demonstrated progress towards defined goals and 
objectives. 
Since the Global Fund does not have staff at country level, it contracts firms to act as “Local 
Fund Agents” (LFAs) to monitor implementation. LFAs are responsible for providing 
recommendations to the Secretariat on the capacity of the PRs and on the soundness of regular 
requests for the disbursement of funds and reports submitted by PRs.  
 
PERFORMANCE-BASED FUNDING (PBF) AND DECISION-MAKING AT THE GLOBAL FUND 
PBF is at the heart of The Global Fund’s operating model. The application of PBF to grant 
management is the most praised contribution of The Global Fund to the field.  Many organizations 
have now adopted this approach as part of their operating model.  
PBF is not a new concept; it was developed in the 1970s in the education sector. It has 
gained a lot of popularity recently and it is now being employed by several aid and grant 
organizations as a way to increase the accountability, efficiency and effectiveness of funded 
programs and services. At The Global Fund, PBF is used as a decision-making tool for disbursement. 
As a result, funds are released incrementally based on demonstrated results measured against 
targets. The grants receive a rating at each disbursement period. 
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Figure 2 depicts the Global Fund operating model. It makes an explicit link between PBF and 
funding, both for grantees and The Global Fund.  
Figure 2.2. The Global Fund operating model 
 
Raise it: The first past of the Global Fun mission is to raise funds to  
 maintain the high levels of funding for the three diseases. 
Invest it:  The funding raised is channelled through grants to 144  
countries. 
Prove it: The achievements of grant activities are measured against  
performance indicators and the results are used for on-going funding decisions.  
The proven performance of Global Fund grants is critical to rising additional  
funding from donors. 
The concept of PBF is present in every process of the Global Fund Secretariat. First, the 
grants are provided with initial funding recommendations based on the quality of their applications. 
The Technical Review Panel (TRP) assesses each application and makes funding recommendations 
based on the technical quality of the proposals. In order to receive the tranches of funding every 
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semester or quarter, the grant needs to demonstrate results against defined performance targets. 
Subsequent financing (for the last 3 years of the grant) can be attained by undergoing an in-depth 
review of the performance of the grant in terms of results achieved, value-for-money and efficient 
management.  
Targets proposed by grantees are negotiated with the Global Fund, thereby ensuring they 
are appropriate to the national context and local program realities. Performance-based funding at 
the Global Fund provides a platform for grants to demonstrate that they can convert financing into 
results, enabling further funds to be committed to the programs fighting AIDS, Tuberculosis and 
Malaria. 
The goal of the PBF framework at the Global Fund is to link funding to the achievement of 
objectives and targets; to ensure that money is spent on delivering services for people in need; and, 
to provide a tool for grant oversight and monitoring by the Global Fund Secretariat. 
Although the PBF model is being implemented by several international health and 
development organizations, it continues to raise concerns that it may penalize poorer countries and 
may not be flexible enough to strengthen health systems. Data from several articles on PBF 
implementation in countries show that it can be a powerful incentive to scale up implementation of 
programs. However, caution is required to ensure that indicators and targets set are controlled by 
countries2.  
In the Global Fund’s performance-based funding model, financing is therefore not only 
linked to the achievement of indicator results but also the overall management of grants. 
Performance-based funding supports decisions based on a comprehensive and transparent 
assessment of program performance which also includes grant management, contextual challenges 
                                                        
2
 The Global Fund to Fight AIDS, Tuberculosis and Malaria (2009). 
www.theglobalfund.org/documents/performance/Performance_PerformanceBasedFunding_Brochure_en/ - Text Version 
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and, ultimately, impact on the fight against the three diseases. The guiding principle of the PBF 
framework is to promote results-based decisions at all levels (Global Fund Secretariat, Country 
Coordinating Mechanism, program implementers) that will allow for acceleration of  
implementation,  investment in capacity strengthening, identification of efficiencies/savings and 
reallocation of funds not used to other grants. 
PBF guides the decision for the amount of funding at every period of a grant. Most grants 
receive funding every quarter. High performing grants tend to receive funding every 6 months. The 
PBF funding decisions are based on increasingly comprehensive information on the grant 
achievement against set targets and higher-level evidence of the success of the programs and their 
impact on the three diseases. The new methodology adopted in 2008 links overall achievement 
against set targets as well as management issues with an indicative disbursement range. It impacts 
not only every disbursement of a grant but the amount of funding committed for Phase 2 (last three 
years of the grant) 
The new Global Fund’s evaluation of program performance is based primarily on results and 
outcomes and is summarize in the table below. 
Table 2.3. The Global Fund Evaluation of Performance 
Elements of Performance 
Evaluation 
Examples 
Programmatic results The achievement of output indicator results vs. targets (for 
example, the number of people on antiretroviral treatment, the 
number of people on DOTS (the internationally recognized 
standard of treatment for Tuberculosis), te number of 
insecticide-treated bed nets (ITNs) distributed).  
 
Achievement of 
Outcomes/impact 
The achievement of long-term outcome and impact results 
related to the Millennium Development Goals (for example, 
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indicators percentage of people infected with HIV, TB case detection and 
treatment success rates, mortality rates among children  
younger than five years, etc).  
 
Program Management The overall management of the grant, including challenges, if 
any, in the areas of: (1) monitoring and evaluation, (2) 
procurement of health commodities, (3) financial management, 
and (4) governance (for example, poor data  
quality, procurement delays, ineligible expenditures, etc).  
 
Financial Performance Analysis of the program expenditures vs. budgets, including 
breakdowns per program area in order to link financial 
performance with programmatic results. 
 
External Factors Only considered in exceptional cases when severe and 
unexpected changes in the external environment (e.g. natural 
disaster, civil unrest, etc.) have had a material  
negative impact on program implementation.  
 
 
In 2008 the Global Fund rolled out a new methodology to ensure that the PB funding 
decisions are consistent across the regions of the world and are more objective. This new 
methodology comprises two major steps: 
1st Step - Assigning a performance rating 
The performance rating of a grant is based on 1) the overall progress achieved against time-
bound targets for key output indicators; and 2) an assessment of management performance 
(notably in the areas of M&E, financial management and systems, pharmaceutical and health 
products management, and program management). The programmatic achievements are the 
primary factor in determining the grant performance rating; however this initial rating based on 
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programmatic performance may be downgraded due to critical management issues (e.g. poor data 
quality, procurement delays and ineligible expenditures). 
Table 2.4. Assigment of Performance Rating for Global Fund grants 
Grant rating Performance Category Progress against targets 
A1 Exceeds expectations >100% 
A2 Meets expectations 100-90% 
B1 Adequate 60-89% 
B2 
Inadequate but potential 
 demonstrated 
30-59% 
C Unacceptable <30% 
 
At the time of grant renewals, the performance rating of a grant may be upgraded if there is 
documented evidence of impact towards the goals of the program. Impact is defined strictly by 
changes in incidence, prevalence and mortality. 
2nd Step - Deciding on a disbursement amount 
Each performance rating category (A1, A2, B1, B2, C) has an indicative disbursement range, 
calculated in order to ensure the relationship between results achieved and funds disbursed by the 
Global Fund. These disbursement ranges are, nevertheless, only indicative and serve as a starting 
point for the disbursement decision. Ultimately, the final disbursement amount is based on: 1) 
overall grant performance; 2) contextual factors (force majeure, political and civil issues, etc.); 3) 
real budget needs in the context of spending ability and (4) actions needed to address identified 
weaknesses in management capacity. 
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TRANSFORMATIONS AT THE GLOBAL FUND 
The Global Fund was set up as a unique global public/private partnership, often referred to 
as the ‘new multilaterals’, dedicated to attracting and disbursing additional resources to prevent and 
treat HIV/AIDS, Tuberculosis and Malaria. This partnership between governments, civil society, the 
private sector and affected communities represents a new approach to international health 
financing. Since its creation in 2002, The Global Fund has become the dominant financier of 
programs to fight AIDS, Tuberculosis and Malaria, contributing to improved impact and cost-
effectiveness of interventions in the three diseases and mobilizing additional financial support to the 
health sector in general.  
Despite its achievements and relevance for international health, the Global Fund’s model 
and achievements were called into question in 2011 when an article on corruption and misuse of 
funds disbursed by the Global Fund to countries was picked up by several newspapers3. Although 
the article was written as a “revelation” of the results of the Global Fund Inspector General’s work, 
all the reports and findings had been previously published on the Global Fund website. 
The publication of this article was the spark that ignited a crisis that culminated with a loss 
of confidence by donors and the international community and resulted in the withdraw of pledges 
for funding from the Scandinavian countries, Germany, Netherlands, Japan and some private 
organizations. The reputational damage seemed very severe at the time and the entire operational 
model of the Global Fund was being called into question.  
In order to address the crisis and restore donors’ confidence, The Board of the Global Fund 
appointed a High-Level Independent Panel (hereafter referred to as the High-Level Panel) with the 
mandate to assess the organization’s fiduciary controls, to offer recommendations to solve 
systematic problems in grant selection and oversight, to advise on risk mitigation and to contribute 
                                                        
3
 Heilpein, J. (2011). Fraud plagues Global Fund for Health. Associated Press, 23 January 2011. 
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to the development of a new strategy for the Global Fund.  The High-Level Panel was chaired by the 
Honarable Michael O. Lewis (former Governor and Secretary of Health and Human Serives) and His 
Excellency Festus Mogae (former President of the Republic of Botswana)4. 
The High-Level Panel conducted an extensive review of published and unpublished 
documentation of the Global Fund as well as interviews and field missions to follow the financing 
from the Secretariat down to the country level and to beneficiaries. The High-Panel acknowledges 
that the crisis was fuelled by a combination of economic distress among donors and the reports 
from the Office of the Inspector General.  
Overall, the High-Level Panel’s recommendations urged the Board and Secretariat to adjust 
to the new economic, technological and epidemiologic realities in order to transition from an 
organization responding to an emergency to a financing institution that is geared towards a 
sustainable response. The transition was envisioned to position the organization to provide 
maximum accountability, comprehensive risk management, efficiency and value for money. The 
High-Level Panel pointed out that three new trends are forcing the Global Fund to change: a new 
austerity environment, demand for accountability from donors and the international community 
and innovations in Medicine, Public Health and technologies. 
The Global Fund was created to respond to the emergency posed by the three diseases with 
the mandate to leverage and disburse large amounts of funding to countries to significantly impact 
the fight against the diseases. The sense of emergency and drive to provide treatment ‘at any cost’ 
formed the culture and modus-operandis of the organization. The rapid growth of the organization 
                                                        
4
 The High-Level Panel was also composed by the following members:  
Ms. Zeinab Bashir El Bakri (Director of the Delivery Unit in the Office of His Highness The Prime Minister of Kuwait and Vice 
President for Sector Operations at the African Development Bank); Mr. Gabriel Jaramillo (Chairman Emeritus of the Board 
of Sovereign Bank in the United States and Special Advisor to the Office of the Special Envoy for Malaria of the United 
Nations Secretry-General); The Honorable Norbert Hauser (Vice President of Federal Court of Auditors in Germany and 
Chairman of the Panel of External Auditors of the United Nations; The Honorable Barry O’Keefe (Justice for the Supreme 
Court of New South Wales, Australia);Mr. Claude Rubinowicz (Chief Executive of Agency for Public Intangibles of France 
and Inspector General of Finance in the French Ministry Economy, Finance and Industry). 
    40 
and the results achieved require the organization to shift from emergency response to sustainability 
and fiduciary responsibility.  
In addition, the economic crisis that still grips major industrial economies has significantly 
reduced the unprecedented outpouring of financial resources to international health. As a result, 
the Global Fund is transitioning from an era of expansion to consolidation. During 2011, the financial 
outlook of the organization raised serious concerns to future and on-going grants.   
The reports from the Office of Inspector General on fraud and misuse of grant funding 
combined with the new economic scenario contributed to the decline of donors’ confidence. More 
than ever, international organizations are required to present accurate data on their programs and 
results while ensuring cost-effectiveness and safeguarding of investments. Consequently, the Global 
Fund must review its fiduciary controls and accountability mechanisms to anchor the transition from 
emergency, 
By assessing the factors that led The Global Fund to a crisis and the way the organization 
responded to it provided invaluable insights into limitations of the Global Fund model and how it 
should be adapted to face the new realities aforementioned. The final report highlights that the 
organization made very few strategic and operational decisions based on risk and that its 
bureaucracy provided a false sense of security while oversight was actually inadequate in detecting 
and preventing fraud and misuse of grant money.  
The recommendations of the final report released in September 2011 and adopted by the 
Board require major changes in the way the Global Fund conducts its business and manages its 
grants. The High-Level Panel found that the Global Fund needs to focus much more on its core 
business of managing grants to save and protect lives. It recommends improving financial and Board 
oversight, simplifying grant application processes, and putting in place a robust risk management 
framework.  
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In order to preserve the efficiency of the Global Fund model, the High-Level Panel argues 
that the organization must become more targeted and move away from a one-model fits-all 
approach. For example, they suggest the Global Fund should assess disease burden and 
implementation risks, prioritizing funding and channelling it to countries and programs that show 
the most need and will therefore have the greatest impact.  
In contrast to an investment bank, the Global Fund cannot deny funding countries that 
present a high risk for corruption. However, the organization cannot accept any degree of misuse of 
funding in any of its programs and it requires that robust system of accountability and fiduciary 
control is implemented in all recipients’ countries. In addition, it is important that the responsibility 
for the effective use of grant money does not lie only with the Global Fund but also with national 
governments and local actors (i.e. civil society and private sector organizations).  
The recommendations from the High-Level Panel were adopted by the Board and the 
Secretariat started making them operational.  In addition to requiring extensive changes in how the 
Global Fund operates, the recommendation also calls for a change in the mentality of the 
organization as well as the implementers and partners. 
Table 2.5. Recommendations from the High Level Independent Panel  
Recommendations Follow-Up Actions 
I. Turn the page from emergency 
to sustainable response 
- No Amnesty for fraud but focus oversight on more recent 
rounds of grants 
- Strengthen the relationship between the Secretariat and 
the Inspector General 
 
II. Declare a doctrine of risk and 
manage to it 
- Adopt a new risk management framework 
- Redefine “country ownership” 
-Apply the risk-management framework to the existing 
portfolio 
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III. Strengthen internal 
governance 
- Focus the Global Fund’s Board on management, strategy 
and risk-management 
- Re-purpose the committees: investment, audit and 
finance committees 
- Create an executive staff to support the Global Fund 
Board 
 
IV. Streamline the grant approval 
process 
- Institute a two-stage grant process 
- Apply risk-differentiated grant processes and 
requirements 
 
V. Empower middle-
management’s decision-making 
- Establish a Chief Risk officer 
- Align the staffing pattern to bolster grant-management 
- Empower the Fund Portfolio Managers 
- Streamline and expand the country teams 
- Reinforce the executive management team 
- Leverage the investments in the Local Fund Agents 
- Define and clarify the role and responsibilities of external 
auditors 
 
VI.Get serious about results - Measure outcomes, not inputs 
- Focus on quality and value, rather than quantity 
- Consolidate the reform agenda 
 
 
The immediate endorsement and operationalization of the High-Level Panel’s 
recommendations in September 2011 has had a positive impact in restoring donors’ confidence in 
the Global Fund and improving the financial outlook of the organization. As early as May 2012, the 
Global Fund estimated to have secured more than $1.6 billion in additional funding for 2012-14 
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period. This was a result of commitments from several donors that had withheld or cancelled their 
contributions in 2011 as well as strategic decisions made by the Board that freed up funds to be 
invested in countries where there is the most pressing demand. 
The recommendation from the High Level Panel and the key decisions at the 2011 Board 
Meeting led to an extensive restructuring of the organization in 2012. The restructuring affected all 
levels of the organizations: from policies to operational procedures to managerial structure and 
even the number of staff. The Board appoint Mr. Gabriel Jaramillo, a former banker specializing in 
the merger of institutions, who was part of the High Level Panel, to implement the restructuring 
rapidly. 
Despite a turbulent 2012, punctuated by lay-offs, a suspension of round of funding and a 
revision of policies and procedures, The Global Fund finds itself now in a stronger position under the 
leadership of Mr. Mark Dybul, former Executive Director of PEPFAR. The early announcements on 
funding pledges indicate that the donors’ confidence in the organization has been restored. 
The recommendations from the High Level Panel and the results of several assessments and 
discussions with partners, led to the reformulation of the funding model. At the time of finalization 
of this study, the Global Fund is testing and making final adjustments in order to launch it in 2014. 
 
ABSORPTIVE CAPACITY OF GLOBAL FUND GRANTS 
The findings of the Literature Review identified several factors that are associated (both 
positively and negatively) with absorptive capacity. These factors can be divided into four main 
categories: 
- Macro-economic and social 
- Institutional and Policy 
- Technical and Managerial 
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- Operational (related to donors’ practices) 
The table below details the factors identified in each category and summarizes the Literature Review 
findings related to the effect onto absorptive capacity. 
Table 2.6. Factors Associated with Absorptive Capacity as per Literature Review  
Category of Factors 
Associated with 
Absorptive Capavity 
Examples of Factors Impact on Absorptive Capacity 
Macro-Economic and 
Social  
 
Level of Development The majority of authors5 agree 
that low and lower middle income 
countries exbiht a higher 
absorption capacity. Exceptions 
are noted for countries that are 
not politically stable.  
External finanacing 
External and internal funding 
for health  
Political Stability Political stability and democracy 
are highlighthed as contributing 
factors for high absorptive 
capacity. 
Diseases Burden Authors point6 out that high 
diseases burden have a spill-over 
effect that reduces the capacity of 
systems (infrastructure, 
managerial, technical) and the 
availability of Human Resources to 
cope with implementation of 
grant.  
Institutional and Policy Governance The findings of the Literature 
Review7 are consistent in pointing 
out good governanace, respect for 
Rule of Law 
Human Rights and Rights of 
                                                        
5
 Cypher and Deitz (1997); Easterly (1997); Moreira (2005);Moyo (2010); Rist (1997) 
6
 Burnside and Dollar (2000); Clems et at (2004); Collier and Dollar (2003); Hansen and Tarp (2000, 2001); 
7
  Lancaster (1999); Monkam (1998); Mooney and Houston (2004); Ostrom et al (2001) 
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Minorities rule of Law, Human Rights and 
Rights of Minority as contributing 
factors for higher absorptive 
capacity.  
Strong bureaucracy and systems 
are also key for optimizing 
absorptive capacity. 
Level of Bureacracy 
Technical and Managerial  Human resources capacity Although the number of studies on 
this category is reduced, authors8 
tend to agree on the importance 
of componenet Human Resources 
and adequadate systems to cope 
with technical and managerial 
requirements for implementing 
grants and external funding. 
Type of grant/program 
Number of grants/programs 
Operational Number of donor 
organizations 
Authors9 agree that some level of 
external funding and presence of 
some of donors have a positive 
impact on absorptive capacity. 
However, if the external fubnding 
becomes too high, it poses 
threaths to local economy and 
bring new challenges. Additionally, 
the lack of coordination among 
donors can have a detrimental 
effect on absorptive capacity.  
Level of coordination among 
donors 
Number of separate reporting  
requirement  
 
                                                        
8  Monkam (1998); Ostrom et al (2001) 
9
 De Rezio (2005); Diarra (2010) ; Leandro et al (2010), Pederson (2001). 
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The factors listed in the table above are not exhaustive and represent the most common 
factors identified in the Literature Review. Based on these factors, the indepedent variables for this 
study were selected: 
Table 2.7. Factors Associated with Absorptive Capacity and Selection of Independent Variables 
Category of Factors 
Associated with 
Absorptive Capavity 
Examples of Factors Independent Variables 
Macro-Economic and 
Social  
 
Level of Development Human Development Index 
External finanacing Direct Health Assistance 
External and internal funding 
for health  
Direct Heath Asssitance per 
Disability-Adjusted Year 
Political Stability Governanace and Risk Index 
Diseases Burden Diseases Burden  
Institutional and Policy Governance Governanace and Risk Index 
Rule of Law 
Human Rights and Rights of 
Minorities 
Level of Bureacracy 
Technical and Managerial  Human resources capacity Number of grants managed by 
Principal RecipientType of grant 
componenet (HIV/AIDS, 
Tuberculosis and Malaria 
Type of grant/program 
Number of grants/programs 
Operational Number of donor 
organizations 
Direct Heath Asssitance per 
Disability-Adjusted Year 
Level of coordination among 
donors 
Number of separate reporting  
requirement  
    47 
 CHAPTER 3: METHODOLOGY 
THEORETICAL AND CONCEPTUAL FRAMEWORK 
The literature review of absorptive capacity in development assistance programs and health 
related programs demonstrate the complexity of this concept and its many interconnections. The 
literature points out that absorptive capacity of aid is influenced, in different degrees, by several 
factors but mainly by the level of governance, degree of corruption, amount of aid received, number 
of donors in vertical projects, the strength of implementing institution and the development rate  of 
the recipient country.  
The goal of this study is to explore the concept of absorptive capacity of health programs by 
focusing on the absorptive capacity for Global Fund grants. It examines to which degree the factors 
found to be associated with absorptive capacity in the literature review influence the absorptive 
capacity of The Global Fund grants. Based on the findings of the Literature Review, representative 
factors from the four main categories were selected to be used in this study.  
This study proposes to use qualitative comparative analysis (QCA), a comparative case-
oriented research approach and technique developed by Charles Ragin in the 1980’s and 1990’s. At 
the general level, it is an approach that allows for a “dialogue between ideas and evidence” (Ragin, 
1987, p. 164) and aims at developing a “synthetic strategy that integrates the best features on the 
case-oriented approach with the best features of the variable-oriented approach (Ragin, 1987, p. 
84). 
QCA is often referred to as a method that is half-way between the quantitative and 
qualitative approach. Rihoux (2003) points out that QCA has the key strengths of a qualitative 
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method as it is case-sensitive and it adopts a concept of causality that leaves room for complexity.  
These are very important as QCA is mostly used to study macrosocial or mesosocial phenomena 
such as revolutions, policy processes and social change.  
QCA strategy focuses on ‘multiple conjunctural causation’, in other words on observed 
phenomenon caused by a combination of factors. Moreover, several different combinations can 
produce the same outcome and, depending on the context, a given condition may have a different 
impact on the outcome. In conclusion, QCA assumes that there are different casual paths to the 
same outcome, which makes it an increasingly popular choice for research in social and political 
sciences. 
QCA also includes some key qualities of the quantitative approach (De Meur and Rihoux 
2002). As a technique, QCA is based on the formal logic of Boolean algebra which allows researchers 
to study a small to medium number of cases and to subsequently derive generalizations. As each 
case is reduced to a set of variables, the research can be replicated, which is an advantage not found 
in the case studies approach often used in Social and Political Sciences. Another key quality of the 
quantitative approach is the ability to identify causal regularities that can be expressed with the 
fewest possible conditions.  
As a result, QCA techniques allow for the development of explanatory models on the basis 
of a systematic comparisons between variables. In summary, QCA interprets cases as a combination 
of attributes and each case is coded for having membership in a set of causal conditions. The 
information is summarized in a truth table that is then reduced, by application of Boolean logic, to 
necessary and sufficient conditions and their possible combinations. 
In 2000 Ragin extended the QCA methodology to a larger number of cases and to values as 
well as dichotomous variables. This became known as the ‘fuzzy-set’ approach (hereafter referred as 
fQCA). It is a method to analyse how casual conditions can combine to produce outcomes of 
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interests. In this method, causality is assumed to be complex as it is rarely the result of one cause 
but rather a result of the interaction of several causes. Moreover, there are several possible 
combinations of the causes which result in an outcome of interest (Weiner 2011). Ragin (2000) 
refers to ‘multiple pathways’ that can achieve the same outcome. 
 fQCA analyzes the relationships between the causes  and explores the complexity of 
phenomenon by applying Boolean algebra and algorithms, which allows for the logical reduction to 
the minimum interaction of causes that achieve the outcome.  
This analysis is possible because in fQCA the set membership of causes is no longer 
restricted to binary values (as it is in the original QCA) but can be refined and calibrated. For 
example, in the original QCA a variable could only be assigned two values to membership of set: 0= 
out, 1= in. The application of fuzzy-set allows the researcher to apply different thresholds: 0=out, 
0.50=cross-over point and 1=in. 
Although the application of fuzzy sets brought additional flexibility and sophistication to the 
method, the use of the inclusion algorithm (Ragin,C.  et al. 2003) circumvents the creation of a truth 
table and forfeits some analytical properties. In order to address this, Ragin (2005) introduced a new 
Truth Table algorithm that was implemented in fs/QCA software, which is used to analyse the data 
of this study. Additionally, the latest version of this software allows the additional calculation of 
consistency and coverage scores. 
Fuzzy-set can also be regarded as a response to critiques of the limitations of crisp set 
analysis. Rhioux (2006) points out that although fuzzy set is usually seen as an expansion of the 
original QCA, they are quite different methods.  Fuzzy-set is suited for large numbers of cases and 
geared more towards the quantitative approach, as the starting point is no longer in the individual 
case but in the variables and generalizations. 
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The use of fQCA is a relevant approach for this study as it holds the potential to provide a 
unique set of tools to compare similarities and differences among cases and identify structural 
conditions which precede the outcome of grant absorptivity. fQCA is also the appropriate choice of 
method as it allows for the identification of different paths to the selected outcomes. 
The fQCA techniques of Boolean algebra allowed this study to present comparisons of 
variables separately and jointly. Based on the results, this study aims to contribute to the debate on 
absorptive capacity within a framework that builds on a review of the literature, discussion of 
concept and evidence from Global Fund grant implementation.  
 
OBJECTIVES, HYPOTHESIS AND OUTCOMES OF INTEREST 
This study explores the concept of absorptive capacity of programs in health by focusing 
specifically on the absorptive capacity for Global Fund grants. Based on the findings of the literature 
review, the main hypothesis of this study is that absorptive capacity for Global Fund grants 
(dependent variable) is influenced by the level of governance and risk, the overall level of funding 
for health, the type of implementer, grant disease type, round of funding, the number of grants 
managed and the development and burden of diseases in the recipient country (independent 
variables). 
This study also investigates the effect of each of the factors mentioned above to the level of 
funding absorption. These factors are analysed individually and in different combinations. 
In order to examine the data, this study has selected two outcomes of interest: low and high 
absorptive capacity. The main outcome of interest is low absorptive capacity for Global Fund grants. 
The hyphothesis associated with this outcome is that low absorptive capacity is influenced by high 
risk, low governance, low development and high disease burden, low assistance to health and high 
number of grants managed by implementer.  
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The alternative outcome is associated with the hypothesis that high absorptive capacity is 
influenced by low risk, high governanace, high development and low disease burden, high assistance 
to health and low number of grants managed by implementer.  
 The table below summarized the key information on this study’s hypothesis and outcomes 
of interests. 
Table 3.1. Study’s Hypothesis and Outcomes of Interest 
Summary of Study’s Hypothesis and Outcomes of Interest 
Hypothesis Absorptive Capacity for Global Fund grants (dependent variable) is 
influenced by the level of governance and risk, the overall level of 
funding for health, the type of implementer, grant disease type, 
round of funding, the number of grants managed and the 
development and  burden of diseases in the recipient country 
(independent variables) 
 
Main Outcome of 
Interest 
Low absorptive capacity is influenced by high risk, low governance, 
low development and high disease burden, low assistance to health 
and high number of grants managed by implementer 
 
Alternative Outcome of 
Interest 
High absorptive capacity is influenced by low risk, high governanace, 
high development and low disease burden, high assistance to health 
and low number of grants managed by implementer 
 
 
 
STUDY DATA 
Criteria for inclusion in study 
As of December 2012, The Global Fund has approved 10 Rounds of Funding for grants for 
HIV/AIDS, Tuberculosis and Malaria. In Round 8 and 10, grants in Health System Strengthening were 
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also recommended for funding. At each Round, the Board approves grants based on the TRP review 
of its technical matters and the Secretariat negotiates each grant before signing with the principal 
recipient.  Grants are, in principle, for 5 years, with an initial commitment of 2 years, known as 
Phase 1. At the end of year 2, grants undergo an evaluation process at the Secretariat to assess the 
funding for the remaining 3 years, a period known as Phase 2.  
At the start of Phase 1 and Phase 2, The Global Fund commits a certain amount of funding 
that corresponds to the grant budget. This amount is then disbursed in quarterly or biannual 
tranches. At the time of each disbursement, the Secretariat evaluates the programmatic results and 
the financial performance and makes adjustments to the amount to be disbursed based on 
performance.  This contributes to a flexible implementation of activities, as the expenditure of 
budget can be accelerated or reduced to better suit the implementation capacity of the Principal 
Recipient and the context of country. However, the time for implementation is set to a maximum of 
5 years; therefore, the recipient can only access the funding during the grant period. A maximum six 
month extension is provided in exceptional circumstances (i.e civil war, natural disasters etc). 
This study examines a set of data that consists of all Global Fund grants that completed the 
Phase 1 (first 2 years of funding) and Phase 2 (total of 5 years of funding) by 31 December 2011. For 
this study, only grants for HIV/AIDS, Tuberculosis and Malaria will be considered. The number of 
Health System Strengthening (HSS) grants is very small. The majority of grants have not yet 
completed Phase 1 of funding (only Round 8 and Round 10 offered the opportunity for HSS grants). 
As of 31 December 2011, the total number of grants to be included in this study is 664 Phase 
1 grants and 321 Phase 2 grants. The complete file on The Global Fund grants, even the ones that 
have come to an end, with information on the recipient country, round of funding, component 
(disease), total amount approved, total lifetime budget, Principal Recipient, date of grant agreement 
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signature, program start date, date of Phase 2 agreement, Phase 2 start date and program end date 
is available at the organization’s website10. 
The information on program start date and program end date were used as the criteria for 
selection of grants to be included in the first data set (grants that completed Phase 1) and grants for 
the second data set (grants that completed Phase 1 and Phase 2). The Appendix 1 depicts the table 
with the all the grants to be included in this study with key information on country, round, type of 
implementer, amount budgeted and amount disbursed.  
Operationalization of terms: Dependent Variable  
The main hypothesis of this study is that absorptive capacity for Global Fund grants 
(dependent variable) is influenced by the level of governance and risk, the overall level of funding 
for health, the type of implementer, grant component, round of funding, the number of grants 
managed and the burden of diseases in the recipient country (independent variables). This study 
investigates the effect of the independent variables on the outcome (dependent variable) 
individually and in combination. 
As reviewed in the literature, absorptive capacity can be defined as “the ability of the public 
sector to design, disburse, coordinate, control, and monitor public spending”. This coordination is 
both vertical (between central and local governments) and horizontal (between line ministries at 
any given level). The question is whether governments or even institutions such as health ministries 
have the capacity to manage a large increase in real expenditures beyond usual trend” (Gottret, P; 
Schieber, G.; 2006 p. 239). Therefore, the definition of the concept can be understood in terms of 
the capacity of recipient to benefit from aid funding and operationalized in terms of how much of 
                                                        
10
 File entitled ‘ Grants in detail’  can be downloaded from http://portfolio.theglobalfund.org/en/Downloads/Index 
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committed funding the recipient was able to spend. The Global Fund grants each have its own 
budget that is approved by the Secretariat to ensure that goals and objectives can be met. 
The variable absorptive capacity is calculated for each grant included in the study data using 
the following formula: 
 
 
 
 
 
 
The Appendix 2 and 3 depict the absorption capacity rate for all countries that received 
Global Fund grants and are included in the data set for this study. 
Operationalization of terms: Independent Variable 
This study has 7 independent variables: 
(I) Level of Governance and Risk; 
(II) Level of disease burden; 
(III) Development assistance for health (DAH) per disability-adjusted life year (DALY); 
(IV) Number of grants managed by implementer (Principal Recipient); 
(V) Round of funding; 
(VI) Type of implementer (Principal Recipient); and, 
(VII) Component of grant 
 The underlying hypothesis is that absorption capacity of Global Fund grants is influenced, in 
different degrees, by the independent variables: overall governance, the overall level of funding for 
health, the level of development, the type of implementer, grant component, round of funding (year 
Absortive Capacity Rate equals: 
Cumulative amount spent at the end of period (Phase 1 or 
Phase 2 of funding) x 100/ Total amount approved for the 
period (Phase 1 or Phase 2 of funding). 
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that grant was awarded) and the burden of disease in the recipient country. Four of these broad 
categories (governance and risk, funding for health, burden of disease and number of grants) are 
measured by a number of separate indicators that refine the measurement and potentially identify a 
pattern of relation in the data set. The remaining variables (grant component, round of funding and 
type of implementer) are measured in separate data sets and are compared with the main overall 
data. 
Independent Variable 1: Governance and Risk 
The definition and operationalization of the independent variables uses the same criteria as 
identified in articles in the literature review.  In order to measure the level of governance in the 
recipient country, this study adopts the same formula used by the High-Level Independent Review 
Panel11 to assess the risk of The Global Fund’s portfolio. The formula adopted is composed of 6 
indicators:   
- (i) Total financing received from the Global Fund,  
- (ii) Aggregated transparency rating,  
- (iii) Recent national elections,  
- (iv) Additional safeguards policy,  
- (v) Evidence of misappropriation,  
- (vi) Previous suspension or termination of grant. 
(i) Total financing received from The Global Fund:  This is measured as the ceiling of the 
Board approved grants for each country. This study also adopts the division into 
quartiles used by the High-Level Panel: 
 
                                                        
11
 The High-Level Independent Review Panel was created by The Global Fund Executive Director in March 2011 after the 
reports of misappropriation of grant funding. The Panel was chaired by President of Botswana Festus Mogae and former 
U.S. Health and Human Services Secretary Michael O. Leavitt. The panel assessed the Global Fund’s current practices in 
financial oversight and implementation and published on 19 September 2011 its report.  The report can be accessed at 
http://www.theglobalfund.org/en/highlevelpanel/ 
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   Category 1: US$ 0-40 million; 
   Category 2: US$ 41-100 million; 
   Category 3: 101-400 million, and; 
   Category 4: over US$ 400 million 
(ii) Aggregated Transparency Rating: This measure is a combination of the rating system of 
Transparency International and, when applicable, the Ibrahim Index score for African countries. The 
Corruption Perceptions Index (CPI) ranks countries according to the perception of corruption in the 
public sector. The CPI is an aggregate indicator that combines different sources of information about 
corruption based on different assessments and business opinion surveys carried out by independent 
institutions. It captures information about the administrative and political aspects of corruption, 
such as bribery of public officials, kickbacks in public procurement, embezzlement of public funds, 
and information on the strength and effectiveness of public sector anti-corruption efforts.  
According to Transparency International, perceptions of corruption have proven to be a 
reliable estimate of existing corruption.  
For African countries, the governance measure also includes the Ibrahim Foundation Index 
that aims to estimate a broad measure of governance. In addition to public perception of 
corruption, this index also measures investments in social sectors like education and health. 
For the 52 countries where the Ibrahim Foundation Index is available, the aggregated 
transparency rating is calculated using the following formula: 
(2010 Transparency International ranking) X 5+ (2010 Ibrahim Index score)/6 
 
For all the other countries, the following formula is applied:  
(2010 Transparency International ranking) X 5/6 
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(iii) Recent National Elections: The Independent High Level Panel states that national elections can 
serve as occasions for misappropriation of money for partisan or wrongful purposes. In order to take 
this factor in to account, the event of national elections in 2010 or 2011, is added to the overall 
rating on governance. 
(iv) Additional Safeguards Policy (ASP): This is a Global Fund policy in place since the first Round of 
funding that reserves the right for the organization to acknowledge serious risks to grants. After a 
detailed review, the Secretariat can decide to apply ASP to a country to safeguard its investments as 
it allows the Global Fund to decide on the institution to manage the funding (Principal Recipient). 
Countries where political instability is rampant or Governments do not abide to internationally 
recognized rules of law are put under ASP policy. Examples of countries currently under ASP policy 
are North Korea, Burma, Haiti and Iran. 
(v) Evidence of Misappropriation of Global Fund grant funding: In cases of evidence of 
misappropriation of grant funding identified by the Office of the Inspector General, countries 
receive a score for this indicator. This will increase the risk (and lower the governance) rating. 
(vi) Previous Suspensions and Termination of Grants, or Change in PR: In cases of gross 
mismanagement of a grant and failure in implementation activities as approved in the grant 
proposal, the Secretariat can suspend the funding. This is a temporary freeze of additional funding 
and it allows the Country Coordinating Mechanism (CCM) and the Principal Recipient to take 
corrective measures and respond to the Secretariat concerns. The decision to suspend funding is 
reviewed after an agreed period of time and it can be reversed if the Secretariat has evidence that 
corrective measures have been properly implemented. In cases when the measures are not 
correctly implemented, the solutions offered do not ease the Secretariat’s concerns or there is gross 
misappropriation and misuse of funding, the Global Fund can terminate a grant (i.e. cease all 
funding with no possibility to reverse the decision).  
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In specific conditions, as identified in the Global Fund’s policies, the Secretariat can request 
the CCM to change the Principal Recipient. In this case, the funding is resumed once a new entity is 
put in place to manage grant funding. 
These measures are applied only in extreme situations and after wide consultation; 
therefore, it serves as an indication of governance level in the country. If a country has had any of 
these measures applied to their grants, the measure for this indicator is included in the overall 
rating. 
The total risk adjusted score, as used by the Independent High Level Panel, to determine the 
level of governance and risk in a country is as follows: 
 
 
 
 
 
 
The Appendix 4 depicts the overall governance and risk score for every country that 
received Global Fund funding and is included in the data set for this study. 
Independent Variable 2: Burden of Diseases and Development process 
In order to capture the information on how much a country is affected by the three diseases 
and by its development process, the Independent High Level Panel created a burden formula that 
combines 2 measures: (i) the Human Development Index as a measure of the development and (ii) 
measure used by the Global Fund Board to assess the burden of the 3 diseases on countries. 
(i) Human Development Index (HDI): HDI is a composite statistic that provides a ranking for 
countries based on the level of human development. It measures development through an array of 
Total Governanace and Risk score equals: 
(Global Fund financing) x (Aggregated Transparency Rating) x (1.25 of national 
elections were held in 2010 or 2011) X (3 if Additional Safeguards Policy is in 
place) X (3 if there is evidence of misappropriation of funds) X (1.5, 2, 2.5, 3 or 
3.5 depending on number of incidents related to previous grants)  
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indicators on health, education, literacy and economy. In order to calculate these dimensions of HDI, 
a separate index is calculated for each based on the raw data. This is then put into a formula with 
minimum and maximum values to create an index. The HDI for each country is then calculated as an 
average of different measures.  
The HDI measures are broken into quartiles: very high human development, high human 
development, medium human development and low human development. This study adopts the 
same methodology as the Independent High Level Panel and assigns the quartiles the ratings of 2, 4, 
6 and 8. 
(ii) Burden of Diseases: On its Twenty-Third Meeting, The Global Fund Board endorsed a new 
methodology for quantifying the burden of the three diseases that is now used as the basis of the 
eligibility and prioritization criteria for funding.  
The burden of HIV is measured by HIV prevalence in general and at-risk populations. The 
burden of TB is measured by a combination of the TB notification rate per 100,000 people and 
countries listed by WHO as high-burden countries. The burden of Malaria is calculated as a 
combination of mortality per 1000 at risk of Malaria, the morbidity rate and the contribution to 
global deaths attributable to Malaria. The Appendix 5 lists the indicators and threshold values for 
the classification. 
The Independent High Level Panel used the same calculations as the Global Fund Board and 
assigned the ratings of 2, 4, 6 and 8 for the quartiles. 
The formula used to assess the burden of a country is as follows: 
 
 
 
 
Total Development and Disease Burden score equals: 
(2010 Human Development Index ranking) + (Global Fund Malaria 
score) + (Global Fund AIDS score) + (Global Fund Tuberculosis score)  
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The Appendix 5 contains the development and disease burden score for countries that are 
included in the data set of this study. 
Independent Variable 3: Development assistance for health (DAH)  
per disability-adjusted life year (DALY) 
 
Considering the current debate in the literature on the merits and potential benefits of 
external funding, this study includes a comparative measure of development assistance for health 
(DAH). The Institute for Health Metrics and Evaluation of the University of Washington compiled 
data on donation and spending on health across the world and publish an annual report that shows 
intricate relationships between assistance to health and health spending. 
DAH comes from many different sources, like national treasuries, private donors, loan 
repayment, etc. These funds then flow through several channels, like United Nations agencies, 
bilateral government agencies, non-governmental organizations, development banks and a myriad 
of foundations. The measurement of DAH is further complicated by the fact that channels of 
assistance often transfer funding to each other and sometimes, implement programs directly.  
Although DAH generally goes to impoverished areas and countries with the largest disease 
burden, the literature shows that a growing number of countries receive DAH for political, economic 
and security interests. There are also cases of a few countries that receive a disproportionally high 
amount of DAH and are nicknamed “donor darling”.  In order to contextualize the financial amounts 
of DAH, this study uses the measurement of DAH per disability-adjusted year (DALY), a measure of 
years lost to premature death and disability. This recent measurement is used by the Institute for 
Health Metrics and Evaluation to assess how much DAH a country is getting relative to its health 
needs.  
The latest data on DAH per disability-adjusted year (DALY) for countries around the world is 
available in Appendix 6.  
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While the first three independent variables are given for a country, the following fours 
variables are grant-specific. In cases where the same country has more than one grant, each grant 
will have its own set of data. The use of this set of variables is designed to add complexity to the 
data set which might contribute for the emergence of connections between variables. 
Independent Variable 4: Round of Funding 
The Global Fund offers funding in Rounds. Until the last Round (10), these were offered 
annually. This year (2011) is the first time that a Round for funding is not being offered on an annual 
basis. The grants included in this study are from Round 1 to Round 8 of funding. This variable of the 
timing of grants is important as the countries, the Secretariat, other organizations and even the 
international market for medicines and health products has changed over the years. 
The data will be analysed for each Phase (Phase 1 and 2) and for each round of funding 
separately.  Appendix 7 shows the data on this variable for all grants included in this study.  
Independent Variable 5: Type of Principal Recipient (PR) 
 The Global Fund grants can be managed by a different number of institutions. This study 
classifies the PRs as Government (i.e. Ministry of Health or any Governmental institution), 
International Organizations (i.e. UNDP, UNICEF) and Non-Governmental Organization, which also 
includes private sector organizations.  
As all categorical independent variables in this study, Phase 1 and Phase 2 data will be 
analysed per type of PR separately.  Appendix 7 shows the data on this variable for all grants 
included in this study.  
Independent Variable 6: Grant component (type of disease) 
 The Global Fund grants to fight against HIV/AIDS, Tuberculosis and Malaria constitute the 
data of this study and these three diseases are key variables to understand if and to what extent 
they influence the absorption capacity. The assumption is that the implementations of programs for 
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each of these diseases face challenges that are specific to the resources, facilities and support 
dedicated to each disease.  
As all categorical independent variables in this study, Phase 1 and Phase 2 data will be 
analysed per type of disease separately.  Appendix 7 shows the data on this variable for all grants 
included in this study.  
Independent Variable 7: Number of Grants managed by PR 
 The Global Fund grants are complex and require specific management and technical skills in 
several areas, like Finance, Monitoring and Evaluation, and Procurement.  It is assumed that a higher 
number of grants to be managed by the same PR will bring additional complexities; therefore the 
number of grants managed by the PR is considered a variable that might influence absorption 
capacity. 
For this study the PRs will be divided into the following categories: 
PRs that manage 1 or 2 grants; 
PRs that manage 3 grants;  
PRs that manage 4 or more grants; 
 Appendix 7 shows the data on this variable for all grants included in this study. The table 
below summarizes the definitions of variables included in this study. 
Table 3.2. Variables: Definition and Formulas 
Depent Variable Definition and Composition Formula Applied  
Absorptive Capacity “The ability of the public sector to 
design, disburse, coordinate, control 
and monitor public spending” 
(Gottret and Schieber, 2006). 
Cumulative amount spent at 
the end of period (Phase 1 or 
Phase 2 of funding) x 100/ Total 
amount approved for the 
period (Phase 1 or Phase 2 of 
funding). 
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Independent 
Variables 
Definitions and Compositions 
Formulas Applied (if 
applicable) 
Governance and Risk - Total financing received from the 
Global Fund 
- Aggregated transparency rating 
- Recent national elections 
- Additional safeguards policy 
-Evidence of misappropriation 
-Previous suspension or termination 
(Global Fund financing) x 
(Aggregated Transparency 
Rating) x (1.25 of national 
elections were held in 2010 or 
2011) X (3 if Additional 
Safeguards Policy is in place) X 
(3 if there is evidence of 
misappropriation of funds) X 
(1.5, 2, 2.5, 3 or 3.5 depending 
on number of incidents related 
to previous grants)  
 
Burden of Disseases 
and Development 
Process 
- Human Development Index 
- Measure of prevalence in general 
and at-risk populations for HIV/AIDS, 
Tuberculosis and Malaria 
(2010 Human Development 
Index ranking) + (Global Fund 
Malaria score) + (Global Fund 
AIDS score) + (Global Fund 
Tuberculosis score)  
 
Overall Funding for 
Health  
- Development Assistance for Health 
(DAH) 
- Disability-Adjusted Life Year (DAH) 
 
DAH/DALY 
Round of Funding - Round of Funding measures goes from 1 to 10 and refers to year that 
grant was awarded 
 
Type of Principal 
Recipient (PR) 
- Governement  
- Civil Society 
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- International Organizations 
 
Grant Component  - HIV/AIDS 
- Tuberculosis 
- Malaria 
 
Number of Grants 
managed by Principal 
Recipient  (PR) 
Categories: 
-1 or 2 grants 
- 3 grants 
- 4 or more grants 
 
DATA ANALYSIS 
This study uses secondary data available at public websites. The analysis of the data using 
fQCA will first involve six broad steps as described by Ragin (2006): 
(i) Identification of outcomes of interest; 
(ii) Identification of set of causal conditions; 
(iii) Calibration of measures of outcome and causal conditions; 
(iv) Construction of data matrix; 
(v) Logical Reduction, and; 
(vi) Application of Algorithm based on Boolean algebra 
Step 1: Identification of outcomes of interest 
This study explores the concept of absorptive capacity of aid programs in health by focusing 
on the absorptive capacity for Global Fund grants. Based on the findings of the literature review, the 
main hypothesis of this study is that the absorptive capacity for Global Fund grants (dependent 
variable) is influenced by the level of governance, the overall level of funding for health, the level of 
development, the type of implementer, round of funding, grant disease and the development and 
disease burden in the recipient country (independent variables). 
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The budgets proposed by the countries are reviewed by the Local Fund Agent and The 
Global Fund Secretariat with the objective of identifying the maximum number of efficiency savings. 
At the Phase 2 review, the budget is also adjusted according to the Phase 1 programmatic and 
financial performance. It is clear that the approved budget will undergo reviews at several levels to 
insure that it is streamlined and cost-effective as possible. 
The hypothesis for the main outcome of interest is that low absorptive capacity of grants is 
influenced by high risk, low governance, high disease burden, low assistance to health and high 
number of grants managed by the same Principal Recipient. 
This study has an alternative outcome of interest, high absorptive capacity of grants. The 
data collected was also reviewed to check how high absorptive capacity is influenced by low risk, 
high governance, low disease burden, high assistance to health and low number of grants managed 
by the same Principal. 
Step 2: Identification of set of causal conditions 
Causal conditions are defined as the factors that are expected to contribute to the outcome. 
The causal conditions for this study were selected based on the literature review and they are the 
independent variables described in the previous section:  
(i) Level of Governance and Risk; 
(ii) Level of disease burden and development; 
(iii) Government contribution to health; 
(iv) Round of funding; 
(v) Type of implementer (Principal Recipient); 
(vi) Component of grant (grant disease), and; 
(vii) Number of grants managed by implementer 
Step 3: Calibration of measures of outcome and causal conditions 
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Based on the findings of the literature review, the values of the outcome and causal 
conditions were transformed from continuous variables into set membership scores. This process 
was not applied to categorical variables of grant component (type of disease), round of funding and 
type of implementer. 
This study  adopted the direct assignment process, which is by far the most common 
method used in fQCA, and it uses a judge to provide numerical membership value based on 
expertise (Verkuile, J. 2005). For this study, the researcher provided the membership values based 
on her knowledge of literature on aid and expertise on Global Fund grants. The data included in this 
study was analysed for each variable and disaggregated to allow the researcher to observe trends as 
well as finer details. Key measurements like average, maximum and minimum values, mode and 
standard variation were applied to the entire data set as well as disaggregated data for each 
variable. 
Based on this analysis, the researcher proposed calibration values for the membership 
scores that were then discussed informally with Fund Portfolio Managers covering different regional 
portfolios at the Grant Management Division of the Global Fund. 
The membership scores have 3 values: full membership (1), full non-membership (0) and the 
cross-over point (0.5). As part of the software program, the data analysis uses the cross-over point 
as an anchor and, based on interval given by upper and lower limits set by the full membership and 
full non-membership, the values are then  re-scaled. The scores were then assigned the 
corresponding algorithms from 0 to 1. 
The data set of this study encompasses data on 664 Phase 1 grants and 321 Phase 2 grants. 
It also includes data on 125 countries that are recipients of Global Fund grants. The data on 
absorptive capacity was first reviewed separately for each Phase of grant implementation and then 
it was disaggregated per Round (1 to 8), grant component (HIV/AIDS, Tuberculosis or Malaria) and 
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type of Principal Recipient (Government, Civil Society, Private Sector and International 
Organizations). 
Dependent Variable: Absorptive Capacity 
The key measurements (i.e. average, maximum and minimum values, mode and standard 
deviation) for this variable was obtained for the full data set for Phase 1 and Phase 2, as well as a 
subset of data for grant component, type of PR and round of funding.  The following table (table 3.1) 
depicts the key findings of the preliminary analysis that guided the calibration of membership scores 
to Absorptive Capacity. The measurements were shared with the group of Fund Portfolio Managers 
that collaborated with the researcher. 
Table 3.3.  Key measurements of Dependent Variable (Absorptive Capacity) 
Absorptive 
Capacity per data set  
Average 
Maximum 
Value 
Minimum 
Value 
Standard 
Deviation 
Mode 
   
P
h
as
e
  Phase 1 96.23 100 20.97 11.28 100 
Phase 2 90.83 100 0 20.76 100 
G
ra
n
t 
C
o
m
p
o
n
e
n
t 
Phase 1 HIV 95.78 100 21.40 12.44 100 
Phase 2 HIV 91.51 100 0 21.67 100 
Phase 1 TB 96.48 100 31.70 10.42 100 
Phase 2 TB 89.67 100 0 21.91 100 
Phase 1 Malaria 96.19 100 20.97 10.18 100 
Phase 2 Malaria 91.63 100 0 17.86 100 
Ty
p
e 
o
f 
P
R
 
Phase 1 Gov. PR 96.27 100 21.40 11.25 100 
Phase 2 Gov. PR 88.91 100 0 24.07 100 
Phase 1 C.S. PR 96.06 100 20.97 11.51 100 
Phase 2 C.S. PR 95.94 100 57.44 8.79 100 
Phase 1 I.O. PR 95.98 100 54.48 11.66 100 
Phase 2 I.O. PR 90.41 100 0 19.43 100 
  R
o
u
n
d
 
o
f 
Fu
n
d
in
g Phase 1 Round 1 99.24 100 56.46 5.44 100 
Phase 2 Round 1 95.91 100 0 17.37 100 
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Phase 1 Round 2 99.18 100 48.54 5.64 100 
Phase 2 Round 2 93.42 100 0 18.03 100 
Phase 1 Round 3 100 100 100 0 100 
Phase 2 Round 3 94.65 100 0 15.78 100 
Phase 1 Round 4 100 100 100 0 100 
Phase 2 Round 4 91.44 100 37.17 14.95 100 
Phase 1 Round 5 97.80 100 40.63 10.86 00 
Phase 2 Round 5 84 100 0 24.24 100 
Phase 1 Round 6 98.63 100 67.47 6.05 100 
Phase 2 Round 6 62.76 100 0 24.24 100 
Phase 1 Round 7 96.02 100 56.51 10.47 100 
Phase 1 Round 8 80.03 100 21.40 21.32 100 
 
The preliminary analysis of data on absorptive capacity for Global Fund grants revealed a 
very high absorptive capacity.  The disaggregated data per disease component, type of implementer, 
and per Round also revealed a consistent high absorption capacity with very little variation. The 
Round 8 data shows a decrease in the absorptive capacity, which is possibly linked to the 
streamlining process for disbursements based on performance undertaken by the Global Fund 
Secretariat in 2008/2009. 
Based on the results of this analysis, the researcher proposed cut-off values for the 3 
membership scores (totally in, totally out and cross-over point) to a group of Fund Portfolio 
Manager peers working in different regions across the Grant Management Division of the Global 
Fund Secretariat. This group commented on the proposed values and shared their perspectives on 
the variables of the study, which contributed to the researcher’s final decision on the calibration 
process. 
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The Appendix 2 and 3 present the absorptive capacity values for all grants included in this 
study. Based on the review process, the membership values adopted for this study are displayed in 
the table below.  
Table 3.4. Membership Values adoped for the Outcomes of Interest 
Main outcome of interest: Low absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Absorptive Capacity 90% and below 91% to 97% 98% and above 
Alternative outcome of interest: High absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Absorptive Capacity 98% and above 91% to 97% 90% and below 
 
Independent Variable: Level of Governance and Risk 
The measurements for governance and risk are part of a risk index formulated by the High-
Level Independent Review Panel on Fiduciary Controls and Oversight Mechanisms on the Global 
Fund. This study uses both measures combined in a matrix. 
The calibration of this variable followed the same procedure: analysis of key indicators (i.e. 
average, maximum and minimum values, mode and standard deviation) and discussion with Fund 
Portfolio Managers at the Global Fund. 
As expected, the level of governance and risk shows a great variation among recipient 
countries of Global Fund grants. The values go from 4 to 100, which an average of 42.62 and a mode 
of 8. The standard variation reflects the diversity of recipient countries with a value of 29.79. The 
Appendix 4 contains the values of Governance and Risk for all recipient countries and the table 3.5 
depicts the key measurements for this variable. 
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Table 3.5. Key measurements for Governance and Risk (independent variable)  
Variable Average 
Maximum 
Value 
Minimum 
Value 
Standard 
Deviation 
Mode 
Governance and Risk 42.62 100 4 29.79 8 
 
The calibration process allowed the research to decide on membership scores for the main 
and alternative outcomes of interest. The table below shows membership values adopted for the 
variable on Governance and Risk.  
Table 3.6. Membership Values adoped for Variable on Governanace and Risk 
Main outcome of interest: Low absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Governance and Risk 50 and above 21 to 49 20 and below 
Alternative outcome of interest: High absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Governance and Risk 20 and below 21 to 49 50 and above 
 
Independent Variable: Development and Disease Burden 
The measurements for the development and disease burden in recipient countries used in 
this study are part of an index formulated by the High-Level Independent Review Panel on Fiduciary 
Controls and Oversight Mechanisms on the Global Fund. The index combines the Human 
Development Index with measures of burden of the three diseases (HIV/AIDS, Tuberculosis and 
Malaria) in each country. The measurements of disease burden for recipient countries are available 
in Appendix 5.  
Similarly to the measurements of Governance and Risk, these measurements reflect the 
diversity of countries that are recipients of Global Fund grants. Due to the nature of the grants, the 
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mode of disease burden presents a high value. The table below presents the key measurements 
used in the initial analysis for the calibration of this variable.  
Table 3.7. Key measurements for Development and Disease Burden (independent variable)  
Variable Average 
Maximum 
Value 
Minimum 
Value 
Standard 
Deviation 
Mode 
Development and Diseases 
Burden 
20.08 28 10 4.65 26 
 
The calibration process allowed the researcher to decide on membership scores for the 
main and alternative outcomes of interest. The table below shows membership values adopted for 
variable on Development level and Diseases Burden. 
Table 3.8. Membership Values adoped for Development and Disease Burden (independent variable) 
Main outcome of interest: Low absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Development and Diseases 
Burden  
25  and above 15 to 24 14  and below 
Alternative outcome of interest: High absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Development and Diseases 
Burden 
14  and below 15 to 24 25 and above 
 
Independent Variable: Development assistance for health (DAH) 
per disability-adjusted life year (DALY) 
 
This variable is collected and reported by the Institute for Health Metrics and Evaluation 
with the goal to capture the nuances of assistance for health received by countries in relation to 
their relative needs.  The key measurements for this variable were expected to have a variation 
similar to the variable development and disease burden; however, as highlighted in the Literature 
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Review, the distribution of aid is not only based on needs and burden identified. In general terms, 
the variation for this variable is higher and does not follow the same distribution as disease burden. 
The Appendix 6 presents the values for each recipient country and the table 3.9 presents the key 
measurements used in the initial analysis for the calibration of this variable (table 3.10). 
Table 3.9. Key measurements for DAH per DALY(independent variable)  
Variable Average 
Maximum 
Value 
Minimum 
Value 
Standard 
Deviation 
Mode 
DAH per DALY 18.714 128.293 0.223 23.12 12.95 
 
The amounts reported by the Institute for Heath Metrics and Evaluation depict the variety 
of relative assistance for health received by countries. The calibration process allowed the 
researcher to decide on membership scores as follow: 
Table 3.10. Membership Values adoped for the DAH per DALY (Independent Variable) 
Main outcome of interest: Low absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
DAH per DALY $ 15 and below $16 to $24 $25 and above 
Alternative outcome of interest: High absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
DAH per DALY $25 and above $16 to $24 $ 15 and below 
 
Independent Variable: Number of grants managed by the Principal Recipient 
The result for this variable was capped at 5 grants being simultaneously managed by the 
same PR, as a very small number of PR managed over 5 grants at the same time. The initial review 
pointed out an average of 3 grants per PR but interestingly, the mode is 1, which depicts the great 
variation of institutes and organizations that operate as a PR, especially in later rounds of funding. 
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The table 3.11 presents the key measurements used in the initial analysis for the calibration of this 
variable.  
Table 3.11. Key measurements for Number of grants managed by the Principal Recipient 
(independent variable) 
Variable Average Standard Deviation Mode 
Number of grants managed by Principal 
Recipient 
3 1.51 1 
 
The calibration process allowed the researcher to decide on membership scores as follows: 
Table 3.12. Membership Values adoped for Number of grants managed by the Principal Recipient 
(independent variable) 
Main outcome of interest: Low absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Number of grants managed by 
PR 
More than 04 3 1 and 2 
Alternative outcome of interest: High absorptive capacity for Global Fund grants 
Membership Values  1  0.5 0  
Number of grants managed by 
PR 
1 and 2 3 More than 04 
 
Step 4: Construction of data matrix 
The data matrix is a table known in the QCA field as a truth table and it is composed by 2k 
rows. K corresponds to the number of causal conditions in the study. This table list all logically 
possible combinations of all causal conditions examined.  In order to analyse the data for both Phase 
1 and Phase 2, as well as data per PR, per grant component and round of funding, a total of 28 truth 
tables were created. These tables can be viewed in Appendix  12. 
    74 
Step 5: Logical Reduction 
Logical reduction consists of reducing the number of rows in the data matrix based on the 
minimum number of cases required to achieve the outcome and the minimum consistency level. In 
fQCA, consistency refers to the degree to which cases displaying a given combination of causal 
conditions also display the same outcome.  
At this step, the researcher also performed several sensitivity tests with the membership 
scores to assess how it affects the outcomes. By changing the values for membership set by 5% in 
both directions (i.e. 5% higher and 5% lower than the original value), the researcher was able to 
check for changes in combinations which strengthens the validity of the study.  
Step 6: Application of Algorithm based on Boolean algebra 
This last step allowed for further reduction of rows in the data matrix by eliminating logically 
or arithmetically redundant causal combinations. The analysis to specify the different combinations 
of conditions linked to the outcome was done using the fsQCA software. This software (available for 
free download from http://www.fsqca.com) produces a bottom-up paired comparison. This aims to 
simplify the data that will result in a list of causal combinations linked to the outcome. The software 
identifies the smallest number of combinations that will cover all positive instances of the outcome. 
Considering the large number of cases, this study will consider valid a combination present 
in at least 5 cases. 
Step 7: Counterfactual Analysis 
This step will be performed on combinations that lacked empirical cases. The objective of 
this analysis is to check for redundant conditions and it will only be applied if the steps described 
above do not produce a result that is significant (i.e. same combination for at least 5 cases) or clear 
(if the analysis cannot identify any combinations linked to outcome).  
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Step 8: Alternative Outcome 
This study also investigates the hypothesis that high absorptive capacity is influenced by low 
risk, high governance, low disease burden, high assistance to health and low number of grants 
managed by the same Principal.  
The data was coded and analysed (steps 3 to 7) considering high absorptive capacity 
hypothesis.  
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CHAPTER 4:  ANALYSIS AND DISCUSSION 
This study examines the concept of absorptive capacity of programs in health by focusing on 
the absorptive capacity for Global Fund grants. It explores to which degree the factors found to be 
associated with absorptive capacity in the literature review influence the absorptive capacity of The 
Global Fund grants. As detailed in the previous chapter, this study has two outcome of interest: low 
absorptive capacity (main outcome) and high absorptive capacity (alternative outcome). 
This chapter first presents the descriptive analysis results for grants that completed Phase 1 
and grants that completed Phase 1 and Phase 2. It then presents the results of the fuzzy-set analysis 
for the main and alternative outcomes.  A discussion presents the key findings, the limitations of this 
research, and recommendations for future research. 
 
DESCRIPTIVE ANALYSIS OF PHASE 1 GRANTS 
A total of 664 Phase 1 grants were included in this study. Forty-four percent of these grants 
were in HIV, 28% were in TB and another 28% were in Malaria. Regarding the implementer, 56% of 
all Phase 1 grants were awarded to Government institutions, while 25% were awarded principally to 
civil societies, and 18% were awarded principally to international organizations. 
Out of the 664 grants, 77 or 11.5% of them exhibited low absorption, meaning less than 90% 
of the funds were absorbed. Of the 291 HIV grants made in Phase 1, about 13% exhibited low 
absorption. About the same percentage of Malaria grants made in Phase 1 exhibited low absorption 
(13%); however, a lower percentage of TB grants in Phase 1 exhibited low absorption (9%). In Phase 
1, grants awarded to governments or international organizations exhibited comparable low-
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absorption rates (9% and 7% respectively). By contrast, 17% of Phase 1 grants awarded to civil 
societies exhibited low absorption. 
Regarding Round of Funding, the grants awarded from Round 1 to 5 exhibited very low 
percentages of low absorption that ranges from zero to 2.5%. However, from Round 6 onwards, the 
percentage of low absorptive capacity grants grew significantly: 11.6% in Round 6, 16.8 % in Round 7 
and 63.6% in Round 8. 
 
DESCRIPTIVE ANALYSIS OF PHASE 2 GRANTS 
The Global Fund approves grants for five (5) years of funding, in principle, with an initial 
commitment of two (2) years. The first two years of the grant are referred to as Phase 1. At the end 
of year 2, grants undergo an in-depth evaluation process at the Secretariat to assess its 
programmatic, financial and managerial performance. Based on this internal assessment, the Global 
Fund can make adjustments to implementation structure, the program scope, as well as the 
financial commitment for the next period, refered to as Phase 2. Based on the Phase 1 
programmatic and financial performance, which considers the absorption capacity, the Global Fund 
can reduce the initial approved investment for Phase 2 or recommend strategic changes to the 
program. 
The Phase 2 grants correspond to the grants that completed the 5 year implementation 
period (Phase 1 and Phase 2). It provides a full picture of the absorptive capacity throughout the 
grant life-cycle. However, these are the grants that might have been adjusted for Phase 2, which is 
expected to result in a more uniform outcome of absorptive capacity. The hypothesis is also that the 
absorptive capacity of grants that completed Phase 2 will be less influenced by the variables than 
grants in the Phase 1 data set. 
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A total of 321 Phase 2 grants were included in this study. Forty-five percent of these grants 
were in HIV, 29% were in TB, and 26% were in Malaria. Regarding the implementer, 57% percent 
were awarded principally to governments, 22% were awarded principally to civil societies, and 20% 
were awarded principally to international organizations. Thirteen percent of Phase 2 grants 
exhibited low absorption, meaning that less than 90% of the funds were absorbed.  
Of the 144 HIV grants made in Phase 2, about 12% exhibited low absorption. About the 
same percentage of TB grants and Malaria grants that completed Phase 2 also exhibited low 
absorption (15% and 12% respectively). In Phase 2, grants awarded principally to governments and 
those awarded to international organizations exhibited comparable low-absorption rates (15% and 
17% respectively). By contrast, only 4% of Phase 2 grants awarded to civil societies exhibited low 
absorption. Regarding the Round of Funding, grants from Round 5 onwards exhibited a much higher 
percentage of low absorptive capacity (from 21% to 50%) than grants from previous Rounds (from 
2.8% to 12%). 
 
DESCRIPTIVE COMPARISON OF PHASE 1 AND PHASE 2 GRANTS 
Although there are fewer grants that completed Phase 2 (321) than only Phase 1 (664) that 
were included in this study, the percentages of grants made in HIV, TB, and Malaria were 
comparable in the two Phases. Slightly fewer grants were awarded principally to civil societies in 
Phase 2 compared to Phase 1 (22% versus 25%). Conversely, slightly more grants were awarded 
principally to international organizations (20% versus 18%). In general, though, the percentages of 
grants awarded principally to government, civil society, and international organizations were largely 
comparable across in both phases. This is an expected result as most of the grants transition from 
Phase 1 to Phase 2 without changing the PR. 
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The percentages of HIV grants and Malaria grants that exhibited low absorption were 
comparable across phases (12-13%). A higher percentage of TB grants exhibited low absorption in 
Phase 2 than in Phase 1 (15% versus 9%). Likewise, a higher percentage of grants awarded 
principally to governments exhibited low absorption in Phase 2 than in Phase 1 (15% versus 9%). The 
same pattern held for grants awarded principally to international organizations (17% versus 7%). By 
contrast, a lower percentage of grants awarded principally to civil society exhibited low absorption 
in Phase 2 than in Phase 1 (4% versus 17%).  
In summary, low absorption rates increased across phases for grants awarded principally to 
governments and international organizations, where low absorption rates decreased across phases 
for grants awarded to civil society.  Regarding the Round of Funding, the Phase 2 exhibited 
significant higher percentage of low absorptive capacity from Round 4 onwards.  
 
FUZZY-SET ANALYSIS OF MAIN OUTCOME: LOW ABSORPTIVE CAPACITY 
The main hypothesis of this study is that low absorptive capacity is a function of four causal 
conditions:  high risk/low governance, low Development and high disease burden, low assistance to 
health, and high number of grants managed by the same Principal Recipient (PR). Using fuzzy-set 
qualitative comparative analysis (fsQCA), I sought to determine whether these causal conditions 
individually or in combination with each other result in low absorptive capacity. I performed this 
analysis separately by phase of grant funding (Phase 1 and Phase 2) and, within each phase, by grant 
component (HIV, TB, and Malaria), PR type (Government, Civil Society, and International 
Organization), and funding round (Rounds 1 through 8 for grants that completed Phase 1 and 
Rounds 1 through 7). In total, I performed 28 analyses in which I tested the main hypothesis of this 
study. 
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For each analysis, I constructed a data matrix, known as a truth table, in which each row 
represented one of the 16 logically possible combinations of the four causal conditions examined in 
this study12.  
  I reviewed each truth table and reduced the number of rows based on two criteria. First, I 
reduced the rows to cover 90% of the cases (frequency) as recommended by Ragin (2008). Second, I 
eliminated those rows that did not meet the minimum consistency threshold of .75 by an amount 
greater than could occur by chance alone (Ragin 2008).  
In fsQCA, the term consistency refers to the degree to which cases exhibiting a given 
combination of causal conditions also display the outcome of interest (i.e., low absorptive capacity). 
A row (or combination of causal conditions) had to meet both the minimum frequency and 
minimum consistency criteria in order to be considered for further analysis. In the 28 analyses 
performed, none of the combinations of causal conditions that met the minimum frequency 
threshold was consistently associated with low absorptive capacity. Stated in the language of fsQCA, 
no combination of causal conditions was sufficient to produce low absorptive capacity.  
To check the robustness of these results, I performed two sensitivity tests. In the first test, I 
increased the full-membership, cross-over membership, and full non-membership values for all 
study measures by 5 (5% or 5 units).  In the second, I decreased the full-membership, cross-over 
membership, and full non-membership values for all study measures by 5 (5% or 5 units). The values 
adopted for full-membership, cross-over membership, and full non-membership for all variables for 
the original analysis and these 2 sensitivity tests can be viewed in Appendix 10 and Chapter 3. 
These sensitivity analyses did not yield different results than my original analysis, suggesting 
that the results of my original analysis are robust regarding minor uncertainties in what constitutes 
                                                        
12
 Appendix 11 has an example of a truth table constructed for this study. All truth tables are available upon request. 
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low absorptive capacity, high risk/low governance, low development and high disease burden, low 
assistance to health, and high number of grants. 
Although no combination of causal conditions was sufficient to produce low absorptive 
capacity, two causal conditions appeared to be necessary to produce low absorptive capacity. A 
sufficient relationship exists when an outcome is always or almost always present when a causal 
condition is present (i.e., when X always or almost always results in Y). A necessary relationship 
exists when a causal condition is always or almost always present when an outcome is present (i.e., 
when Y always or almost always occurs when X occurs). Note that a causal condition can be 
necessary but not sufficient. In other words, X might be necessary for Y but does not guarantee Y. 
When a condition necessary but not sufficient relationship, one can observe the condition without 
the outcome (X can occur without Y), but one never or rarely observes the outcome without the 
condition (Y does not occur without X).  
Inspection of the sufficiency-necessity matrix (a table produced in fsQCA that indicates the 
degree of overlapping membership in the set representing the outcome and the individual sets 
representing each of the four causal conditions) suggested that high risk/low governance and low 
development and high disease burden might demonstrate a necessary relationship with low 
absorptive capacity. In a statistical test for necessity, both conditions were highly consistent with the 
outcome of low absorptive capacity, with each exceeding the .75 consistency threshold by an 
amount greater than could be expected by chance alone (.94 and .98 respectively, p < .001).  
In sum, no causal conditions, alone or in combination, were sufficient to produce low 
absorptive capacity for grants. However, two conditions were necessary but not sufficient to 
produce low absorptive capacity. Neither high risk/low governance nor low development and high 
disease burden guarantees a grant will exhibit low absorptive capacity. Nevertheless, almost every 
instance of low absorptive capacity exhibited either or both these conditions.  
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FUZZY-SET ANALYSIS OF ALTERNATIVE OUTCOME: HIGH ABSORPTIVE CAPACITY 
The hypothesis for the alternative outcome of this study is that high absorptive capacity is a 
function of four causal conditions:  low risk/high governance, high development and low disease 
burden, high assistance to health, and low number of grants managed by the same Principal 
Recipient (PR). Using fuzzy-set qualitative comparative analysis (fsQCA), I sought to determine 
whether these causal conditions individually or in combination with each other result in high 
absorptive capacity. I performed this analysis separately by phase of grant funding (Phase 1 and 
Phase 2) and, within each phase, by grant component (HIV, TB, and Malaria), PR type (government, 
civil society, and international organization), and funding round (Rounds 1 through 8 for grants that 
completed Phase 1 and Rounds 1 through 6 for grants that completed Phase 2). In sum, I performed 
28 analyses in which I tested the alternative hypothesis of this study. 
The same methodological steps were applied to determine the relation among the 
independent variables and the alternative outcome. Similarly, I constructed the truth tables for each 
of the 28 analysis and then reduced the number of rows to cover 90% of the cases (frequency). The 
threshold of 0.75 was first applied to the data but as it yielded a very high number of combinations, I 
adjusted to 0.80 as recommended by Ragin (2008). The table 4.1 depicts the frequency threshold 
and number of cases retained for each data set of Phase 1 and Phase 2. 
Table 4.1 Truth Table Analysis: frequency threshold and number of cases retained per data set 
Data Set 
Truth Table Threshold 
Frequency cut-off Number of cases retained 
All Phase 1 Grants 91% 465 
Phase 1 HIV Grants 91% 227 
Phase 1 TB Grants 91% 132 
Phase 1 Malaria Grants 91% 131 
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Phase 1 Gov PR 92% 304 
Phase 1 CS PR 89% 112 
Phase 1 IO PR 90% 67 
Phase 1 Round 1 96% 48 
Phase 1 Round 2 91% 68 
Phase 1 Round 3  92% 50 
Phase 1 Round 4 96% 55 
Phase 1 Round 5 94% 54 
Phase 1 Round 6 91% 76 
Phase 1 Round 7 90% 65 
Phase 1 Round 8 90% 75 
All Phase 2 Grants 89% 222 
Phase 2 HIV Grants 90% 105 
Phase 2 TB Grants 91% 64 
Phase 2 Malaria Grants 91% 57 
Phase 2 Gov PR 89% 137 
Phase 2 CS PR 90% 37 
Phase 2 IO PR 90% 40 
Phase 2 Round 1 93% 30 
Phase 2 Round 2 92% 50 
Phase 2 Round 3  92% 37 
Phase 2 Round 4 92% 51 
Phase 2 Round 5 90% 39 
Phase 2 Round 6 93% 16 
 
The fsQCA analysis resulted in a series of combinations or causal pathways to the high 
absorption capacity. The combinations are expressed using specific symbols and abbreviations. The 
Table 4.2 depicts such symbols and abbreviations used to present such combinations for both Phase 
1 and Phase 2 results. 
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Table 4.2 Notation used for fQCA results13 
Symbol and Abbreviations Meaning 
~ Negation 
Symbol used to express that not being part of certain group is 
an element in combination to achieve outcome. 
Example: ~burden – Not having high development and low 
diseases burden has a causal pathway to outcome (high 
absorption capacity). Not being part of category of low disease 
burden does not equal to having high disease burden. For 
additional details, please refer to section 3.4 on calibration of 
variables. 
* Union, and 
Symbol used to connect 2 or more elements of a combination 
that lead to outcome. 
Example: assistance to health * number of grants – both 
elements (high assistance to health and small number of 
grants) are part of a pathway to outcome 
Governance/Risk (Gov/risk) This variable is an index that measures several aspects of 
country governance and risks for grant implementation. In the 
context of alternative outcome, this variable refers to high 
governance and low risk.  
Burden of 3 Diseases 
(Burden) 
This variable is also an index that combines measures of the 
burden of the three diseases in a country with the Human 
Development Index (HDI). For the combinations presented in 
this study, this notation refers to low burden of the three 
diseases. For more details on the composition of this index and 
calibration of variable, please refer to chapter 3.  
Assistance to Health 
(Assist. Health) 
This variable measures development assistance to health per 
disability-adjusted life year.  Regarding the alternative 
                                                        
13
 Appendix 12 contains an example of a FsQCA software solution. All solutions are available upon request. 
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outcome, it refers to high development assistance to health per 
disability-adjusted life year. 
Number of Grants 
(No. Grants) 
This variable refers to the number of grants managed by the 
same Principal Recipient. In the context of alternative outcome, 
it refers to low number of grants managed by the same PR. 
 
Phase 1 Result 
The 28 analyses performed on all Phase 1 grants yielded a total of 10 different combinations 
that were sufficient to produce high absorptive capacity. As shown in the table below, many of 
these combinations were found in several of the 28 analyses. The notation for these combinations 
as well as number of times each of them was observed in the results can be viewed in the table 
below. 
Table 4.3 Phase 1 combinations  
Phase 1 Combinations 
Number of times observed in the Phase 1 
results  
~Burden*~Gov/Risk 11 times out of 29 (37.9%) 
~Assist. Health*Gov/Risk*No. Grants 4 times out of 29 (13.7%) 
Assist. Health*~Burden* ~Gov/Risk 3 times out of 29 (10.3%) 
Assist. Health*~Burden*No. Grants 3 times out of 29 (10.3%) 
~Burden*No. Grants 2 times out of 29 (6.8%) 
~Burden*~Gov/Risk*~No. Grants 2 times out of 29 (6.8%) 
Assist. Health*~Burden*No. Grants 1 time out of 29 (3.4%) 
Assist. Health*Burden*Gov/Risk*No. Grants 1 time out of 29 (3.4%) 
~Burden*Gov/Risk* No. Grants 1 time out of 29 (3.4%) 
~Assist. Health*Burden*No. Grants 1 time out of 29 (3.4%) 
 
All of the 10 combinations identified are sufficient for the outcome of high absorptive 
capacity. The most frequent combination (present in 37.9% of the analysis) includes the negation of 
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two conditions that I thought would be consistently associated with high absorptive capacity based 
on the literature review. Contrary to expectations, NOT low disease burden and NOT low risk/high 
governance were consistently associated with high absorptive capacity in the analysis of all Phase 1 
grants together. This combination exhibited high consistency (.92), indicating that nearly all of the 
grants made in Phase 1 that exhibited this combination also exhibited high absorptive capacity. This 
combination also exhibited high coverage, indicating that this combination was a common 
“pathway” for high absorption of Phase 1 grants. 
It is important to note that “NOT low disease burden” does not mean “high disease burden” 
because I defined low disease burden as a score of 14 or less on the index used in this study whereas 
I defined high disease burden in my analysis of the main outcome (above) as a score of 25 or more. 
The same is true for the negation of other conditions examined in the study, such as low risk/high 
governance. “NOT low risk/high governance” does not mean “high risk/low governance.” In set 
relations, the negation or absence of a condition does not imply the affirmation or presence of its 
opposite.  
The combination of NOT low disease burden and NOT low risk/high governance observed in 
the analysis of all Phase 1 grants together was also observed in the sub-analysis of Phase 1 HIV 
grants, Phase 1 TB grants, and Phase 1 Malaria grants. This combination was also observed for 
grants awarded principally to governments. A variation of this combination was observed for grants 
awarded principally to civil society and international organizations. For these two types of principal 
recipients, an additional condition was observed in the combination:  high assistance for health.  
The second most frequent combination represents 13.7% of the results yields NOT high 
assistance for health per disability-adjusted year and high governance and low risk and low number 
of grants gives rise to high absorptive capacity. This result is also very interesting as it shows that 
recipients with not high assistance for health (meaning not many partners and donors supporting 
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the country) but with good governance, few risks and few numbers of grants to manage can attain 
high absorptive capacity. This combination draws attention to the role of assistance to health, which 
not only captures the relative investment in health but also encompasses the gains of the 
partnership between implementers/countries with international donors (i.e. training, job coaching, 
supervision, etc). 
The next two combinations are both ranked third in terms of frequency representing 10.3% 
each of all combinations. The combination high Assistance to Health and NOT low burden and high 
HDI and NOT high governance and low risk is a pathway to high absorptive capacity. This is a very 
interesting result as it combines the variable Assistance to Health (DAH per DALY) with the most 
frequent combination (NOT high disease burden and NOT low risk/high governance). As discussed, 
this dyad alone accounts for 37.5% of the results and it highlights that not low burden and not high 
governance and not low risk not only are not a hindrance to the outcome, but a key element in the 
most frequent recipe for high absorptive capacity.  
The third combination adds the variable of Assistance to Health, which similarly to the 
second combination, stresses the benefits from high level of investment in health as well as the 
resulting partnership fostered between donors and implementers. By joining the third combination 
high Assistance to Health and NOT low disease burden and Not low risk/high governance with the 
most frequent combination (NOT low disease burden and Not low risk/high governance),   one can 
group 48.2% of combinations identified in the results.  
The fourth combination (High Assistance to Health and NOT low disease burden and NOT 
few number of grants) comprises 10.3% of all combinations yielded and can be understood as not 
high Assistance to Health with no low burden and not high HDI with a few number of grants to be 
managed by the same implementer is a recipe for high absorptive capacity. This combination puts in 
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evidence that in a context of not high support to health sector and some burden from the 3 diseases 
and lower HDI, having few grants to manage contributes to a high absorptive capacity. 
This fourth combination (High Assistance to health and NOT low disease burden and few 
grants managed by the same PR) is similar to the second most frequent combination: High 
Assistance to Health and low risk/high governance and few grants managed by the same PR. This 
finding highlights that in countries that have not low burden, not high governance and not low risk 
level, the Assistance to Health (DAH per DALY) plays a crucial role in attaining high absorptive 
capacity.  
Part of the fourth combination forms the fifth combination: NOT low disease burden and 
few numbers of grants managed by the same PR.  This combination was noted twice in the results 
and it accounts for 6.8% of all combination identified. This combination can be read as not low 
burden in combination with few grants to manage and it is a pathway to high absorptive capacity.  
The sixth combination (NOT low disease burden and NOT low risk/high governance and NOT 
few numbers of grants managed by the same PR) also accounts for 6.8% of all combinations 
identified and it can be interpreted as not low burden in combination with not high governance and 
not low risk and not few grants to manage. Although this combination is not as significant as it was 
not observed in many cases, it is relevant to note that high absorptive capacity can be and is 
achieved under such circumstances.  
There are 4 combinations that were noted once in the results and they each account for 
3.4% of the results:  
- High Assistance to Health and NOT low disease burden and few grants  
managed by the same PR; 
-NOT low disease burden and Low risk/high governance and few grants  
managed by the same PR; 
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-NOT High Assistance to Health and low disease burden and few grants  
managed by the same PR; 
-High Assistance to Health and low disease burden and low risk/high governance  
and few grants managed by the same PR 
 Although these combinations were noted only once, they emphasize the complex nature of 
high absorptive capacity and they show additional scenarios and different combinations of the 
variables that can achieve the outcome. 
Phase 2 Results 
The analysis of all Phase 2 grants yielded a total of 9 combinations that were sufficient to 
produce high absorptive capacity. These 9 combinations appear in a total of 20 analyses as each 
analysis yielded a different number of combinations, sometimes repeated. The notation for these 
combinations as well as number of times each of them was observed in the results can be viewed in 
the table below. 
Table 4.4 Phase 2 combinations  
Phase 2 Combinations 
Number of times observed in the Phase 2 
results  
Assist.Health*~Burden*~Gov/Risk*~No.Grants  6 times out of 20 (30%) 
~Assist.Health*~Burden*~Gov/Risk*No.Grants  5 times out of 20 (25%) 
~Burden*~Gov/Risk  2 times out of 20 (10%) 
~Assist. Health*~Burden *No.Grants  2 times out of 20 (10%) 
Assist. Health*~Burden*No.Grants  1 time out of 20 (5%) 
Assist. Health*~Burden*~Gov/Risk 1 time out of 20 (5%) 
*~Burden*~Gov/Risk*~No.Grants  1 time out of 20 (5%) 
~Assist.Health*~Burden*Gov/Risk*~No.Grants  1 time out of 20 (5%) 
~Burden*~Gov/Risk*No.Grants  1 time out of 20 (5%) 
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 Similar to Phase 1, the 20 analysis performed on all Phase 2 grants yielded a total of 9 
causal combinations that are sufficient for high absorptive capacity. The most frequent causal 
combination, observed in 30% of the combinations, includes one of the Phase 1 causal conditions 
(NOT low disease burden and NOT low risk/high governance) combined with high assistance to 
health and NOT few number of grants managed by the same PR. This combination exhibited high 
consistency (.89), indicating that nearly all of the grants that completed Phase 2 that exhibited this 
combination also exhibited high absorptive capacity. This combination also exhibited high coverage, 
indicating that this combination was a common “pathway” for high absorption of Phase 2 grants 
The combination of high Assistance to Health, NOT low disease burden,  NOT low risk/high 
governance and  NOT few number of grants managed by the same PR observed in the analysis of all 
Phase 2  grants was also observed in the sub-analysis of Phase 2  HIV grants, Phase 2 TB grants, and 
Phase 2 Malaria grants.  
The second most frequent combination, observed in 20% of combinations, yields that NOT 
high assistance to health (DAH per DALY), NOT low disease burden and not low HDI together with 
not high governance and low risk and few number of grants result in high absorptive capacity. This 
combination maintains the very frequent dyad, NOT low disease burden and NOT low risk/high 
governance, and confirms the relation between assistance to health and number of grants. On the 
previous combination, high assistance to health combined with not few number of grants managed 
by the same PR were part of the combination to high absorptive capacity; this solution shows that 
the flip side of this relation is also a pathway to the outcome: not high Assistance to health 
combined with few grants to manage. 
These two combinations account for 55% of the results and complement each other and 
while keeping the dyad NOT low disease burden and NOT low risk/high governance constant. They 
also contribute to strengthen the relationship between assistance to health and number of grants.  
    91 
The third and fourth combinations were each observed twice in the results and they 
maintain many of the combinations observed in the previous combinations. The third combination is 
the dyad NOT low disease burden and NOT low risk/high governance that was observed as part of 
the combinations in Phase 2 and was the most frequent combination in Phase 1. The fourth 
combination (High assistance to health and NOT low disease burden and few numbers of grants 
managed by the same PR) contributes to strengthen the relationship between assistance to Health 
and number of grants demonstrated in the paragraphs above. 
The Phase 2 results also yielded 4 more combinations that were each observed once in the 
results: 
- High assistance to health and NOT low disease burden and few numbers of grants  
managed by the same PR; 
- NOT low burden and NOT low risk/high governance and NOT few numbers of grants 
managed by the same PR; 
-NOT High assistance to health and NOT low disease burden and low risk/high governance 
and NOT few numbers of grants managed by the same PR; 
-NOT low disease burden and NOT low risk/high governance and few numbers of grants 
managed by the same PR 
These combinations maintain some of the patterns previously discussed but also present 
some new combinations, which confirm that more than the absence or presence of one or several 
factors, it is the pattern of combinations that yield high absorptive capacity. 
The fuzzy-set analysis for main outcome (low absorptive capacity) revealed that no causal 
combination was sufficient to produce the outcome but 2 factors (High risk/Low governance and 
High disease burden) were necessary conditions for the outcome.  Surprisingly, the fuzzy set analysis 
for the alternative outcome (high absorption capacity) revealed a high number of causal 
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combinations sufficient to produce the outcome (10 for Phase 1 grants and 9 for Phase1 and Phase 2 
grants) but no factor was singled out as a necessary condition for the outcome.   As discussed, a 
sufficient relationship exists when an outcome is always or almost always present when a causal 
condition is present (i.e., when X always or almost always results in Y). A necessary relationship 
exists when a causal condition is always or almost always present when an outcome is present (i.e., 
when Y always or almost always occurs when X occurs). The results for the main outcome (low 
absorptive capacity) show that a causal condition can be necessary but not sufficient. In other 
words, X might be necessary for Y but does not guarantee Y. When a condition is necessary but not 
sufficient, one can observe the condition without the outcome (X can occur without Y), but one 
never or rarely observes the outcome without the condition (Y does not occur without X).  
 
DISCUSSION 
The results of the Comparative Analysis and fQCA identified in this study are powerful and 
surprising. First of all, the results obtained confirm the complex nature of absorptive capacity by 
demonstrating that there are multiple pathways to low and high absorptive capacity. Secondly, the 
results challenge the findings of the Literature Review and this study’s hypothesis for low and high 
absorptive capacity. 
The analysis of Global Fund grants by Phase of implementation (Phase 1 and Phase 2), 
component (HIV/AIDS, TB and Malaria), implementer (Government, Civil Society and International 
Organization) and round of funding (rounds 1 to 8 for grants that completed Phase 1 and rounds 1 
to 6 for grants that completed Phase 2) revealed that there is not a single causal combination that is 
sufficient to yield the outcome of low absorptive capacity. This finding is very important to The 
Global Fund as it shows that there is no single factor or combination of factors that a country or a 
grant recipient might have that will be sufficient to result in low absorption capacity. In other words, 
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even if a country or recipient exhibit what is usually considered in aid literature as very difficult 
conditions for implementation programs and absorption of funds, it does not guarantee it will 
exhibit low absorption capacity. Countries and recipients considered as challenges to the aid 
community have demonstrated that they can have high absorptive capacity for Global Fund grants. 
For the Global Fund, this finding shows that investments can be successful, even in the most difficult 
situations and that there is not fixed set of conditions that guarantee low absorption of investments. 
Another finding that challenges the Literature Review is the 2 causal conditions that are 
necessary (but not sufficient) to yield the outcome of low absorptive capacity: high risk/low 
governance and high disease burden. One can consider these 2 conditions as warning signals but 
they do not guarantee low absorptive capacity. These 2 necessary conditions are actually the flip-
side of this study’s hypothesis and it brings a new dimension to the current discussions on 
absorption of aid. 
These 2 necessary conditions can be understood if we consider that the goal of The Global 
Fund (for the period covered by this study) was to capture and disburse large amounts of financing 
to quickly respond to the growing spread of HIV/AIDS, Tuberculosis and Malaria. At the time of its 
creation, there were large gaps in funding for countries that were severely affected by these 
diseases and countries that faced serious challenges in terms of governance.  Operating differently 
than traditional financial institutions (like International Monetary Fund), the Global Fund allowed 
countries to design their own proposals and as long as the proposal were technically sound and key 
management structures were put in place, their demand could be met. As a result, countries had 
unprecedented access to large amounts of financing for these diseases. 
This study shows that having funding approved does not equal implementation. High 
risk/low governance translates into deficiencies in the macro socio-economic structure as well as 
lack of managerial systems, especially in the public sector, which leads to severe difficulties to 
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implement and report the expenditure of a grant. As any donor, The Global Fund has its reporting 
requirements to ensure that funding is spent according to an agreed work plan and budget.  
Although one would expect high disease burden to be linked to high absorptive capacity, 
this study shows the opposite: high disease burden is a necessary condition to low absorption 
capacity. This finding points out that having a demand for funding does not equal implementation 
and absorption of funding. The association of high risk/low governance and high disease burden 
with low absorptive capacity highlights the importance of systems to roll out programs, manage 
grants and track and report programmatic and financial information. 
The strong association of high disease burden with low absorption capacity led me to reflect 
on countries that are so heavily affected by HIV/AIDS that its systems (health, financial, managerial) 
collapse. An investigation of this hypothesis would require a follow-up study on a few selected 
countries to understand to what extent HIV/AIDS, as well as Tuberculosis and Malaria, can affect the 
structural systems of a country. 
This study also explored the causal combinations associated with high absorptive capacity 
for Global Fund grants. The findings identified in the analysis of high absorptive capacity also 
confirm the complex nature of this concept and challenge the findings of the Literature Review. The 
application of algorithms based on Boolean algebra on Phase 1 and Phase 2 data sets respectively 
yielded 10 and 09 (respectively) different combinations or causal pathways to high absorptive 
capacity. These results confirm the assumption that high absorptive capacity is a complex 
phenomenon to which there are multiple pathways.  This result challenges the rather simplistic view 
that high absorption is linked to a specific factor or a specific combination of factors.  
Although this result does not confirm this study’s hypothesis, it confirms the role of the 
independent variables (governance, risk level, disease burden, assistance to health per disability-
adjusted year and number of grants) in achieving the outcome. It is important to note that the roles 
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these independent variables play are not constant and they change according to the situation. For 
example, in one combination NOT low disease burden might be linked to the outcome but in 
another, it might be low disease burden that is linked to high absorptive capacity. 
Surprisingly, the association of NOT low disease burden and NOT low risk/high governance 
was the most frequent pathway to high absorption capacity for both Phase 1 and Phase 2. These 2 
causal conditions were also observed as part of other combinations with different variables in the 
results for Phase 1 and Phase 2 grants.  
 This finding challenges the literature view that countries need to meet a rigid set of criteria 
to have high absorptive capacity. It shows that some degree of disease burden and some degree of 
systems in place can be a winning combination for high absorptive capacity. We can hypothesis that 
NOT low disease burden would mean that the impact of the diseases make it important for the 
country to receive technical assistance and funding from different partners but not so severe that it 
can cripple the existing systems.  
The combination with NOT low risk/high governance also indicates the need to have some 
degree of systems in place to implement the grants. The combination of these 2 variables seems to 
indicate that high absorption is reached when there is an emergency to address these 3 diseases 
and some systems to ensure the implementation and reporting. Countries in these situations are in 
the best position to receive (and benefit from) technical assistance and funding for specific projects.  
In addition to confirming that all variables are part of causal pathways to the outcome, the 
results also show that the variables acted in different ways. For example, the low burden and not 
low burden were part of pathways to high absorptive capacity. This finding is important as it 
demonstrates that it is the combination of factors that can lead high absorptive capacity and not the 
presence or absence of a single factor. This finding challenges the literature of development 
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assistance by showing that the effect of disease burden on absorptive capacity depends on the 
presence or absence of other conditions. 
It is worth noting that two of the variables, disease burden and number of grants, appear 
more in a certain form. The burden variable appears more frequently as NOT low disease burden 
while the variable number of grants is much more frequent as few number of grants managed by 
the same PR.  These findings highlight that being a country with low burden of the three diseases 
and high HDI is not a very common ingredient in the recipe for high absorptive capacity, which is 
encouraging to the majority of grant recipients. Another popular ingredient for high absorptive 
capacity is having few Global Fund grants to manage, especially when there isn’t a high level of 
national and international investment in health. 
In summary, the results show that there are several pathways to high absorptive capacity, 
which confirms the complex nature of this concept and challenges the literature review by 
demonstrating that high absorptive capacity can be achieved by a multiple of causal combinations. 
Many of these are counter-intuitive (for example NOT low disease burden and NOT low risk/high 
governance) and show that countries and recipients of aid, in the most diverse and difficult 
situations, can benefit from investments and achieve a high absorptive capacity. The fact that 
several combinations were identified was sufficient but not a single variable was identified as a 
necessary condition confirms thete are no ‘fixed-ingredients’ for the recipe of high absorptive 
capacity. 
The supporters of the ‘Big Push’ in the on-going debate around aid would see the results of 
this study as another argument that countries can absorb large amounts of funding, even  under 
difficult circumstance and that there is no single factor can ultimately prevent absorption of funds. 
However, the most important finding relates to the complexity of absorptive capacity. The factors 
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associated with low and high absorptive capacity are not symmetrical and they do not affect 
absorptive capacity in a linear manner.  
The most important outcome of this study is to contribute to move the on-going debate 
beyond a simplistic understanding of absorptive capacity of aid recipients. 
 
IMPORTANCE OF FINDINGS AND FUTURE RESEARCH 
The literature of development aid is vast and it encompasses a multitude of themes and 
issues related to recipient country, donors and the dynamics that arise from this relationship. The 
literature is also complex and it is intertwined with politics abd different economic approaches. 
Despite the large number of articles, there are few empirical studies on development in general and 
even fewer on aid and assistance for health.  
This study contributes to the literature with an empirical study that investigates a large 
quantity of data from hundreds of grants implemented in the last ten years. The importance of this 
study is also related to the on-going debate on the effectiveness of assistance to health and 
development in general. In one side there is a growing number of critics that argue that the failures 
of development aid outweighs its successes; and on the other side, there is a group of authors that 
calls for an increase in aid in order to achieve meaningful and lasting results.  
Absorptive capacity has recently become a very popular term in the literature but many 
articles and studies apply it haphazardly, without clear definitions. This study looks into the 
definition and construction of the concept of absorptive capacity and its operationalization in order 
to measure it and understand how it relates to key variables.    
The findings of this study reveal a new perspective for grant recipients and the Global Fund 
Secretariat on the factors associated with high and low absorptive capacity. Some of these findings, 
as discussed above, are quite surprising and bring some new elements to the field.  
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Additional research is necessary to fully investigate the implication of the findings. New 
studies could focus on each variable and investigate in detail how it affects the absorptive capacity 
of grants. For example, a study on how managerial aspects of PRs or leadership style affect 
absorptive capacity would complement the findings of this study. 
 
STUDY LIMITATIONS 
Although the findings of this study contribute to the literature and bring some new 
interesting perspectives, it has several limitations. First of all, this is a study only on Global Fund 
grants. Although one can use the findings to enlighten a discussion of absorptive capacity in general, 
the results obtained with fQCA are specific to the Global Fund and considering its Performance-
Based Funding model, it might not be easily transferred to programs funded by organizations with a 
different operating model.  
It is important to note that the majority of grants included in this study (88%) exbhited high 
absorptive capacity, which is a reflection of the performance-based funding methodology applied by 
the Global Fund.  Another limitation of this study is that it did not consider how cultural differences 
across regions might affect absorptive capacity. The practices and values of a culture can have a 
significant impact on management style and level of engagement with in-country stakeholders 
(CCMs, PRs, NGOs, donor’s organizations) and staff at the Global Fund. 
Another limitation is due to the methodology used. fQCA brought many advantages to this 
study and it allowed the researcher to analyze a large amount of data and maintain some interesting 
aspects of qualitative research. However, the significance of the findings must be investigated in 
case study methodology to be fully understood. 
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The third limitation of this study arises from the variables selected and the measurements 
used. Although this study had a large number of variables, with several measurements, it cannot be 
considered exhaustive. 
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CHAPTER 5: IMPLICATIONS AND PLAN FOR CHANGE  
The results from this study contribute to the current discussions on countries absorptive 
capacity of additional aid. By analysing the specific data from The Global Fund grants, this study aims at 
contributing to a broader discussion on (1) allocation of additional resources for health and 
development and (2) potential strategies and policies that could improve the absorption capacity of 
recipient countries. 
The findings on the causal conditions that lead to low and high absorptive capacity are specific 
to the Global Fund grants but can be extrapolated to other programs in international health and 
development in general. This section will discuss potential implications of the findings and translate it in 
to concrete recommendations for implementers and the Global Fund Secretariat.  
This study confirms the complex nature of absorptive capacity and it demonstrates that there 
are multiple pathways to low and high absorptive capacity. The findings also confirm that the selected 
variables of governance, risk level, disease burden, assistance to health per disability-adjusted year and 
number of grants all have an impact on the outcome of absorptive capacity.  
My plan for change is based on my reflections on the literature review, the result of this study 
and my experience with donor institutions and grant-making in health. The goal is to outline the key 
changes necessary to improve the grant-making process for the Global Fund and to improve the 
absorptive capacity of recipients of grants. In this plan I describe actions I have already taken as a Fund 
Portfolio Manager, actions I plan to take, and actions I hope to influence others to take. Those actions 
make use of my legitimate, referent power and expert power and they aim to create changes in the 
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grant processes and management for the Global Fund. This plan also includes the changes I would like to 
influence in the countries requesting and receiving grants from the Global Fund. 
 
LEADERSHIP MODEL 
The development of the Plan for Change was challenging as I had to reflect on how to introduce 
changes to an organization and to processes that are undergoing major transformational and 
operational changes.  From early 2012 until now, The Global Fund has initiated the reorganization of the 
Secretariat, changed its funding model and made reforms in the governance, risk management and 
financial systems. As a result, my Plan for Change does not seek to promote new large changes in the 
organization and its processes but rather aims to spot key opportunities for small changes in processes 
that can have a positive impact in grant management. 
This Plan for Change is also challenging as it needs to address the general sense of ‘fatigue’ from 
change in the staff and in grant recipients.  
Based on these considerations, my Plan is based on both Kotter’s  and Lewin’s models of 
change. Both these models focus on change and complement each other. While Lewin’s model focuses 
on main phases of change, Kotter’s model shows the necessary steps to navigate from one phase to the 
next. In addition, the combination of these models helped me focused on how to introduce change to an 
organization and to processes that are already undergoing change.  
Lewin’s model 
Lewin (1947) provided a linear model for a change process. In his model, Lewin observed that 
any living system is always in a state of change, but that the system will tend toward some kind of 
'quasi-stationary equilibrium’. A balance of forces pushing in different directions achieves the 
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equilibrium. The behavior of the system, according to Lewin, can be understood as the combination of 
forces trying to maintain the status quo and forces pushing for change.  
Lewin suggested that weakening the forces that are maintaining the status quo produces less 
tension and resistance than increasing forces for change and that the former is a more effective change 
strategy. Lewin conceived change as a modification of those forces keeping a system’s behaviour stable. 
He designed a three-stage model of change that is known as ‘unfreezing-change-refreeze’. 
Table 5.1. Lewin’s 3-stage Change Model 
Lewin’s 3-Stage Change Model 
Stage 1  
Build motivation to 
change (‘unfreezing’) 
 
This stage requires adding new forces for change or removing of 
some of the existing factors that perpetuate the situation. This 
unfreezing process involves a cognitive redefinition of the situation, 
in which one realizes that previous beliefs are no longer valid and 
that there is an urgent need for change. This stage tends to be the 
most difficult and stressful as people are questioning their ways of 
operating. 
Stage 2  
Implementing changes 
(‘change’) 
 
Lewin described the change as a process that happens when there is 
sufficient dissatisfaction with current conditions and a real desire to 
implement change.  In this stage, the anxieties from Stage 1 dissolve 
and people resolve their uncertainties and start acting in a new way. 
The transition between unfreeze to change takes time as people 
need to internalize the need for change and change their beliefs and 
assumptions.  
 
Stage 3  
Making the change 
permanent 
(‘refreeezing’) 
 
This is the last stage where the new behaviour and culture becomes 
habitual, which includes developing a new self-concepts and beliefs 
about the processes. During this stage the changes are internalized 
or institutionalized, meaning they are incorporated to an  everyday 
way of operating. This stage brings a new sense of stability that 
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makes people comfortable with the new ways of working 
 
Kotter’s model 
Kotter’s model focuses on how to implement transformational change. Kotter (1995) reflected 
on failed efforts to change organizations and on most common mistakes made by leaders. Based on 
these reflections, he devised a model of 8 key sequential steps for successful implementation of change: 
(i) Establish a sense of urgency 
(ii) Create a guiding coalition 
(iii) Develop a vision and strategy  
(iv) Communicate the change vision  
(v) Empower broad-based action  
(vi) Generate short-term wins  
(vii) Consolidate gains and expand the change  
(viii)  Anchor the new approaches in the culture  
Kotter’s model is compatible with Lewin’s model and it seems like an extension of it. Kotter’s 8 
steps for change are well aligned with Lewin’s model: 
Table 5.2 Alignment of Kotter’s and Lewin’s models for change 
Lewin’s  3-stage Model Kotter’s 8-step Model 
Unfreeze 1. Establish a sense of urgency 
2. Create a guiding coalition 
3. Develop a vision and strategy  
4. Communicate the change vision  
Change 5. Empower broad-based action  
6. Generate short-term wins  
7. Consolidate gains and expand the change  
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Refreeze 8. Anchor the new approaches in the culture  
 
 
THE GLOBAL FUND: APPLICATION OF THE MODELS 
The combination of the two models has the advantage to understand that change in a complex 
organization can consist of several processes taking place at the same time. Change can also happen at 
different speed within the organization, creating additional tension and imbalance between 
departments. In the case of The Global Fund, the profound changes started with a crisis at the end of 
2011, a restructuring process in 2012, and changes of values, cultures and operating models in 2013. As 
the organization prepares to launch its new funding model and its new internal process in early 2014, 
important changes in culture continue to take place. During the same period of time, the financial crisis 
has deeply affected donors, recipient countries, and organizations, compounding an already complex 
situation. 
From the perspective of the Grant Management Division, the change is experienced both at the 
Secretariat level as well as at the recipient level, where the countries, implementers and partners are 
also suffering the effect of the changes. 
By applying the models to the current situation of The Global Fund, I identify that the 
organization is still ‘in the change’ phase, as defined by Lewin but on step number 7 ‘consolidate gains 
and expand change’, as defined by Kotter. The table 5.1 shows that this step is the last one in the 
‘change’ phase before the organization can ‘refreeze’ and achieve its new equilibrium. At this moment, 
the organization is testing and starting to apply the new procedures and ways of working internally and 
with recipients and countries. The players (i.e. staff, implementers and partners) have accepted the 
need for change and are moving towards acceptance. At the same time, additional changes remain to be 
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concluded as the implementation processes have brought new issues and questions that were not 
anticipated.  
Overall, this current moment at the end of the ‘change’ phase is very favourable for the 
implementation of my Plan for Change. The players are more receptive for exploring different ways of 
working and further expanding the change. The most important consideration is to propose specific 
changes that bring a rapid benefit, so the players can perceive it as an extension of the on-going process 
and not a new transformation of the systems. As a result, my Plan for Change is based on a few 
recommendations that can be easily implemented in the current scenario and have the advantage of 
promoting changes that will help to consolidate the organization.   
 
THE PLAYERS, RESOURCES AND PARAMETERS 
The players in this plan are people and organizations across the several regions and countries 
that are involved in managing and implementing The Global Fund grants. Among the stakeholders are 
the people that work with the managing and implementation of the grants, as well as the people 
charged with the evaluation and review of key programmatic and financial data. In a broader context, 
the stakeholders involve other organizations that support the health sector and the overall development 
of countries. 
The resources I rely on are already in the systems, both at the level of donor organizations and 
implementers. I also rely on my own power to change and affect the processes in my capacity as a Fund 
Portfolio Manager at The Global Fund. 
The policy parameters include the legal agreements in place between The Global Fund and the 
recipients of funding, the policies and operational procedures that regulate the management of grants, 
and the operational manuals and policies used for the management of health programs in recipient 
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countries. The policy parameters take into account the changes currently being implemented and 
planned for the new funding model. It also includes the broad international and regional commitments 
of donors and recipient countries and organizations to combat specific diseases, improve the health 
sector and increase spending in health. 
This plan is based on 3 recommendations that have the objective to bring together the players, 
the resources, and parameters to create actions that will catalyze efforts and improve efficacy of aid. 
The on-going changes are likely to foster openness toward my recommendations and will help these 
very timely actions evolve into a large transformation of existing systems into a more efficient and 
responsive one. 
 
KEY RECOMMENDATIONS 
The recommendations presented below are based on my reflections on the results of this study. 
Working in an international organization and reviewing the literature on aid, I was very much surprised 
by the results. It forced me to ponder the changes taking place in the last few years and the lively debate 
over aid.  During this process, I had to examine my understanding of risks associated with programs, 
financing of grants as well as my tools for assessment and evaluation of successful implementation.  
My Plan for Change contains 3 key recommendations that summarize the main direction of the 
changes proposed. Each recommendation contains several actions that I plan to implement as a Fund 
Portfolio Manager, as a staff member and part of the development community. 
Recommendation 1: Redefine your risks 
 This study confirms the complex nature of absorptive capacity and it demonstrates that there 
are multiple pathways to low and high absorptive capacity. The findings also confirm that the selected 
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variables of governance, risk level, disease burden, assistance to health per disability-adjusted year and 
number of grants all have an impact on the outcome of absorptive capacity.  
The analysis of Global Fund grants by Phase of implementation (Phase 1 and Phase 2), 
component (HIV/AIDS, TB and Malaria), implementer (Government, Civil Society and International 
Organization) and round of funding (rounds 1 to 8 for grants that completed Phase 1 and rounds 1 to 6 
for grants that completed Phase 2) revealed that there is not a single causal combination or single 
variable that is sufficient to yield the outcome of low absorptive capacity. 
This finding challenges part of the Literature Review that establishes key factors that are 
strongly associated with low absorptive capacity of aid investments. It is widely accepted that macro-
economic issues and level of development significantly influence the capacity of a country to absorb 
funding. This study shows that, at least for Global Fund grants, there are  2 causal conditions that are 
necessary (but not sufficient) to yield the outcome of low absorptive capacity: high risk/low governance 
and high disease burden. These 2 necessary conditions are actually the flip-side of the study’s 
hypothesis and the findings of the Literature Review.  
This result led to the recommendation to redefine the risks associated with absorptive capacity. 
This recommendation can be broken down into 3 major goals and several actions that are part of the 
Plan for Change: 
i.  Goal: To ensure that the revised concept of risk is based on a combination model 
The revision of the concept and understanding of risks is a key part of the transformation of The 
Global Fund as an organization. As the new framework is currently being drafted, I will strive to 
disseminate the findings of this study and organize a working group to review and assess the current 
riskframework. The table below details the key actions required to fulfill this goal. 
Table 5.3 Key activities planned to review concept of risk. 
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Goal (i) : To ensure that the revised concept of risk is based on a combination model 
Key Actions  Timelines 
To schedule brown-bag lunches to disseminate study’s results First Quarter 2014 
To draft summary of study’s results to publish in internal 
newsletter 
First Quarter 2014 
To participate in the ‘Risk Framework’ working group and 
contribute to discussions on the model of risk and factors taken 
into account in the Global Fund’s risk model.  
On-going 
To organize one session about the Global Fund risk framework at 
the Regional Meeting for Latin America and Caribbean (LAC) 
Region (8-10 April 2014). This session will last around 4 to 6 hours 
will allow representatives from Ministries of Health, Ministries of 
Finance, CCMs and Principal  Recipients to  discuss how the Risk 
Framework can be adapted to the LAC Region. 
8-10 April 2014 
To draft and disseminate the report from the Regional Meeting 
and request feedback on proposed actions and risk model. The 
feedback will be requested from different groups: NGOs, partners 
organizations, implementers and CCMs. 
April and May 2014 
Based on inputs from the region, to create a pilot risk framework 
for my portfolio. I will implement the revised risk framework for 1 
year and compare changes in management, especially regarding 
disbursement decisions and management actions to be 
implemented.  
From June 2014 to May 
2015 
To share the results from the pilot risk framework with Senior 
Management at the Global Fund (Regional Manager and Division 
Head) 
June and July 2015 
   
ii.  Goal: To ensure that the new risk framework is communicated and implemented by countries 
The results show that there is no single factor, no fixed recipe that leads to low absorptive 
capacity. It is rather a combination of factors that plays out differently in each situation. As a Fund 
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Portfolio Manager, I will ensure that the results of this study and the new framework on risks are shared 
with the countries where I work, as well as the region that I support. The actions described in the table 
below have the potential to ignite important discussions at country-level with Government, Civil Society 
organizations and partners about risk of low absorptive capacity. 
 
Table 5.4 Key activities planned to ensure communication of new risk framework 
Goal (ii): To ensure that the new risk framework is communicated and implemented by 
countries 
Key Actions Timelines 
To  share the report from LAC Regional Meeting with working 
group and senior management at the Global Fund 
June 2014 
To  share the report from LAC Regional Meeting with countries’ 
stakeholders, including Civil Society Organizations and parterns’ 
organizations 
June 2014 
To develop simple tool for country stakeholders to implement and 
monitor new risk framework 
May and June 2014 
To pilot new risk framework in my portfolio during 6 months July to December 2014 
To produce a joint report on the pilot with inputs from country 
stakeholdres and share it with Regional Manager and Division 
Head at the Global Fund 
January and February 2015 
 
iii. Goal: To promote frequent assessments and discussions of findings 
The results show that low absorptive capacity cannot be predicted by a fixed recipe, that it 
arises from a combination of factors that is specific to the grant. In order to address the issue of low 
absorptive capacity, I will promote within The Global Fund and with my counter-parts in countries 
(Government, Civil Society Organizations, Technical Partners and CCMs) the use of frequent assessments 
of bottlenecks and structural issues that is or might be a cause for lower absorption of funding. The 
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actions planned call for a development of a quick assessment tool of bottlenecks associated with 
absorption of funding and engagement with partners in country. 
Table 5.5 Key activities planned to promote frequent assessment of bottlenecks associated with 
absorptive capacity 
Goal (iii): To promote frequent assessments and discussions of findings 
Key Actions  Timelines 
To develop, together with my peers and with contribution from 
partners’ organizations, a simple tool to guide the CCMs and PRs 
to implement quarterly assessment of factors associated with 
absorptive capacity. 
January to March 2014 
To pilot the quarterly assessment in countries of my portfolio for 1 
year. I will participate via teleconference in the quarterly 
discussions around the assessment.  
April 2014 to March 2015 
To evaluate (1) if regular assessment of bottleneck led to early 
identification of issues affecting absorptive capacity and (2) if 
issues could be resolved in a timely manner   
May and June 2015 
To share the results from the pilot with Senior Management at the 
Global Fund (Regional Manager and Division Head) 
July 2015 
To share the pilot results with peers at different teams at the 
Global Fund.  
August to December 2015 
 
iv.  Goal: To support a joint tailored approach 
The practice of frequent assessment and discussions on bottlenecks with all stakeholders will 
contribute to advance the understanding of the combination of factors that have the potential to lower 
absorption of funding. Based on this understanding, I will work with CCM, Government, Civil Society 
Organizations and Technical Partners to coordinate a plan to address and respond to factors identified. 
    111 
I will also discuss with countries planning to apply for additional funding through the new 
funding model how to incorporate such a plan into their request. 
The 2 necessary conditions identified in this study (high risk/low governance and high disease 
burden) are related to the macro issues of a country. The support to build structures, to improve 
governance and to fund the burden caused by diseases are extremely important and these are long-
term strategies and investments. This goal calls for a concentrated effort to address bottlenecks 
associated with low absorptive rate in the context of a grant. 
Table 5.6 Key activities planned to develop joint tailor approach 
Goal (iv): To support a joint tailored approach 
Key Actions Timeline 
To convene a working group with LAC team to discuss the results 
of the pilots on new risk framework and regular assessment of 
bottlenecks implemented in my portfolio. This meeting will guide 
the discussion of the lessons-learned from these 2 projects and 
examine how these could be applied to the LAC regional team. 
August 2015 
To discuss the results with counterparts at Regional Organizations 
(i.e. PAHO, UNAIDS etc) and request their inputs. 
September 2015 
To develop with countries stakeholders of my portfolio a tailored 
approach to guide strategic investments, technical assistance, 
level of Human Resources and training needs. 
October to December 2015 
To share the pilots’ results and the joint tailored approach with 
CCMs and PRs from different regions at their Regional Meetings 
July to December 2015 
 
Recommendation 02: Explore the pathways to high Absorptive Capacity 
The results of this study confirm that high absorptive capacity is a complex phenomenon that 
can be achieved by several combinations of different factors.  Equally important, the results show that 
the independent variables selected for this study (governance and risk, burden of diseases and HDI, 
    112 
development assistance to health per disability-adjust year and number of grants) have a direct impact 
on the absorptive capacity. CCMs, PRs and The Global Fund Secretariat should reflect on these variables, 
their combinations and how they might be affecting the absorptive capacity of their grants.   
Although this study’s hypothesis for the outcome of high absorptive capacity was not validated, 
the results show that the independent variables have, in different combinations, a causal relationship to 
high absorptive capacity. For the CCMs, PRs and Secretariat it is key to understand that the most 
frequent combinations associated with high absorptive capacity are surprisingly different and 
contradictory to the literature, which opens up the discussion on strategies to attain high absorptive 
capacity. 
The most frequent combination identified in the data shows that NOT high disease burden and 
NOT low risk/high governance have a causal relationship with high absorptive capacity. Besides being 
surprising, this finding is very good news to the majority of countries implementing Global Fund grants, 
as it shows that the factor usually associated with low absorptive capacity have in fact, a causal 
relationship with high absorptive capacity.  
The second most frequent combination yields that NOT high assistance for health, low risk/high 
governance and low number of grants give rise to high absorptive capacity. This is also very good news 
for all stakeholders as it shows that recipient countries with not many donors but with good governance 
and few numbers of grants to manage can attain high absorptive capacity.  
The most important finding for CCMs and PRs is that all variables have a causal relation to high 
absorptive capacity but they can combine in different ways to reach the outcome. The results show that 
the variables have an impact on the outcome and that the same variable can have a different impact 
depending on the combination. For example, the low burden and not low burden were part of pathways 
to high absorptive capacity. This finding is important as it puts in evidence that it is the combinations of 
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factors can lead high absorptive capacity and not the presence or absence of a single factor. In 
summary, these findings show that high absorptive capacity is possible to be achieved by CCMs and PRs 
in different combinations, and even in the most challenging environments. 
The results of this study led to the recommendation to explore the multiple pathways to high 
absorptive capacity. This recommendation can be broken down into four goals and several actions that 
are part of the Plan for Change: 
i.  Goal: To map-out examples and best-practices 
Considering the many combinations identified as sufficient for high absorptive capacity, this goal 
calls for more understanding of the combinations observed in current grants. I will work first with my 
counter-parts in countries (i.e. Government, Civil Society Organizations, Technical Partners, CCMs etc) to 
map out the examples of high absorption capacity observed in grants. I will use the same tool described 
in Recommendation 1 Goal (iii) but I will look at the period of highest absorption rate. Similar to the 
process described in the Recommendation 1, I will adopt a participatory approach with contributions 
from different stakeholders. The specific actions planned for this goal as described in the table below. 
Table 5.7 Key activities planned to map out best-practices related to high absorptive capacity 
Goal (i): To map-out examples and best-practices 
Key Actions Timelines 
The tool described in the First Recommendation 1 Goal (iii) will 
also include elements to guide the identification and discussion 
of factors associated with absorptive capacity. 
January to March 2014 
To pilot the quarterly assessment in countries of my portfolio for 
1 year. I will participate via teleconference in the quarterly 
discussions around the assessment. 
April 2014 to March 2015 
To evaluate (1) if regular assessment of factors associated with 
situational high absorptive capacity led to an overall 
May and June 2015 
    114 
improvement of grant absorptive capacity. I will also map out the 
factors and combination of factors associated with high 
absorptive capacity in my portfolio. 
To share the pilot results with Senior Management at the Global 
Fund (Regional Manager and Division Head). 
July 2015 
To share the pilot results with peers at different teams at the 
Global Fund.  
August to December 2015 
 
ii. To promote frequent assessments and discussions of findings 
While the mapping exercise described above focuses on the period with the highest absorption 
rate, this action is to be implemented throughout the entire grant life-cycle. I will promote the frequent 
assessment and discussions (preferably at the CCM level) about absorptive capacity with Government, 
Civil Society Organization and technical partners to refine the understanding of how each factor acts and 
combines with other factors to improve the absorption rate. 
This goal contributes to deepen the understanding of the combinations specific to the realities 
of each country. The actions planned to achieve this goal are drscribed in the table below. 
Table 5.8 Key activities planned to promote frequent assessment of high absorptive capacity examples 
Goal (ii): To promote frequent assessments and discussions of findings 
Key Actions Timeline 
To convene a working group with LAC team to discuss the results 
of the regular assessment of factors associated with high 
absorptive capacity in my portfolio.This meeting will guide the 
discussion of the lessons-learned from this project and examine 
how it can be applied to other portfolios. 
August 2015 
To develop with countries stakeholders of my portfolio a tailored 
tool for regular assessment of absorptive capacity. This tool will 
benefit from the feedback and pilot experience and it would be 
October to December 2015 
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available for other teams at the Global Fund and partners’ 
organization to use it.   
To share the pilots’ results and the revised tool with CCMs and PRs 
from different regions at their Regional Meetings 
July to December 2015 
 
iii. To explore combinations to overcome ‘risk factors’ 
This study shows that countries with the 2 necessary conditions for low absorptive capacity as 
well as countries exhibiting factors traditionally associated with low absorptive capacity can achieve high 
absorption rate. In addition to exploring how the combinations of factors leading to high absorptive 
capacity operate, it is important to understand factors and combinations that can overcome the so-
called ‘risk factors’. 
The actions described below will be implemented in countries in the LAC region that have high 
risk/low governance and high disease burden. These actions aim (1) to promote a discussion with 
Country Teams, CCMs and Technical Partners on combinations leading to high absorptive capacity and 
(2) to identify the combinations most frequently present in the regional portfolio. 
Table 5.9 Key activities planned to explore combinations to overcome ‘risk factors’ 
Goal (iii): To explore combinations to overcome ‘risk factors’ 
Key Actions Timeline 
To select countries in LAC region that exbhit high risk/low 
governance and high disease burden and to review historical data 
(1) map out absorptive capacity and (2) to identify potential 
factors and/or combination of factors that could contribute to 
overcome ‘risk factors’.  
August  to September 
2014 
To convene a meeting with LAC tema to discuss my findings and 
exchange experience on selected grants. The goal of this review is 
to include quanlitative elements.  
October 2014 
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To finalize analysis of factors associated with overcoming ‘risk 
factors’ and to discuss report with Senior Management. If 
approved, to share results with other teams at the Global Fund to 
explore factors and combination of factors in other regions.  
This approach will allow considering potential effect of cultural 
differences across the regions. 
November to December 
2014 
 
iv.  To promote sharing of experiences within Latin America and Caribbean region and between 
different regions 
Although this study revealed the importance of the specific context of a country and even of a 
grant in understanding the absorptive capacity, I think that countries, implementers and technical 
partners can learn a lot by sharing their own experience on bottlenecks and contributing factors to high 
absorptive capacity. I will first promote the exchange of experience among the countries that I managed 
within one region by (a) organizing joint meetings, (b) developing exchange programs and (c) identifying 
common challenges. 
I will also use the next Regional Meeting for Global Fund grantees to have a session on 
absorptive capacity. In this session I will present the finding of these studies and have a few countries 
present their best practice and challenges. The goal is to start a broad exchange of experiences, 
practices and tools to understand absorptive capacity across different regions.   
In order to broaden the discussion, I am planning to apply for a poster presentation in the next 
International HIV/AIDS Conference. 
Table 5.10 Key activities planned to promote exchange of experience among Global Fund implementers 
Goal (iv): To promote sharing of experiences within LAC region and between different regions 
Key Actions Timeline 
To organize and lead a session on absorptive capacity at the LAC April 2014 
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Regional Meeting in Kingston, Jamaica. This session aims to share 
this study’s results and to engage stakeholders to share their views 
and experiences.  
To organize and lead a session on absorptive capacity at the 
Annual Review of PANCAP (Pan-Caribbean Partnership against 
HIV/AIDS). This partnership is led by the Regional Organization of 
Caribbean States and I currently manage their Global Fund grant. 
The goal of this session is to exchange experiences and best 
practices regarding high absorptive capacity among the Caribbean 
States. 
July 2014 
To organize an exchange visit between PRs in Guyana and 
Suriname. The goal of this exvhange visit is to promote exchange 
of best practices and promote partnership. 
October 2014 
 
Recommendation 3: Build-up the connections 
The combinations identified as sufficient for high absorptive capacity highlight the impact of the 
variable development assistance to health per disability-adjusted life year. This variable captures the 
relative investment in health by different donors adjusted to the needs of the country and it was part of 
60% of Phase 1 combinations and 66% of Phase 2 combinations associated with high absorptive 
capacity.   
The most frequent combination features high assistance for health associated with NOT low 
disease burden and NOT low risk/high governance as a pathway to high absorptive capacity. This 
combination brings assistance to health with the most frequent combination (NOT low disease burden 
and NOT low risk/high governance), which strengthen the role of partnership and its positive effect on 
health and social sectors.  
The results also show that number of grants managed by the same PR has an impact in the 
overall absorptive capacity of the grant, especially in the long term. This variable is very often combined 
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with assistance to health (DAH per DALY) in the solutions and one can clearly see that the presence of 
partners can counterbalance the “negative” effect that a large number of grants to manage has on 
absorptive capacity. 
This study shows that absorptive capacity is not only a reflection of effective management of 
grants; it is a complex phenomenon that has no simple recipe. In addition, the specificities of each 
country and grant can explain high absorptive capacity in difficult countries and risky scenarios.  
This recommendation is about the important role that local stakeholders can play in improving 
the absorptive capacity of grants. This recommendation can be broken down into two goals and several 
actions that are part of the Plan for Change. 
i. To build and foster partnerships 
The results from this study demonstrate the important role of partners in supporting and 
helping implementers (in the majority Governments and Civil Society Organizations) to achieve good 
implementation of activities, which translates into high absorptive capacity. In the past, The Global Fund 
has positioned itself as a financial organization that should not be involved in the strategic and 
programmatic decisions at the country level. As a result, there was a limited engagement with partners. 
However, this has now changed. In the recent transformation, the importance of the relationship with 
partners has come into focus and the Secretariat is more and more engaged with strategic and 
programmatic decisions at the country level, together with partners. 
As part of my Plan of Change, I have reviewed my strategies to work with partners in countries 
and I have decided on key activities to help me to establish a new model of working with partners. This 
foundation will be crucial for 2014, when the new funding model is launched and partners will play a 
participatory role in the development of requests for funding. The table below describes the activities 
planned for this goal. 
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Table 5.11 Key activities planned to build and foster partnerships 
Goal (i): To build and foster partnerships 
Key  actions Timeline 
To map out the existing partners in the three diseases in each of 
the countries where I work and to establish relationships. 
January to June 2014 
To have at least 2 joint-missions with partners. Joint missions are 
unique opportunities to develop commom approaches to 
address implementation and reporting issues. 
January to December 2014 
To have monthly teleconferences with partners in each of the 
countries in my portfolio. 
Every month 
To support and participate in Joint Annual Reviews with the 
national programs and partners 
July to December 2014 
To submit an abstract to the International HIV/AIDS Conference. 
If accepted, an oral or poster presentation would be an excellent 
opportunity to expand my network with partners and engage 
them in discussions around absorptive capacity.  
January 2014 for 
submission; July 2014 for 
conference 
 
ii. To support the development of strong CCMs 
Similar to partners, the importance of well-functioning strong CCMs became evident in the 
evaluation of the High Level Panel. CCMs can be a powerful body that represent different areas of 
society, including organizations representing key-affected populations, faith-based organizations, 
community organizations, Government, private sector, NGOs and international partners. Although the 
CCM is a requirement for accessing funding from The Global Fund, it has become a forum for the health 
sector in a few countries, which demonstrates the potential of such an organization. 
As such, the CCM can play an important role in mitigating the ‘risk factors’ for low absorptive 
capacity by boosting the coordination among stakeholders and advocating for technical assistance and 
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support when needed. In order to be effective, the CCM must be governed by clear guidelines and have 
strong oversight and governance committees. 
The table below describes the activities included in my Plan for Change to achieve the goal of 
supporting the development of CCMs. 
Table 5.12 Key activities planned to support the development of CCMs 
Goal (ii): To support the development of CCMs 
Key actions Timeline 
To guide CCMs in the countries I work to implement the new self-
assessment tool. This tool will be launched by the Global Fund in 
January 2014. 
February and March 2014 
To discuss the results of the self-assessment with partners 
organizations  to obtain additional feedback to inform discussion 
on findings with CCMs 
April and May 2014 
To develop a workplan with each CCM with technical assistance to 
improve its efficacy as a coordinating mechanism 
June and  July 2014 
To support and guide the CCMs through the application for 
Secretariat funding so it can be fully functional. 
August to December 2014 
 
The table below summarizes the proposed Recommendations, Goals and activities   of my Plan 
for Change. 
Table 5.13. Recommendations and Actions proposed for Plan for Change 
Recommendations Goals 
Redefine your risks To ensure that the revised concept of risk is based on 
a combination model 
To ensure that the new framework of risk is 
communicated and implemented by countries 
To promote frequent assessments and discussions of 
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findings 
To support a joint tailored approach 
Explore the pathways to high 
Absorptive Capacity 
To map-out examples and best-practices 
To promote frequent assessments and discussions of 
findings 
To explore combinations to overcome ‘risk factors’ 
To promote sharing of experiences within regions and 
between different regions 
Build-up the connections To build and foster partnerships 
To support the development of strong CCMs 
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APPENDIX 1: KEY INFORMATION ON GLOBAL FUND GRANTS INCLUDED IN THIS STUDY 
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933
9.3 
30/
09/
201
2 
Thai
land 
6 TB The 
Departm
ent of 
Disease 
Control, 
Ministry 
of Public 
Health 
of the 
Royal 
Govern
ment of 
Thailand 
Gov
: 
MO
H 
THA-
607-
G07-T 
01/
10/
200
7 
444
035
4 
429
861
0.01 
873
896
4.01 
444
035
4 
354
277
9.94 
798
313
3.9 
30/
09/
201
2 
Thai
land 
7 Ma
lari
a 
The 
Departm
ent of 
Disease 
Control, 
Ministry 
of Public 
Health 
of the 
Gov
: 
MO
H 
THA-
708-
G09-
M 
01/
07/
200
8 
119
393
46 
358
745
9 
155
268
05 
119
393
46 
358
745
8.82 
155
268
05 
30/
06/
201
3 
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Royal 
Govern
ment of 
Thailand 
Thai
land 
8 TB The 
Departm
ent of 
Disease 
Control, 
Ministry 
of Public 
Health 
of the 
Royal 
Govern
ment of 
Thailand 
Gov
: 
MO
H 
THA-
809-
G13-T 
01/
07/
200
9 
902
267
0.54 
0 902
267
0.54 
902
267
0.54 
0 902
267
0.5 
30/
06/
201
1 
Thai
land 
8 HIV
/AI
DS 
RAKS 
THAI 
FOUNDA
TION 
CS/
PS: 
NG
O 
THA-
809-
G12-H 
01/
06/
200
9 
858
055
2.3 
0 858
055
2.3 
858
055
2.3 
0 858
055
2.4 
30/
09/
201
1 
Thai
land 
8 HIV
/AI
DS 
The 
Departm
ent of 
Disease 
Control, 
Ministry 
of Public 
Health 
of the 
Royal 
Govern
ment of 
Thailand 
Gov
: 
MO
H 
THA-
809-
G10-H 
01/
07/
200
9 
150
712
73.3
1 
0 150
712
73.3
1 
150
712
73.3
1 
0 150
712
73 
30/
09/
201
1 
Thai
land 
8 HIV
/AI
DS 
POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
PS: 
NG
O 
THA-
809-
G11-H 
01/
07/
200
9 
604
504
2.48 
0 604
504
2.48 
604
504
2.48 
0 604
504
2.5 
30/
09/
201
1 
Tim
or-
Lest
e 
2 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
Gov
: 
MO
H 
TMP-
202-
G01-
M-00 
01/
09/
200
3 
230
074
4 
434
030.
25 
273
477
4.25 
230
074
4 
434
030.
23 
273
477
4.2 
31/
08/
200
6 
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ment of 
the 
Democra
tic 
Republic 
of 
Timor-
Leste 
Tim
or-
Lest
e 
3 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Democra
tic 
Republic 
of 
Timor-
Leste 
Gov
: 
MO
H 
TMP-
304-
G02-T 
01/
03/
200
5 
604
411.
3 
0 604
411.
3 
604
411.
3 
0 604
411
.3 
28/
02/
200
7 
Tim
or-
Lest
e 
5 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Democra
tic 
Republic 
of 
Timor-
Leste 
Gov
: 
MO
H 
TMP-
506-
G03-H 
01/
06/
200
7 
381
811
0 
454
328
4.01 
836
139
4.01 
381
811
0 
432
021
6.5 
813
832
6.5 
31/
12/
201
1 
Tim
or-
Lest
e 
7 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Democra
tic 
Gov
: 
MO
H 
TMP-
709-
G05-
M 
01/
04/
200
9 
616
868
7 
302
782.
16 
647
146
9.16 
616
868
7 
302
782.
16 
647
146
9.2 
31/
03/
201
4 
    143 
Republic 
of 
Timor-
Leste 
Tim
or-
Lest
e 
7 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Democra
tic 
Republic 
of 
Timor-
Leste 
Gov
: 
MO
H 
TMP-
708-
G04-T 
01/
01/
200
9 
289
420
5 
225
352
5.01 
514
773
0.01 
289
420
5 
109
110
1 
398
530
6 
31/
12/
201
3 
Viet 
Na
m 
1 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Viet 
Nam 
Gov
: 
MO
H 
VTN-
102-
G01-
H-00 
01/
02/
200
4 
750
000
0 
441
878
9.33 
119
187
89.3
3 
750
000
0 
441
878
9.32 
119
187
89 
31/
03/
200
8 
Viet 
Na
m 
1 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Viet 
Nam 
Gov
: 
MO
H 
VTN-
102-
G02-T-
00 
01/
06/
200
4 
250
000
0 
290
471
2.52 
540
471
2.52 
250
000
0 
290
471
2.5 
540
471
2.5 
31/
12/
200
7 
Viet 
Na
m 
3 Ma
lari
a 
The 
National 
Institute 
of 
Malariol
ogy, 
Parasitol
ogy and 
Entomol
ogy / 
Gov
: 
MO
H 
VTN-
304-
G03-
M 
01/
01/
200
5 
133
884
02 
778
955
3.52 
211
779
55.5
2 
133
884
02 
778
955
3.5 
211
779
56 
31/
12/
200
8 
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Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Socialist 
Republic 
of Viet 
Nam 
Viet 
Na
m 
6 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Viet 
Nam 
Gov
: 
MO
H 
VTN-
607-
G05-T 
01/
01/
200
8 
620
962
2 
733
615
8.01 
135
457
80.0
1 
620
962
2 
561
750
5.73 
118
271
28 
31/
12/
201
1 
Viet 
Na
m 
6 HIV
/AI
DS 
Administ
ration of 
HIV/AID
S and 
Control 
(VAAC), 
Ministry 
of 
Health in 
Viet 
Nam 
Gov
: 
MO
H 
VTN-
607-
G04-H 
01/
01/
200
8 
106
959
06.0
5 
0 106
959
06.0
5 
106
959
06.0
5 
0 106
959
06 
31/
03/
201
0 
Viet 
Na
m 
7 Ma
lari
a 
The 
National 
Institute 
of 
Malariol
ogy, 
Parasitol
ogy and 
Entomol
ogy / 
Ministry 
of 
Health 
of the 
Govern
Gov
: 
MO
H 
VTN-
708-
G06-
M 
01/
01/
200
9 
119
263
29 
821
184
6.02 
201
381
75.0
2 
119
263
29 
424
358
0.19 
161
699
09 
31/
12/
201
3 
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ment of 
the 
Socialist 
Republic 
of Viet 
Nam 
Alb
ania 
5 TB Ministry 
of 
Health, 
Institute 
of Public 
Health 
Gov
: 
MO
H 
ALB-
506-
G02-T 
01/
04/
200
7 
776
298 
487
192 
126
349
0 
776
298 
472
158.
64 
124
845
6.6 
31/
03/
201
2 
Alb
ania 
5 HIV
/AI
DS 
Ministry 
of 
Health, 
Institute 
of Public 
Health 
Gov
: 
MO
H 
ALB-
506-
G01-H 
01/
04/
200
7 
250
285
8 
243
337
1 
493
622
9 
250
285
8 
242
222
7 
492
508
5 
31/
03/
201
2 
Arm
enia 
1
0 
TB                       
Arm
enia 
2 HIV
/AI
DS 
World 
Vision 
Internati
onal 
CS/
PS: 
NG
O 
ARM-
202-
G01-
H-00 
01/
11/
200
3 
316
664
1 
593
834
8 
910
498
9 
316
664
1 
593
834
8 
910
498
9 
30/
09/
200
9 
Arm
enia 
5 TB The 
Ministry 
of 
Health 
of the 
Republic 
of 
Armenia 
Gov
: 
MO
H 
ARM-
506-
G02-T 
01/
01/
200
7 
362
514
0 
0   343
450
8 
0 343
450
8 
31/
12/
201
1 
Arm
enia 
8 TB The 
Ministry 
of 
Health 
of the 
Republic 
of 
Armenia 
Gov
: 
MO
H 
ARM-
809-
G03-T 
01/
09/
200
9 
197
956
0.04 
0 197
956
0.04 
197
956
0.04 
0 197
956
0 
30/
11/
201
1 
Aze
rbai
jan 
4 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
Gov
: 
MO
H 
AZE-
405-
G01-H 
01/
06/
200
5 
609
860
0 
424
295
0 
103
415
50 
609
860
0 
423
144
8.7 
103
300
49 
30/
06/
201
0 
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ment of 
the 
Republic 
of 
Azerbaij
an 
Aze
rbai
jan 
5 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Azerbaij
an 
Gov
: 
MO
H 
AZE-
506-
G02-T 
01/
10/
200
6 
434
500
6.15 
0 434
500
6.15 
434
500
6.15 
0 434
500
6.2 
30/
09/
200
8 
Aze
rbai
jan 
7 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Azerbaij
an 
Gov
: 
MO
H 
AZE-
708-
G04-
M 
01/
10/
200
8 
338
536
4.32
9 
142
953
7.63
3 
481
490
1.96
1 
338
536
4.32
9 
120
268
2.30
1 
458
804
6.6 
30/
09/
201
3 
Aze
rbai
jan 
7 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Azerbaij
an 
Gov
: 
MO
H 
AZE-
708-
G03-T 
01/
10/
200
8 
103
564
39.2
4 
711
484
2.02
3 
174
712
81.2
7 
103
564
39.2
4 
690
908
6.01
7 
172
655
25 
30/
09/
201
3 
Bela
rus 
3 HIV
/AI
DS 
United 
Nations 
Develop
ment 
MO
: 
UN
DP 
BLR-
304-
G01-H 
01/
12/
200
4 
681
879
6 
994
503
4.01 
243
369
58 
681
879
6 
994
503
4.01 
228
369
37 
30/
11/
201
2 
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Program
me 
Bela
rus 
6 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BLR-
607-
G02-T 
01/
10/
200
7 
635
434
0 
288
977
2 
924
411
2 
635
434
0 
288
977
2 
924
411
2 
31/
12/
201
0 
Bela
rus 
8 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BLR-
809-
G03-H 
01/
01/
201
0 
134
810
21.2
9 
0 134
810
21.2
9 
134
810
21.2
9 
0 134
810
21 
31/
12/
201
4 
Bos
nia 
and 
Her
zeg
ovin
a 
5 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BIH-
506-
G01-H 
01/
11/
200
6 
483
238
5 
620
987
2 
110
422
57 
483
238
5 
615
977
6.41 
109
921
61 
31/
10/
201
1 
Bos
nia 
and 
Her
zeg
ovin
a 
6 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BIH-
607-
G02-T 
01/
10/
200
7 
302
551
3 
713
710 
373
922
3 
302
551
3 
713
710 
373
922
3 
30/
09/
201
2 
Bulg
aria 
2 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Republic 
of 
Bulgaria 
Gov
: 
MO
H 
BUL-
202-
G01-
H-00 
01/
01/
200
4 
689
427
0 
881
761
2 
157
118
82 
689
427
0 
881
761
2 
157
118
82 
31/
12/
200
8 
Bulg
aria 
6 TB The 
Ministry 
of 
Health 
of the 
Republic 
of 
Bulgaria 
Gov
: 
MO
H 
BUL-
607-
G02-T 
01/
11/
200
7 
960
072
1.08 
977
341
8.24
6 
193
741
39.3
3 
960
072
1.08 
666
010
6.24 
162
608
27 
31/
10/
201
2 
Geo
rgia 
2 HIV
/AI
The 
Georgia 
Gov
: 
GEO-
202-
01/
03/
401
833
103
449
143
632
401
833
103
449
143
632
31/
12/
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DS Health 
and 
Social 
Projects 
Impleme
ntation 
Center 
Oth G01-
H-00 
200
4 
2 22.0
2 
54.0
2 
2 21.8 54 200
9 
Geo
rgia 
3 Ma
lari
a 
The 
Georgia 
Health 
and 
Social 
Projects 
Impleme
ntation 
Center 
Gov
: 
Oth 
GEO-
304-
G02-
M 
01/
07/
200
4 
645
700 
160
600.
01 
806
300.
01 
645
700 
160
600 
806
300 
30/
06/
200
7 
Geo
rgia 
4 TB The 
Georgia 
Health 
and 
Social 
Projects 
Impleme
ntation 
Center 
Gov
: 
Oth 
GEO-
405-
G03-T 
01/
04/
200
5 
182
921
8 
370
774
7 
553
696
5 
182
921
8 
370
774
6.95 
553
696
5 
31/
03/
201
0 
Geo
rgia 
6 TB The 
Georgia 
Health 
and 
Social 
Projects 
Impleme
ntation 
Center 
Gov
: 
Oth 
GEO-
607-
G05-T 
01/
07/
200
7 
919
263
4.23 
0.03 919
263
4.26 
919
263
4.23 
0 919
263
4.2 
31/
03/
201
1 
Geo
rgia 
6 HIV
/AI
DS 
The 
Georgia 
Health 
and 
Social 
Projects 
Impleme
ntation 
Center 
Gov
: 
Oth 
GEO-
607-
G06-H 
01/
01/
200
8 
613
072
4 
191
637
6.69 
804
710
0.69 
613
072
4 
191
637
6.67 
804
710
0.7 
31/
12/
201
0 
Geo
rgia 
6 Ma
lari
a 
The 
Georgia 
Health 
Gov
: 
Oth 
GEO-
607-
G04-
01/
07/
200
158
796
0 
587
254.
49 
217
521
4.49 
158
796
0 
587
254.
46 
217
521
4.5 
31/
03/
201
    149 
and 
Social 
Projects 
Impleme
ntation 
Center 
M 7 1 
Geo
rgia 
S HIV
/AI
DS 
The 
Georgia 
Health 
and 
Social 
Projects 
Impleme
ntation 
Center 
Gov
: 
Oth 
GEO-
S10-
G07-H 
01/
01/
201
0 
334
495
5.28
1 
0 334
495
5.28
1 
334
495
4.7 
0 334
495
4.7 
31/
03/
201
1 
Kaz
akh
stan 
2 HIV
/AI
DS 
The 
Republic
an 
Center 
for 
Prophyla
ctics and 
Control 
of AIDS 
of the 
Govern
ment of 
the 
Republic 
of 
Kazakhst
an 
Gov
: 
Oth 
KAZ-
202-
G01-
H-00 
01/
12/
200
3 
650
200
0 
137
866
67.0
9 
202
886
67.0
9 
650
200
0 
137
866
67.0
7 
202
886
67 
30/
11/
200
8 
Kaz
akh
stan 
6 TB National 
Center 
of TB 
Problem
s of the 
Ministry 
of 
Health 
of the 
Republic 
of 
Kazakhst
an 
Gov
: 
MO
H 
KAZ-
607-
G02-T 
01/
09/
200
7 
544
259
8 
367
238
3.01 
911
498
1.01 
544
259
8 
292
273
8 
836
533
6 
31/
08/
201
2 
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Kaz
akh
stan 
7 HIV
/AI
DS 
The 
Republic
an 
Center 
for 
Prophyla
ctics and 
Control 
of AIDS 
of the 
Govern
ment of 
the 
Republic 
of 
Kazakhst
an 
Gov
: 
Oth 
KAZ-
708-
G03-H 
01/
01/
200
9 
146
535
08 
306
145
5.01 
177
149
63.0
1 
146
535
08 
306
145
5 
177
149
63 
31/
12/
201
3 
Kaz
akh
stan 
8 TB National 
Center 
of TB 
Problem
s of the 
Ministry 
of 
Health 
of the 
Republic 
of 
Kazakhst
an 
Gov
: 
MO
H 
KAZ-
809-
G04-T 
01/
01/
201
0 
355
837
55 
0 355
837
55 
354
835
23 
0 354
835
23 
31/
03/
201
2 
Kos
ovo 
4 TB Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Kosovo 
Gov
: 
MO
H 
KOS-
405-
G01-T 
01/
04/
200
6 
212
240
1 
0   212
240
0.53 
0 212
240
0.5 
31/
03/
201
1 
Kos
ovo 
7 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Govern
ment of 
Gov
: 
MO
H 
KOS-
708-
G02-H 
01/
10/
200
8 
288
741
3.16 
-
0.71
607
034
6 
288
741
2.44
4 
288
741
3.16 
-
0.71
607
034
6 
288
741
3.2 
31/
12/
201
0 
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the 
Republic 
of 
Kosovo 
Kyr
gyzs
tan 
2 TB National 
Center 
of 
Phthisiol
ogy 
under 
the 
Ministry 
of 
Health 
of the 
Republic 
of 
Kyrgyzst
an 
Gov
: 
MO
H 
KGZ-
202-
G02-T-
00 
01/
03/
200
4 
121
283
5 
155
823
5.01 
277
107
0.01 
121
283
5 
155
823
5 
277
107
0 
28/
02/
200
9 
Kyr
gyzs
tan 
2 HIV
/AI
DS 
National 
AIDS 
Centre 
of the 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Kyrgyzst
an 
Gov
: 
Oth 
KGZ-
202-
G01-
H-00 
01/
03/
200
4 
495
803
8 
121
152
68.0
1 
170
733
06.0
1 
495
803
8 
121
152
67.5
3 
170
733
06 
28/
02/
200
9 
Kyr
gyzs
tan 
5 Ma
lari
a 
State 
Sanitary 
Epidemi
ological 
Departm
ent 
Gov
: 
Oth 
KGZ-
506-
G03-
M 
01/
04/
200
6 
210
306
5 
132
306
0.01 
342
612
5.01 
210
306
5 
112
611
1.37 
322
917
6.4 
31/
03/
201
1 
Kyr
gyzs
tan 
6 TB National 
Center 
of 
Phthisiol
ogy 
under 
Gov
: 
MO
H 
KGZ-
607-
G04-T 
01/
07/
200
7 
424
457
8 
199
231
4.69 
623
689
2.69 
424
457
8 
199
231
4.67 
623
689
2.7 
30/
06/
201
2 
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the 
Ministry 
of 
Health 
of the 
Republic 
of 
Kyrgyzst
an 
Kyr
gyzs
tan 
7 HIV
/AI
DS 
National 
AIDS 
Centre 
of the 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Kyrgyzst
an 
Gov
: 
MO
H 
KGZ-
708-
G05-H 
01/
01/
200
9 
110
355
60.8
9 
0 110
355
60.8
9 
110
355
60.8
9 
0 110
355
61 
30/
06/
201
1 
Kyr
gyzs
tan 
8 Ma
lari
a 
State 
Sanitary 
Epidemi
ological 
Departm
ent 
Gov
: 
Oth 
KGZ-
809-
G06-
M 
01/
01/
201
0 
750
996 
0 750
996 
633
876.
98 
0 633
876
.98 
31/
12/
201
1 
Mac
edo
nia 
(For
mer 
Yug
osla
v 
Rep
ubli
c) 
3 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Former 
Yugoslav 
Republic 
of 
Macedo
nia 
Gov
: 
MO
H 
MKD-
304-
G01-H 
01/
11/
200
4 
434
859
9 
155
576
8.01 
590
436
7.01 
434
859
9 
145
386
3.38 
580
246
2.4 
31/
03/
200
8 
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Mac
edo
nia 
(For
mer 
Yug
osla
v 
Rep
ubli
c) 
5 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Former 
Yugoslav 
Republic 
of 
Macedo
nia 
Gov
: 
MO
H 
MKD-
506-
G02-T 
01/
04/
200
6 
144
248
9 
0   144
248
9 
0 144
248
9 
31/
03/
201
1 
Mac
edo
nia 
(For
mer 
Yug
osla
v 
Rep
ubli
c) 
7 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Former 
Yugoslav 
Republic 
of 
Macedo
nia 
Gov
: 
MO
H 
MKD-
708-
G03-H 
01/
04/
200
8 
410
982
7.20
7 
273
506
4.75
4 
684
489
1.96
2 
410
982
7.20
7 
273
506
4.75
4 
684
489
2.4 
31/
03/
201
3 
Mol
dov
a 
1 HIV
/TB 
The 
Project 
Coordina
tion, 
Impleme
ntation 
and 
Monitori
ng Unit 
of the 
Ministry 
of 
Health 
of the 
Republic 
of 
Moldova 
Gov
: 
MO
H 
MOL-
102-
G01-C-
00 
01/
05/
200
3 
525
794
1 
644
708
3.51 
117
050
24.5
1 
525
794
1 
644
708
3.49 
117
050
24 
30/
04/
200
8 
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Mol
dov
a 
6 TB The 
Project 
Coordina
tion, 
Impleme
ntation 
and 
Monitori
ng Unit 
of the 
Ministry 
of 
Health 
of the 
Republic 
of 
Moldova 
Gov
: 
MO
H 
MOL-
607-
G02-T 
01/
10/
200
7 
567
550
7 
177
314
4.02 
744
865
1.02 
567
550
7 
177
314
4 
744
865
1 
30/
09/
201
2 
Mol
dov
a 
6 HIV
/AI
DS 
The 
Project 
Coordina
tion, 
Impleme
ntation 
and 
Monitori
ng Unit 
of the 
Ministry 
of 
Health 
of the 
Republic 
of 
Moldova 
Gov
: 
MO
H 
MOL-
607-
G03-H 
01/
01/
200
8 
673
427
2 
0 673
427
2 
673
427
2 
0 673
427
2 
31/
03/
201
0 
Mol
dov
a 
8 HIV
/AI
DS 
Center 
for 
Health 
Policies 
and 
Studies 
(PAS 
Center) 
CS/
PS: 
NG
O 
MOL-
809-
G06-H 
01/
01/
201
0 
114
596
55.7
8 
0 114
596
55.7
8 
938
140
7.5 
0 938
140
7.5 
31/
12/
201
2 
Mol
dov
a 
8 TB The 
Project 
Coordina
tion, 
Gov
: 
MO
H 
MOL-
809-
G04-T 
01/
10/
200
9 
312
720
6.43 
0 312
720
6.43 
312
720
6.43 
0 312
720
6.4 
30/
09/
201
1 
    155 
Impleme
ntation 
and 
Monitori
ng Unit 
of the 
Ministry 
of 
Health 
of the 
Republic 
of 
Moldova 
Mo
nte
neg
ro 
5 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
MNT-
506-
G01-H 
01/
08/
200
6 
178
455
4.93
2 
146
813
0.83
1 
325
268
5.76
3 
178
455
4.93
2 
146
813
0.81
8 
325
268
5.8 
31/
07/
201
0 
Mo
nte
neg
ro 
6 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
MNT-
607-
G02-T 
01/
07/
200
7 
118
381
2.40
5 
630
685.
279
2 
181
449
7.68
4 
118
381
2.40
5 
630
685.
265
1 
181
449
7.7 
30/
06/
201
2 
Ro
ma
nia 
2 HIV
/AI
DS 
The 
Ministry 
of 
Health 
and 
Family of 
the 
Govern
ment of 
Romania 
Gov
: 
MO
H 
ROM-
202-
G01-
H-00 
01/
01/
200
4 
218
010
00 
468
118
9.02 
264
821
89.0
2 
218
010
00 
468
118
9 
264
821
89 
31/
12/
200
8 
Ro
ma
nia 
2 TB The 
Ministry 
of 
Health 
and 
Family of 
the 
Govern
ment of 
Romania 
Gov
: 
MO
H 
ROM-
202-
G02-T-
00 
01/
02/
200
4 
166
847
09 
0 166
847
09 
166
847
09 
0 166
847
09 
31/
07/
200
8 
    156 
Ro
ma
nia 
6 HIV
/AI
DS 
Romania
n Angel 
Appeal 
Foundati
on 
CS/
PS: 
NG
O 
ROM-
607-
G03-H 
01/
07/
200
7 
922
867
5.49
8 
219
630
1.51
4 
114
249
77.0
1 
922
867
5.49
8 
219
630
1.12
2 
114
249
77 
30/
06/
201
0 
Ro
ma
nia 
6 TB Romania
n Angel 
Appeal 
Foundati
on 
CS/
PS: 
NG
O 
ROM-
607-
G04-T 
01/
10/
200
7 
514
530
0.76
1 
505
320
2.22
7 
101
985
02.9
9 
514
530
0.76
1 
433
381
3.40
9 
947
911
4.2 
30/
09/
201
2 
Rus
sian 
Fed
erat
ion 
3 TB Partners 
In Health 
CS/
PS: 
NG
O 
RUS-
304-
G02-T 
01/
12/
200
4 
630
686
9 
445
961
7 
107
664
86 
630
686
9 
445
961
7 
107
664
86 
30/
11/
200
9 
Rus
sian 
Fed
erat
ion 
3 HIV
/AI
DS 
The 
Open 
Health 
Institute 
CS/
PS: 
NG
O 
RUS-
304-
G01-H 
15/
08/
200
4 
315
963
07 
799
460
47.0
4 
111
542
354 
315
963
07 
794
098
99 
111
006
206 
31/
12/
201
1 
Rus
sian 
Fed
erat
ion 
4 TB The 
Russian 
Health 
Care 
Foundati
on 
CS/
PS: 
NG
O 
RUS-
405-
G04-T 
01/
12/
200
5 
494
360
16 
387
294
32.0
1 
881
654
48.0
1 
494
360
16 
384
211
35.4 
878
571
51 
30/
11/
201
0 
Rus
sian 
Fed
erat
ion 
4 HIV
/AI
DS 
The 
Russian 
Health 
Care 
Foundati
on 
CS/
PS: 
NG
O 
RUS-
405-
G03-H 
01/
09/
200
5 
341
769
31 
102
320
879 
136
497
810 
341
769
31 
102
320
878.
1 
136
497
809 
31/
08/
201
1 
Rus
sian 
Fed
erat
ion 
5 HIV
/AI
DS 
Non-
profit 
Partners
hip to 
Support 
Social 
Preventi
on 
Program
s in 
Public 
Health 
"ESVERO
" 
CS/
PS: 
NG
O 
RUS-
506-
G05-H 
01/
09/
200
6 
428
130
8.40
1 
954
507
7.23
3 
138
263
85.6
3 
428
130
8.40
1 
949
877
2.64
9 
137
800
81 
31/
08/
201
1 
    157 
Ser
bia 
1 HIV
/AI
DS 
The 
Economi
cs 
Institute 
in 
Belgrade 
CS/
PS: 
PS 
SER-
102-
G01-
H-00 
01/
11/
200
3 
271
871
4 
856
496.
02 
357
521
0.02 
271
871
4 
856
496 
357
521
0 
31/
01/
200
7 
Ser
bia 
3 TB Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Serbia 
Gov
: 
MO
H 
SER-
304-
G02-T 
01/
12/
200
4 
242
898
6 
165
899
3.01 
408
797
9.01 
242
898
6 
165
899
3 
408
797
9 
31/
03/
201
0 
Ser
bia 
6 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Serbia 
Gov
: 
MO
H 
SER-
607-
G03-H 
01/
06/
200
7 
652
216
4.92
8 
634
964
4.78
4 
128
718
09.7
1 
652
216
4.92
8 
595
781
0.94
2 
124
799
76 
31/
05/
201
2 
Ser
bia 
8 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Serbia 
Gov
: 
MO
H 
SER-
809-
G04-H 
01/
07/
200
9 
228
232
3.93
2 
284
681
4.53
5 
512
913
8.46
6 
228
232
3.93
2 
292
643.
648
5 
257
496
7.6 
30/
06/
201
4 
Ser
bia 
8 HIV
/AI
DS 
Youth of 
JAZAS 
CS/
PS: 
NG
O 
SER-
809-
G05-H 
01/
07/
200
9 
330
749
6.72
5 
187
598
6.86
6 
518
348
3.59
1 
330
749
6.72
5 
166
882.
195 
347
437
8.9 
30/
06/
201
4 
Taji
kist
an 
1 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
102-
G01-
H-00 
01/
05/
200
3 
147
452
0 
950
725.
01 
242
524
5.01 
147
452
0 
950
725 
242
524
5 
30/
04/
200
6 
Taji
kist
an 
3 TB Project 
HOPE 
CS/
PS: 
NG
TAJ-
304-
G02-T 
01/
11/
200
119
385
5 
156
802
2.02 
660
949
7.04 
119
385
5 
156
802
2.02 
609
559
1.3 
30/
09/
201
    158 
O 4 2 
Taji
kist
an 
4 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
404-
G03-H 
01/
01/
200
5 
250
872
0 
556
794
7.01 
807
666
7.01 
250
872
0 
555
353
2.06 
806
225
2.1 
31/
12/
200
9 
Taji
kist
an 
5 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
506-
G04-
M 
01/
04/
200
6 
314
363
2 
223
987
8.01 
538
351
0.01 
314
363
2 
221
478
1.14 
535
841
3.1 
31/
03/
201
0 
Taji
kist
an 
6 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
607-
G06-T 
01/
08/
200
7 
652
734
7 
0 652
734
7 
652
734
7 
0 652
734
7 
30/
09/
200
9 
Taji
kist
an 
6 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
607-
G05-H 
01/
05/
200
7 
519
029
4 
113
713
5.02 
632
742
9.02 
519
029
4 
113
237
5.59 
632
266
9.6 
30/
04/
201
2 
Taji
kist
an 
8 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
809-
G09-T 
01/
10/
200
9 
229
937
79.0
1 
0   229
937
79 
0 229
937
79 
30/
09/
201
3 
Taji
kist
an 
8 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
809-
G08-
M 
01/
10/
200
9 
685
991
6.65
2 
474
338
4.77
2 
116
033
01.4
2 
685
991
6.65
2 
138
179
4.96
8 
824
171
1.6 
30/
09/
201
3 
Taji
kist
an 
8 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TAJ-
809-
G07-H 
01/
10/
200
9 
200
281
40.0
1 
0   200
281
38 
0 200
281
38 
30/
09/
201
4 
Tur
key 
4 HIV
/AI
DS 
The 
Ministry 
of 
Gov
: 
MO
TUR-
405-
G01-H 
01/
08/
200
327
276
2.62 
0 327
276
2.62 
327
276
2.62 
0 327
276
2.6 
31/
01/
200
    159 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Turkey 
H 5 8 
Ukr
aine 
1 HIV
/AI
DS 
The 
Internati
onal 
HIV/AID
S 
Alliance 
CS/
PS: 
NG
O 
UKR-
102-
G04-
H-00 
15/
03/
200
4 
233
541
16 
0   233
541
16 
0 233
541
16 
31/
03/
200
9 
Ukr
aine 
1 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Ukraine 
Gov
: 
MO
H 
UKR-
102-
G02-
H-00 
28/
01/
200
3 
541
681.
93 
0 541
681.
93 
541
681.
93 
0 541
681
.93 
27/
01/
200
5 
Ukr
aine 
1 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
UKR-
102-
G03-
H-00 
17/
02/
200
3 
452
948.
27 
0 452
948.
27 
452
948.
27 
0 452
948
.27 
16/
02/
200
5 
Ukr
aine 
1 HIV
/AI
DS 
The 
Ukrainia
n Fund 
to Fight 
HIV 
Infection 
and AIDS 
Gov
: 
Oth 
UKR-
102-
G01-
H-00 
18/
03/
200
3 
311
888.
55 
0 311
888.
55 
311
888.
55 
0 311
888
.55 
17/
03/
200
5 
Ukr
aine 
1 HIV
/AI
DS 
The 
Internati
onal 
HIV/AID
S 
Alliance 
CS/
PS: 
NG
O 
UKR-
102-
A04-
H-00 
09/
03/
200
4 
300
000 
0 300
000 
300
000 
0 300
000 
09/
03/
201
5 
Ukr
aine 
6 HIV
/AI
DS 
All-
Ukrainia
n 
Network 
of 
CS/
PS: 
NG
O 
UKR-
607-
G06-H 
01/
08/
200
7 
139
830
21 
383
311
93.0
1 
523
142
14.0
1 
139
830
21 
343
912
18.8
5 
483
742
40 
31/
07/
201
2 
    160 
People 
Living 
with 
HIV/AID
S 
Ukr
aine 
6 HIV
/AI
DS 
Internati
onal 
HIV/AID
S 
Alliance 
in 
Ukraine 
CS/
PS: 
NG
O 
UKR-
607-
G05-H 
01/
08/
200
7 
156
661
66 
635
566
55.0
1 
792
228
21.0
1 
156
661
66 
582
353
49.4
6 
739
015
15 
31/
07/
201
2 
Uzb
ekis
tan 
3 HIV
/AI
DS 
The 
National 
AIDS 
Center 
of the 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Uzbekist
an 
Gov
: 
MO
H 
UZB-
304-
G01-H 
01/
12/
200
4 
476
075
5 
157
854
54.2
5 
205
462
09.2
5 
476
075
5 
157
854
54.2
3 
205
462
09 
31/
12/
201
0 
Uzb
ekis
tan 
4 Ma
lari
a 
The 
Republic
an 
Center 
of State 
Sanitary-
Epidemi
ological 
Surveilla
nce 
Gov
: 
Oth 
UZB-
405-
G02-
M 
01/
04/
200
5 
134
346
6 
959
009.
9 
230
247
5.9 
134
346
6 
959
009.
9 
230
247
5.9 
31/
03/
201
0 
Uzb
ekis
tan 
4 TB The 
Republic
an DOTS 
Center 
of the 
Govern
ment of 
the 
Gov
: 
MO
H 
UZB-
405-
G03-T 
01/
04/
200
5 
605
652
2 
443
758
8.91 
104
941
10.9
1 
605
652
2 
443
758
8.91 
104
941
11 
31/
03/
201
0 
    161 
Republic 
of 
Uzbekist
an 
Uzb
ekis
tan 
8 TB The 
Republic
an DOTS 
Center 
of the 
Govern
ment of 
the 
Republic 
of 
Uzbekist
an 
Gov
: 
MO
H 
UZB-
809-
G05-T 
01/
12/
200
9 
120
984
45 
0 120
984
45 
111
723
51.3
4 
0 111
723
51 
31/
03/
201
2 
Uzb
ekis
tan 
8 Ma
lari
a 
The 
Republic
an 
Center 
of State 
Sanitary-
Epidemi
ological 
Surveilla
nce 
Gov
: 
Oth 
UZB-
809-
G04-
M 
01/
01/
201
0 
211
803
8 
0 211
803
8 
132
630
2 
0 132
630
2 
31/
03/
201
2 
Arg
enti
na 
1 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ARG-
102-
G01-
H-00 
01/
07/
200
3 
886
576
9.71 
0 886
576
9.71 
886
576
9.71 
0 886
576
9.7 
30/
09/
200
5 
Arg
enti
na 
1 HIV
/AI
DS 
UBATEC 
S.A. 
CS/
PS: 
PS 
ARG-
102-
G02-
H-00 
01/
01/
200
6 
278
308
1 
133
233
47.2 
161
064
28.2 
278
308
1 
133
233
47.2 
161
064
29 
31/
12/
200
8 
Beli
ze 
3 HIV
/AI
DS 
Belize 
Enterpris
e for 
Sustaina
ble 
Technol
ogy 
CS/
PS: 
NG
O 
BEL-
304-
G01-H 
01/
11/
200
4 
129
888
4 
110
479
3 
240
367
7 
129
888
4 
799
092 
209
797
6 
31/
10/
200
9 
Boli
via 
(Plu
3 HIV
/AI
DS 
United 
Nations 
Develop
MO
: 
UN
BOL-
306-
G04-H 
01/
05/
200
195
041
1.52 
0 195
041
1.52 
195
041
1.52 
0 195
041
1.5 
31/
01/
200
    162 
rina
tion
al 
Stat
e) 
ment 
Program
me 
DP 6 7 
Boli
via 
(Plu
rina
tion
al 
Stat
e) 
3 HIV
/AI
DS 
Centro 
de 
Investiga
ción, 
Educació
n y 
Servicios 
(CIES) 
CS/
PS: 
NG
O 
BOL-
304-
G01-H 
26/
07/
200
4 
264
175
1.45 
0 264
175
1.45 
264
175
1.45 
0 264
175
1.5 
25/
07/
200
6 
Boli
via 
(Plu
rina
tion
al 
Stat
e) 
3 TB Centro 
de 
Investiga
ción, 
Educació
n y 
Servicios 
(CIES) 
CS/
PS: 
NG
O 
BOL-
304-
G03-T 
26/
07/
200
4 
108
448
6.16 
0 108
448
6.16 
108
448
6.16 
0 108
448
6.2 
25/
07/
200
6 
Boli
via 
(Plu
rina
tion
al 
Stat
e) 
3 HIV
/AI
DS 
Asociaci
ón Ibis - 
Hivos 
CS/
PS: 
NG
O 
BOL-
307-
G07-H 
01/
02/
200
7 
691
702.
55 
100
508
47.4
9 
107
425
50.0
4 
691
702.
55 
100
508
47.4
5 
107
425
50 
31/
01/
201
0 
Boli
via 
(Plu
rina
tion
al 
Stat
e) 
3 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BOL-
306-
G06-T 
01/
05/
200
6 
120
497
7 
300
961
1.01 
421
458
8.01 
120
497
7 
300
961
1 
421
458
8 
31/
10/
200
9 
Boli
via 
(Plu
rina
tion
al 
Stat
e) 
3 Ma
lari
a 
Centro 
de 
Investiga
ción, 
Educació
n y 
Servicios 
(CIES) 
CS/
PS: 
NG
O 
BOL-
304-
G02-
M 
26/
07/
200
4 
302
573
6.12 
0 302
573
6.12 
302
573
6.12 
0 302
573
6.1 
25/
07/
200
6 
    163 
Boli
via 
(Plu
rina
tion
al 
Stat
e) 
3 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BOL-
306-
G05-
M 
01/
05/
200
6 
208
535
5.54 
0 208
535
5.54 
208
535
5.54 
0 208
535
5.5 
31/
07/
200
7 
Boli
via 
(Plu
rina
tion
al 
Stat
e) 
8 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BOL-
809-
G08-
M 
01/
10/
200
9 
606
029
3 
187
765
2 
793
794
5 
606
029
3 
981
941.
29 
704
223
4.3 
30/
09/
201
4 
Braz
il 
5 TB Fundaçã
o Para O 
Desenvo
lvimento 
Científic
o E 
Tecnológ
ico Em 
Saúde 
(FIOTEC) 
CS/
PS: 
Oth 
BRA-
506-
G02-T 
01/
05/
200
7 
878
442
7 
966
455
0 
184
489
77 
878
442
7 
860
401
3 
173
884
40 
30/
04/
201
2 
Braz
il 
5 TB Fundaçã
o 
Ataulph
o de 
Paiva 
CS/
PS: 
Oth 
BRA-
506-
G01-T 
01/
05/
200
7 
281
800
0 
175
402
8 
457
202
8 
281
800
0 
126
148
8.25 
407
948
8.3 
30/
04/
201
2 
Braz
il 
8 Ma
lari
a 
Fundaçã
o de 
Medicin
a 
Tropical 
do 
Amazon
as (FMT-
AM) 
CS/
PS: 
NG
O 
BRA-
809-
G04-
M 
01/
12/
200
9 
158
461
71.1
6 
0 158
461
71.1
6 
123
893
97.7
7 
0 123
893
98 
30/
11/
201
1 
Braz
il 
8 Ma
lari
a 
Fundaçã
o 
Faculdad
e de 
Medicin
a (FFM) 
CS/
PS: 
NG
O 
BRA-
809-
G03-
M 
01/
12/
200
9 
771
032
5.30
5 
0 771
032
5.30
5 
561
975
6.92 
0 561
975
6.9 
30/
11/
201
1 
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Chil
e 
1 HIV
/AI
DS 
Consejo 
de las 
América
s 
CS/
PS: 
PS 
CHL-
102-
G01-
H-00 
01/
08/
200
3 
135
740
98 
152
612
09 
288
353
07 
135
740
98 
152
612
09 
288
353
07 
31/
07/
200
8 
Col
om
bia 
2 HIV
/AI
DS 
The 
Internati
onal 
Organiza
tion for 
Migratio
n (IOM) 
MO
: 
Oth 
COL-
202-
G01-
H-00 
01/
07/
200
4 
348
263
6 
502
743
2.86 
851
006
8.86 
348
263
6 
502
743
2.83 
851
006
8.8 
30/
06/
200
8 
Cos
ta 
Rica 
2 HIV
/AI
DS 
The 
Consejo 
Técnico 
de 
Asistenci
a 
Médico 
Social 
(CTAMS) 
of the 
Govern
ment of 
the 
Republic 
of Costa 
Rica 
Gov
: 
Oth 
COR-
202-
G01-
H-00 
01/
10/
200
3 
176
735
9.12 
0 176
735
9.12 
176
735
9.12 
0 176
735
9.1 
30/
09/
200
5 
Cos
ta 
Rica 
2 HIV
/AI
DS 
HIVOS 
(Humani
stic 
Institute 
for 
Coopera
tion with 
Developi
ng 
Countrie
s) 
CS/
PS: 
NG
O 
COR-
202-
G02-
H-00 
01/
01/
200
6 
495
219.
88 
130
437
0.01 
179
958
9.89 
495
219.
88 
130
437
0 
179
958
9.9 
30/
09/
200
8 
Cub
a 
2 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CUB-
202-
G01-
H-00 
01/
07/
200
3 
114
651
29 
152
527
32.0
2 
373
006
29.0
4 
114
651
29 
152
527
32.0
2 
356
263
00 
31/
12/
201
4 
Cub
a 
6 HIV
/AI
United 
Nations 
MO
: 
CUB-
607-
01/
10/
143
697
182
913
326
611
143
697
119
202
262
899
31/
12/
    165 
DS Develop
ment 
Program
me 
UN
DP 
G02-H 200
7 
43 96.0
1 
39.0
1 
43 01 44 201
2 
Cub
a 
7 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CUB-
708-
G03-T 
01/
01/
200
9 
545
574
5 
142
746
7.01 
688
321
2.01 
545
574
5 
904
554 
636
029
9 
31/
12/
201
3 
Do
mini
can 
Rep
ubli
c 
2 HIV
/AI
DS 
Consejo 
Presiden
cial del 
SIDA 
(COPRES
IDA) of 
the 
Govern
ment of 
the 
Dominic
an 
Republic 
Gov
: 
Oth 
DMR-
202-
G01-
H-00 
01/
06/
200
4 
146
987
74 
337
857
08.0
1 
797
894
96.0
3 
146
987
74 
337
857
08.0
1 
767
653
69 
31/
05/
201
2 
Do
mini
can 
Rep
ubli
c 
3 TB Asociaci
ón 
Dominic
ana Pro-
Bienesta
r de la 
Familia 
(PROFA
MILIA) 
CS/
PS: 
NG
O 
DMR-
304-
G02-T 
01/
10/
200
4 
263
681
6 
196
658
2.01 
460
339
8.01 
263
681
6 
196
658
1.74 
460
339
7.7 
30/
09/
200
9 
Do
mini
can 
Rep
ubli
c 
7 TB Asociaci
ón 
Dominic
ana Pro-
Bienesta
r de la 
Familia 
(PROFA
MILIA) 
CS/
PS: 
NG
O 
DMR-
708-
G03-T 
01/
10/
200
8 
297
517
6 
0 297
517
6 
297
517
6 
0 297
517
6 
30/
09/
201
0 
Do
mini
can 
Rep
ubli
7 TB Subsecre
taria de 
Estado 
de Salud 
Colectiva 
Gov
: 
MO
H 
DMR-
708-
G08-T 
01/
10/
200
8 
267
484
6 
213
892
6.01 
481
377
2.01 
180
163
4.26 
0 180
163
4.3 
30/
04/
201
3 
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c at the 
Ministry 
of Public 
Health 
and 
Welfare 
Do
mini
can 
Rep
ubli
c 
8 Ma
lari
a 
Centro 
Nacional 
de 
Control 
de 
Enferme
dades 
Tropical
es/Servic
io 
Nacional 
de 
Erradica
cion de 
la 
Malaria 
(CENCET
) 
Gov
: 
MO
H 
DMR-
809-
G06-
M 
01/
10/
200
9 
246
131
6 
726
979 
318
829
5 
246
131
6 
546
05.4
8 
251
592
1.5 
30/
09/
201
4 
Do
mini
can 
Rep
ubli
c 
8 Ma
lari
a 
Instituto 
Dermato
logico y 
Cirugia 
de Piel 
CS/
PS: 
NG
O 
DMR-
809-
G05-
M 
01/
10/
200
9 
149
419
0 
841
378 
233
556
8 
149
419
0 
146
052.
11 
164
024
2.1 
30/
09/
201
4 
Ecu
ado
r 
2 HIV
/AI
DS 
The 
Ministry 
of Public 
Health 
of the 
Republic 
of 
Ecuador 
Gov
: 
MO
H 
ECU-
202-
G01-
H-00 
01/
03/
200
5 
555
766
5 
381
603
3.36 
937
369
8.36 
555
766
5 
381
603
3.35 
937
369
8.4 
28/
02/
201
1 
Ecu
ado
r 
2 HIV
/AI
DS 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
ECU-
202-
G03-
H-00 
01/
06/
200
6 
189
156
0 
246
438
5.01 
435
594
5.01 
189
156
0 
240
178
1.33 
429
334
1.3 
28/
02/
201
0 
Ecu
ado
r 
4 TB CARE 
Internati
onal 
CS/
PS: 
NG
O 
ECU-
405-
G02-T 
01/
11/
200
5 
890
145
6 
675
536
6.02 
156
568
22.0
2 
890
145
6 
675
536
6 
156
568
22 
31/
10/
201
0 
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El 
Salv
ado
r 
2 HIV
/AI
DS 
Ministry 
of 
Health El 
Salvador 
Gov
: 
MO
H 
SLV-
202-
G03-
H-00 
01/
11/
200
6 
0 218
011
6.02 
437
977
4.06 
0 218
011
6.02 
437
977
4.1 
30/
09/
201
1 
El 
Salv
ado
r 
2 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SLV-
202-
G01-
H-00 
01/
08/
200
3 
128
567
29 
517
661
5.04 
249
122
30.9
4 
128
567
29 
517
661
5.04 
249
122
31 
30/
09/
201
1 
El 
Salv
ado
r 
2 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SLV-
202-
G02-T-
00 
01/
12/
200
3 
191
834
4 
317
044.
87 
223
538
8.87 
191
834
4 
317
044.
85 
223
538
8.9 
31/
03/
200
7 
El 
Salv
ado
r 
2 TB Ministry 
of 
Health El 
Salvador 
Gov
: 
MO
H 
SLV-
202-
G04-T-
00 
01/
11/
200
6 
0 154
283
6.03 
154
283
6.03 
0 154
201
5 
154
201
5 
30/
09/
200
9 
El 
Salv
ado
r 
7 HIV
/AI
DS 
Ministry 
of 
Health El 
Salvador 
Gov
: 
MO
H 
SLV-
708-
G05-H 
01/
10/
200
8 
562
990
6 
0 562
990
6 
562
990
5.4 
0 562
990
5.4 
30/
09/
201
1 
El 
Salv
ado
r 
7 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SLV-
708-
G06-H 
01/
10/
200
8 
801
360
6.44 
0 801
360
6.44 
801
360
6.44 
0 801
360
6.4 
30/
09/
201
1 
Gua
tem
ala 
3 HIV
/AI
DS 
World 
Vision 
Internati
onal 
CS/
PS: 
NG
O 
GUA-
304-
G01-H 
01/
12/
200
4 
842
380
7 
326
712
18.4 
410
950
25.4 
842
380
7 
326
712
18.3
8 
410
950
25 
30/
09/
201
0 
Gua
tem
ala 
4 Ma
lari
a 
World 
Vision 
Internati
onal 
CS/
PS: 
NG
O 
GUA-
405-
G02-
M 
01/
09/
200
5 
924
697
5 
362
397
7.22 
128
709
52.2
2 
924
697
5 
350
662
5.47 
127
536
00 
31/
08/
201
0 
Gua
tem
ala 
6 TB World 
Vision 
Internati
onal 
CS/
PS: 
NG
O 
GUA-
607-
G03-T 
01/
08/
200
7 
346
930
8.05 
0 346
930
8.05 
346
930
8.05 
0 346
930
8.1 
31/
01/
201
0 
Guy
ana 
3 Ma
lari
a 
The 
Ministry 
of 
Health 
Gov
: 
MO
H 
GYA-
304-
G02-
M 
01/
01/
200
5 
205
567
5 
740
44.0
2 
247
330
1.04 
205
567
5 
740
44.0
2 
247
330
0.8 
31/
08/
201
3 
    168 
of 
Guyana 
Guy
ana 
3 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of 
Guyana 
Gov
: 
MO
H 
GYA-
304-
G01-H 
01/
01/
200
5 
888
168
6 
112
691
86.0
1 
341
094
47.0
3 
888
168
6 
112
691
86.0
1 
265
298
85 
31/
03/
201
3 
Guy
ana 
4 TB The 
Ministry 
of 
Health 
of 
Guyana 
Gov
: 
MO
H 
GYA-
405-
G03-T 
01/
10/
200
5 
701
125 
406
616.
01 
110
774
1.01 
701
125 
403
355.
08 
110
448
0.1 
30/
09/
201
0 
Guy
ana 
7 Ma
lari
a 
The 
Ministry 
of 
Health 
of 
Guyana 
Gov
: 
MO
H 
GYA-
708-
G04-
M 
01/
05/
200
9 
120
791
6.46 
0 120
791
6.46 
120
791
6.46 
0 120
791
6.5 
31/
08/
201
1 
Hait
i 
1 HIV
/AI
DS 
Fondatio
n 
SOGEBA
NK 
CS/
PS: 
PS 
HTI-
102-
G01-
H-00 
01/
01/
200
3 
256
018
03.9
4 
831
927
11.0
3 
123
597
042.
1 
256
018
03.9
4 
831
927
11.0
3 
114
761
089 
31/
12/
201
0 
Hait
i 
1 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
HTI-
102-
G02-
H-00 
01/
01/
200
3 
614
038
6 
0 614
038
6 
614
038
6 
0 614
038
6 
31/
10/
200
5 
Hait
i 
3 Ma
lari
a 
Fondatio
n 
SOGEBA
NK 
CS/
PS: 
PS 
HTI-
304-
G03-
M 
01/
08/
200
4 
739
055
6 
624
195
2.02 
136
325
08.0
2 
739
055
6 
545
498
4 
128
455
40 
30/
09/
200
9 
Hait
i 
3 TB Fondatio
n 
SOGEBA
NK 
CS/
PS: 
PS 
HTI-
304-
G04-T 
01/
08/
200
4 
813
183
6 
590
282
9.02 
140
346
65.0
2 
813
183
6 
555
106
5.17 
136
829
01 
16/
05/
201
1 
Hait
i 
5 HIV
/AI
DS 
Fondatio
n 
SOGEBA
NK 
CS/
PS: 
PS 
HTI-
506-
G05-H 
01/
01/
200
7 
188
217
54.0
6 
0 188
217
54.0
6 
188
217
54.0
6 
0 188
217
54 
31/
12/
200
8 
Hait
i 
7 HIV
/AI
DS 
Fondatio
n 
SOGEBA
NK 
CS/
PS: 
PS 
HTI-
708-
G06-H 
01/
11/
200
8 
619
955
4 
0 619
955
4 
350
332
1 
0 350
332
1 
31/
10/
201
0 
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Hon
dur
as 
1 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
HND-
102-
G03-
M-00 
01/
05/
200
3 
409
605
0 
303
157
3.18 
712
762
3.18 
409
605
0 
303
157
3.18 
712
762
3.3 
30/
04/
200
8 
Hon
dur
as 
1 Ma
lari
a 
Coopera
tive 
Housing 
Foundati
on, 
(d/b/a 
CHF 
Internati
onal) 
CS/
PS: 
Oth 
HND-
102-
G05-
M-00 
01/
05/
200
8 
0 726
096.
01 
484
997
5.03 
0 726
096.
01 
375
368
2.1 
31/
12/
201
4 
Hon
dur
as 
1 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
HND-
102-
G02-T-
00 
01/
05/
200
3 
379
050
0 
231
917
3.02 
610
967
3.02 
379
050
0 
230
440
0.09 
609
490
0.1 
30/
04/
200
8 
Hon
dur
as 
1 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
HND-
102-
G01-
H-00 
01/
05/
200
3 
130
449
67 
134
829
25.3
1 
265
278
92.3
1 
130
449
67 
134
829
25.2
6 
265
278
92 
30/
04/
200
8 
Jam
aica 
3 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Jamaica 
Gov
: 
MO
H 
JAM-
304-
G01-H 
01/
06/
200
4 
756
036
5 
152
946
94.0
1 
228
550
59.0
1 
756
036
5 
152
946
94 
228
550
59 
31/
05/
200
9 
Jam
aica 
7 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Jamaica 
Gov
: 
MO
H 
JAM-
708-
G02-H 
01/
08/
200
8 
158
093
30 
156
335
30.0
1 
314
428
60.0
1 
158
093
30 
156
335
30.0
1 
314
428
60 
31/
07/
201
3 
Nica
rag
ua 
2 HIV
/AI
DS 
Federaci
ón Red 
NICASAL
CS/
PS: 
NG
NIC-
202-
G03-
01/
03/
200
402
568
9 
579
959
3.86 
982
528
2.86 
402
568
9 
579
959
3.81 
982
528
2.8 
28/
02/
201
    170 
UD O H-00 4 0 
Nica
rag
ua 
2 Ma
lari
a 
Federaci
ón Red 
NICASAL
UD 
CS/
PS: 
NG
O 
NIC-
202-
G01-
M-00 
01/
03/
200
4 
340
467
1 
217
141
6.42 
557
608
7.42 
340
467
1 
217
141
6.38 
557
608
7.4 
28/
02/
200
9 
Nica
rag
ua 
2 TB Federaci
ón Red 
NICASAL
UD 
CS/
PS: 
NG
O 
NIC-
202-
G02-T-
00 
01/
03/
200
4 
127
182
0 
135
088
1.14 
262
270
1.14 
127
182
0 
135
088
1.1 
262
270
1.1 
28/
02/
200
9 
Nica
rag
ua 
7 Ma
lari
a 
Federaci
ón Red 
NICASAL
UD 
CS/
PS: 
NG
O 
NIC-
708-
G04-
M 
01/
04/
200
9 
286
854
2 
158
799
4 
445
653
6 
286
854
2 
832
018 
370
056
0 
31/
03/
201
4 
Nica
rag
ua 
8 HIV
/AI
DS 
Instituto 
Nicaragu
ense de 
Segurida
d Social 
(INSS) 
CS/
PS: 
NG
O 
NIC-
809-
G06-H 
01/
01/
201
0 
233
590
81 
0 233
590
81 
196
110
71 
0 196
110
71 
31/
03/
201
2 
Pan
ama 
1 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
PAN-
102-
G01-T-
00 
01/
04/
200
3 
440
000 
113
816.
56 
553
816.
56 
440
000 
113
816.
54 
553
816
.54 
31/
03/
200
5 
Par
agu
ay 
3 TB Alter 
Vida - 
Centro 
de 
Estudios 
y 
Formaci
ón para 
el 
Ecodesar
rollo 
CS/
PS: 
NG
O 
PRY-
304-
G01-T 
01/
12/
200
4 
119
490
2.04 
160
464
3.01 
332
920
0.09 
119
490
2.04 
160
464
3.01 
332
920
0 
30/
11/
201
2 
Par
agu
ay 
6 HIV
/AI
DS 
FUNDAC
ION 
COMUNI
TARIA 
CENTRO 
DE 
INFORM
ACION Y 
RECURS
OS PARA 
CS/
PS: 
NG
O 
PRY-
607-
G02-H 
01/
06/
200
7 
347
189
2 
536
022
5.01 
883
211
7.01 
347
189
2 
477
881
7 
825
070
9 
31/
05/
201
2 
    171 
EL 
DESARR
OLLO 
(CIRD) 
Par
agu
ay 
7 TB Alter 
Vida - 
Centro 
de 
Estudios 
y 
Formaci
ón para 
el 
Ecodesar
rollo 
CS/
PS: 
NG
O 
PRY-
708-
G03-T 
01/
07/
200
8 
214
920
6 
0 214
920
6 
214
920
6 
0 214
920
6 
30/
06/
201
0 
Par
agu
ay 
8 HIV
/AI
DS 
FUNDAC
ION 
COMUNI
TARIA 
CENTRO 
DE 
INFORM
ACION Y 
RECURS
OS PARA 
EL 
DESARR
OLLO 
(CIRD) 
CS/
PS: 
NG
O 
PRY-
809-
G04-H 
01/
09/
200
9 
473
522
3.90
8 
178
459
3.58
6 
651
981
7.49
4 
473
522
3.90
8 
583
736.
472 
531
896
0.4 
31/
08/
201
4 
Per
u 
2 HIV
/AI
DS 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
PER-
202-
G01-
H-00 
04/
11/
200
3 
157
183
54 
562
877
9.77 
213
471
33.7
7 
157
183
54 
562
877
9.74 
213
471
34 
31/
12/
200
8 
Per
u 
2 TB CARE 
Internati
onal 
CS/
PS: 
NG
O 
PER-
202-
G02-T-
00 
01/
12/
200
3 
201
538
18 
487
336
4.26 
250
271
82.2
6 
201
538
18 
487
336
4.22 
250
271
82 
31/
12/
200
8 
Per
u 
5 TB CARE 
Internati
onal 
CS/
PS: 
NG
O 
PER-
506-
G04-T 
01/
09/
200
6 
136
030
65 
160
682
99.0
1 
296
713
64.0
1 
136
030
65 
143
257
48.5
2 
279
288
14 
30/
09/
201
1 
Per
u 
5 HIV
/AI
DS 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
PER-
506-
G03-H 
01/
09/
200
6 
806
144
2 
480
602
3.01 
128
674
65.0
1 
806
144
2 
394
126
8.84 
120
027
11 
30/
09/
201
1 
Per 6 HIV CARE CS/ PER- 01/ 241 851 326 241 590 300 30/
    172 
u /AI
DS 
Internati
onal 
PS: 
NG
O 
607-
G05-H 
10/
200
7 
536
62 
614
7.01 
698
09.0
1 
536
62 
793
0.94 
615
93 
09/
201
2 
Suri
na
me 
3 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Surinam
e 
Gov
: 
MO
H 
SUR-
305-
G01-H 
01/
02/
200
5 
218
843
2 
308
296
1.02 
527
139
3.02 
218
843
2 
301
856
5.84 
520
699
7.8 
31/
01/
201
2 
Suri
na
me 
4 Ma
lari
a 
Medisch
e 
Zending 
- Primary 
Health 
Care 
Surinam
e 
CS/
PS: 
NG
O 
SUR-
404-
G02-
M 
01/
02/
200
5 
296
395
0 
169
822
3.88 
466
217
3.88 
296
395
0 
169
822
3.86 
466
217
3.9 
31/
10/
201
0 
Suri
na
me 
5 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Surinam
e 
Gov
: 
MO
H 
SUR-
506-
G03-H 
01/
02/
200
7 
239
500
0 
144
370
6.01 
383
870
6.01 
239
500
0 
114
747
8.17 
354
247
8.2 
31/
01/
201
2 
Suri
na
me 
7 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Surinam
Gov
: 
MO
H 
SUR-
708-
G04-
M 
01/
04/
200
9 
262
174
7 
779
661 
340
140
8 
262
174
7 
271
118 
289
286
5 
31/
03/
201
4 
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e 
Alge
ria 
3 HIV
/AI
DS 
The 
Ministry 
of 
Health, 
Populati
on and 
Hospital 
Reform 
of the 
Govern
ment of 
the 
People's 
Democra
tic 
Republic 
of 
Algeria 
Gov
: 
MO
H 
DZA-
304-
G01-H 
01/
01/
200
5 
618
500
0 
760
288.
95 
694
528
8.95 
618
500
0 
760
288.
93 
694
528
8.9 
30/
06/
200
8 
Cha
d 
2 TB The 
Fonds de 
Soutien 
aux 
Activités 
en 
matière 
de 
Populati
on(FOSA
P) 
Gov
: 
Oth 
TCD-
202-
G01-T-
00 
01/
05/
200
4 
126
396
3 
177
535
8.01 
303
932
1.01 
126
396
3 
111
652
2.26 
238
048
5.3 
30/
04/
201
0 
Cha
d 
3 HIV
/AI
DS 
The 
Fonds de 
Soutien 
aux 
Activités 
en 
matière 
de 
Populati
on(FOSA
P) 
Gov
: 
Oth 
TCD-
304-
G02-H 
01/
08/
200
4 
738
015
6 
104
031
88.0
1 
177
833
44.0
1 
738
015
6 
600
532
7.03 
133
854
83 
31/
07/
201
0 
Cha
d 
7 Ma
lari
a 
United 
Nations 
Develop
MO
: 
UN
TCD-
708-
G03-
01/
03/
200
104
776
31 
0 104
776
31 
911
047
2.11 
0 911
047
2.1 
30/
06/
201
    174 
ment 
Program
me 
DP M 9 1 
Cha
d 
8 HIV
/AI
DS 
National 
Union of 
Diocesan 
Associati
ons 
(UNAD) 
CS/
PS: 
NG
O 
TCD-
810-
G06-H 
01/
01/
201
0 
697
609
4.42
9 
0 697
609
4.42
9 
331
215
2.61 
0 331
215
2.6 
31/
12/
201
1 
Cha
d 
8 HIV
/AI
DS 
Associati
on of 
Social 
Marketi
ng in 
Chad 
(AMASO
T) 
CS/
PS: 
NG
O 
TCD-
810-
G04-H 
01/
01/
201
0 
598
943
1.71
2 
0 598
943
1.71
2 
326
729
8.13 
0 326
729
8.1 
31/
12/
201
1 
Cha
d 
8 HIV
/AI
DS 
The 
Fonds de 
Soutien 
aux 
Activités 
en 
matière 
de 
Populati
on(FOSA
P) 
Gov
: 
Oth 
TCD-
810-
G05-H 
01/
01/
201
0 
210
132
57.2
8 
0 210
132
57.2
8 
126
687
00.8
2 
0 126
687
01 
31/
12/
201
1 
Djib
outi 
4 HIV
/AI
DS 
Executiv
e 
secretari
at for 
the fight 
against 
AIDS, 
Malaria 
and 
Tubercul
osis 
Gov
: 
MO
H 
DJB-
404-
G01-H 
01/
03/
200
5 
727
140
0 
434
690
1.01 
116
183
01.0
1 
727
140
0 
434
690
1.01 
116
183
01 
30/
04/
200
8 
Djib
outi 
6 TB Executiv
e 
secretari
at for 
the fight 
against 
AIDS, 
Gov
: 
MO
H 
DJB-
607-
G03-T 
01/
06/
200
7 
226
909
8 
0 226
909
8 
178
497
3.29 
0 178
497
3.3 
31/
05/
200
9 
    175 
Malaria 
and 
Tubercul
osis 
Djib
outi 
6 Ma
lari
a 
Executiv
e 
secretari
at for 
the fight 
against 
AIDS, 
Malaria 
and 
Tubercul
osis 
Gov
: 
MO
H 
DJB-
607-
G02-
M 
01/
06/
200
7 
300
738
8 
0 300
738
8 
287
116
4 
0 287
116
4 
31/
05/
200
9 
Djib
outi 
6 HIV
/AI
DS 
Executiv
e 
secretari
at for 
the fight 
against 
AIDS, 
Malaria 
and 
Tubercul
osis 
Gov
: 
MO
H 
DJB-
607-
G04-H 
01/
06/
200
7 
788
667
1.77 
0 788
667
1.77 
645
350
4.34 
0 645
350
4.3 
31/
05/
200
9 
Egy
pt 
2 TB National 
Tubercul
osis 
Control 
Program
, The 
Ministry 
of 
Health 
and 
Populati
on of the 
Govern
ment of 
Egypt 
Gov
: 
MO
H 
EGY-
202-
G01-T-
00 
01/
07/
200
4 
248
021
9 
155
179
5.01 
403
201
4.01 
248
021
9 
148
513
0.24 
396
534
9.2 
30/
06/
200
9 
Egy
pt 
6 HIV
/AI
DS 
National 
AIDS 
Program
me, 
Ministry 
Gov
: 
MO
H 
EGY-
608-
G03-H 
01/
04/
200
8 
532
088
0 
322
252
6.01 
854
340
6.01 
532
088
0 
196
591
0 
728
679
0 
31/
03/
201
3 
    176 
of 
Health 
and 
Populati
on 
Egy
pt 
6 TB National 
Tubercul
osis 
Control 
Program
, The 
Ministry 
of 
Health 
and 
Populati
on of the 
Govern
ment of 
Egypt 
Gov
: 
MO
H 
EGY-
607-
G02-T 
01/
09/
200
7 
537
554
8 
412
408
0.01 
949
962
8.01 
537
554
8 
187
064
4.8 
724
619
2.8 
31/
08/
201
2 
Iraq 6 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
IRQ-
607-
G01-T 
01/
01/
200
8 
644
390
0 
500
159
5.02 
114
454
95.0
2 
644
390
0 
500
159
5 
114
454
95 
30/
09/
201
0 
Jord
an 
2 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Hashemi
te 
Kingdom 
of 
Jordan 
Gov
: 
MO
H 
JOR-
202-
G01-
H-00 
01/
11/
200
3 
177
860
0 
648
808.
26 
242
740
8.26 
177
860
0 
648
808.
24 
242
740
8.2 
31/
10/
200
6 
Jord
an 
5 TB Ministry 
of 
Health / 
National 
Tubercul
osis 
Program 
Gov
: 
MO
H 
JOR-
506-
G02-T 
01/
07/
200
6 
107
286
4 
171
000
0.01 
278
286
4.01 
107
286
4 
171
000
0 
278
286
4 
30/
06/
201
1 
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Jord
an 
6 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Hashemi
te 
Kingdom 
of 
Jordan 
Gov
: 
MO
H 
JOR-
607-
G03-H 
01/
07/
200
7 
306
950
8 
292
715
0.01 
599
665
8.01 
306
950
8 
198
959
6.23 
505
910
4.2 
30/
06/
201
2 
Mal
i 
1 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Mali 
Gov
: 
MO
H 
MAL-
102-
G01-
M-00 
01/
12/
200
3 
202
342
4 
568
892.
01 
259
231
6.01 
202
342
4 
568
892 
259
231
6 
30/
04/
200
7 
Mal
i 
4 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Mali 
Gov
: 
MO
H 
MAL-
405-
G03-T 
01/
08/
200
5 
256
376
8 
418
384
2.01 
674
761
0.01 
256
376
8 
250
953
1.97 
507
330
0 
31/
01/
201
1 
Mal
i 
4 HIV
/AI
DS 
The 
National 
High 
Council 
for 
HIV/AID
S control 
of the 
governm
ent of 
the 
Republic 
of Mali 
Gov
: 
Oth 
MAL-
405-
G02-H 
01/
07/
200
5 
234
832
34 
288
572
02.0
1 
523
404
36.0
1 
234
832
34 
217
054
17.6
1 
451
886
52 
30/
06/
201
0 
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Mal
i 
6 Ma
lari
a 
Groupe 
Pivot 
Santé 
Populati
on 
CS/
PS: 
NG
O 
MAL-
607-
G05-
M 
01/
09/
200
7 
588
619
0 
896
524
2.01 
148
514
32.0
1 
588
619
0 
424
104
0 
101
272
30 
31/
08/
201
2 
Mal
i 
6 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Mali 
Gov
: 
MO
H 
MAL-
607-
G04-
M 
01/
11/
200
7 
333
638
2 
0 333
638
2 
255
598
8.99 
0 255
598
9 
30/
04/
201
0 
Mal
i 
7 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Mali 
Gov
: 
MO
H 
MAL-
708-
G06-T 
01/
08/
200
8 
424
890
8.31
6 
0 424
890
8.31
6 
288
041
6.72 
0 288
041
6.7 
31/
07/
201
0 
Mal
i 
8 HIV
/AI
DS 
The 
National 
High 
Council 
for 
HIV/AID
S control 
of the 
governm
ent of 
the 
Republic 
of Mali 
Gov
: 
Oth 
MAL-
809-
G08-H 
01/
01/
201
0 
271
208
67.4
5 
0 271
208
67.4
5 
171
482
82.6 
0 171
482
83 
31/
03/
201
2 
Mal
i 
8 HIV
/AI
DS 
Groupe 
Pivot 
Santé 
Populati
on 
CS/
PS: 
NG
O 
MAL-
809-
G07-H 
01/
01/
201
0 
129
317
14.8
6 
0 129
317
14.8
6 
437
833
0.49 
0 437
833
0.5 
31/
12/
201
1 
Ma
urit
ania 
2 Ma
lari
a 
United 
Nations 
Develop
MO
: 
UN
MRT-
202-
G02-
01/
04/
200
824
044 
207
494
9.01 
289
899
3.01 
824
044 
122
711
7.31 
205
116
1.3 
31/
03/
200
    179 
ment 
Program
me 
DP M-00 4 9 
Ma
urit
ania 
2 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
MRT-
202-
G01-T-
00 
01/
05/
200
4 
110
474
2 
162
314
7.01 
272
788
9.01 
110
474
2 
130
148
3.37 
240
622
5.4 
31/
03/
200
9 
Ma
urit
ania 
5 HIV
/AI
DS 
Sécretari
at 
Exécutif, 
Comité 
National 
de Lutte 
Contre 
le SIDA 
Gov
: 
Oth 
MRT-
506-
G03-H 
01/
09/
200
6 
657
341
6 
853
785
7.01 
151
112
73.0
1 
267
105
2.12 
0 267
105
2.1 
30/
08/
201
1 
Ma
urit
ania 
6 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
MRT-
607-
G05-T 
01/
12/
200
7 
444
168
6 
0 444
168
6 
360
332
8.01 
0 360
332
8 
30/
11/
201
0 
Ma
urit
ania 
6 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
MRT-
607-
G04-
M 
01/
12/
200
7 
431
512
6 
0 431
512
6 
296
042
6.36 
0 296
042
6.4 
30/
11/
201
0 
Mor
occ
o 
1 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Kingdom 
of 
Morocco 
Gov
: 
MO
H 
MOR-
102-
G01-
H-00 
01/
03/
200
3 
473
880
6 
449
185
5.61 
923
066
1.61 
473
880
6 
449
185
5.59 
923
066
1.6 
28/
02/
200
7 
Mor
occ
o 
6 TB The 
Ministry 
of 
Health 
of the 
Govern
Gov
: 
MO
H 
MOR-
607-
G03-T 
01/
07/
200
7 
222
197
5 
193
582
5.01 
415
780
0.01 
222
197
5 
108
036
9.34 
330
234
4.3 
30/
06/
201
2 
    180 
ment of 
the 
Kingdom 
of 
Morocco 
Mor
occ
o 
6 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Kingdom 
of 
Morocco 
Gov
: 
MO
H 
MOR-
607-
G02-H 
01/
07/
200
7 
106
807
98 
141
958
01.0
1 
248
765
99.0
1 
106
807
98 
118
921
38.2
6 
225
729
36 
30/
06/
201
2 
Nig
er 
3 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
NGR-
306-
G06-
M 
01/
12/
200
6 
391
956 
896
675.
15 
128
863
1.15 
391
956 
896
675.
15 
128
863
1.5 
30/
11/
200
7 
Nig
er 
3 Ma
lari
a 
Centre 
of 
Internati
onal 
Coopera
tion in 
Health 
and 
Develop
ment 
(CCISD) 
CS/
PS: 
NG
O 
NGR-
304-
G02-
M 
01/
09/
200
4 
431
719
0.43 
0 431
719
0.43 
431
719
0.03 
0 431
719
0 
30/
09/
200
6 
Nig
er 
3 HIV
/AI
DS 
The 
National 
Multi-
sectorial 
Coordina
tion Unit 
for the 
Fight 
Against 
HIV/AID
S/STI of 
the 
Govern
Gov
: 
Oth 
NGR-
304-
G01-H 
01/
09/
200
4 
847
529
7 
194
456
5.73 
104
198
62.7
3 
847
529
7 
194
456
5.72 
104
198
63 
28/
02/
200
8 
    181 
ment of 
the 
Republic 
of Niger 
Nig
er 
4 Ma
lari
a 
The 
Internati
onal 
Federati
on of 
Red 
Cross 
and Red 
Crescent 
Societies 
MO
: 
Oth 
NGR-
405-
G03-
M 
01/
07/
200
5 
111
897
39 
0 111
897
39 
111
897
39 
0 111
897
39 
30/
06/
200
7 
Nig
er 
5 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
NGR-
506-
G05-T 
01/
07/
200
6 
716
759
8.40
4 
604
782
2.68
6 
132
154
21.0
9 
716
759
8.40
4 
367
016
6.55
6 
108
377
65 
30/
06/
201
1 
Nig
er 
5 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
NGR-
506-
G04-
M 
01/
07/
200
6 
462
743
4 
666
507
5.02 
112
925
09.0
2 
462
743
4 
432
344
9.38 
895
088
3.4 
30/
06/
201
1 
Nig
er 
7 HIV
/AI
DS 
The 
National 
Multi-
sectorial 
Coordina
tion Unit 
for the 
Fight 
Against 
HIV/AID
S/STI of 
the 
Govern
ment of 
the 
Republic 
of Niger 
Gov
: 
Oth 
NGR-
708-
G08-H 
01/
07/
200
8 
140
945
47.9
3 
152
778
42.3
4 
293
723
90.2
7 
140
945
47.9
3 
365
224
5.31
7 
177
467
93 
30/
06/
201
3 
Nig
er 
7 Ma
lari
Catholic 
Relief 
CS/
PS: 
NGR-
708-
01/
07/
312
452
417
577
354
209
309
677
0 309
677
30/
06/
    182 
a Services FBO G07-
M 
200
8 
16.7
3 
3.18
7 
89.9
1 
53 53 201
3 
Som
alia 
2 Ma
lari
a 
United 
Nations 
Children'
s Fund 
MO
: 
Oth 
SOM-
202-
G01-
M-00 
01/
07/
200
4 
889
049
7 
399
591
6.01 
128
864
13.0
1 
889
049
7 
399
591
6 
128
864
13 
31/
08/
200
7 
Som
alia 
3 TB World 
Vision 
Internati
onal 
CS/
PS: 
NG
O 
SOM-
304-
G02-T 
16/
08/
200
4 
560
121
5 
822
413
6.01 
138
253
51.0
1 
560
121
5 
806
022
8.49 
136
614
43 
31/
01/
201
0 
Som
alia 
4 HIV
/AI
DS 
United 
Nations 
Children'
s Fund 
MO
: 
Oth 
SOM-
405-
G03-H 
01/
06/
200
5 
100
046
44 
149
173
63.0
1 
249
220
07.0
1 
100
046
44 
140
930
96.6
8 
240
977
41 
31/
08/
201
0 
Som
alia 
6 Ma
lari
a 
United 
Nations 
Children'
s Fund 
MO
: 
Oth 
SOM-
607-
G04-
M 
01/
11/
200
7 
157
358
67 
926
016
6.01 
249
960
33.0
1 
157
358
67 
696
864
9.61 
227
045
17 
31/
10/
201
2 
Som
alia 
7 TB World 
Vision 
Internati
onal 
CS/
PS: 
NG
O 
SOM-
708-
G05-T 
01/
10/
200
8 
873
284
4 
895
872
3.01 
176
915
67.0
1 
873
284
4 
895
872
2.06 
176
915
66 
31/
12/
201
2 
Som
alia 
8 HIV
/AI
DS 
United 
Nations 
Children'
s Fund 
MO
: 
Oth 
SOM-
809-
G06-H 
01/
01/
201
0 
263
167
53 
0 263
167
53 
225
328
29.5
2 
0 225
328
30 
31/
03/
201
2 
Sou
th 
Sud
an 
2 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SSD-
202-
G02-T-
00 
01/
10/
200
4 
584
293
2 
865
515
5.01 
144
980
87.0
1 
584
293
2 
865
515
5 
144
980
87 
31/
03/
201
0 
Sou
th 
Sud
an 
2 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SSD-
202-
G01-
M-00 
01/
10/
200
4 
128
554
90 
122
121
70.0
1 
250
676
60.0
1 
128
554
90 
122
121
70 
250
676
60 
30/
09/
201
0 
Sou
th 
Sud
an 
4 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SSD-
405-
G05-H 
01/
08/
200
6 
881
717
0 
181
181
95.0
1 
269
353
65.0
1 
881
717
0 
179
624
43.8
6 
267
796
14 
30/
11/
201
1 
Sou
th 
5 TB United 
Nations 
MO
: 
SSD-
506-
01/
10/
857
245
130
412
216
137
857
245
114
187
199
912
31/
03/
    183 
Sud
an 
Develop
ment 
Program
me 
UN
DP 
G06-T 200
6 
7 97.0
1 
54.0
1 
7 76 33 201
2 
Sou
th 
Sud
an 
7 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SSD-
708-
G11-T 
01/
01/
200
9 
617
280
5 
500
020
8.01 
111
730
13.0
1 
617
280
5 
260
631
2.99 
877
911
8 
31/
12/
201
3 
Sou
th 
Sud
an 
7 Ma
lari
a 
POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
PS: 
NG
O 
SSD-
708-
G09-
M 
01/
12/
200
8 
335
128
96 
218
202
38 
553
331
34 
335
128
96 
218
202
38 
553
331
34 
30/
11/
201
3 
Sud
an 
2 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SUD-
202-
G03-
M-00 
01/
04/
200
5 
142
378
53 
188
401
89.3
3 
330
780
42.3
3 
142
378
53 
188
401
89.3
2 
330
780
42 
30/
09/
200
9 
Sud
an 
3 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SUD-
305-
G04-H 
01/
04/
200
5 
784
214
0 
121
859
09.7
1 
200
280
49.7
1 
784
214
0 
121
859
09.7 
200
280
50 
30/
09/
201
0 
Sud
an 
5 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SUD-
506-
G08-H 
01/
01/
200
7 
294
211
45 
555
548
90.0
1 
849
760
35.0
1 
294
211
45 
386
987
65 
681
199
10 
30/
06/
201
2 
Sud
an 
5 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SUD-
506-
G07-T 
01/
01/
200
7 
683
001
3 
485
490
4.02 
116
849
17.0
2 
683
001
3 
485
490
4 
116
849
17 
31/
12/
201
1 
Sud
an 
7 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SUD-
708-
G10-
M 
01/
04/
200
9 
382
968
73 
266
402
57 
649
371
30 
382
968
73 
119
962
51 
502
931
24 
31/
03/
201
4 
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Sud
an 
8 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SUD-
809-
G12-T 
01/
01/
201
0 
388
631
4 
0 388
631
4 
388
631
4 
0 388
631
4 
31/
12/
201
1 
Syri
an 
Ara
b 
Rep
ubli
c 
6 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
SYR-
607-
G01-T 
01/
12/
200
7 
457
804
7 
279
907
8.01 
737
712
5.01 
457
804
7 
133
851
0.47 
591
655
7.5 
30/
11/
201
2 
Tuni
sia 
6 HIV
/AI
DS 
National 
Office 
for 
Family 
and 
Populati
on 
(Office 
National 
de la 
famille 
et de la 
populati
on) - 
ONFP 
Gov
: 
MO
H 
TUN-
607-
G01-H 
01/
09/
200
7 
956
550
0 
661
484
6.01 
161
803
46.0
1 
956
550
0 
477
101
3.08 
143
365
13 
31/
08/
201
2 
Wes
t 
Ban
k 
and 
Gaz
a 
7 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
PSE-
708-
G01-H 
01/
12/
200
8 
501
433
0 
330
581
5 
832
014
5 
491
168
7.26 
0 491
168
7.3 
30/
11/
201
3 
Wes
t 
Ban
k 
and 
Gaz
a 
8 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
PSE-
809-
G02-T 
01/
12/
200
9 
125
000
0.77 
0 125
000
0.77 
107
513
7.64 
0 107
513
7.6 
29/
02/
201
2 
Yem
en 
2 Ma
lari
a 
The 
National 
Malaria 
Program
Gov
: 
MO
H 
YEM-
202-
G01-
M-00 
01/
03/
200
4 
415
963
2 
771
857
4.01 
118
782
06.0
1 
415
963
2 
771
857
3.67 
118
782
06 
30/
04/
200
9 
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me at 
the 
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of Public 
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and 
Populati
on of the 
Republic 
of 
Yemen 
Yem
en 
3 HIV
/AI
DS 
National 
Populati
on 
Council - 
Technica
l 
Secretari
at 
Gov
: 
MO
H 
YEM-
305-
G03-H 
01/
07/
200
5 
164
505
6 
0 164
505
6 
164
505
6 
0 164
505
6 
30/
06/
200
7 
Yem
en 
3 HIV
/AI
DS 
The 
National 
AIDS 
Program 
Gov
: 
MO
H 
YEM-
305-
G02-H 
01/
07/
200
5 
224
700
2 
0 224
700
2 
224
700
2 
0 224
700
2 
30/
06/
200
7 
Yem
en 
3 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
YEM-
307-
G05-H 
01/
01/
200
8 
160
834
6 
936
068
5.01 
109
690
31.0
1 
160
834
6 
896
011
3 
105
684
59 
31/
12/
201
2 
Yem
en 
4 TB The 
National 
Tubercul
osis 
Control 
Program 
Gov
: 
MO
H 
YEM-
405-
G04-T 
01/
07/
200
5 
257
917
4 
355
068
6.83 
612
986
0.83 
257
917
4 
355
068
6.82 
612
986
0.8 
31/
12/
201
0 
Yem
en 
7 Ma
lari
a 
The 
National 
Malaria 
Program
me at 
the 
Ministry 
of Public 
Health 
and 
Populati
Gov
: 
MO
H 
YEM-
708-
G06-
M 
01/
12/
200
8 
801
369
4 
145
157
51 
225
294
45 
756
141
2.8 
0 756
141
2.8 
30/
11/
201
3 
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Afg
hani
stan 
2 HIV
/TB 
The 
Ministry 
of Public 
Health 
of the 
Islamic 
Republic 
of 
Afghanis
tan 
Gov
: 
MO
H 
AFG-
202-
G01-I-
00 
01/
12/
200
4 
312
560
5 
0 312
560
5 
312
560
5 
0 312
560
5 
30/
11/
200
6 
Afg
hani
stan 
4 TB The 
Ministry 
of Public 
Health 
of the 
Islamic 
Republic 
of 
Afghanis
tan 
Gov
: 
MO
H 
AFG-
405-
G02-T 
01/
09/
200
5 
0 267
896
0.64 
267
896
0.64 
0 267
896
0.64 
267
896
0.6 
28/
02/
200
9 
Afg
hani
stan 
5 Ma
lari
a 
HealthN
et TPO 
CS/
PS: 
NG
O 
AFG-
509-
G06-
M 
01/
02/
200
9 
0 717
187
1.31 
717
187
1.31 
0 717
187
1.31 
717
187
1.3 
04/
01/
201
0 
Afg
hani
stan 
5 Ma
lari
a 
The 
Ministry 
of Public 
Health 
of the 
Islamic 
Republic 
of 
Afghanis
tan 
Gov
: 
MO
H 
AFG-
506-
G03-
M 
01/
11/
200
6 
145
652
56 
346
288
3 
180
281
39 
145
652
56 
222
624
7.32 
167
915
03 
31/
10/
201
1 
Afg
hani
stan 
7 HIV
/AI
DS 
GTZ-IS 
(Gesellc
haft fur 
Technisc
he 
Zusamm
enarbeit 
- 
Gov
: 
Oth 
AFG-
708-
G05-H 
01/
10/
200
8 
413
116
7 
165
585
6 
578
702
3 
413
116
7 
314
862.
94 
444
602
9.9 
30/
09/
201
3 
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German 
Technica
l 
Coopera
tion - 
Internati
onal 
Services) 
Afg
hani
stan 
7 HIV
/AI
DS 
The 
Ministry 
of Public 
Health 
of the 
Islamic 
Republic 
of 
Afghanis
tan 
Gov
: 
MO
H 
AFG-
708-
G04-H 
01/
10/
200
8 
100
711
4 
205
796 
121
291
0 
766
097.
4 
0 766
097
.4 
30/
09/
201
3 
Afg
hani
stan 
8 TB BRAC 
AFGHAN
ISTAN 
CS/
PS: 
NG
O 
AFG-
809-
G07-T 
01/
10/
200
9 
100
627
75.3
8 
0 100
627
75.3
8 
689
813
0.56 
0 689
813
0.6 
30/
09/
201
1 
Ban
glad
esh 
2 HIV
/AI
DS 
Save the 
Children 
USA 
CS/
PS: 
NG
O 
BAN-
202-
G12-
H-00 
01/
12/
200
9 
0 151
898
02.5 
267
596
00.7
8 
0 151
898
02.5 
179
542
40 
30/
11/
201
2 
Ban
glad
esh 
2 HIV
/AI
DS 
The 
Economi
c 
Relation
s 
Division, 
Ministry 
of 
Finance, 
The 
Govern
ment of 
the 
People's 
Republic 
of 
Banglad
esh 
Gov
: 
MO
F 
BAN-
202-
G01-
H-00 
01/
03/
200
4 
601
014
0 
136
214
99 
196
316
39 
601
014
0 
136
214
99 
196
316
39 
31/
10/
200
9 
Ban
glad
3 TB BRAC 
(Banglad
CS/
PS: 
BAN-
304-
01/
08/
111
728
155
703
267
431
111
728
155
703
267
431
31/
07/
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esh esh 
Rural 
Advance
ment 
Committ
ee) 
NG
O 
G02-T 200
4 
46 00 46 46 00 46 200
9 
Ban
glad
esh 
3 TB The 
Economi
c 
Relation
s 
Division, 
Ministry 
of 
Finance, 
The 
Govern
ment of 
the 
People's 
Republic 
of 
Banglad
esh 
Gov
: 
MO
F 
BAN-
304-
G03-T 
01/
09/
200
4 
547
022
8 
471
513
9.58 
101
853
67.5
8 
547
022
8 
471
513
9.29 
101
853
67 
31/
08/
200
9 
Ban
glad
esh 
5 TB BRAC 
(Banglad
esh 
Rural 
Advance
ment 
Committ
ee) 
CS/
PS: 
NG
O 
BAN-
506-
G04-T 
01/
05/
200
6 
432
644
1 
184
149
27 
227
413
68 
432
644
1 
174
099
16 
217
363
57 
30/
06/
201
1 
Ban
glad
esh 
5 TB The 
Economi
c 
Relation
s 
Division, 
Ministry 
of 
Finance, 
The 
Govern
ment of 
the 
People's 
Gov
: 
MO
F 
BAN-
506-
G05-T 
01/
05/
200
6 
579
957
4 
147
600
34 
205
596
08 
579
957
4 
900
099
3.69 
148
005
68 
30/
04/
201
1 
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of 
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esh 
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glad
esh 
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DS 
The 
Economi
c 
Relation
s 
Division, 
Ministry 
of 
Finance, 
The 
Govern
ment of 
the 
People's 
Republic 
of 
Banglad
esh 
Gov
: 
MO
F 
BAN-
607-
G08-H 
01/
05/
200
7 
160
772
31 
413
899
2.26 
202
162
23.2
6 
160
772
31 
413
899
2.26 
202
162
23 
30/
04/
201
2 
Ban
glad
esh 
6 Ma
lari
a 
BRAC 
(Banglad
esh 
Rural 
Advance
ment 
Committ
ee) 
CS/
PS: 
NG
O 
BAN-
607-
G06-
M 
01/
05/
200
7 
761
556
2 
309
990
9 
107
154
71 
761
556
2 
309
990
9 
107
154
71 
30/
06/
201
0 
Ban
glad
esh 
6 Ma
lari
a 
The 
Economi
c 
Relation
s 
Division, 
Ministry 
of 
Finance, 
The 
Govern
ment of 
the 
People's 
Republic 
of 
Gov
: 
MO
F 
BAN-
607-
G07-
M 
01/
06/
200
7 
115
539
11 
254
879
2.81 
141
027
03.8
1 
115
539
11 
254
879
2.81 
141
027
04 
31/
05/
201
2 
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Banglad
esh 
Ban
glad
esh 
8 TB BRAC 
(Banglad
esh 
Rural 
Advance
ment 
Committ
ee) 
CS/
PS: 
NG
O 
BAN-
809-
G10-T 
01/
10/
200
9 
191
301
2 
0 191
301
2 
191
301
2 
0 191
301
2 
30/
09/
201
1 
Bhu
tan 
4 TB Gross 
National 
Happine
ss (GNH) 
Commiss
ion, 
Royal 
Govern
ment of 
Bhutan 
Gov
: 
Oth 
BTN-
405-
G02-T 
01/
04/
200
5 
560
568 
433
730 
994
298 
560
568 
372
402.
21 
932
970
.21 
31/
03/
201
0 
Bhu
tan 
4 Ma
lari
a 
Gross 
National 
Happine
ss (GNH) 
Commiss
ion, 
Royal 
Govern
ment of 
Bhutan 
Gov
: 
Oth 
BTN-
405-
G01-
M 
01/
04/
200
5 
100
095
7 
342
240.
81 
134
319
7.81 
100
095
7 
342
240.
81 
134
319
7.8 
31/
03/
201
0 
Bhu
tan 
6 TB Gross 
National 
Happine
ss (GNH) 
Commiss
ion, 
Royal 
Govern
ment of 
Bhutan 
Gov
: 
Oth 
BTN-
607-
G04-T 
01/
01/
200
8 
741
689 
341
225 
108
291
4 
741
689 
227
504.
33 
969
193
.33 
31/
12/
201
2 
Bhu
tan 
6 HIV
/AI
DS 
Gross 
National 
Happine
ss (GNH) 
Gov
: 
Oth 
BTN-
607-
G03-H 
01/
02/
200
8 
150
244
5 
942
408 
244
485
3 
150
244
5 
761
884.
66 
226
432
9.7 
31/
01/
201
3 
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Commiss
ion, 
Royal 
Govern
ment of 
Bhutan 
Bhu
tan 
7 Ma
lari
a 
Gross 
National 
Happine
ss (GNH) 
Commiss
ion, 
Royal 
Govern
ment of 
Bhutan 
Gov
: 
Oth 
BTN-
708-
G05-
M 
01/
07/
200
8 
204
698
6 
599
176 
264
616
2 
204
698
6 
383
274.
37 
243
026
0.4 
30/
06/
201
3 
Indi
a 
1 TB The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
India 
Gov
: 
Oth 
IDA-
102-
G01-T-
00 
01/
04/
200
3 
565
099
9 
259
942
2.02 
825
042
1.02 
565
099
9 
259
942
2 
825
042
1 
30/
09/
200
6 
Indi
a 
2 HIV
/AI
DS 
The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
India 
Gov
: 
Oth 
IDA-
202-
G02-
H-00 
01/
05/
200
4 
261
160
00 
802
492
33.0
2 
234
768
252 
261
160
00 
802
492
33.0
2 
190
363
835 
30/
11/
201
2 
Indi
a 
2 TB The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Gov
: 
Oth 
IDA-
202-
G03-T-
00 
01/
04/
200
4 
757
286
9.96 
409
657
06.9
8 
107
685
429.
1 
757
286
9.96 
409
657
06.9
8 
857
046
08 
31/
03/
201
2 
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Govern
ment of 
India 
Indi
a 
3 HIV
/TB 
The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
India 
Gov
: 
Oth 
IDA-
304-
G04-C 
01/
01/
200
5 
266
734
6 
121
524
26.0
1 
148
197
72.0
1 
266
734
6 
121
524
25.9
9 
148
197
72 
31/
12/
200
9 
Indi
a 
4 HIV
/AI
DS 
The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
India 
Gov
: 
Oth 
IDA-
405-
G06-H 
01/
09/
200
5 
216
725
59 
100
996
078 
239
823
274 
216
725
59 
100
996
078 
197
964
601 
30/
09/
201
2 
Indi
a 
4 TB The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
India 
Gov
: 
Oth 
IDA-
405-
G08-T 
01/
04/
200
5 
681
900
0 
122
949
43.0
7 
191
139
43.0
7 
681
900
0 
122
949
43.0
5 
191
139
43 
31/
03/
200
9 
Indi
a 
4 HIV
/AI
DS 
The 
Populati
on 
Foundati
on of 
India 
CS/
PS: 
NG
O 
IDA-
405-
G05-H 
01/
04/
200
5 
415
846
5 
273
864
70.0
2 
340
888
43.0
4 
415
846
5 
217
647
98 
259
232
63 
31/
03/
201
3 
Indi
a 
4 Ma
lari
a 
The 
Departm
ent of 
Economi
Gov
: 
MO
F 
IDA-
405-
G07-
M 
01/
07/
200
5 
301
588
33 
260
659
66.0
1 
562
247
99.0
1 
301
588
33 
260
659
66 
562
247
99 
30/
06/
201
0 
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c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
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Indi
a 
6 TB The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
India 
Gov
: 
Oth 
IDA-
607-
G09-T 
01/
04/
200
7 
857
959
4.04 
0 857
959
4.04 
857
959
4.04 
0 857
959
4 
31/
03/
200
9 
Indi
a 
6 HIV
/AI
DS 
The 
Populati
on 
Foundati
on of 
India 
CS/
PS: 
NG
O 
IDA-
607-
G10-H 
01/
06/
200
7 
929
716
7 
517
521
5.02 
144
723
82.0
2 
929
716
7 
517
521
5 
144
723
82 
31/
03/
201
0 
Indi
a 
6 HIV
/AI
DS 
India 
HIV/AID
S 
Alliance 
CS/
PS: 
NG
O 
IDA-
607-
G12-H 
01/
06/
200
7 
477
971
6 
912
429
4.01 
139
040
10.0
1 
477
971
6 
845
201
6 
132
317
32 
31/
03/
201
1 
Indi
a 
6 HIV
/AI
DS 
The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Finance, 
Govern
ment of 
India 
Gov
: 
Oth 
IDA-
607-
G11-H 
01/
07/
200
7 
726
379
37 
224
940
83.0
2 
951
320
20.0
2 
726
379
37 
224
940
83 
951
320
20 
30/
06/
201
2 
Indi
a 
7 HIV
/AI
DS 
The 
Departm
ent of 
Economi
c Affairs, 
Ministry 
of 
Gov
: 
Oth 
IDA-
708-
G13-H 
01/
09/
200
8 
833
061
9 
145
545
36 
228
851
55 
833
061
9 
686
380
7 
151
944
26 
31/
08/
201
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Finance, 
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7 HIV
/AI
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Indian 
Nursing 
Council 
Gov
: 
MO
H 
IDA-
708-
G14-H 
01/
09/
200
8 
157
989
95 
812
584
4 
239
248
39 
157
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95 
317
348
6.88 
189
724
82 
31/
08/
201
3 
Indi
a 
7 HIV
/AI
DS 
Tata 
Institute 
of Social 
Sciences 
(TISS) 
CS/
PS: 
Oth 
IDA-
708-
G15-H 
01/
09/
200
8 
846
436
5 
428
445
3 
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488
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5 
144
241
2 
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677
7 
31/
08/
201
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Iran 
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2 HIV
/AI
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Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
IRN-
202-
G01-
H-00 
01/
05/
200
5 
569
800
0 
102
248
55.0
1 
159
228
55.0
1 
569
800
0 
939
643
0.74 
150
944
31 
30/
04/
201
0 
Iran 
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Rep
ubli
c) 
7 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
IRN-
708-
G03-T 
01/
10/
200
8 
126
522
86 
339
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5.01 
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448
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1 
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86 
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685
44 
30/
09/
201
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United 
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Develop
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: 
UN
DP 
IRN-
708-
G02-
M 
01/
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200
8 
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488
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30/
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6 HIV
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United 
Nations 
Develop
ment 
Program
me 
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: 
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DP 
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G01-H 
01/
09/
200
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31/
08/
201
2 
Nep
al 
2 Ma
lari
a 
POPULA
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INTERNA
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01/
12/
200
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171
279
5 
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4 
436
599
6 
483
151.
2 
484
914
7.2 
436
599
6 
483
151.
19 
484
914
7.2 
30/
09/
200
8 
Nep
al 
4 TB The 
Ministry 
of 
Health 
and 
Populati
on of the 
Govern
ment of 
Nepal 
Gov
: 
MO
H 
NEP-
405-
G03-T 
01/
05/
200
6 
335
408
0 
382
548
2.21 
717
956
2.21 
335
408
0 
382
548
2.19 
717
956
2.2 
30/
04/
201
1 
Nep
al 
7 HIV
/AI
DS 
Family 
Planning 
Associati
on of 
Nepal 
CS/
PS: 
NG
O 
NEP-
708-
G11-H 
16/
11/
200
8 
264
196
3 
329
493
7.01 
593
690
0.01 
264
196
3 
166
853
6.9 
431
049
9.9 
15/
11/
201
3 
Nep
al 
7 Ma
lari
a 
The 
Ministry 
of 
Health 
and 
Populati
on of the 
Govern
Gov
: 
MO
H 
NEP-
708-
G07-
M 
16/
09/
200
8 
165
954
9 
0 165
954
9 
165
954
8.94 
0 165
954
8.9 
15/
12/
201
0 
    196 
ment of 
Nepal 
Nep
al 
7 Ma
lari
a 
POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
PS: 
NG
O 
NEP-
708-
G06-
M 
16/
09/
200
8 
702
484
4 
0 702
484
4 
646
722
9 
0 646
722
9 
15/
01/
201
1 
Nep
al 
7 HIV
/AI
DS 
Save the 
Children 
USA, 
Himalay
an 
Country 
Office 
CS/
PS: 
NG
O 
NEP-
708-
G10-H 
01/
11/
200
8 
294
483
2 
143
391
0.65 
437
874
2.65 
294
483
2 
143
391
0.65 
437
874
2.7 
15/
11/
201
3 
Nep
al 
7 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
NEP-
708-
G09-H 
01/
12/
200
8 
673
471
7 
559
734
6 
123
320
63 
673
471
7 
231
017
8.2 
904
489
5.2 
15/
02/
201
1 
Nep
al 
7 TB The 
Ministry 
of 
Health 
and 
Populati
on of the 
Govern
ment of 
Nepal 
Gov
: 
MO
H 
NEP-
708-
G08-T 
16/
11/
200
8 
356
286
4 
0 356
286
4 
356
286
4 
0 356
286
4 
15/
11/
201
0 
Paki
stan 
2 TB The 
National 
AIDS 
Control 
Program
me on 
the 
Behalf of 
the 
Ministry 
of 
Health 
of the 
Govern
Gov
: 
MO
H 
PKS-
202-
G03-T-
00 
01/
01/
200
4 
224
880
0 
179
410
0.01 
404
290
0.01 
224
880
0 
165
263
7 
390
143
7 
31/
12/
200
8 
    197 
ment of 
Pakistan 
Paki
stan 
2 Ma
lari
a 
The 
National 
AIDS 
Control 
Program
me on 
the 
Behalf of 
the 
Ministry 
of 
Health 
of the 
Govern
ment of 
Pakistan 
Gov
: 
MO
H 
PKS-
202-
G02-
M-00 
01/
01/
200
4 
353
780
2 
0 353
780
2 
353
780
2 
0 353
780
2 
31/
03/
200
6 
Paki
stan 
2 HIV
/AI
DS 
The 
National 
AIDS 
Control 
Program
me on 
the 
Behalf of 
the 
Ministry 
of 
Health 
of the 
Govern
ment of 
Pakistan 
Gov
: 
MO
H 
PKS-
202-
G01-
H-00 
01/
01/
200
4 
382
270
0 
382
453
6.01 
764
723
6.01 
382
270
0 
382
453
6 
764
723
6 
31/
05/
201
0 
Paki
stan 
3 TB The 
National 
AIDS 
Control 
Program
me on 
the 
Behalf of 
the 
Ministry 
Gov
: 
MO
H 
PKS-
304-
G05-T 
01/
01/
200
5 
560
543
1 
276
752
9.27 
837
296
0.27 
560
543
1 
276
752
9.26 
837
296
0.3 
31/
12/
200
8 
    198 
of 
Health 
of the 
Govern
ment of 
Pakistan 
Paki
stan 
3 Ma
lari
a 
The 
National 
AIDS 
Control 
Program
me on 
the 
Behalf of 
the 
Ministry 
of 
Health 
of the 
Govern
ment of 
Pakistan 
Gov
: 
MO
H 
PKS-
304-
G04-
M 
01/
01/
200
5 
154
863
6 
0 154
863
6 
138
278
4 
0 138
278
4 
31/
03/
200
7 
Paki
stan 
6 TB Mercy 
Corps 
CS/
PS: 
NG
O 
PKS-
607-
G06-T 
01/
10/
200
7 
106
821
92 
265
185
8.51 
133
340
50.5
1 
106
821
92 
265
185
8.49 
133
340
50 
30/
09/
201
2 
Paki
stan 
6 TB National 
TB 
Control 
Program
me 
(NTP) 
Pakistan 
Gov
: 
MO
H 
PKS-
607-
G07-T 
01/
11/
200
7 
136
541
50.2
9 
0.01 136
541
50.3 
136
541
50.2
9 
0 136
541
50 
31/
10/
201
2 
Paki
stan 
7 Ma
lari
a 
Director
ate of 
Malaria 
Control, 
Ministry 
of 
Health, 
Govern
ment of 
the 
Islamic 
Republic 
of 
Gov
: 
MO
H 
PKS-
708-
G08-
M 
01/
09/
200
8 
152
564
42 
-
216
373
0.56 
130
927
11.4
4 
130
927
11.4
4 
-
216
373
0.56 
130
927
11 
31/
08/
201
3 
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Pakistan 
Paki
stan 
8 TB National 
TB 
Control 
Program
me 
(NTP) 
Pakistan 
Gov
: 
MO
H 
PKS-
809-
G09-T 
01/
09/
200
9 
568
401
9 
0 568
401
9 
538
023
5.54 
0 538
023
5.5 
31/
08/
201
1 
Paki
stan 
8 TB Green 
Star 
Social 
Marketi
ng 
Pakistan 
(Guarant
ee) 
Limited 
CS/
PS: 
PS 
PKS-
809-
G10-T 
01/
09/
200
9 
318
362
3 
0 318
362
3 
207
701
0.58 
0 207
701
0.6 
31/
08/
201
1 
Sri 
Lan
ka 
1 TB Lanka 
Jatika 
Sarvoda
ya 
Shramad
ana 
Sangama
ya 
CS/
PS: 
NG
O 
SRL-
102-
G04-T-
00 
01/
03/
200
3 
475
020 
0 475
020 
268
292 
0 268
292 
31/
07/
200
5 
Sri 
Lan
ka 
1 TB The 
Ministry 
of 
Healthca
re, 
Nutrition 
and UVA 
Wellassa 
Develop
ment of 
the 
Govern
ment of 
Sri Lanka 
Gov
: 
MO
H 
SRL-
102-
G03-T-
00 
01/
03/
200
3 
238
498
0 
152
485
5.29 
390
983
5.29 
238
498
0 
152
485
5.27 
390
983
5.3 
28/
02/
200
9 
Sri 
Lan
ka 
1 Ma
lari
a 
Lanka 
Jatika 
Sarvoda
ya 
Shramad
CS/
PS: 
NG
O 
SRL-
102-
G02-
M-00 
01/
03/
200
3 
446
748
0 
166
407.
19 
463
388
7.19 
446
748
0 
166
407.
17 
463
388
7.2 
31/
08/
200
9 
    200 
ana 
Sangama
ya 
Sri 
Lan
ka 
1 Ma
lari
a 
The 
Ministry 
of 
Healthca
re, 
Nutrition 
and UVA 
Wellassa 
Develop
ment of 
the 
Govern
ment of 
Sri Lanka 
Gov
: 
MO
H 
SRL-
102-
G01-
M-00 
01/
03/
200
3 
730
140 
134
708
3.01 
207
722
3.01 
730
140 
134
708
3 
207
722
3 
28/
02/
200
9 
Sri 
Lan
ka 
4 Ma
lari
a 
Lanka 
Jatika 
Sarvoda
ya 
Shramad
ana 
Sangama
ya 
CS/
PS: 
NG
O 
SRL-
405-
G06-
M 
01/
10/
200
5 
797
200 
550
000.
01 
134
720
0.01 
797
200 
355
483.
81 
115
268
3.8 
30/
09/
201
0 
Sri 
Lan
ka 
4 Ma
lari
a 
The 
Ministry 
of 
Healthca
re, 
Nutrition 
and UVA 
Wellassa 
Develop
ment of 
the 
Govern
ment of 
Sri Lanka 
Gov
: 
MO
H 
SRL-
405-
G05-
M 
01/
10/
200
5 
132
236
7 
102
774
8.01 
235
011
5.01 
132
236
7 
836
754.
74 
215
912
1.7 
30/
09/
201
0 
Sri 
Lan
ka 
6 HIV
/AI
DS 
The 
Ministry 
of 
Healthca
re, 
Nutrition 
and UVA 
Gov
: 
MO
H 
SRL-
607-
G09-H 
01/
01/
200
8 
366
899 
291
223.
01 
658
122.
01 
366
899 
291
223 
658
122 
31/
12/
201
0 
    201 
Wellassa 
Develop
ment of 
the 
Govern
ment of 
Sri Lanka 
Sri 
Lan
ka 
6 TB The 
Ministry 
of 
Healthca
re, 
Nutrition 
and UVA 
Wellassa 
Develop
ment of 
the 
Govern
ment of 
Sri Lanka 
Gov
: 
MO
H 
SRL-
607-
G07-T 
01/
01/
200
8 
322
860
2 
323
999
9.01 
646
860
1.01 
322
860
2 
277
030
4.22 
599
890
6.2 
31/
12/
201
2 
Sri 
Lan
ka 
6 TB Lanka 
Jatika 
Sarvoda
ya 
Shramad
ana 
Sangama
ya 
CS/
PS: 
NG
O 
SRL-
607-
G08-T 
01/
01/
200
8 
957
593 
0 957
593 
624
995 
0 624
995 
30/
06/
201
0 
Sri 
Lan
ka 
8 Ma
lari
a 
Lanka 
Jatika 
Sarvoda
ya 
Shramad
ana 
Sangama
ya 
CS/
PS: 
NG
O 
SRL-
809-
G12-
M 
01/
10/
200
9 
597
072
0 
0 597
072
0 
423
494
8 
0 423
494
8 
30/
09/
201
1 
Sri 
Lan
ka 
8 Ma
lari
a 
Tropical 
and 
Environ
mental 
Diseases 
and 
Health 
Associat
es (Pvt) 
CS/
PS: 
NG
O 
SRL-
809-
G11-
M 
01/
09/
200
9 
599
524
9 
0 599
524
9 
446
358
4 
0 446
358
4 
30/
11/
201
1 
    202 
Ltd 
(TEDHA) 
Sri 
Lan
ka 
8 Ma
lari
a 
The 
Ministry 
of 
Healthca
re, 
Nutrition 
and UVA 
Wellassa 
Develop
ment of 
the 
Govern
ment of 
Sri Lanka 
Gov
: 
MO
H 
SRL-
809-
G10-
M 
01/
10/
200
9 
104
378
17 
0 104
378
17 
737
481
1 
0 737
481
1 
30/
09/
201
4 
Bur
und
i 
1 HIV
/AI
DS 
The 
Permane
nt 
Executiv
e 
Secretari
at of the 
National 
Council 
for the 
Fight 
Against 
AIDS 
(SEP/CN
LS) 
Gov
: 
Oth 
BRN-
102-
G01-
H-00 
31/
03/
200
3 
487
700
0 
378
000
0 
865
700
0 
487
700
0 
378
000
0 
865
700
0 
30/
03/
200
6 
Bur
und
i 
2 Ma
lari
a 
The 
Projet 
Sante et 
Populati
on II of 
The 
Ministry 
of Public 
Health in 
the 
Republic 
of 
Burundi 
Gov
: 
MO
H 
BRN-
202-
G02-
M-00 
01/
10/
200
3 
137
921
26 
277
620
4.89 
165
683
30.8
9 
137
921
26 
277
620
4.89 
165
683
31 
30/
09/
200
6 
    203 
Bur
und
i 
2 Ma
lari
a 
The 
Permane
nt 
Executiv
e 
Secretari
at of the 
National 
Council 
for the 
Fight 
Against 
AIDS 
(SEP/CN
LS) 
Gov
: 
MO
H 
BRN-
202-
G05-
M-00 
01/
10/
200
6 
0 422
452
2.03 
285
595
69 
0 422
452
2.03 
235
731
86 
30/
04/
201
4 
Bur
und
i 
4 TB The 
Program
me 
National 
Lèpre et 
Tubercul
ose(PNL
T) Govt 
of the 
Republic 
of 
Burundi 
Gov
: 
MO
H 
BRN-
405-
G03-T 
01/
05/
200
5 
188
717
5 
149
449
0 
338
166
5 
188
717
5 
133
860
7.31 
322
578
2.3 
30/
04/
201
0 
Bur
und
i 
5 HIV
/AI
DS 
The 
Permane
nt 
Executiv
e 
Secretari
at of the 
National 
Council 
for the 
Fight 
Against 
AIDS 
(SEP/CN
LS) 
Gov
: 
Oth 
BRN-
506-
G04-H 
01/
06/
200
6 
130
538
66 
176
479
43.2
1 
307
018
09.2
1 
130
538
66 
176
479
43.2 
307
018
09 
30/
11/
201
0 
Bur
und
i 
7 TB The 
Program
me 
National 
Gov
: 
MO
H 
BRN-
708-
G06-T 
01/
09/
200
8 
401
817
7 
365
691
2 
767
508
9 
401
817
7 
254
372
3.1 
656
190
0.1 
31/
08/
201
3 
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Lèpre et 
Tubercul
ose(PNL
T) Govt 
of the 
Republic 
of 
Burundi 
Bur
und
i 
8 HIV
/AI
DS 
Reseau 
Burundai
s des 
Personn
es Vivant 
avec le 
VIH/SID
A 
(RBP+). 
CS/
PS: 
NG
O 
BRN-
809-
G08-H 
01/
01/
201
0 
139
044
12 
0 139
044
12 
114
781
30 
0 114
781
30 
31/
03/
201
2 
Bur
und
i 
8 HIV
/AI
DS 
The 
Permane
nt 
Executiv
e 
Secretari
at of the 
National 
Council 
for the 
Fight 
Against 
AIDS 
(SEP/CN
LS) 
Gov
: 
Oth 
BRN-
809-
G07-H 
01/
01/
201
0 
228
851
79 
0 228
851
79 
187
125
10.7
7 
0 187
125
11 
31/
03/
201
2 
Co
mor
os 
2 Ma
lari
a 
Associati
on 
Comorie
nne pour 
le Bien-
Etre de 
la 
Famille 
(ASCOBE
F) 
CS/
PS: 
NG
O 
COM-
202-
G01-
M-00 
01/
06/
200
4 
153
463
1 
951
247.
01 
248
587
8.01 
153
463
1 
887
839.
77 
242
247
0.8 
30/
11/
200
9 
Co
mor
os 
3 HIV
/AI
DS 
Associati
on 
Comorie
nne pour 
CS/
PS: 
NG
O 
COM-
304-
G02-H 
01/
01/
200
5 
685
600 
452
988.
02 
113
858
8.02 
685
600 
449
625.
67 
113
522
5.7 
31/
12/
201
0 
    205 
le Bien-
Etre de 
la 
Famille 
(ASCOBE
F) 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
2 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZAR-
202-
G01-T-
00 
01/
08/
200
3 
640
874
1 
121
703
2.01 
762
577
3.01 
640
874
1 
108
189
0 
749
063
1 
31/
07/
200
6 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
3 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZAR-
304-
G03-
M 
01/
01/
200
5 
318
466
76 
220
899
33.0
1 
539
366
09.0
1 
318
466
76 
220
899
32.3
2 
539
366
08 
30/
06/
200
9 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
3 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZAR-
304-
G02-H 
01/
01/
200
5 
436
624
20 
699
840
33.0
2 
113
646
453 
436
624
20 
699
164
26.5
6 
113
578
847 
31/
03/
201
0 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
5 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZAR-
506-
G04-T 
01/
12/
200
6 
207
030
92.8
2 
113
068
52.1
9 
320
099
45.0
1 
207
030
92.8
2 
840
367
4.73 
291
067
68 
30/
09/
201
1 
Con
go 
(De
moc
6 TB United 
Nations 
Develop
ment 
MO
: 
UN
DP 
ZAR-
607-
G05-T 
01/
10/
200
7 
818
230
0.18 
0 818
230
0.18 
818
230
0.18 
0 818
230
0.2 
30/
09/
200
9 
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rati
c 
Rep
ubli
c) 
Program
me 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
7 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZAR-
708-
G06-H 
01/
12/
200
8 
226
751
88 
156
692
89 
383
444
77 
226
751
88 
114
904
14 
341
656
02 
30/
06/
201
2 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
8 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZAR-
809-
G10-H 
01/
01/
201
0 
563
627
41 
0 563
627
41 
307
041
23.2 
0 307
041
23 
31/
12/
201
1 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
8 Ma
lari
a 
POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
PS: 
NG
O 
ZAR-
809-
G07-
M 
01/
01/
201
0 
778
638
57 
0 778
638
57 
673
573
30.4
2 
0 673
573
30 
31/
03/
201
2 
Con
go 
(De
moc
rati
c 
Rep
ubli
c) 
8 Ma
lari
a 
Eglise du 
Christ au 
Congo 
(ECC)/SA
NRU 
CS/
PS: 
NG
O 
ZAR-
810-
G08-
M 
01/
01/
201
0 
376
907
25 
0 376
907
25 
376
907
25 
0 376
907
25 
31/
03/
201
2 
Eritr
ea 
2 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Gov
: 
MO
H 
ERT-
202-
G01-
M-00 
28/
11/
200
3 
261
763
3 
457
230
3.88 
718
993
6.88 
261
763
3 
457
230
3.86 
718
993
6.9 
27/
11/
200
8 
    207 
Govern
ment of 
the State 
of 
Eritrea 
Eritr
ea 
3 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the State 
of 
Eritrea 
Gov
: 
MO
H 
ERT-
304-
G02-H 
01/
09/
200
4 
812
491
0 
856
724
6.02 
166
921
56.0
2 
812
491
0 
856
724
6 
166
921
56 
31/
08/
200
9 
Eritr
ea 
5 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the State 
of 
Eritrea 
Gov
: 
MO
H 
ERT-
506-
G03-H 
01/
09/
200
6 
131
390
10 
155
191
55.0
1 
286
581
65.0
1 
131
390
10 
142
928
09.4
7 
274
318
19 
31/
08/
201
1 
Eritr
ea 
6 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the State 
of 
Eritrea 
Gov
: 
MO
H 
ERT-
607-
G04-T 
01/
11/
200
7 
547
083
4 
882
752.
02 
635
358
6.02 
547
083
4 
882
751.
94 
635
358
5.9 
31/
10/
201
2 
Eritr
ea 
6 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the State 
of 
Eritrea 
Gov
: 
MO
H 
ERT-
607-
G05-
M 
01/
11/
200
7 
594
313
0 
635
813
5.01 
123
012
65.0
1 
594
313
0 
374
963
6 
969
276
6 
31/
10/
201
2 
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Eritr
ea 
8 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the State 
of 
Eritrea 
Gov
: 
MO
H 
ERT-
809-
G06-H 
01/
12/
200
9 
151
742
49 
0 151
742
49 
133
198
50 
0 133
198
50 
30/
11/
201
1 
Ethi
opia 
1 TB The 
Federal 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Federal 
Democra
tic 
Republic 
of 
Ethiopia 
Gov
: 
MO
H 
ETH-
102-
G01-T-
00 
01/
08/
200
3 
109
626
00 
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The 
HIV/AID
S 
Preventi
on and 
Control 
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Gov
: 
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202-
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H-00 
01/
01/
200
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The 
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of 
Health 
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the 
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of 
Gov
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202-
G02-
M-00 
01/
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200
3 
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The 
HIV/AID
S 
Preventi
on and 
Control 
Office 
Gov
: 
Oth 
ETH-
405-
G04-H 
01/
03/
200
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418
958
84 
335
172
691.
3 
377
068
575.
3 
418
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84 
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3 
377
068
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31/
08/
201
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a 
The 
Federal 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Federal 
Democra
tic 
Republic 
of 
Ethiopia 
Gov
: 
MO
H 
ETH-
506-
G05-
M 
01/
07/
200
6 
591
138
29 
815
735
84.0
1 
140
687
413 
591
138
29 
731
769
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4 
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290
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30/
06/
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6 TB The 
Federal 
Ministry 
of 
Health 
of the 
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ment of 
the 
Federal 
Democra
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of 
Ethiopia 
Gov
: 
MO
H 
ETH-
607-
G06-T 
01/
02/
200
8 
117
925
74 
264
755
83.0
1 
382
681
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925
74 
143
046
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972
62 
31/
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for 
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01/
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184
464
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597
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31/
03/
201
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The 
HIV/AID
S 
Preventi
on and 
Control 
Office 
Gov
: 
Oth 
ETH-
708-
G08-H 
01/
01/
200
9 
416
665
16 
131
086
2 
429
773
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358
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058
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The 
Federal 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Federal 
Democra
tic 
Republic 
of 
Ethiopia 
Gov
: 
MO
H 
ETH-
809-
G10-
M 
01/
11/
200
9 
133
089
526 
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Kenya 
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of 
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AIDS 
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NG
O 
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G02-
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01/
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200
3 
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31/
03/
200
5 
Ken
ya 
1 HIV
/AI
DS 
Sanaa 
Art 
Promoti
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CS/
PS: 
NG
O 
KEN-
102-
G01-
H-00 
01/
04/
200
3 
265
081
3 
0 265
081
3 
265
081
3 
0 265
081
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31/
03/
200
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The 
Ministry 
of 
Finance 
of the 
Govern
ment of 
the 
Republic 
of Kenya 
Gov
: 
MO
F 
KEN-
202-
G05-
M-00 
01/
10/
200
3 
464
044
7 
0.02
000
000
3 
464
044
7.02 
464
044
7 
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044
7 
30/
09/
200
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ya 
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The 
Ministry 
of 
Finance 
of the 
Govern
ment of 
the 
Republic 
of Kenya 
Gov
: 
MO
F 
KEN-
202-
G03-
H-00 
01/
12/
200
3 
367
218
07 
312
850
74.0
2 
680
068
81.0
2 
367
218
07 
312
850
74 
680
068
81 
30/
11/
200
8 
Ken
ya 
2 TB The 
Ministry 
of 
Finance 
of the 
Govern
ment of 
the 
Republic 
of Kenya 
Gov
: 
MO
F 
KEN-
202-
G04-T-
00 
01/
11/
200
3 
329
952
2 
0.02 329
952
2.02 
329
952
2 
0 329
952
2 
31/
10/
200
8 
Ken
ya 
4 Ma
lari
a 
The 
Ministry 
of 
Finance 
of the 
Govern
ment of 
the 
Republic 
of Kenya 
Gov
: 
MO
F 
KEN-
405-
G06-
M 
01/
02/
200
6 
817
497
56 
804
233
29.0
1 
162
173
085 
817
497
56 
651
546
94.5
2 
146
904
451 
30/
06/
201
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Ken
ya 
5 TB The 
Ministry 
of 
Finance 
of the 
Govern
Gov
: 
MO
F 
KEN-
506-
G07-T 
01/
09/
200
6 
517
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0.02 517
066
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ya 
6 TB The 
Ministry 
of 
Finance 
of the 
Govern
ment of 
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Republic 
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Gov
: 
MO
F 
KEN-
607-
G08-T 
01/
04/
200
8 
296
180
6 
0 296
180
6 
296
180
6 
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31/
12/
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Ken
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7 HIV
/AI
DS 
CARE 
Internati
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CS/
PS: 
NG
O 
KEN-
708-
G10-H 
01/
04/
200
9 
160
077
46 
877
425
6 
247
820
02 
160
077
46 
119
807
3 
172
058
19 
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03/
201
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/AI
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Ministry 
of 
Finance 
of the 
Govern
ment of 
the 
Republic 
of Kenya 
Gov
: 
MO
F 
KEN-
708-
G09-H 
01/
06/
200
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301
469
06 
0 301
469
06 
301
469
06 
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30/
08/
201
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dag
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POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
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NG
O 
MDG-
102-
G01-
M-00 
01/
02/
200
3 
175
029
9 
122
064.
02 
187
236
3.02 
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029
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236
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31/
07/
200
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/AI
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NG
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MDG-
202-
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3 
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692
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977
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POPULA
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SERVICE
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INTERNA
TIONAL 
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NG
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MDG-
202-
G03-
H-00 
01/
05/
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3 
303
204
8 
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008
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499
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204
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04/
200
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/AI
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Sécrétari
at 
Exécutif 
du 
Comité 
National 
de Lutte 
Contre 
le 
VIH/SID
A 
Gov
: 
Oth 
MDG-
304-
G04-H 
01/
11/
200
4 
134
151
18 
904
993.
37 
143
201
11.3
7 
134
151
18 
904
993.
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143
201
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31/
01/
201
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Ma
dag
asca
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3 Ma
lari
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Gestion 
des 
Projets 
d'Appui 
au 
Secteur 
Santé 
Gov
: 
MO
H 
MDG-
304-
G05-
M 
01/
11/
200
4 
523
244
8 
476
997
3.01 
100
024
21.0
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523
244
8 
476
997
3 
100
024
21 
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04/
201
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Ma
dag
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r 
4 Ma
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Unité de 
Gestion 
des 
Projets 
d'Appui 
au 
Secteur 
Santé 
Gov
: 
MO
H 
MDG-
405-
G06-
M 
01/
04/
200
5 
100
423
88 
114
042
67.1
1 
214
466
55.1
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423
88 
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042
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214
466
55 
30/
09/
200
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Ma
dag
asca
r 
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POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
PS: 
NG
O 
MDG-
405-
G07-
M 
01/
03/
200
5 
116
741
38 
778
552
2.01 
475
078
27.0
5 
116
741
38 
778
552
2.01 
433
019
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28/
02/
201
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Ma
dag
asca
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4 TB Sécrétari
at 
Exécutif 
du 
Comité 
National 
de Lutte 
Contre 
le 
VIH/SID
A 
Gov
: 
Oth 
MDG-
404-
G08-T 
01/
02/
200
5 
398
201
8 
396
467
0.92 
794
668
8.92 
398
201
8 
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467
0.91 
794
668
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31/
01/
201
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Unité de 
Gestion 
des 
Projets 
d'Appui 
au 
Secteur 
Santé 
Gov
: 
MO
H 
MDG-
708-
G09-
M 
01/
10/
200
8 
215
669
42 
838
537
9.01 
299
523
21.0
1 
215
669
42 
260
370
9.64 
241
706
52 
30/
09/
201
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Ma
dag
asca
r 
8 HIV
/AI
DS 
Sécrétari
at 
Exécutif 
du 
Comité 
National 
de Lutte 
Contre 
le 
VIH/SID
A 
Gov
: 
Oth 
MDG-
809-
G11-H 
01/
10/
200
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576
474
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547
464
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464
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09/
201
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Ma
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r 
8 HIV
/AI
DS 
POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
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NG
O 
MDG-
809-
G12-H 
01/
10/
200
9 
403
436
9 
0 403
436
9 
321
917
9 
0 321
917
9 
30/
12/
201
4 
Ma
uriti
us 
8 HIV
/AI
DS 
Mauritiu
s Family 
and 
Planning 
Welfare 
Associati
on 
CS/
PS: 
NG
O 
MUS-
809-
G02-H 
01/
01/
201
0 
162
494
0.78 
0 162
494
0.78 
162
494
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494
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31/
12/
201
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8 HIV
/AI
DS 
National 
AIDS 
Secretari
at 
Gov
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G01-H 
01/
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238
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984.
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3 
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Ministry 
of 
Health 
of the 
Govern
ment of 
Rwanda 
Gov
: 
MO
H 
RWN-
304-
G03-
M 
01/
10/
200
4 
130
452
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463
093
9.01 
422
899
10.0
3 
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452
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09/
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of 
Health 
of the 
Govern
ment of 
Rwanda 
Gov
: 
MO
H 
RWN-
304-
G02-H 
01/
08/
200
4 
148
607
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417
857
24.5
1 
566
464
59.5
1 
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607
35 
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857
24.5 
566
464
60 
31/
01/
201
0 
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nda 
4 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Rwanda 
Gov
: 
MO
H 
RWN-
404-
G04-T 
01/
01/
200
5 
594
634
7 
461
725
5.01 
125
184
00.0
5 
594
634
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725
5.01 
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184
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30/
06/
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nda 
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The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Rwanda 
Gov
: 
MO
H 
RWN-
506-
G06-
M 
01/
03/
200
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281
407
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110
087
31.0
1 
391
495
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31/
08/
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nda 
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Govern
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Gov
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H 
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01/
03/
200
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268
114
0 
187
266
6.02 
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30/
06/
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Gov
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Ministry 
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Health 
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ment of 
Rwanda 
Gov
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RWN-
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01/
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01/
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: 
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01/
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464
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c) 
3 HIV
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Ministry 
of 
Finance 
of the 
Govern
ment of 
the 
United 
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of 
Tanzania 
Gov
: 
MO
F 
TNZ-
304-
G03-C 
01/
11/
200
4 
239
510
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427
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a 
The 
Ministry 
of 
Finance 
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INTERNA
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01/
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200
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and 
Research 
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of 
Finance 
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Govern
ment of 
the 
United 
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of 
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: 
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F 
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01/
11/
200
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Finance 
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ment of 
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United 
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of 
Tanzania 
Gov
: 
MO
F 
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01/
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200
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G02-
M-00 
15/
03/
200
4 
210
547
81.3
5 
0 210
547
81.3
5 
210
547
81.3
5 
0 210
547
81 
30/
09/
200
6 
Uga
nda 
2 TB The 
Ministry 
of 
Finance, 
Gov
: 
MO
F 
UGD-
202-
G03-T-
00 
15/
03/
200
4 
469
202
0.77 
0 469
202
0.77 
459
950
6 
0 459
950
6 
14/
03/
200
6 
    220 
Planning 
and 
Economi
c 
Develop
ment of 
the 
Govern
ment of 
Uganda 
Uga
nda 
3 HIV
/AI
DS 
The 
Ministry 
of 
Finance, 
Planning 
and 
Economi
c 
Develop
ment of 
the 
Govern
ment of 
Uganda 
Gov
: 
MO
F 
UGD-
304-
G04-H 
01/
07/
200
5 
463
620
90.8
7 
0.02 463
620
90.8
9 
463
620
90.8
7 
0 463
620
91 
31/
12/
200
8 
Uga
nda 
4 Ma
lari
a 
The 
Ministry 
of 
Finance, 
Planning 
and 
Economi
c 
Develop
ment of 
the 
Govern
ment of 
Uganda 
Gov
: 
MO
F 
UGD-
405-
G05-
M 
01/
12/
200
5 
664
321
48 
459
954
41.0
2 
112
427
589 
664
321
48 
229
743
13.8
8 
894
064
62 
31/
12/
201
2 
Uga
nda 
6 TB The 
Ministry 
of 
Finance, 
Planning 
and 
Economi
c 
Gov
: 
MO
F 
UGD-
607-
G06-T 
01/
03/
200
8 
810
310
6 
112
752
3 
923
062
9 
442
574
1 
0 442
574
1 
31/
08/
201
0 
    221 
Develop
ment of 
the 
Govern
ment of 
Uganda 
Uga
nda 
7 HIV
/AI
DS 
The 
Ministry 
of 
Finance, 
Planning 
and 
Economi
c 
Develop
ment of 
the 
Govern
ment of 
Uganda 
Gov
: 
MO
F 
UGD-
708-
G07-H 
01/
08/
200
9 
702
777
26 
0 702
777
26 
450
959
60.9
8 
0 450
959
61 
31/
10/
201
1 
Uga
nda 
7 Ma
lari
a 
The 
Ministry 
of 
Finance, 
Planning 
and 
Economi
c 
Develop
ment of 
the 
Govern
ment of 
Uganda 
Gov
: 
MO
F 
UGD-
708-
G08-
M 
01/
12/
200
9 
514
221
98 
0 514
221
98 
511
941
27.0
9 
0 511
941
27 
30/
11/
201
1 
Zan
ziba
r 
1 Ma
lari
a 
The 
Ministry 
of 
Health 
and 
Social 
Welfare 
of the 
Revoluti
onary 
Govern
ment of 
Gov
: 
MO
H 
ZAN-
102-
G01-
M-00 
01/
06/
200
3 
781
220 
371
860.
01 
115
308
0.01 
781
220 
371
860 
115
308
0 
30/
11/
200
6 
    222 
Zanzibar 
Zan
ziba
r 
2 HIV
/AI
DS 
Zanzibar 
AIDS 
Commiss
ion 
Gov
: 
Oth 
ZAN-
202-
G02-
H-00 
01/
09/
200
3 
111
600
0 
316
274.
51 
143
227
4.51 
111
600
0 
316
274.
5 
143
227
4.5 
31/
08/
200
8 
Zan
ziba
r 
3 TB The 
Ministry 
of 
Health 
and 
Social 
Welfare 
of the 
Revoluti
onary 
Govern
ment of 
Zanzibar 
Gov
: 
MO
H 
ZAN-
304-
G03-T 
01/
12/
200
4 
959
482 
150
652.
01 
111
013
4.01 
959
482 
150
652 
111
013
4 
30/
11/
200
9 
Zan
ziba
r 
4 Ma
lari
a 
The 
Ministry 
of 
Health 
and 
Social 
Welfare 
of the 
Revoluti
onary 
Govern
ment of 
Zanzibar 
Gov
: 
MO
H 
ZAN-
404-
G04-
M 
01/
01/
200
5 
508
936
1 
334
942
7.01 
843
878
8.01 
508
936
1 
334
942
7 
843
878
8 
30/
06/
200
9 
Zan
ziba
r 
6 HIV
/AI
DS 
The 
Ministry 
of 
Health 
and 
Social 
Welfare 
of the 
Revoluti
onary 
Govern
ment of 
Zanzibar 
Gov
: 
MO
H 
ZAN-
607-
G05-H 
01/
12/
200
7 
310
347
2 
291
179.
01 
339
465
1.01 
209
397
4 
0 209
397
4 
30/
11/
201
2 
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Zan
ziba
r 
6 HIV
/AI
DS 
Zanzibar 
AIDS 
Commiss
ion 
Gov
: 
Oth 
ZAN-
607-
G06-H 
01/
12/
200
7 
135
695 
0 135
695 
135
695 
0 135
695 
28/
02/
201
0 
Ang
ola 
3 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
AGO-
305-
G01-
M 
01/
04/
200
5 
284
733
54 
655
651
8 
350
298
72 
284
733
54 
636
023
3.94 
348
335
88 
30/
09/
200
8 
Ang
ola 
4 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
AGO-
405-
G02-T 
01/
08/
200
5 
735
059
0 
296
809
8.87 
103
186
88.8
7 
735
059
0 
296
809
8.87 
103
186
89 
30/
09/
201
0 
Ang
ola 
4 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
AGO-
405-
G03-H 
01/
10/
200
5 
276
708
10 
584
494
05 
861
202
15 
276
708
10 
345
549
50.5 
622
257
61 
30/
09/
201
2 
Ang
ola 
7 Ma
lari
a 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Angola 
Gov
: 
MO
H 
AGO-
708-
G04-
M 
01/
11/
200
8 
325
126
48 
0 325
126
48 
271
716
90.9 
0 271
716
91 
31/
01/
201
1 
Bot
swa
na 
2 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Botswan
a 
Gov
: 
MO
H 
BOT-
202-
G01-
H-00 
01/
07/
200
4 
185
804
14 
0 185
804
14 
901
911
9 
0 901
911
9 
30/
06/
200
6 
Bot
swa
na 
5 TB Ministry 
of 
Health 
Gov
: 
MO
BOT-
506-
G02-T 
01/
01/
200
551
590
0 
276
934
5.01 
828
524
5.01 
551
590
0 
853
389.
37 
636
928
9.4 
31/
12/
201
    224 
of the 
Govern
ment of 
the 
Republic 
of 
Botswan
a 
H 7 1 
Les
oth
o 
2 TB The 
Ministry 
of 
Finance 
and 
Develop
ment 
Planning 
of the 
Govern
ment of 
the 
Kingdom 
of 
Lesotho 
Gov
: 
MO
F 
LSO-
202-
G02-T-
00 
01/
01/
200
4 
200
000
0 
300
000
0.01 
500
000
0.01 
200
000
0 
132
567
0.45 
332
567
0.5 
30/
06/
200
9 
Les
oth
o 
2 HIV
/AI
DS 
The 
Ministry 
of 
Finance 
and 
Develop
ment 
Planning 
of the 
Govern
ment of 
the 
Kingdom 
of 
Lesotho 
Gov
: 
MO
F 
LSO-
202-
G01-
H-00 
01/
01/
200
4 
105
570
00 
187
550
00.0
1 
293
120
00.0
1 
105
570
00 
168
118
98.2
9 
273
688
98 
30/
06/
200
9 
Les
oth
o 
5 HIV
/AI
DS 
The 
Ministry 
of 
Finance 
and 
Develop
ment 
Planning 
Gov
: 
MO
F 
LSO-
506-
G03-H 
01/
11/
200
6 
100
133
83 
576
818
8.96 
157
815
71.9
6 
100
133
83 
576
818
8.94 
157
815
72 
31/
10/
201
1 
    225 
of the 
Govern
ment of 
the 
Kingdom 
of 
Lesotho 
Les
oth
o 
6 TB The 
Ministry 
of 
Finance 
and 
Develop
ment 
Planning 
of the 
Govern
ment of 
the 
Kingdom 
of 
Lesotho 
Gov
: 
MO
F 
LSO-
607-
G04-T 
01/
07/
200
7 
379
880
5 
174
500
0.01 
554
380
5.01 
379
880
5 
441
081.
8 
423
988
6.8 
30/
06/
201
2 
Les
oth
o 
7 HIV
/AI
DS 
The 
Ministry 
of 
Finance 
and 
Develop
ment 
Planning 
of the 
Govern
ment of 
the 
Kingdom 
of 
Lesotho 
Gov
: 
MO
F 
LSO-
708-
G05-H 
01/
07/
200
8 
106
266
65 
736
982
8.01 
179
964
93.0
1 
106
266
65 
112
161
5.45 
117
482
80 
30/
06/
201
3 
Les
oth
o 
8 HIV
/AI
DS 
The 
Ministry 
of 
Finance 
and 
Develop
ment 
Planning 
of the 
Gov
: 
MO
F 
LSO-
809-
G06-H 
01/
11/
200
9 
499
992
04.0
1 
0 499
992
04.0
1 
317
854
24.9 
0 317
854
25 
31/
10/
201
1 
    226 
Govern
ment of 
the 
Kingdom 
of 
Lesotho 
Mal
awi 
1 HIV
/AI
DS 
The 
Register
ed 
Trustees 
of the 
National 
AIDS 
Commiss
ion Trust 
of the 
Republic 
of 
Malawi 
Gov
: 
Oth 
MLW-
102-
G01-
H-00 
01/
10/
200
3 
417
515
00 
136
862
764 
342
557
595 
417
515
00 
136
862
764 
316
721
459 
31/
03/
201
2 
Mal
awi 
2 Ma
lari
a 
The 
Govern
ment of 
the 
Republic 
of 
Malawi 
through 
the 
Ministry 
of 
Health 
Gov
: 
MO
H 
MLW-
202-
G02-
M-00 
01/
02/
200
6 
179
577
14 
0 179
577
14 
179
577
14 
0 179
577
14 
31/
01/
200
8 
Mal
awi 
5 HIV
/AI
DS 
The 
Register
ed 
Trustees 
of the 
National 
AIDS 
Commiss
ion Trust 
of the 
Republic 
of 
Malawi 
Gov
: 
Oth 
MLW-
506-
G03-H 
01/
10/
200
6 
770
833
1 
988
110
7.01 
175
894
38.0
1 
770
833
1 
530
658
2 
130
149
13 
30/
09/
201
1 
    227 
Mal
awi 
7 TB The 
Govern
ment of 
the 
Republic 
of 
Malawi 
through 
the 
Ministry 
of 
Health 
Gov
: 
MO
H 
MLW-
708-
G06-T 
01/
01/
200
9 
780
203
7 
131
877
9 
912
081
6 
344
745
0.17 
0 344
745
0.2 
31/
12/
201
3 
Mal
awi 
7 HIV
/AI
DS 
The 
Register
ed 
Trustees 
of the 
National 
AIDS 
Commiss
ion Trust 
of the 
Republic 
of 
Malawi 
Gov
: 
Oth 
MLW-
708-
G07-H 
01/
10/
200
8 
150
784
17 
108
991
85 
259
776
02 
150
784
17 
275
017
9 
178
285
96 
30/
09/
201
3 
Mal
awi 
7 Ma
lari
a 
The 
Govern
ment of 
the 
Republic 
of 
Malawi 
through 
the 
Ministry 
of 
Health 
Gov
: 
Oth 
MLW-
708-
G05-
M 
01/
01/
200
9 
177
293
12 
400
117
64.0
2 
577
410
76.0
2 
177
293
12 
309
817
90.4
1 
487
111
02 
31/
12/
201
3 
Moz
am
biq
ue 
2 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Mozamb
ique 
Gov
: 
MO
H 
MOZ-
202-
G04-T-
00 
01/
01/
200
5 
920
214
0 
130
206
0.19 
105
042
00.1
9 
920
214
0 
130
206
0.18 
105
042
00 
30/
06/
201
0 
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Moz
am
biq
ue 
2 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Mozamb
ique 
Gov
: 
MO
H 
MOZ-
202-
G03-
M-00 
01/
01/
200
5 
122
173
93 
145
669
33.3
3 
267
843
26.3
3 
122
173
93 
142
853
01.6 
265
026
95 
30/
06/
201
0 
Moz
am
biq
ue 
2 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Mozamb
ique 
Gov
: 
MO
H 
MOZ-
202-
G02-
H-00 
01/
01/
200
5 
219
596
84 
661
207
99.0
6 
880
804
83.0
6 
219
596
84 
658
325
03.1
6 
877
921
87 
30/
06/
201
0 
Moz
am
biq
ue 
2 HIV
/AI
DS 
The 
National 
AIDS 
Council 
(CNCS) 
of 
Mozamb
ique 
Gov
: 
Oth 
MOZ-
202-
G01-
H-00 
01/
07/
200
6 
773
295
6 
0 773
295
6 
615
689
7.68 
0 615
689
7.7 
30/
11/
200
8 
Moz
am
biq
ue 
6 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Mozamb
ique 
Gov
: 
MO
H 
MOZ-
607-
G06-
M 
01/
07/
200
7 
255
918
25 
726
453
8.36 
328
563
63.3
6 
255
918
25 
539
651
1.9 
309
883
37 
31/
12/
201
0 
Moz
am
biq
ue 
6 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
Mozamb
ique 
Gov
: 
MO
H 
MOZ-
607-
G05-H 
01/
07/
200
7 
227
488
53 
342
538
74.9 
570
027
27.9 
227
488
53 
342
538
74.8
9 
570
027
28 
31/
12/
201
0 
Moz
am
7 TB The 
Ministry 
Gov
: 
MOZ-
708-
01/
07/
673
530
0 673
530
213
483
0 213
483
30/
06/
    229 
biq
ue 
of 
Health 
of the 
Govern
ment of 
Mozamb
ique 
MO
H 
G07-T 200
8 
3 3 3.86 3.9 201
0 
Na
mibi
a 
2 HIV
/AI
DS 
The 
Ministry 
of 
Health 
and 
Social 
Services 
of the 
Govern
ment of 
Namibia 
Gov
: 
MO
H 
NMB-
202-
G01-
H-00 
01/
01/
200
5 
260
828
02 
779
214
09.0
2 
151
295
230 
260
828
02 
779
214
09.0
2 
118
290
004 
30/
06/
201
3 
Na
mibi
a 
2 TB The 
Ministry 
of 
Health 
and 
Social 
Services 
of the 
Govern
ment of 
Namibia 
Gov
: 
MO
H 
NMB-
202-
G02-T-
00 
01/
01/
200
5 
904
969 
389
641.
01 
144
245
9.03 
904
969 
389
641.
01 
144
245
9 
31/
12/
201
2 
Na
mibi
a 
2 Ma
lari
a 
The 
Ministry 
of 
Health 
and 
Social 
Services 
of the 
Govern
ment of 
Namibia 
Gov
: 
MO
H 
NMB-
202-
G03-
M-00 
01/
01/
200
5 
371
935
4 
251
659
6.01 
700
921
2 
371
935
4 
251
659
6.01 
644
879
8.3 
30/
06/
201
3 
Na
mibi
a 
5 TB The 
Ministry 
of 
Health 
and 
Social 
Gov
: 
MO
H 
NMB-
506-
G04-T 
01/
06/
200
6 
722
275
3 
998
177
3.01 
172
045
26.0
1 
722
275
3 
537
016
6.8 
125
929
20 
31/
05/
201
1 
    230 
Services 
of the 
Govern
ment of 
Namibia 
Na
mibi
a 
6 Ma
lari
a 
The 
Ministry 
of 
Health 
and 
Social 
Services 
of the 
Govern
ment of 
Namibia 
Gov
: 
MO
H 
NMB-
607-
G06-
M 
01/
08/
200
7 
853
806
3 
483
467
8.02 
133
727
41.0
2 
853
806
3 
292
692
8.21 
114
649
91 
31/
07/
201
2 
Sou
th 
Afri
ca 
1 HIV
/TB 
The 
National 
Treasury 
of the 
Republic 
of South 
Africa 
Gov
: 
MO
F 
SAF-
102-
G02-C-
00 
01/
08/
200
3 
178
726
65 
0 178
726
65 
178
726
65 
0 178
726
65 
31/
12/
200
5 
Sou
th 
Afri
ca 
1 HIV
/TB 
The 
National 
Treasury 
of the 
Republic 
of South 
Africa 
Gov
: 
MO
F 
SAF-
102-
G03-C-
00 
01/
01/
200
4 
267
415
29 
230
302
94.0
1 
497
718
23.0
1 
267
415
29 
215
795
35.2
5 
483
210
64 
30/
06/
200
9 
Sou
th 
Afri
ca 
1 HIV
/TB 
The 
National 
Treasury 
of the 
Republic 
of South 
Africa 
Gov
: 
MO
F 
SAF-
102-
G01-C-
00 
08/
12/
200
3 
235
400
0 
0 235
400
0 
235
400
0 
0 235
400
0 
07/
12/
200
4 
Sou
th 
Afri
ca 
2 HIV
/TB 
The 
National 
Departm
ent of 
Health 
of the 
Govern
ment of 
the 
Gov
: 
MO
H 
SAF-
202-
G05-C-
00 
01/
01/
200
6 
841
400
0 
159
862
20.0
1 
244
002
20.0
1 
841
400
0 
875
453
2.62 
171
685
33 
31/
12/
201
0 
    231 
Republic 
of South 
Africa 
Sou
th 
Afri
ca 
3 HIV
/AI
DS 
The 
Provinci
al Health 
Departm
ent of 
the 
Western 
Cape, 
South 
Africa 
Gov
: 
MO
H 
SAF-
304-
G04-H 
01/
09/
200
4 
212
509
01 
452
507
28.0
1 
102
035
239 
212
509
01 
452
507
28.0
1 
863
354
85 
30/
06/
201
3 
Sou
th 
Afri
ca 
6 HIV
/AI
DS 
The 
National 
Departm
ent of 
Health 
of the 
Govern
ment of 
the 
Republic 
of South 
Africa 
Gov
: 
MO
H 
SAF-
607-
G06-H 
01/
01/
200
8 
550
719
06 
822
987
2.01 
633
017
78.0
1 
550
719
06 
822
987
1.79 
633
017
78 
31/
12/
201
2 
Swa
zila
nd 
2 Ma
lari
a 
The 
National 
Emergen
cy 
Respons
e 
Council 
on 
HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
of 
Swazilan
d 
Gov
: 
Oth 
SWZ-
202-
G02-
M-00 
01/
09/
200
3 
978
000 
499
327.
71 
147
732
7.71 
978
000 
499
327.
68 
147
732
7.7 
31/
08/
200
8 
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Swa
zila
nd 
2 HIV
/AI
DS 
The 
National 
Emergen
cy 
Respons
e 
Council 
on 
HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
of 
Swazilan
d 
Gov
: 
Oth 
SWZ-
202-
G01-
H-00 
01/
08/
200
3 
296
333
00 
182
448
65.7
3 
478
781
65.7
3 
296
333
00 
182
448
65.7 
478
781
66 
31/
07/
200
8 
Swa
zila
nd 
3 TB The 
National 
Emergen
cy 
Respons
e 
Council 
on 
HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
of 
Swazilan
d 
Gov
: 
Oth 
SWZ-
304-
G03-T 
01/
01/
200
5 
134
840
0 
115
760
0.01 
250
600
0.01 
134
840
0 
110
475
5.82 
245
315
5.8 
31/
12/
200
9 
Swa
zila
nd 
4 HIV
/AI
DS 
The 
National 
Emergen
cy 
Respons
e 
Council 
on 
Gov
: 
Oth 
SWZ-
405-
G04-H 
01/
10/
200
5 
163
968
10 
291
336
9.47 
193
101
79.4
7 
163
968
10 
291
336
9.45 
193
101
79 
30/
09/
201
0 
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HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
of 
Swazilan
d 
Swa
zila
nd 
7 HIV
/AI
DS 
The 
National 
Emergen
cy 
Respons
e 
Council 
on 
HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
of 
Swazilan
d 
Gov
: 
Oth 
SWZ-
708-
G05-H 
01/
01/
200
9 
533
920
57 
272
957
83 
806
878
40 
520
995
12.4
1 
0 520
995
12 
31/
12/
201
1 
Swa
zila
nd 
8 HIV
/AI
DS 
The 
National 
Emergen
cy 
Respons
e 
Council 
on 
HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
Gov
: 
Oth 
SWZ-
809-
G08-S 
01/
01/
201
0 
704
924
1 
0 704
924
1 
563
866
9.23 
0 563
866
9.2 
31/
03/
201
2 
    234 
of 
Swazilan
d 
Swa
zila
nd 
8 TB The 
National 
Emergen
cy 
Respons
e 
Council 
on 
HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
of 
Swazilan
d 
Gov
: 
Oth 
SWZ-
809-
G07-T 
01/
01/
201
0 
416
387
3 
0 416
387
3 
267
039
9.56 
0 267
039
9.6 
31/
12/
201
1 
Swa
zila
nd 
8 Ma
lari
a 
The 
National 
Emergen
cy 
Respons
e 
Council 
on 
HIV/AID
S 
(NERCH
A) of the 
Govern
ment of 
the 
Kingdom 
of 
Swazilan
d 
Gov
: 
Oth 
SWZ-
809-
G06-
M 
01/
07/
200
9 
505
155
5 
436
73 
509
522
8 
475
741
2.61 
0 475
741
2.6 
30/
06/
201
4 
Zam
bia 
1 HIV
/AI
DS 
The 
Ministry 
of 
Finance 
Gov
: 
MO
F 
ZAM-
102-
G07-
H-00 
01/
03/
200
5 
325
713
4 
0 325
713
4 
305
713
4 
0 305
713
4 
28/
02/
200
7 
    235 
and 
National 
Planning 
of the 
Govern
ment of 
Zambia 
Zam
bia 
1 TB Zambia 
National 
AIDS 
Network 
CS/
PS: 
NG
O 
ZAM-
102-
G15-T-
00 
01/
12/
200
5 
0 116
467
6 
116
467
6 
0 116
467
6 
116
467
6 
31/
01/
200
9 
Zam
bia 
1 TB The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
102-
G06-T-
00 
25/
07/
200
3 
230
796
2 
805
672
8.01 
103
646
90.0
1 
230
796
2 
805
672
8 
103
646
90 
25/
07/
200
8 
Zam
bia 
1 Ma
lari
a 
The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
102-
G05-
M-00 
01/
08/
200
3 
852
600 
252
990
0.01 
338
250
0.01 
852
600 
252
989
1.4 
338
249
1.4 
31/
08/
200
8 
Zam
bia 
1 HIV
/AI
DS 
Zambia 
National 
AIDS 
Network 
CS/
PS: 
NG
O 
ZAM-
102-
G08-
H-00 
25/
07/
200
3 
807
301
3 
121
314
68.0
1 
202
044
81.0
1 
807
301
3 
121
314
68 
202
044
81 
24/
01/
200
9 
Zam
bia 
1 HIV
/AI
DS 
The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
102-
G04-
H-00 
25/
07/
200
3 
661
495
8 
162
256
53.0
1 
228
406
11.0
1 
661
495
8 
162
256
53 
228
406
11 
24/
07/
200
8 
Zam
bia 
1 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Zambia 
Gov
: 
MO
H 
ZAM-
102-
G01-
H-00 
25/
07/
200
3 
212
142
71 
150
430
20.3
8 
362
572
91.3
8 
212
142
71 
145
430
20.3
6 
357
572
91 
14/
02/
200
9 
Zam
bia 
1 Ma
lari
a 
Ministry 
of 
Health 
Gov
: 
MO
ZAM-
102-
G02-
15/
08/
200
170
392
00 
184
520
99.8
354
912
99.8
170
392
00 
182
520
99.8 
352
913
00 
14/
02/
200
    236 
of the 
Govern
ment of 
the 
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of 
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H M-00 3 2 2 9 
Zam
bia 
1 TB Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Zambia 
Gov
: 
MO
H 
ZAM-
102-
G03-T-
00 
25/
07/
200
3 
124
472
94 
640
684
3.2 
188
541
37.2 
124
472
94 
590
684
3.18 
183
541
37 
24/
07/
200
8 
Zam
bia 
4 HIV
/AI
DS 
Zambia 
National 
AIDS 
Network 
CS/
PS: 
NG
O 
ZAM-
405-
G11-H 
01/
07/
200
5 
481
484
0 
282
085
55.0
1 
330
233
95.0
1 
481
484
0 
162
025
91.6
4 
210
174
32 
31/
12/
201
0 
Zam
bia 
4 HIV
/AI
DS 
The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
405-
G10-H 
01/
07/
200
5 
848
792
0 
572
640
52.7
9 
657
519
72.7
9 
848
792
0 
562
640
52.7
8 
647
519
73 
31/
12/
201
0 
Zam
bia 
4 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Zambia 
Gov
: 
MO
H 
ZAM-
405-
G09-H 
01/
11/
200
5 
110
916
40 
385
362
77.7
2 
496
279
17.7
2 
110
916
40 
334
020
97.6
4 
444
937
38 
30/
04/
201
1 
Zam
bia 
4 HIV
/AI
DS 
The 
Ministry 
of 
Finance 
and 
National 
Planning 
of the 
Govern
Gov
: 
MO
F 
ZAM-
405-
G12-H 
01/
10/
200
5 
237
637
6 
569
458
0.15 
807
095
6.15 
237
637
6 
519
458
0.14 
757
095
6.1 
31/
03/
201
1 
    237 
ment of 
Zambia 
Zam
bia 
4 Ma
lari
a 
The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
405-
G14-
M 
01/
07/
200
5 
582
988
7 
666
810
8.01 
124
979
95.0
1 
582
988
7 
637
966
7.88 
122
095
55 
31/
12/
201
0 
Zam
bia 
4 Ma
lari
a 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Zambia 
Gov
: 
MO
H 
ZAM-
405-
G13-
M 
01/
11/
200
5 
144
500
63 
769
236
8.91 
221
424
31.9
1 
144
500
63 
666
124
2.32 
211
113
05 
30/
04/
201
1 
Zam
bia 
7 Ma
lari
a 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Zambia 
Gov
: 
MO
H 
ZAM-
708-
G17-
M 
01/
07/
200
8 
0 0 0 0 0 0 31/
12/
201
0 
Zam
bia 
7 TB Zambia 
National 
AIDS 
Network 
CS/
PS: 
NG
O 
ZAM-
708-
G20-T 
01/
11/
200
8 
736
965 
0 736
965 
613
667.
63 
0 613
667
.63 
31/
10/
201
0 
Zam
bia 
7 TB The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
708-
G18-T 
01/
07/
200
8 
187
450
9 
136
370
0 
323
820
9 
187
450
9 
222
604 
209
711
3 
30/
06/
201
3 
Zam
bia 
7 TB Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Gov
: 
MO
H 
ZAM-
708-
G16-T 
01/
07/
200
8 
114
792
9.73 
0 114
792
9.73 
114
792
9.73 
0 114
792
9.7 
31/
12/
201
0 
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Republic 
of 
Zambia 
Zam
bia 
7 Ma
lari
a 
The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
708-
G19-
M 
01/
07/
200
8 
522
595
3 
157
286
9 
679
882
2 
522
595
3 
146
140
0.23 
668
735
3.2 
30/
06/
201
3 
Zam
bia 
8 HIV
/AI
DS 
Zambia 
National 
AIDS 
Network 
CS/
PS: 
NG
O 
ZAM-
809-
G22-H 
01/
12/
200
9 
999
349
3 
0 999
349
3 
291
410
9.2 
0 291
410
9.2 
30/
11/
201
1 
Zam
bia 
8 HIV
/AI
DS 
The 
Ministry 
of 
Finance 
and 
National 
Planning 
of the 
Govern
ment of 
Zambia 
Gov
: 
MO
F 
ZAM-
809-
G23-H 
01/
01/
201
0 
137
779
56 
0 137
779
56 
294
915
0 
0 294
915
0 
31/
12/
201
1 
Zam
bia 
8 HIV
/AI
DS 
The 
Churche
s Health 
Associati
on of 
Zambia 
CS/
PS: 
FBO 
ZAM-
809-
G21-H 
01/
01/
201
0 
312
895
18 
0 312
895
18 
253
786
17 
0 253
786
17 
31/
12/
201
1 
Zim
bab
we 
1 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
102-
G01-
H-00 
01/
05/
200
5 
631
253
2.94 
0 631
253
2.94 
631
253
2.94 
0 631
253
2.9 
30/
04/
200
8 
Zim
bab
we 
1 HIV
/AI
DS 
National 
AIDS 
Council 
of 
Zimbab
we 
Gov
: 
Oth 
ZIM-
102-
G07-H 
01/
11/
200
7 
246
924
7 
234
709
2.61 
481
633
9.61 
246
924
7 
234
709
2.59 
481
633
9.6 
30/
04/
200
8 
Zim
bab
we 
1 Ma
lari
a 
The 
Ministry 
of 
Health 
Gov
: 
MO
H 
ZIM-
102-
G02-
M-00 
01/
06/
200
3 
671
625
0 
209
946.
6 
692
619
6.6 
671
625
0 
209
946.
58 
692
619
6.6 
31/
01/
200
8 
    239 
and 
Child 
Welfare 
of the 
Govern
ment of 
Zimbab
we 
Zim
bab
we 
5 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
509-
G08-T 
01/
08/
200
9 
569
452
9 
143
775
2.98 
713
228
1.98 
569
452
9 
143
775
2.97 
713
228
2 
31/
08/
201
0 
Zim
bab
we 
5 HIV
/AI
DS 
Zimbab
we 
Associati
on of 
Church 
Related 
Hospital
s 
CS/
PS: 
FBO 
ZIM-
506-
G04-H 
01/
07/
200
7 
126
536
0.45 
0 126
536
0.45 
126
536
0.45 
0 126
536
0.5 
31/
07/
200
9 
Zim
bab
we 
5 Ma
lari
a 
The 
Ministry 
of 
Health 
and 
Child 
Welfare 
of the 
Govern
ment of 
Zimbab
we 
Gov
: 
MO
H 
ZIM-
506-
G06-
M 
01/
10/
200
7 
833
719
6 
0 833
719
6 
795
650
5.42 
0 795
650
5.4 
31/
07/
200
9 
Zim
bab
we 
5 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
509-
G10-H 
01/
08/
200
9 
204
400
40 
210
339
88.1
3 
414
740
28.1
3 
204
400
40 
210
339
88.1
2 
414
740
28 
31/
07/
201
0 
Zim
bab
we 
5 TB Zimbab
we 
Associati
on of 
Church 
Related 
CS/
PS: 
FBO 
ZIM-
506-
G05-T 
01/
09/
200
7 
274
774
3.98 
0 274
774
3.98 
274
774
3.98 
0 274
774
4 
31/
07/
200
9 
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Hospital
s 
Zim
bab
we 
5 HIV
/AI
DS 
National 
AIDS 
Council 
of 
Zimbab
we 
Gov
: 
Oth 
ZIM-
506-
G03-H 
01/
08/
200
7 
136
433
09.8
1 
0 136
433
09.8
1 
136
433
09.8
1 
0 136
433
10 
31/
07/
200
9 
Zim
bab
we 
5 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
509-
G09-
M 
01/
08/
200
9 
117
844
74 
365
864
8.86 
154
431
22.8
6 
117
844
74 
365
864
8.85 
154
431
23 
30/
09/
201
0 
Zim
bab
we 
8 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
809-
G12-T 
01/
01/
201
0 
282
361
13 
0 282
361
13 
253
712
82.1
7 
0 253
712
82 
31/
03/
201
2 
Zim
bab
we 
8 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
809-
G14-S 
01/
01/
201
0 
353
971
83 
0 353
971
83 
327
547
58.3
8 
0 327
547
58 
31/
03/
201
2 
Zim
bab
we 
8 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
809-
G11-H 
01/
01/
201
0 
846
412
14 
0 846
412
14 
731
250
58.1
3 
0 731
250
58 
31/
03/
201
2 
Zim
bab
we 
8 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
ZIM-
809-
G13-
M 
01/
01/
201
0 
328
102
90 
0 328
102
90 
315
501
06.5
1 
0 315
501
07 
31/
03/
201
2 
Ben
in 
1 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BEN-
102-
G01-
M-00 
01/
05/
200
3 
238
918
5 
565
847 
295
503
2 
238
918
5 
177
948.
96 
256
713
4 
30/
09/
200
6 
Ben
in 
2 HIV
/AI
United 
Nations 
MO
: 
BEN-
202-
25/
07/
113
480
538
157
167
295
113
480
392
816
152
761
31/
10/
    241 
DS Develop
ment 
Program
me 
UN
DP 
G03-
H-00 
200
3 
00 6.78 76.7
8 
00 2.78 63 200
6 
Ben
in 
2 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BEN-
202-
G02-T-
00 
01/
11/
200
3 
217
340
4 
921
754.
5 
309
515
8.5 
217
340
4 
657
808.
5 
283
121
2.5 
31/
10/
200
6 
Ben
in 
3 Ma
lari
a 
Africare CS/
PS: 
NG
O 
BEN-
304-
G04-
M 
01/
11/
200
4 
138
393
1 
107
299
9 
245
693
0 
138
393
1 
105
978
3.85 
244
371
4.9 
30/
09/
200
9 
Ben
in 
5 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Benin 
Gov
: 
MO
H 
BEN-
506-
G05-H 
01/
01/
200
7 
221
415
04.6
5 
107
154
95.0
9 
328
569
99.7
4 
221
415
04.6
5 
858
218
7.15
2 
307
236
92 
31/
12/
201
1 
Ben
in 
6 TB Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of Benin 
Gov
: 
MO
H 
BEN-
607-
G06-T 
01/
06/
200
7 
521
678
7.42
7 
775
537.
495 
599
232
4.92
2 
521
678
7.42
7 
775
535.
922
8 
599
232
3.4 
31/
05/
201
2 
Ben
in 
7 Ma
lari
a 
Catholic 
Relief 
Services 
CS/
PS: 
FBO 
BEN-
708-
G07-
M 
01/
07/
200
8 
121
636
73.1
9 
171
001
9.68 
138
736
92.8
7 
121
636
73.1
9 
347
220.
412
2 
125
108
94 
30/
06/
201
3 
Bur
kina 
Fas
o 
2 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BUR-
202-
G01-
M-00 
01/
12/
200
3 
681
249
1.76 
0 681
249
1.76 
681
249
1.76 
0 681
249
1.8 
30/
11/
200
5 
Bur
kina 
Fas
o 
2 HIV
/AI
DS 
United 
Nations 
Develop
ment 
MO
: 
UN
DP 
BUR-
202-
G02-
H-00 
01/
12/
200
3 
713
040
0 
165
860
9.67 
878
900
9.67 
713
040
0 
165
860
9.67 
878
900
9.7 
30/
09/
200
6 
    242 
Program
me 
Bur
kina 
Fas
o 
2 HIV
/AI
DS 
National 
Council 
for the 
Struggle 
against 
HIV/AID
S and STI 
(SP/CNL
S-IST) 
Gov
: 
MO
H 
BUR-
202-
G04-
H-00 
01/
10/
200
6 
0 536
302
3.9 
536
302
3.9 
0 536
302
3.9 
536
302
3.9 
28/
02/
200
8 
Bur
kina 
Fas
o 
4 TB National 
Council 
for the 
Struggle 
against 
HIV/AID
S and STI 
(SP/CNL
S-IST) 
Gov
: 
MO
H 
BUR-
407-
G05-T 
01/
04/
200
7 
190
579
0 
877
973
7.07 
106
855
27.0
7 
190
579
0 
877
973
7.06 
106
855
27 
31/
12/
200
9 
Bur
kina 
Fas
o 
4 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
BUR-
404-
G03-T 
01/
01/
200
5 
549
261
3.61 
0 549
261
3.61 
549
261
3.61 
0 549
261
3.6 
28/
02/
200
7 
Bur
kina 
Fas
o 
6 HIV
/AI
DS 
National 
Council 
for the 
Struggle 
against 
HIV/AID
S and STI 
(SP/CNL
S-IST) 
Gov
: 
Oth 
BUR-
607-
G06-H 
01/
10/
200
7 
284
236
55.8
7 
269
293
55.7
3 
553
530
11.6 
284
236
55.8
7 
191
883
96.3
1 
476
120
52 
30/
09/
201
1 
Bur
kina 
Fas
o 
7 Ma
lari
a 
National 
Council 
for the 
Struggle 
against 
HIV/AID
S and STI 
(SP/CNL
S-IST) 
Gov
: 
Oth 
BUR-
708-
G07-
M 
01/
05/
200
8 
185
310
13.4
8 
685
401
3.49
1 
253
850
26.9
7 
185
310
13.4
8 
437
073
0.52
9 
229
017
44 
30/
04/
201
3 
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Bur
kina 
Fas
o 
8 Ma
lari
a 
Program
me 
d'appui 
au 
develop
pment 
sanitaire 
of the 
Govern
ment of 
Burkina 
Faso 
(PADS) 
Gov
: 
Oth 
BUR-
809-
G08-
M 
01/
09/
200
9 
405
561
68.9
8 
0 405
561
68.9
8 
403
336
25.5
1 
0 403
336
26 
31/
12/
201
1 
Bur
kina 
Fas
o 
8 Ma
lari
a 
Plan 
Internati
onal, Inc. 
CS/
PS: 
NG
O 
BUR-
809-
G09-
M 
01/
09/
200
9 
136
123
57.6 
0 136
123
57.6 
134
143
30.2
4 
0 134
143
30 
31/
12/
201
1 
Ca
mer
oon 
3 TB The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Camero
on 
Gov
: 
MO
H 
CMR-
304-
G03-T 
01/
01/
200
5 
298
622
0 
281
874
1.01 
580
496
1.01 
298
622
0 
249
259
8.95 
547
881
9 
31/
12/
200
9 
Ca
mer
oon 
3 HIV
/AI
DS 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Camero
on 
Gov
: 
MO
H 
CMR-
304-
G01-H 
01/
01/
200
5 
146
414
07 
408
592
10 
555
006
17 
146
414
07 
408
592
09.8
6 
555
006
17 
31/
12/
200
9 
Ca
mer
oon 
3 HIV
/AI
DS 
The 
Ministry 
of Public 
Health 
of the 
Gov
: 
MO
H 
CMR-
304-
G01-
H-e 
01/
01/
201
0 
0 167
405
38.0
4 
167
405
38.0
4 
0 123
958
02.0
9 
123
958
02 
31/
12/
201
1 
    244 
Govern
ment of 
the 
Republic 
of 
Camero
on 
Ca
mer
oon 
3 Ma
lari
a 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Camero
on 
Gov
: 
MO
H 
CMR-
304-
G02-
M 
01/
01/
200
5 
169
387
94 
148
423
93.0
1 
317
811
87.0
1 
169
387
94 
129
426
69.9 
298
814
64 
31/
12/
200
9 
Ca
mer
oon 
4 HIV
/AI
DS 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
CMR-
404-
G04-H 
01/
01/
200
5 
634
729
6 
984
679
3.01 
161
940
89.0
1 
634
729
6 
956
816
1.91 
159
154
58 
31/
12/
200
9 
Ca
mer
oon 
5 HIV
/AI
DS 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Camero
on 
Gov
: 
MO
H 
CMR-
506-
G05-H 
01/
08/
200
6 
431
804
3.16
8 
797
554
0.30
3 
122
935
83.4
7 
431
804
3.16
8 
539
734
2.98
2 
971
538
6.2 
31/
07/
201
1 
Ca
mer
oon 
5 Ma
lari
a 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Camero
Gov
: 
MO
H 
CMR-
506-
G06-
M 
01/
11/
200
6 
141
442
93.5
9 
440
803.
454
1 
145
850
97.0
5 
103
479
63.4
4 
0 103
479
63 
31/
10/
201
1 
    245 
on 
Cen
tral 
Afri
can 
Rep
ubli
c 
2 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CAF-
202-
G01-
H-00 
01/
10/
200
3 
819
892
1 
148
577
70.8
2 
230
566
91.8
2 
819
892
1 
125
577
70.8
2 
207
566
92 
31/
01/
200
9 
Cen
tral 
Afri
can 
Rep
ubli
c 
4 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CAF-
404-
G03-T 
01/
01/
200
5 
203
388
5 
135
175
9.06 
338
564
4.06 
203
388
5 
135
175
9.04 
338
564
4 
31/
12/
200
9 
Cen
tral 
Afri
can 
Rep
ubli
c 
4 TB National 
Coordina
tion of 
the 
National 
AIDS 
Control 
Committ
ee of the 
Govern
ment of 
the 
Central 
African 
Republic 
Gov
: 
MO
H 
CAF-
409-
G07-T 
01/
07/
200
9 
0 562
701 
562
701 
0 256
983 
256
983 
30/
06/
201
0 
Cen
tral 
Afri
can 
Rep
ubli
c 
4 HIV
/AI
DS 
National 
Coordina
tion of 
the 
National 
AIDS 
Control 
Committ
ee of the 
Govern
ment of 
the 
Central 
African 
Gov
: 
MO
H 
CAF-
409-
G06-H 
01/
07/
200
9 
0 216
341
5 
216
341
5 
0 151
574
2 
151
574
2 
30/
06/
201
0 
    246 
Republic 
Cen
tral 
Afri
can 
Rep
ubli
c 
4 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CAF-
404-
G02-H 
01/
01/
200
5 
469
501
2 
380
025
0.31 
849
526
2.31 
469
501
2 
380
025
0.31 
849
526
2.3 
31/
12/
200
9 
Cen
tral 
Afri
can 
Rep
ubli
c 
4 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CAF-
405-
G04-
M 
01/
05/
200
5 
105
928
16 
607
108
1 
166
638
97 
105
928
16 
304
081
9.71 
136
336
36 
31/
10/
201
0 
Cen
tral 
Afri
can 
Rep
ubli
c 
7 HIV
/AI
DS 
National 
Coordina
tion of 
the 
National 
AIDS 
Control 
Committ
ee of the 
Govern
ment of 
the 
Central 
African 
Republic 
Gov
: 
MO
H 
CAF-
708-
G05-H 
01/
01/
200
9 
157
998
99 
0 157
998
99 
144
267
07.8
6 
0 144
267
08 
31/
12/
201
1 
Con
go 
5 HIV
/AI
DS 
Secretari
at 
Executif 
du 
Conseil 
National 
de Lutte 
Contre 
le Sida 
(CNLS) 
Gov
: 
Oth 
COG-
506-
G01-H 
01/
12/
200
6 
120
434
07 
0   112
382
17.3
4 
0 112
382
17 
30/
11/
201
1 
Côt
e 
d'Iv
2 HIV
/AI
DS 
CARE 
Internati
onal 
CS/
PS: 
NG
CIV-
202-
G05-H 
01/
08/
200
0 261
711
18.0
261
711
18.0
0 227
994
34.9
227
994
35 
31/
05/
201
    247 
oire O 7 2 2 2 0 
Côt
e 
d'Iv
oire 
2 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CIV-
202-
G01-
H-00 
01/
12/
200
3 
180
993
98 
288
794
9.56 
209
873
47.5
6 
180
993
98 
288
794
9.27 
209
873
47 
30/
09/
200
7 
Côt
e 
d'Iv
oire 
3 HIV
/AI
DS 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
CIV-
304-
G02-H 
01/
04/
200
4 
102
346
6.93 
0 102
346
6.93 
102
346
6.93 
0 102
346
6.9 
28/
02/
200
6 
Côt
e 
d'Iv
oire 
3 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
CIV-
304-
G03-T 
01/
04/
200
4 
287
012
2 
959
985.
01 
383
010
7.01 
287
012
2 
872
223.
52 
374
234
5.5 
31/
03/
200
9 
Côt
e 
d'Iv
oire 
5 HIV
/AI
DS 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
CIV-
506-
G04-H 
01/
08/
200
6 
401
706
9.08
2 
0 401
706
9.08
2 
401
326
0.45 
0 401
326
0.5 
31/
10/
200
8 
Côt
e 
d'Iv
oire 
6 Ma
lari
a 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
CIV-
607-
G06-
M 
01/
12/
200
7 
102
650
35.2
6 
0 102
650
35.2
6 
944
737
9.95 
0 944
738
0 
30/
06/
201
0 
Côt
e 
d'Iv
oire 
6 TB National 
Program 
to Fight 
Against 
Tubercul
osis 
(PNLT) 
Gov
: 
MO
H 
CIV-
607-
G07-T 
01/
04/
200
8 
347
375
4.53 
0 347
375
4.53 
347
375
4.53 
0 347
375
4.5 
30/
06/
201
0 
Côt
e 
d'Iv
oire 
8 Ma
lari
a 
National 
Program 
fo 
Malaria 
Control(
PNLP),M
inistry of 
Health & 
Public 
Hygiene 
of the 
Govt of 
the 
Gov
: 
MO
H 
CIV-
809-
G09-
M 
01/
01/
201
0 
547
797
52.2
7 
0 547
797
52.2
7 
264
260
39.5 
0 264
260
40 
30/
06/
201
2 
    248 
Republic 
of Cote 
d'Ivoire 
Côt
e 
d'Iv
oire 
8 Ma
lari
a 
CARE 
Internati
onal 
CS/
PS: 
NG
O 
CIV-
809-
G08-
M 
01/
01/
201
0 
825
035
33.4
6 
0 825
035
33.4
6 
572
198
64.4
2 
0 572
198
64 
30/
06/
201
2 
Equ
ator
ial 
Gui
nea 
4 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GNQ-
405-
G01-H 
01/
07/
200
5 
439
876
4 
542
607
2.01 
982
483
6.01 
439
876
4 
341
138
3.11 
781
014
7.1 
30/
06/
201
1 
Equ
ator
ial 
Gui
nea 
5 Ma
lari
a 
Medical 
Care 
Develop
ment 
Internati
onal 
CS/
PS: 
NG
O 
GNQ-
506-
G02-
M 
01/
10/
200
6 
129
061
11 
101
681
95.0
1 
230
743
06.0
1 
129
061
11 
101
002
16.2
5 
230
063
27 
30/
09/
201
1 
Gab
on 
3 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GAB-
304-
G01-
H-e 
01/
10/
200
4 
0 179
751
5.62 
179
751
5.62 
0 179
751
5.62 
179
751
5.6 
30/
09/
200
9 
Gab
on 
3 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GAB-
304-
G01-H 
01/
10/
200
4 
315
450
0 
193
846
7 
509
296
7 
315
450
0 
193
846
7 
509
296
7 
30/
09/
200
7 
Gab
on 
4 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GAB-
404-
G02-
M 
01/
01/
200
5 
741
962
4 
119
669
8.02 
861
632
2.02 
741
962
4 
119
669
8 
861
632
2 
31/
12/
200
7 
Gab
on 
5 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GAB-
506-
G03-
M 
01/
08/
200
6 
416
032
2.50
8 
0 416
032
2.50
8 
416
032
1.98 
0 416
032
2 
31/
07/
200
8 
    249 
Gab
on 
5 Ma
lari
a 
Ministry 
of 
Health 
and 
Public 
Hygiene 
of the 
Governe
mnt of 
the 
Gabones
e 
Republic 
Gov
: 
MO
H 
GAB-
509-
G04-
M 
01/
04/
200
9 
0 966
720
9.23
9 
966
720
9.23
9 
0 476
289
1.98 
476
289
2 
31/
01/
201
1 
Gab
on 
8 HIV
/AI
DS 
Ministry 
of 
Health 
and 
Public 
Hygiene 
of the 
Governe
mnt of 
the 
Gabones
e 
Republic 
Gov
: 
MO
H 
GAB-
809-
G05-H 
01/
12/
200
9 
684
536
2.89
6 
0 684
536
2.89
6 
525
336
5.85 
0 525
336
5.9 
29/
02/
201
2 
Ga
mbi
a 
3 Ma
lari
a 
The 
Departm
ent of 
State for 
Health 
of the 
Republic 
of the 
Gambia 
Gov
: 
MO
H 
GMB-
304-
G02-
M 
01/
10/
200
4 
566
550
0 
912
920
4.02 
147
947
04.0
2 
566
550
0 
912
920
4 
147
947
04 
30/
04/
201
0 
Ga
mbi
a 
3 HIV
/AI
DS 
The 
National 
AIDS 
Secretari
at of the 
Republic 
of the 
Gambia 
Gov
: 
Oth 
GMB-
304-
G01-H 
01/
10/
200
4 
624
174
3 
832
216
4.3 
145
639
07.3 
624
174
3 
832
216
4.29 
145
639
07 
30/
09/
200
9 
Ga
mbi
a 
5 TB Ministry 
of 
Health 
Gov
: 
MO
GMB-
506-
G03-T 
01/
06/
200
256
132
7 
247
160
2.01 
503
292
9.01 
256
132
7 
233
940
3.55 
490
073
0.6 
31/
05/
201
    250 
and 
Social 
welfare 
of the 
Govern
ment of 
the 
Republic 
of the 
Gambia 
H 6 1 
Ga
mbi
a 
6 Ma
lari
a 
The 
Departm
ent of 
State for 
Health 
of the 
Republic 
of the 
Gambia 
Gov
: 
MO
H 
GMB-
607-
G04-
M 
01/
07/
200
7 
955
277
9 
203
241
3.99 
115
851
92.9
9 
955
277
9 
203
241
3.97 
115
851
93 
30/
06/
201
2 
Ga
mbi
a 
8 HIV
/AI
DS 
The 
National 
AIDS 
Secretari
at of the 
Republic 
of the 
Gambia 
Gov
: 
Oth 
GMB-
809-
G05-H 
01/
12/
200
9 
163
717
12.3 
0 163
717
12.3 
122
031
95.9
4 
0 122
031
96 
29/
02/
201
2 
Ga
mbi
a 
8 HIV
/AI
DS 
Action 
Aid The 
Gambia 
CS/
PS: 
NG
O 
GMB-
809-
G06-H 
01/
12/
200
9 
555
922
7.34
5 
0 555
922
7.34
5 
531
713
6.7 
0 531
713
6.7 
29/
02/
201
2 
Gha
na 
1 TB The 
Ministry 
of 
Health 
of the 
Republic 
of Ghana 
Gov
: 
MO
H 
GHN-
102-
G02-T-
00 
01/
01/
200
3 
233
694
0 
334
855
2.56 
568
549
2.56 
233
694
0 
334
855
2.55 
568
549
2.6 
31/
12/
200
7 
Gha
na 
1 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Republic 
of Ghana 
Gov
: 
MO
H 
GHN-
102-
G01-
H-00 
01/
01/
200
3 
496
547
8 
920
474
4.01 
141
702
22.0
1 
496
547
8 
920
474
4 
141
702
22 
31/
12/
200
7 
    251 
Gha
na 
2 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Republic 
of Ghana 
Gov
: 
MO
H 
GHN-
202-
G03-
M-00 
01/
09/
200
3 
459
611
1 
425
338
0.01 
884
949
1.01 
459
611
1 
425
337
9.98 
884
949
1 
31/
08/
200
8 
Gha
na 
4 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Republic 
of Ghana 
Gov
: 
MO
H 
GHN-
405-
G04-
M 
01/
03/
200
5 
216
276
15 
203
264
14.0
1 
111
556
235 
216
276
15 
203
264
14.0
1 
879
006
66 
29/
02/
201
2 
Gha
na 
5 TB The 
Ministry 
of 
Health 
of the 
Republic 
of Ghana 
Gov
: 
MO
H 
GHN-
506-
G05-T 
01/
05/
200
6 
145
475
46 
169
242
38.0
1 
314
717
84.0
1 
145
475
46 
165
144
68.7
2 
310
620
15 
30/
04/
201
1 
Gha
na 
5 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Republic 
of Ghana 
Gov
: 
MO
H 
GHN-
506-
G06-H 
01/
05/
200
6 
316
300
98 
823
659
06.0
1 
113
996
004 
316
300
98 
719
814
81.4 
103
611
579 
30/
04/
201
3 
Gha
na 
8 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Republic 
of Ghana 
Gov
: 
MO
H 
GHN-
809-
G11-H 
01/
01/
201
0 
358
779
81 
0 358
779
81 
255
304
56 
0 255
304
56 
31/
03/
201
2 
Gha
na 
8 HIV
/AI
DS 
Planned 
Parenth
ood 
Associati
on of 
Ghana 
CS/
PS: 
NG
O 
GHN-
809-
G10-H 
01/
01/
201
0 
292
136
6 
0 292
136
6 
208
078
5 
0 208
078
5 
31/
03/
201
2 
Gha
na 
8 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Gov
: 
MO
H 
GHN-
809-
G07-
M 
01/
01/
201
0 
228
850
4 
0 228
850
4 
228
850
4 
0 228
850
4 
31/
12/
201
1 
    252 
Republic 
of Ghana 
Gha
na 
8 HIV
/AI
DS 
Adventis
t 
Develop
ment 
and 
Relief 
Agency 
(ADRA) 
of Ghana 
CS/
PS: 
NG
O 
GHN-
809-
G09-H 
01/
01/
201
0 
485
099
3 
0 485
099
3 
429
025
0 
0 429
025
0 
31/
03/
201
2 
Gha
na 
8 HIV
/AI
DS 
Ghana 
AIDS 
Commiss
ion 
CS/
PS: 
NG
O 
GHN-
809-
G12-H 
01/
01/
201
0 
137
744
66 
0 137
744
66 
130
905
04 
0 130
905
04 
31/
03/
201
2 
Gha
na 
8 Ma
lari
a 
AngloGo
ld 
Ashanti 
(Ghana) 
Malaria 
Control 
Limited 
CS/
PS: 
NG
O 
GHN-
809-
G08-
M 
01/
01/
201
0 
305
005
00 
0 305
005
00 
639
506
8 
0 639
506
8 
31/
12/
201
2 
Gui
nea 
2 HIV
/AI
DS 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea 
Gov
: 
MO
H 
GIN-
202-
G01-
H-00 
01/
04/
200
4 
480
469
6 
484
640
9.01 
965
110
5.01 
480
469
6 
432
011.
32 
523
670
7.3 
30/
09/
200
9 
Gui
nea 
2 Ma
lari
a 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea 
Gov
: 
MO
H 
GIN-
202-
G02-
M-00 
01/
04/
200
4 
600
806
4.32 
0 600
806
4.32 
600
806
4.32 
0 600
806
4.3 
30/
09/
200
9 
    253 
Gui
nea 
5 TB The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea 
Gov
: 
MO
H 
GIN-
506-
G03-T 
01/
02/
200
7 
398
165
1.23
8 
574
477.
903
9 
455
612
9.14
2 
398
165
1.23
8 
574
477.
903
9 
455
612
9.2 
31/
01/
201
2 
Gui
nea 
6 Ma
lari
a 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea 
Gov
: 
MO
H 
GIN-
607-
G05-
M 
01/
01/
200
8 
173
392
48 
0 173
392
48 
128
561
32.5
8 
0 128
561
33 
30/
06/
201
0 
Gui
nea 
6 HIV
/AI
DS 
The 
Ministry 
of Public 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea 
Gov
: 
MO
H 
GIN-
607-
G04-H 
01/
01/
200
8 
458
540
5 
889
936
1.01 
134
847
66.0
1 
458
540
5 
477
292
0.18 
935
832
5.2 
31/
12/
201
2 
Gui
nea
-
Biss
au 
3 TB The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea-
Bissau 
(CG/PND
Gov
: 
MO
H 
GNB-
309-
G06-T 
01/
07/
200
8 
0 609
179.
01 
609
179.
01 
0 609
179 
609
179 
31/
12/
200
9 
    254 
S) 
Gui
nea
-
Biss
au 
3 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GNB-
304-
G01-T 
01/
07/
200
4 
150
358
7 
423
481.
41 
192
706
8.41 
150
358
7 
423
481.
39 
192
706
8.4 
30/
06/
200
8 
Gui
nea
-
Biss
au 
4 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GNB-
404-
G03-
M 
01/
01/
200
5 
188
579
1 
234
538.
22 
212
032
9.22 
188
579
1 
234
538.
2 
212
032
9.2 
30/
06/
200
8 
Gui
nea
-
Biss
au 
4 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea-
Bissau 
(CG/PND
S) 
Gov
: 
MO
H 
GNB-
409-
G08-
M 
01/
07/
200
8 
0 599
333.
01 
599
333.
01 
0 599
333 
599
333 
30/
09/
201
0 
Gui
nea
-
Biss
au 
4 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
GNB-
404-
G02-H 
01/
11/
200
4 
116
680
1 
754
641.
86 
192
144
2.86 
116
680
1 
754
641.
84 
192
144
2.8 
30/
06/
200
8 
Gui
nea
-
Biss
au 
4 HIV
/AI
DS 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea-
Gov
: 
MO
H 
GNB-
409-
G07-H 
01/
07/
200
8 
0 120
322
6.01 
120
322
6.01 
0 120
322
6 
120
322
6 
30/
09/
201
0 
    255 
Bissau 
(CG/PND
S) 
Gui
nea
-
Biss
au 
6 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Guinea-
Bissau 
(CG/PND
S) 
Gov
: 
MO
H 
GNB-
607-
G04-
M 
01/
12/
200
7 
313
424
0.72 
0 313
424
0.72 
313
424
0.72 
0 313
424
0.7 
30/
06/
201
0 
Gui
nea
-
Biss
au 
7 HIV
/AI
DS 
National 
Secretari
at to 
Fight 
AIDS of 
the 
Govern
ment of 
Guinea-
Bissau 
Gov
: 
Oth 
GNB-
708-
G05-H 
01/
01/
200
9 
939
354
0.45 
0   939
354
0.45 
0 939
354
0.5 
31/
12/
201
3 
Libe
ria 
2 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
LBR-
202-
G01-
H-00 
01/
12/
200
4 
742
326
7.69 
0 742
326
7.69 
742
326
7.69 
0 742
326
7.7 
28/
02/
200
7 
Libe
ria 
2 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
LBR-
202-
G02-T-
00 
01/
12/
200
4 
428
851
6.31 
0 428
851
6.31 
428
851
6.31 
0 428
851
6.3 
28/
02/
200
7 
Libe
ria 
3 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
LBR-
304-
G03-
M 
01/
12/
200
4 
118
689
92.3
1 
0 118
689
92.3
1 
118
689
92.3
1 
0 118
689
92 
28/
02/
200
7 
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Libe
ria 
6 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
LBR-
607-
G04-H 
01/
06/
200
7 
167
374
14 
660
25.0
1 
168
034
39.0
1 
167
374
14 
660
25 
168
034
39 
30/
04/
201
0 
Libe
ria 
7 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
LBR-
708-
G06-T 
01/
06/
200
8 
640
887
2 
316
529
3.01 
957
416
5.01 
640
887
2 
316
529
3 
957
416
5 
31/
05/
201
3 
Libe
ria 
7 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
LBR-
708-
G05-
M 
01/
06/
200
8 
126
959
07 
679
433
9.01 
194
902
46.0
1 
126
959
07 
679
433
9 
194
902
46 
31/
05/
201
1 
Nig
eria 
1 HIV
/AI
DS 
National 
Action 
Committ
ee on 
AIDS of 
the 
Federal 
Govern
ment of 
Nigeria 
Gov
: 
Oth 
NGA-
102-
G01-
H-00 
01/
01/
200
4 
677
027
6 
0 677
027
6 
677
027
6 
0 677
027
6 
31/
05/
200
6 
Nig
eria 
1 HIV
/AI
DS 
The 
Yakubu 
Gowon 
Center 
for 
National 
Unity 
and 
Internati
onal 
Coopera
tion 
CS/
PS: 
NG
O 
NGA-
102-
G02-
H-00 
01/
12/
200
3 
816
305 
0 816
305 
816
305 
0 816
305 
30/
11/
200
4 
Nig
eria 
1 HIV
/AI
DS 
National 
Action 
Committ
ee on 
AIDS of 
the 
Gov
: 
Oth 
NGA-
102-
G03-
H-00 
01/
01/
200
4 
129
483
23 
0 129
483
23 
129
483
23 
0 129
483
23 
31/
05/
200
6 
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Federal 
Govern
ment of 
Nigeria 
Nig
eria 
2 Ma
lari
a 
The 
Yakubu 
Gowon 
Center 
for 
National 
Unity 
and 
Internati
onal 
Coopera
tion 
CS/
PS: 
NG
O 
NGA-
202-
G04-
M-00 
01/
12/
200
4 
202
417
84 
0 202
417
84 
202
417
84 
0 202
417
84 
31/
05/
200
7 
Nig
eria 
4 Ma
lari
a 
The 
Yakubu 
Gowon 
Center 
for 
National 
Unity 
and 
Internati
onal 
Coopera
tion 
CS/
PS: 
NG
O 
NGA-
404-
G05-
M 
01/
01/
200
5 
204
670
00 
234
336
96.0
2 
439
006
96.0
2 
204
670
00 
180
147
06.6
4 
384
817
07 
30/
06/
201
0 
Nig
eria 
4 Ma
lari
a 
SOCIETY 
FOR 
FAMILY 
HEALTH 
CS/
PS: 
NG
O 
NGA-
407-
G10-
M 
01/
01/
200
8 
0 306
415
91.0
1 
306
415
91.0
1 
0 256
702
95 
256
702
95 
30/
06/
201
0 
Nig
eria 
5 TB Associati
on For 
Reprodu
ctive 
And 
Family 
Health 
(ARFH) 
CS/
PS: 
NG
O 
NGA-
509-
G15-T 
01/
10/
200
9 
163
757
6 
103
569
62.0
1 
119
945
38.0
1 
163
757
6 
103
569
61.9
9 
119
945
38 
30/
06/
201
2 
Nig
eria 
5 HIV
/AI
DS 
Associati
on For 
Reprodu
ctive 
And 
Family 
CS/
PS: 
NG
O 
NGA-
506-
G09-H 
01/
01/
200
7 
115
991
64 
664
370
7.02 
182
428
71.0
2 
115
991
64 
664
370
7 
182
428
71 
31/
03/
201
1 
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Health 
(ARFH) 
Nig
eria 
5 HIV
/AI
DS 
SOCIETY 
FOR 
FAMILY 
HEALTH 
CS/
PS: 
NG
O 
NGA-
506-
G08-H 
01/
01/
200
7 
641
742
2 
890
725
4.56 
153
246
76.5
6 
641
742
2 
890
725
4.53 
153
246
77 
31/
03/
201
1 
Nig
eria 
5 HIV
/AI
DS 
National 
Agency 
for the 
Control 
of AIDS 
Gov
: 
Oth 
NGA-
506-
G07-H 
01/
01/
200
7 
506
036
61 
235
672
22.0
2 
741
708
83.0
2 
506
036
61 
235
672
22 
741
708
83 
31/
12/
201
1 
Nig
eria 
5 TB Christian 
Health 
Associati
on of 
Nigeria 
CS/
PS: 
FBO 
NGA-
506-
G06-T 
01/
01/
200
7 
239
324
85 
0 239
324
85 
239
324
85 
0 239
324
85 
31/
12/
200
8 
Nig
eria 
8 HIV
/AI
DS 
National 
Agency 
for the 
Control 
of AIDS 
Gov
: 
Oth 
NGA-
809-
G12-S 
01/
11/
200
9 
553
799
35 
0 553
799
35 
209
752
88 
0 209
752
88 
31/
10/
201
1 
Nig
eria 
8 Ma
lari
a 
SOCIETY 
FOR 
FAMILY 
HEALTH 
CS/
PS: 
NG
O 
NGA-
809-
G11-
M 
01/
08/
200
9 
877
498
01 
0 877
498
01 
587
296
23.8
7 
0 587
296
24 
31/
03/
201
2 
Nig
eria 
8 Ma
lari
a 
National 
Malaria 
Control 
Program
me of 
the 
Federal 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Federal 
Republic 
of 
Nigeria, 
NMCP 
Gov
: 
MO
H 
NGA-
809-
G14-
M 
01/
11/
200
9 
107
789
890 
0 107
789
890 
981
693
71.2
8 
0 981
693
71 
31/
12/
201
1 
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Nig
eria 
8 Ma
lari
a 
The 
Yakubu 
Gowon 
Center 
for 
National 
Unity 
and 
Internati
onal 
Coopera
tion 
CS/
PS: 
NG
O 
NGA-
809-
G13-
M 
01/
11/
200
9 
103
171
584 
0 103
171
584 
861
153
13.0
6 
0 861
153
13 
31/
12/
201
1 
Sao 
To
me 
and 
Prin
cipe 
4 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
STP-
405-
G01-
M 
01/
03/
200
5 
194
135
9 
146
943
9.01 
341
079
8.01 
194
135
9 
146
943
9.01 
341
079
8.4 
31/
01/
201
1 
Sao 
To
me 
and 
Prin
cipe 
5 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
STP-
506-
G02-H 
01/
10/
200
6 
506
480 
864
202.
02 
137
068
2.02 
506
480 
769
956.
31 
127
643
6.3 
30/
09/
201
1 
Sao 
To
me 
and 
Prin
cipe 
7 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
STP-
708-
G03-
M 
01/
11/
200
8 
243
024
7 
0 243
024
7 
243
024
7 
0 243
024
7 
31/
01/
201
1 
Sao 
To
me 
and 
Prin
cipe 
8 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
STP-
809-
G04-T 
01/
12/
200
9 
101
508
0 
0 101
508
0 
591
980 
0 591
980 
29/
02/
201
2 
Sen
egal 
1 HIV
/AI
DS 
Alliance 
National
e Contre 
le SIDA 
CS/
PS: 
NG
O 
SNG-
102-
G04-
H-00 
01/
04/
200
6 
0 290
632
6.01 
290
632
6.01 
0 290
632
6 
290
632
6 
31/
03/
200
8 
Sen
egal 
1 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
Gov
: 
MO
H 
SNG-
102-
G02-
M-00 
01/
04/
200
3 
152
677
0 
0 152
677
0 
152
677
0 
0 152
677
0 
31/
05/
200
5 
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ment of 
the 
Republic 
of 
Senegal 
Sen
egal 
1 HIV
/AI
DS 
The 
National 
AIDS 
Council 
of 
Senegal 
Gov
: 
Oth 
SNG-
102-
G01-
H-00 
01/
04/
200
3 
600
000
0 
274
891
4.92 
874
891
4.92 
600
000
0 
274
891
4.91 
874
891
4.9 
31/
03/
200
8 
Sen
egal 
4 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Senegal 
Gov
: 
MO
H 
SNG-
405-
G03-
M 
01/
09/
200
5 
214
505
70 
732
769
0.01 
287
782
60.0
1 
214
505
70 
272
341
0.7 
241
739
81 
31/
08/
201
0 
Sen
egal 
6 HIV
/AI
DS 
The 
National 
AIDS 
Council 
of 
Senegal 
Gov
: 
Oth 
SNG-
607-
G05-H 
01/
06/
200
7 
715
007
9.33
2 
357
606
1.97
6 
107
261
41.3
1 
715
007
9.33
2 
357
606
1.94
8 
107
261
41 
31/
05/
201
2 
Sen
egal 
6 HIV
/AI
DS 
Alliance 
National
e Contre 
le SIDA 
CS/
PS: 
NG
O 
SNG-
607-
G06-H 
01/
06/
200
7 
439
816
9.04
9 
181
764
7.05
9 
621
581
6.10
9 
439
816
9.04
9 
181
764
7.03
1 
621
581
6.1 
31/
05/
201
2 
Sen
egal 
7 TB The 
Ministry 
of 
Health 
and 
Medical 
Preventi
on 
(MSPM), 
Govern
ment of 
the 
Repbulic 
of 
Gov
: 
MO
H 
SNG-
708-
G08-T 
01/
11/
200
8 
416
191
5.87
3 
455
96.7
671 
420
751
2.64 
416
191
5.87
3 
440
89.2
466
8 
420
600
5.1 
31/
12/
201
1 
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Senegal 
Sen
egal 
7 Ma
lari
a 
The 
Ministry 
of 
Health 
of the 
Govern
ment of 
the 
Republic 
of 
Senegal 
Gov
: 
MO
H 
SNG-
708-
G07-
M 
01/
06/
200
8 
272
690
88.0
4 
-
466
472
4.91
7 
226
043
63.1
3 
202
576
81.4
3 
0 202
576
81 
01/
05/
201
3 
Sier
ra 
Leo
ne 
2 TB The 
Sierra 
Leone 
Red 
Cross 
Society 
CS/
PS: 
NG
O 
SLE-
202-
G01-T-
00 
01/
01/
200
4 
256
910
3 
246
173
3.9 
503
083
6.9 
256
910
3 
246
173
3.88 
503
083
6.9 
31/
12/
200
8 
Sier
ra 
Leo
ne 
4 Ma
lari
a 
The 
Sierra 
Leone 
Red 
Cross 
Society 
CS/
PS: 
NG
O 
SLE-
405-
G03-
M 
01/
05/
200
5 
695
609
7 
0 695
609
7 
695
609
7 
0 695
609
7 
30/
04/
200
7 
Sier
ra 
Leo
ne 
4 HIV
/AI
DS 
The 
Sierra 
Leone 
National 
HIV/AID
S 
Secretari
at 
Gov
: 
Oth 
SLE-
405-
G02-H 
01/
06/
200
5 
857
425
5 
924
654
8.01 
178
208
03.0
1 
857
425
5 
725
039
7.74 
158
246
53 
31/
08/
201
0 
Sier
ra 
Leo
ne 
6 HIV
/AI
DS 
The 
Sierra 
Leone 
National 
HIV/AID
S 
Secretari
at 
Gov
: 
Oth 
SLE-
607-
G04-H 
01/
02/
200
8 
967
431
8.79 
0 967
431
8.79 
967
431
8.79 
0 967
431
8.8 
31/
08/
201
0 
Sier
ra 
Leo
ne 
7 Ma
lari
a 
Ministry 
of 
Health 
and 
Gov
: 
MO
H 
SLE-
708-
G05-
M 
01/
05/
200
8 
100
112
50 
230
604
0.21 
123
172
90.2
1 
100
112
50 
230
604
0.2 
123
172
90 
30/
04/
201
3 
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Sanitatio
n 
Sier
ra 
Leo
ne 
7 TB Ministry 
of 
Health 
and 
Sanitatio
n 
Gov
: 
MO
H 
SLE-
708-
G06-T 
01/
11/
200
8 
433
644
8 
281
812
4 
715
457
2 
433
644
8 
338
30.3
1 
437
027
8.3 
31/
10/
201
3 
Tog
o 
2 HIV
/AI
DS 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TGO-
202-
G01-
H-00 
01/
10/
200
3 
140
883
07.8
8 
0 140
883
07.8
8 
140
883
07.8
8 
0 140
883
08 
31/
03/
200
9 
Tog
o 
3 TB United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TGO-
304-
G03-T 
01/
05/
200
4 
175
298
2 
489
06.2
2 
180
188
8.22 
168
469
3.07 
0 168
469
3.1 
30/
04/
200
7 
Tog
o 
3 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TGO-
304-
G02-
M 
01/
05/
200
4 
347
933
6 
237
749
9.47 
585
683
5.47 
347
933
6 
223
814
9.71 
571
748
5.7 
30/
04/
200
9 
Tog
o 
4 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TGO-
405-
G05-
M 
01/
10/
200
5 
606
603
4 
462
894
7.01 
106
949
81.0
1 
606
603
4 
460
105
0.98 
106
670
85 
30/
09/
201
0 
Tog
o 
4 HIV
/AI
DS 
POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
PS: 
NG
O 
TGO-
405-
G04-H 
01/
04/
200
5 
115
176
43 
211
369
12.0
2 
326
545
55.0
2 
115
176
43 
192
437
29.8
7 
307
613
73 
28/
02/
201
1 
Tog
o 
6 Ma
lari
a 
United 
Nations 
Develop
ment 
Program
me 
MO
: 
UN
DP 
TGO-
607-
G06-
M 
01/
01/
200
8 
784
058
9.52
4 
121
598
3.05
9 
905
657
2.58
3 
784
058
9.52
4 
983
581.
665
5 
882
417
1.2 
31/
12/
201
0 
Tog
o 
6 TB United 
Nations 
MO
: 
TGO-
607-
01/
01/
333
515
219
047
552
563
333
515
118
222
451
738
31/
12/
    263 
Develop
ment 
Program
me 
UN
DP 
G07-T 200
8 
6.78
3 
7.51
2 
4.29
4 
6.78
3 
3.82
7 
0.6 201
2 
Tog
o 
8 HIV
/AI
DS 
Ministry 
of 
Health 
of the 
Governe
mnt of 
the 
Togolese 
Republic 
Gov
: 
MO
H 
TGO-
809-
G08-H 
01/
12/
200
9 
278
283
48.4
8 
0 278
283
48.4
8 
232
228
40.0
2 
0 232
228
40 
29/
02/
201
2 
Tog
o 
8 HIV
/AI
DS 
POPULA
TION 
SERVICE
S 
INTERNA
TIONAL 
CS/
PS: 
NG
O 
TGO-
809-
G09-H 
01/
12/
200
9 
101
038
17.7 
0 101
038
17.7 
707
237
1.28 
0 707
237
1.3 
29/
02/
201
2 
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APPENDIX 2: DATA ON ABSORPTIVE CAPACITY FOR PHASE 1 GRANTS INCLUDED IN THIS STUDY 
 
 
C
o
u
n
tr
y 
R
o
u
n
d
 
C
o
m
p
. 
P
R
N
am
e 
P
R
Ty
p
e 
G
ra
n
t 
N
u
m
b
er
 
P
h
as
e 
1
 
G
ra
n
t 
A
m
o
u
n
t 
 
(U
SD
) 
P
h
as
e 
1
 
D
is
b
u
rs
ed
 
A
m
o
u
n
t 
(U
SD
) 
P
h
as
e
 1
 
A
b
so
rt
iv
e 
C
ap
ac
it
y 
(%
) 
Myan
mar 
2 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MYN-
202-
G01-T-
00 
2,642,166.55 2,642,166.55 100 
Myan
mar 
3 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MYN-
305-
G03-M 
2,169,078.93 2,169,078.93 100 
Myan
mar 
3 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MYN-
305-
G02-H 
5,837,009.41 5,837,009.41 100 
Belaru
s 
3 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BLR-
304-
G01-H 
6,818,796.00 6,818,796.00 100 
Belaru
s 
6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BLR-
607-
G02-T 
6,354,340.00 6,354,340.00 100 
Belaru
s 
8 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BLR-
809-
G03-H 
13,481,021.2
9 
13,481,021.2
9 
100 
Bosnia 
and 
Herze
govina 
5 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BIH-
506-
G01-H 
4,832,385.00 4,832,385.00 100 
Bosnia 
and 
Herze
govina 
6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BIH-
607-
G02-T 
3,025,513.00 3,025,513.00 100 
Mont
enegr
o 
5 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MNT-
506-
G01-H 
1,784,554.93 1,784,554.93 100 
    265 
Mont
enegr
o 
6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MNT-
607-
G02-T 
1,183,812.40 1,183,812.40 100 
Tajikis
tan 
1 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
102-
G01-H-
00 
1,474,520.00 1,474,520.00 100 
Tajikis
tan 
4 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
404-
G03-H 
2,508,720.00 2,508,720.00 100 
Tajikis
tan 
5 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
506-
G04-M 
3,143,632.00 3,143,632.00 100 
Tajikis
tan 
6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
607-
G06-T 
6,527,347.00 6,527,347.00 100 
Tajikis
tan 
6 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
607-
G05-H 
5,190,294.00 5,190,294.00 100 
Tajikis
tan 
8 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
809-
G09-T 
22,993,779.0
1 
22,993,779.0
0 
100 
Tajikis
tan 
8 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
809-
G08-M 
6,859,916.65 6,859,916.65 100 
Tajikis
tan 
8 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TAJ-
809-
G07-H 
20,028,140.0
1 
20,028,138.0
0 
100 
Ukrain
e 
1 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
UKR-
102-
G03-H-
00 
452,948.27 452,948.27 100 
Argen
tina 
1 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ARG-
102-
G01-H-
00 
8,865,769.71 8,865,769.71 100 
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Bolivia 
(Plurin
ationa
l 
State) 
3 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BOL-
306-
G04-H 
1,950,411.52 1,950,411.52 100 
Bolivia 
(Plurin
ationa
l 
State) 
3 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BOL-
306-
G06-T 
1,204,977.00 1,204,977.00 100 
Bolivia 
(Plurin
ationa
l 
State) 
3 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BOL-
306-
G05-M 
2,085,355.54 2,085,355.54 100 
Bolivia 
(Plurin
ationa
l 
State) 
8 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BOL-
809-
G08-M 
6,060,293.00 6,060,293.00 100 
Colom
bia 
2 HIV/
AIDS 
The 
International 
Organization 
for Migration 
(IOM) 
MO: 
Oth 
COL-
202-
G01-H-
00 
3,482,636.00 3,482,636.00 100 
Cuba 2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CUB-
202-
G01-H-
00 
11,465,129.0
0 
11,465,129.0
0 
100 
Cuba 6 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CUB-
607-
G02-H 
14,369,743.0
0 
14,369,743.0
0 
100 
Cuba 7 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CUB-
708-
G03-T 
5,455,745.00 5,455,745.00 100 
El 
Salvad
or 
2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SLV-
202-
G01-H-
00 
12,856,729.0
0 
12,856,729.0
0 
100 
El 
Salvad
or 
2 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SLV-
202-
G02-T-
00 
1,918,344.00 1,918,344.00 100 
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El 
Salvad
or 
7 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SLV-
708-
G06-H 
8,013,606.44 8,013,606.44 100 
Haiti 1 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
HTI-
102-
G02-H-
00 
6,140,386.00 6,140,386.00 100 
Hondu
ras 
1 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
HND-
102-
G03-
M-00 
4,096,050.00 4,096,050.00 100 
Hondu
ras 
1 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
HND-
102-
G02-T-
00 
3,790,500.00 3,790,500.00 100 
Hondu
ras 
1 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
HND-
102-
G01-H-
00 
13,044,967.0
0 
13,044,967.0
0 
100 
Pana
ma 
1 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
PAN-
102-
G01-T-
00 
440,000.00 440,000.00 100 
Chad 7 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TCD-
708-
G03-M 
10,477,631.0
0 
9,110,472.11 87 
Iraq 6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
IRQ-
607-
G01-T 
6,443,900.00 6,443,900.00 100 
Mauri
tania 
2 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MRT-
202-
G02-
M-00 
824,044.00 824,044.00 100 
Mauri
tania 
2 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MRT-
202-
G01-T-
00 
1,104,742.00 1,104,742.00 100 
Mauri
tania 
6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MRT-
607-
G05-T 
4,441,686.00 3,603,328.01 81 
Mauri
tania 
6 Mala
ria 
United 
Nations 
MO: 
UNDP 
MRT-
607-
4,315,126.00 2,960,426.36 69 
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Developmen
t Programme 
G04-M 
Niger 3 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
NGR-
306-
G06-M 
391,956.00 391,956.00 100 
Niger 4 Mala
ria 
The 
International 
Federation 
of Red Cross 
and Red 
Crescent 
Societies 
MO: 
Oth 
NGR-
405-
G03-M 
11,189,739.0
0 
11,189,739.0
0 
100 
Niger 5 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
NGR-
506-
G05-T 
7,167,598.40 7,167,598.40 100 
Niger 5 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
NGR-
506-
G04-M 
4,627,434.00 4,627,434.00 100 
Somali
a 
2 Mala
ria 
United 
Nations 
Children's 
Fund 
MO: 
Oth 
SOM-
202-
G01-
M-00 
8,890,497.00 8,890,497.00 100 
Somali
a 
4 HIV/
AIDS 
United 
Nations 
Children's 
Fund 
MO: 
Oth 
SOM-
405-
G03-H 
10,004,644.0
0 
10,004,644.0
0 
100 
Somali
a 
6 Mala
ria 
United 
Nations 
Children's 
Fund 
MO: 
Oth 
SOM-
607-
G04-M 
15,735,867.0
0 
15,735,867.0
0 
100 
Somali
a 
8 HIV/
AIDS 
United 
Nations 
Children's 
Fund 
MO: 
Oth 
SOM-
809-
G06-H 
26,316,753.0
0 
22,532,829.5
2 
86 
South 
Sudan 
2 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SSD-
202-
G02-T-
00 
5,842,932.00 5,842,932.00 100 
South 
Sudan 
2 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SSD-
202-
G01-
M-00 
12,855,490.0
0 
12,855,490.0
0 
100 
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South 
Sudan 
4 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SSD-
405-
G05-H 
8,817,170.00 8,817,170.00 100 
South 
Sudan 
5 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SSD-
506-
G06-T 
8,572,457.00 8,572,457.00 100 
South 
Sudan 
7 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SSD-
708-
G11-T 
6,172,805.00 6,172,805.00 100 
Sudan 2 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SUD-
202-
G03-
M-00 
14,237,853.0
0 
14,237,853.0
0 
100 
Sudan 3 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SUD-
305-
G04-H 
7,842,140.00 7,842,140.00 100 
Sudan 5 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SUD-
506-
G08-H 
29,421,145.0
0 
29,421,145.0
0 
100 
Sudan 5 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SUD-
506-
G07-T 
6,830,013.00 6,830,013.00 100 
Sudan 7 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SUD-
708-
G10-M 
38,296,873.0
0 
38,296,873.0
0 
100 
Sudan 8 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SUD-
809-
G12-T 
3,886,314.00 3,886,314.00 100 
Syrian 
Arab 
Repub
lic 
6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
SYR-
607-
G01-T 
4,578,047.00 4,578,047.00 100 
West 
Bank 
and 
Gaza 
7 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
PSE-
708-
G01-H 
5,014,330.00 4,911,687.26 98 
West 
Bank 
8 TB United 
Nations 
MO: 
UNDP 
PSE-
809-
1,250,000.77 1,075,137.64 86 
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and 
Gaza 
Developmen
t Programme 
G02-T 
Yeme
n 
3 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
YEM-
307-
G05-H 
1,608,346.00 1,608,346.00 100 
Iran 
(Islami
c 
Repub
lic) 
2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
IRN-
202-
G01-H-
00 
5,698,000.00 5,698,000.00 100 
Iran 
(Islami
c 
Repub
lic) 
7 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
IRN-
708-
G03-T 
12,652,286.0
0 
12,652,286.0
0 
100 
Iran 
(Islami
c 
Repub
lic) 
7 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
IRN-
708-
G02-M 
5,615,598.00 5,615,598.00 100 
Maldi
ves 
6 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
MDV-
607-
G01-H 
2,655,685.00 2,655,685.00 100 
Nepal 7 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
NEP-
708-
G09-H 
6,734,717.00 6,734,717.00 100 
Congo 
(Dem
ocrati
c 
Repub
lic) 
2 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZAR-
202-
G01-T-
00 
6,408,741.00 6,408,741.00 100 
Congo 
(Dem
ocrati
c 
Repub
lic) 
3 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZAR-
304-
G03-M 
31,846,676.0
0 
31,846,676.0
0 
100 
Congo 
(Dem
ocrati
c 
Repub
3 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZAR-
304-
G02-H 
43,662,420.0
0 
43,662,420.0
0 
100 
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lic) 
Congo 
(Dem
ocrati
c 
Repub
lic) 
5 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZAR-
506-
G04-T 
20,703,092.8
2 
20,703,092.8
2 
100 
Congo 
(Dem
ocrati
c 
Repub
lic) 
6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZAR-
607-
G05-T 
8,182,300.18 8,182,300.18 100 
Congo 
(Dem
ocrati
c 
Repub
lic) 
7 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZAR-
708-
G06-H 
22,675,188.0
0 
22,675,188.0
0 
100 
Congo 
(Dem
ocrati
c 
Repub
lic) 
8 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZAR-
809-
G10-H 
56,362,741.0
0 
30,704,123.2
0 
54 
Angol
a 
3 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
AGO-
305-
G01-M 
28,473,354.0
0 
28,473,354.0
0 
100 
Angol
a 
4 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
AGO-
405-
G02-T 
7,350,590.00 7,350,590.00 100 
Angol
a 
4 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
AGO-
405-
G03-H 
27,670,810.0
0 
27,670,810.0
0 
100 
Zimba
bwe 
1 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZIM-
102-
G01-H-
00 
6,312,532.94 6,312,532.94 100 
Zimba
bwe 
5 TB United 
Nations 
Developmen
MO: 
UNDP 
ZIM-
509-
G08-T 
5,694,529.00 5,694,529.00 100 
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t Programme 
Zimba
bwe 
5 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZIM-
509-
G10-H 
20,440,040.0
0 
20,440,040.0
0 
100 
Zimba
bwe 
5 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZIM-
509-
G09-M 
11,784,474.0
0 
11,784,474.0
0 
100 
Zimba
bwe 
8 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZIM-
809-
G12-T 
28,236,113.0
0 
25,371,282.1
7 
90 
Zimba
bwe 
8 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZIM-
809-
G14-S 
35,397,183.0
0 
32,754,758.3
8 
93 
Zimba
bwe 
8 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZIM-
809-
G11-H 
84,641,214.0
0 
73,125,058.1
3 
86 
Zimba
bwe 
8 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
ZIM-
809-
G13-M 
32,810,290.0
0 
31,550,106.5
1 
96 
Benin 1 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BEN-
102-
G01-
M-00 
2,389,185.00 2,389,185.00 100 
Benin 2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BEN-
202-
G03-H-
00 
11,348,000.0
0 
11,348,000.0
0 
100 
Benin 2 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BEN-
202-
G02-T-
00 
2,173,404.00 2,173,404.00 100 
Burkin
a Faso 
2 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BUR-
202-
G01-
M-00 
6,812,491.76 6,812,491.76 100 
Burkin
a Faso 
2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BUR-
202-
G02-H-
00 
7,130,400.00 7,130,400.00 100 
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Burkin
a Faso 
4 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
BUR-
404-
G03-T 
5,492,613.61 5,492,613.61 100 
Centra
l 
Africa
n 
Repub
lic 
2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CAF-
202-
G01-H-
00 
8,198,921.00 8,198,921.00 100 
Centra
l 
Africa
n 
Repub
lic 
4 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CAF-
404-
G03-T 
2,033,885.00 2,033,885.00 100 
Centra
l 
Africa
n 
Repub
lic 
4 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CAF-
404-
G02-H 
4,695,012.00 4,695,012.00 100 
Centra
l 
Africa
n 
Repub
lic 
4 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CAF-
405-
G04-M 
10,592,816.0
0 
10,592,816.0
0 
100 
Côte 
d'Ivoir
e 
2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CIV-
202-
G01-H-
00 
18,099,398.0
0 
18,099,398.0
0 
100 
Côte 
d'Ivoir
e 
3 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
CIV-
304-
G03-T 
2,870,122.00 2,870,122.00 100 
Equat
orial 
Guine
a 
4 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
GNQ-
405-
G01-H 
4,398,764.00 4,398,764.00 100 
Gabon 3 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
GAB-
304-
G01-H 
3,154,500.00 3,154,500.00 100 
Gabon 4 Mala
ria 
United 
Nations 
MO: 
UNDP 
GAB-
404-
7,419,624.00 7,419,624.00 100 
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Developmen
t Programme 
G02-M 
Gabon 5 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
GAB-
506-
G03-M 
4,160,322.51 4,160,321.98 100 
Guine
a-
Bissau 
3 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
GNB-
304-
G01-T 
1,503,587.00 1,503,587.00 100 
Guine
a-
Bissau 
4 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
GNB-
404-
G03-M 
1,885,791.00 1,885,791.00 100 
Guine
a-
Bissau 
4 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
GNB-
404-
G02-H 
1,166,801.00 1,166,801.00 100 
Liberia 2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
LBR-
202-
G01-H-
00 
7,423,267.69 7,423,267.69 100 
Liberia 2 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
LBR-
202-
G02-T-
00 
4,288,516.31 4,288,516.31 100 
Liberia 3 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
LBR-
304-
G03-M 
11,868,992.3
1 
11,868,992.3
1 
100 
Liberia 6 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
LBR-
607-
G04-H 
16,737,414.0
0 
16,737,414.0
0 
100 
Liberia 7 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
LBR-
708-
G06-T 
6,408,872.00 6,408,872.00 100 
Liberia 7 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
LBR-
708-
G05-M 
12,695,907.0
0 
12,695,907.0
0 
100 
Sao 
Tome 
and 
Princi
4 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
STP-
405-
G01-M 
1,941,359.00 1,941,359.00 100 
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pe 
Sao 
Tome 
and 
Princi
pe 
5 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
STP-
506-
G02-H 
506,480.00 506,480.00 100 
Sao 
Tome 
and 
Princi
pe 
7 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
STP-
708-
G03-M 
2,430,247.00 2,430,247.00 100 
Sao 
Tome 
and 
Princi
pe 
8 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
STP-
809-
G04-T 
1,015,080.00 591,980.00 58 
Togo 2 HIV/
AIDS 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TGO-
202-
G01-H-
00 
14,088,307.8
8 
14,088,307.8
8 
100 
Togo 3 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TGO-
304-
G03-T 
1,752,982.00 1,684,693.07 96 
Togo 3 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TGO-
304-
G02-M 
3,479,336.00 3,479,336.00 100 
Togo 4 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TGO-
405-
G05-M 
6,066,034.00 6,066,034.00 100 
Togo 6 Mala
ria 
United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TGO-
607-
G06-M 
7,840,589.52 7,840,589.52 100 
Togo 6 TB United 
Nations 
Developmen
t Programme 
MO: 
UNDP 
TGO-
607-
G07-T 
3,335,156.78 3,335,156.78 100 
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APPENDIX 3: DATA ON ABSORPTIVE CAPACITY FOR PHASE 2 GRANTS INCLUDED IN THIS STUDY 
 
C
o
u
n
tr
y 
R
o
u
n
d
 
C
o
m
p
o
n
en
t 
P
R
 N
am
e 
P
R
 T
yp
e 
G
ra
n
t 
N
u
m
b
er
 
P
h
as
e 
2
 G
ra
n
t 
A
m
o
u
n
t 
 
P
h
as
e 
2
 
D
is
b
u
rs
ed
 
A
m
o
u
n
t 
 
P
h
as
e 
2
 
A
b
so
rp
ti
ve
 
C
ap
ac
it
y 
(%
) 
Cam
bodi
a 
1 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Cambodia 
Gov: 
MOH 
CAM-
102-
G01-H-
00 
3,458,960.26 3,458,959.93 100.00 
Cam
bodi
a 
2 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Cambodia 
Gov: 
MOH 
CAM-
202-
G02-H-
00 
9,395,061.00 9,212,793.14 98.06 
Cam
bodi
a 
2 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of Cambodia 
Gov: 
MOH 
CAM-
202-
G03-M-
00 
4,717,083.00 4,670,610.38 99.01 
Cam
bodi
a 
2 TB The Ministry 
of Health of 
the 
Government 
of Cambodia 
Gov: 
MOH 
CAM-
202-
G04-T-
00 
3,664,478.00 3,664,478.00 100.00 
Cam
bodi
a 
4 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Cambodia 
Gov: 
MOH 
CAM-
405-
G05-H 
27,751,152.0
0 
26,998,010.69 97.29 
Cam
bodi
a 
4 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of Cambodia 
Gov: 
MOH 
CAM-
405-
G06-M 
4,636,649.00 4,147,518.67 89.45 
Cam
bodi
a 
5 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Cambodia 
Gov: 
MOH 
CAM-
506-
G07-H 
16,866,914.0
0 
15,208,929.10 90.17 
Cam
bodi
5 TB The Ministry 
of Health of 
Gov: 
MOH 
CAM-
506-
5,339,354.16 4,794,798.18 89.80 
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a the 
Government 
of Cambodia 
G09-T 
Chin
a 
1 TB The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
102-
G01-T-
00 
28,374,995.0
2 
28,374,995.02 100.00 
Chin
a 
1 Mala
ria 
The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
102-
G02-M-
00 
2,719,035.75 2,719,035.75 100.00 
Chin
a 
4 HIV/
AIDS 
The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
405-
G05-H 
33,916,689.6
2 
33,916,689.62 100.00 
Chin
a 
4 TB The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
405-
G04-T 
28,249,999.8
8 
28,249,999.88 100.00 
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Chin
a 
5 TB The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
506-
G08-T 
1,286,893.56 1,286,893.56 100.00 
Chin
a 
5 TB The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
506-
G08-T-e 
18,382,301.6
9 
18,382,301.69 100.00 
Chin
a 
5 Mala
ria 
The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
506-
G07-M 
11,065,170.0
0 
10,902,149.61 98.53 
Chin
a 
5 HIV/
AIDS 
The Chinese 
Centre for 
Disease 
Control and 
Prevention of 
the 
Government 
of the People's 
Republic of 
China 
Gov: 
Oth 
CHN-
506-
G06-H 
8,907,862.00 8,907,862.00 100.00 
Indo
nesi
a 
1 TB Directorate 
General of 
Disease 
Control and 
Environmental 
Health of The 
Gov: 
MOH 
IND-
102-
G01-T-
00 
30,153,737.8
1 
30,153,737.77 100.00 
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Ministry of 
Health of The 
Republic of 
Indonesia 
Indo
nesi
a 
1 HIV/
AIDS 
Directorate 
General of 
Disease 
Control and 
Environmental 
Health of The 
Ministry of 
Health of The 
Republic of 
Indonesia 
Gov: 
MOH 
IND-
102-
G03-H-
00 
0.02 0.00 0.00 
Indo
nesi
a 
1 Mala
ria 
Directorate of 
Vector Borne 
Disease 
Control of the 
Ministry of 
Health of the 
Republic of 
Indonesia 
Gov: 
MOH 
IND-
102-
G02-M-
00 
7,968,924.42 7,968,924.40 100.00 
Indo
nesi
a 
4 HIV/
AIDS 
Directorate 
General of 
Disease 
Control and 
Environmental 
Health of The 
Ministry of 
Health of The 
Republic of 
Indonesia 
Gov: 
MOH 
IND-
405-
G04-H 
12,317,163.1
9 
10,721,000.19 87.04 
Indo
nesi
a 
5 TB Directorate 
General of 
Disease 
Control and 
Environmental 
Health of The 
Ministry of 
Health of The 
Republic of 
Indonesia 
Gov: 
MOH 
IND-
506-
G05-T 
31,663,748.0
1 
23,391,774.92 73.88 
Lao 
(Peo
ples 
1 HIV/
AIDS 
The Ministry 
of Health of 
the 
Gov: 
MOH 
LAO-
102-
G01-H-
2,067,942.75 2,067,942.73 100.00 
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Dem
ocra
tic 
Rep
ublic
) 
Government 
of the Lao 
People's 
Democratic 
Republic 
00 
Lao 
(Peo
ples 
Dem
ocra
tic 
Rep
ublic
) 
1 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the Lao 
People's 
Democratic 
Republic 
Gov: 
MOH 
LAO-
102-
G02-M-
00 
9,553,935.01 9,553,935.00 100.00 
Lao 
(Peo
ples 
Dem
ocra
tic 
Rep
ublic
) 
2 TB The Ministry 
of Health of 
the 
Government 
of the Lao 
People's 
Democratic 
Republic 
Gov: 
MOH 
LAO-
202-
G03-T-
00 
1,915,057.06 1,915,057.04 100.00 
Lao 
(Peo
ples 
Dem
ocra
tic 
Rep
ublic
) 
4 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the Lao 
People's 
Democratic 
Republic 
Gov: 
MOH 
LAO-
405-
G04-H 
4,150,245.39 4,150,245.37 100.00 
Lao 
(Peo
ples 
Dem
ocra
tic 
Rep
ublic
) 
4 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the Lao 
People's 
Democratic 
Republic 
Gov: 
MOH 
LAO-
405-
G05-M 
11,212,533.0
1 
10,791,652.96 96.25 
Lao 
(Peo
ples 
Dem
4 TB The Ministry 
of Health of 
the 
Government 
Gov: 
MOH 
LAO-
405-
G06-T 
2,441,955.01 2,381,549.39 97.53 
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ocra
tic 
Rep
ublic
) 
of the Lao 
People's 
Democratic 
Republic 
Mon
golia 
1 TB The Ministry 
of Health of 
the 
Government 
of Mongolia 
Gov: 
MOH 
MON-
102-
G01-T-
00 
1,086,000.01 1,086,000.01 100.00 
Mon
golia 
2 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Mongolia 
Gov: 
MOH 
MON-
202-
G02-H-
00 
4,062,345.02 4,062,345.02 100.00 
Papu
a 
New 
Guin
ea 
3 Mala
ria 
The 
Department of 
Health of the 
Government 
of Papua New 
Guinea 
Gov: 
MOH 
PNG-
304-
G01-M 
10,110,793.8
2 
10,110,793.81 100.00 
Papu
a 
New 
Guin
ea 
4 HIV/
AIDS 
The 
Department of 
Health of the 
Government 
of Papua New 
Guinea 
Gov: 
MOH 
PNG-
405-
G02-H 
9,059,910.01 5,665,339.34 62.53 
Phili
ppin
es 
2 TB Tropical 
Disease 
Foundation, 
Inc. 
CS/P
S: PS 
PHL-
202-
G02-T-e 
7,279,600.91 7,279,600.91 100.00 
Phili
ppin
es 
2 TB Tropical 
Disease 
Foundation, 
Inc. 
CS/P
S: PS 
PHL-
202-
G02-T-
00 
4,866,772.46 4,866,772.46 100.00 
Phili
ppin
es 
2 Mala
ria 
Tropical 
Disease 
Foundation, 
Inc. 
CS/P
S: PS 
PHL-
202-
G01-M-
00 
4,583,395.23 4,583,395.23 100.00 
Phili
ppin
es 
3 HIV/
AIDS 
Tropical 
Disease 
Foundation, 
Inc. 
CS/P
S: PS 
PHL-
304-
G03-H 
1,765,314.33 1,765,314.29 100.00 
Phili
ppin
es 
5 HIV/
AIDS 
Tropical 
Disease 
Foundation, 
CS/P
S: PS 
PHL-
506-
G04-H 
1,267,679.34 1,267,679.30 100.00 
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Inc. 
Phili
ppin
es 
5 HIV/
AIDS 
Department of 
Health 
Gov: 
MOH 
PHL-
509-
G10-H 
1,905,260.00 1,905,260.00 100.00 
Phili
ppin
es 
5 Mala
ria 
Pilipinas Shell 
Foundation 
CS/P
S: PS 
PHL-
506-
G05-M 
1,870,518.14 1,520,499.52 81.29 
Thail
and 
1 HIV/
AIDS 
The 
Department of 
Disease 
Control, 
Ministry of 
Public Health 
of the Royal 
Government 
of Thailand 
Gov: 
MOH 
THA-
102-
G01-H-
00 
78,420,496.0
1 
78,420,496.01 100.00 
Thail
and 
1 TB The 
Department of 
Disease 
Control, 
Ministry of 
Public Health 
of the Royal 
Government 
of Thailand 
Gov: 
MOH 
THA-
102-
G02-T-
00 
3,834,652.74 3,267,500.72 85.21 
Thail
and 
2 Mala
ria 
The Ministry 
of Public 
Health of the 
Government 
of Thailand 
Gov: 
MOH 
THA-
202-
G05-M-
00 
3,002,000.01 2,984,161.77 99.41 
Thail
and 
2 HIV/
AIDS 
RAKS THAI 
FOUNDATION 
CS/P
S: 
NGO 
THA-
202-
G03-H-
00 
9,461,310.02 8,780,633.60 92.81 
Thail
and 
3 HIV/
AIDS 
RAKS THAI 
FOUNDATION 
CS/P
S: 
NGO 
THA-
304-
G06-H 
324,566.40 324,566.38 100.00 
Timo
r-
Lest
e 
2 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the 
Democratic 
Republic of 
Timor-Leste 
Gov: 
MOH 
TMP-
202-
G01-M-
00 
434,030.25 434,030.23 100.00 
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Timo
r-
Lest
e 
5 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the 
Democratic 
Republic of 
Timor-Leste 
Gov: 
MOH 
TMP-
506-
G03-H 
4,543,284.01 4,320,216.50 95.09 
Viet 
Nam 
1 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Viet Nam 
Gov: 
MOH 
VTN-
102-
G01-H-
00 
4,418,789.33 4,418,789.32 100.00 
Viet 
Nam 
1 TB The Ministry 
of Health of 
the 
Government 
of Viet Nam 
Gov: 
MOH 
VTN-
102-
G02-T-
00 
2,904,712.52 2,904,712.50 100.00 
Viet 
Nam 
3 Mala
ria 
The National 
Institute of 
Malariology, 
Parasitology 
and 
Entomology / 
Ministry of 
Health of the 
Government 
of the Socialist 
Republic of 
Viet Nam 
Gov: 
MOH 
VTN-
304-
G03-M 
7,789,553.52 7,789,553.50 100.00 
Viet 
Nam 
6 TB The Ministry 
of Health of 
the 
Government 
of Viet Nam 
Gov: 
MOH 
VTN-
607-
G05-T 
7,336,158.01 5,617,505.73 76.57 
Arm
enia 
2 HIV/
AIDS 
World Vision 
International 
CS/P
S: 
NGO 
ARM-
202-
G01-H-
00 
5,938,348.00 5,938,348.00 100.00 
Azer
baija
n 
4 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the 
Republic of 
Azerbaijan 
Gov: 
MOH 
AZE-
405-
G01-H 
4,242,950.00 4,231,448.70 99.73 
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Bela
rus 
6 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
BLR-
607-
G02-T 
2,889,772.00 2,889,772.00 100.00 
Bosn
ia 
and 
Herz
egov
ina 
5 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
BIH-
506-
G01-H 
6,209,872.00 6,159,776.41 99.19 
Bulg
aria 
2 HIV/
AIDS 
The Ministry 
of Health of 
the Republic 
of Bulgaria 
Gov: 
MOH 
BUL-
202-
G01-H-
00 
8,817,612.00 8,817,612.00 100.00 
Geor
gia 
2 HIV/
AIDS 
The Georgia 
Health and 
Social Projects 
Implementatio
n Center 
Gov: 
Oth 
GEO-
202-
G01-H-
00 
10,344,922.0
2 
10,344,921.80 100.00 
Geor
gia 
3 Mala
ria 
The Georgia 
Health and 
Social Projects 
Implementatio
n Center 
Gov: 
Oth 
GEO-
304-
G02-M 
160,600.01 160,600.00 100.00 
Geor
gia 
4 TB The Georgia 
Health and 
Social Projects 
Implementatio
n Center 
Gov: 
Oth 
GEO-
405-
G03-T 
3,707,747.00 3,707,746.95 100.00 
Geor
gia 
6 TB The Georgia 
Health and 
Social Projects 
Implementatio
n Center 
Gov: 
Oth 
GEO-
607-
G05-T 
0.03 0.00 0.00 
Geor
gia 
6 HIV/
AIDS 
The Georgia 
Health and 
Social Projects 
Implementatio
n Center 
Gov: 
Oth 
GEO-
607-
G06-H 
1,916,376.69 1,916,376.67 100.00 
Geor
gia 
6 Mala
ria 
The Georgia 
Health and 
Social Projects 
Implementatio
n Center 
Gov: 
Oth 
GEO-
607-
G04-M 
587,254.49 587,254.46 100.00 
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Kaza
khst
an 
2 HIV/
AIDS 
The 
Republican 
Center for 
Prophylactics 
and Control of 
AIDS of the 
Government 
of the 
Republic of 
Kazakhstan 
Gov: 
Oth 
KAZ-
202-
G01-H-
00 
13,786,667.0
9 
13,786,667.07 100.00 
Koso
vo 
7 HIV/
AIDS 
Ministry of 
Health of the 
Government 
of the 
Republic of 
Kosovo 
Gov: 
MOH 
KOS-
708-
G02-H 
-0.72 -0.72 100.00 
Kyrg
yzsta
n 
2 TB National 
Center of 
Phthisiology 
under the 
Ministry of 
Health of the 
Republic of 
Kyrgyzstan 
Gov: 
MOH 
KGZ-
202-
G02-T-
00 
1,558,235.01 1,558,235.00 100.00 
Kyrg
yzsta
n 
2 HIV/
AIDS 
National AIDS 
Centre of the 
Ministry of 
Health of the 
Government 
of the 
Republic of 
Kyrgyzstan 
Gov: 
Oth 
KGZ-
202-
G01-H-
00 
12,115,268.0
1 
12,115,267.53 100.00 
Kyrg
yzsta
n 
5 Mala
ria 
State Sanitary 
Epidemiologic
al Department 
Gov: 
Oth 
KGZ-
506-
G03-M 
1,323,060.01 1,126,111.37 85.11 
Mac
edon
ia 
(For
mer 
Yugo
slav 
Rep
ublic
) 
3 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the Former 
Yugoslav 
Republic of 
Macedonia 
Gov: 
MOH 
MKD-
304-
G01-H 
1,555,768.01 1,453,863.38 93.45 
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Mon
tene
gro 
5 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
MNT-
506-
G01-H 
1,468,130.83 1,468,130.82 100.00 
Rom
ania 
2 HIV/
AIDS 
The Ministry 
of Health and 
Family of the 
Government 
of Romania 
Gov: 
MOH 
ROM-
202-
G01-H-
00 
4,681,189.02 4,681,189.00 100.00 
Rom
ania 
6 HIV/
AIDS 
Romanian 
Angel Appeal 
Foundation 
CS/P
S: 
NGO 
ROM-
607-
G03-H 
2,196,301.51 2,196,301.12 100.00 
Russi
an 
Fede
ratio
n 
3 TB Partners In 
Health 
CS/P
S: 
NGO 
RUS-
304-
G02-T 
4,459,617.00 4,459,617.00 100.00 
Russi
an 
Fede
ratio
n 
3 HIV/
AIDS 
The Open 
Health 
Institute 
CS/P
S: 
NGO 
RUS-
304-
G01-H 
79,946,047.0
4 
79,409,899.00 99.33 
Russi
an 
Fede
ratio
n 
4 TB The Russian 
Health Care 
Foundation 
CS/P
S: 
NGO 
RUS-
405-
G04-T 
38,729,432.0
1 
38,421,135.40 99.20 
Russi
an 
Fede
ratio
n 
4 HIV/
AIDS 
The Russian 
Health Care 
Foundation 
CS/P
S: 
NGO 
RUS-
405-
G03-H 
102,320,879.
02 
102,320,878.1
3 
100.00 
Russi
an 
Fede
ratio
n 
5 HIV/
AIDS 
Non-profit 
Partnership to 
Support Social 
Prevention 
Programs in 
Public Health 
"ESVERO" 
CS/P
S: 
NGO 
RUS-
506-
G05-H 
9,545,077.23 9,498,772.65 99.51 
Serbi
a 
1 HIV/
AIDS 
The Economics 
Institute in 
Belgrade 
CS/P
S: PS 
SER-
102-
G01-H-
00 
856,496.02 856,496.00 100.00 
Serbi
a 
3 TB Ministry of 
Health of the 
Government 
Gov: 
MOH 
SER-
304-
G02-T 
1,658,993.01 1,658,993.00 100.00 
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of the 
Republic of 
Serbia 
Tajik
istan 
1 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
TAJ-102-
G01-H-
00 
950,725.01 950,725.00 100.00 
Tajik
istan 
4 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
TAJ-404-
G03-H 
5,567,947.01 5,553,532.06 99.74 
Tajik
istan 
5 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
TAJ-506-
G04-M 
2,239,878.01 2,214,781.14 98.88 
Uzbe
kista
n 
3 HIV/
AIDS 
The National 
AIDS Center of 
the Ministry of 
Health of the 
Government 
of the 
Republic of 
Uzbekistan 
Gov: 
MOH 
UZB-
304-
G01-H 
15,785,454.2
5 
15,785,454.23 100.00 
Uzbe
kista
n 
4 Mala
ria 
The 
Republican 
Center of 
State Sanitary-
Epidemiologic
al Surveillance 
Gov: 
Oth 
UZB-
405-
G02-M 
959,009.90 959,009.90 100.00 
Uzbe
kista
n 
4 TB The 
Republican 
DOTS Center 
of the 
Government 
of the 
Republic of 
Uzbekistan 
Gov: 
MOH 
UZB-
405-
G03-T 
4,437,588.91 4,437,588.91 100.00 
Arge
ntin
a 
1 HIV/
AIDS 
UBATEC S.A. CS/P
S: PS 
ARG-
102-
G02-H-
00 
13,323,347.2
0 
13,323,347.20 100.00 
Beliz
e 
3 HIV/
AIDS 
Belize 
Enterprise for 
Sustainable 
Technology 
CS/P
S: 
NGO 
BEL-
304-
G01-H 
1,104,793.00 799,092.00 72.33 
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Boliv
ia 
(Plur
inati
onal 
Stat
e) 
3 HIV/
AIDS 
Asociación Ibis 
- Hivos 
CS/P
S: 
NGO 
BOL-
307-
G07-H 
10,050,847.4
9 
10,050,847.45 100.00 
Boliv
ia 
(Plur
inati
onal 
Stat
e) 
3 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
BOL-
306-
G06-T 
3,009,611.01 3,009,611.00 100.00 
Chile 1 HIV/
AIDS 
Consejo de las 
Américas 
CS/P
S: PS 
CHL-
102-
G01-H-
00 
15,261,209.0
0 
15,261,209.00 100.00 
Colo
mbia 
2 HIV/
AIDS 
The 
International 
Organization 
for Migration 
(IOM) 
MO: 
Oth 
COL-
202-
G01-H-
00 
5,027,432.86 5,027,432.83 100.00 
Cost
a 
Rica 
2 HIV/
AIDS 
HIVOS 
(Humanistic 
Institute for 
Cooperation 
with 
Developing 
Countries) 
CS/P
S: 
NGO 
COR-
202-
G02-H-
00 
1,304,370.01 1,304,370.00 100.00 
Dom
inica
n 
Rep
ublic 
3 TB Asociación 
Dominicana 
Pro-Bienestar 
de la Familia 
(PROFAMILIA) 
CS/P
S: 
NGO 
DMR-
304-
G02-T 
1,966,582.01 1,966,581.74 100.00 
Ecua
dor 
2 HIV/
AIDS 
The Ministry 
of Public 
Health of the 
Republic of 
Ecuador 
Gov: 
MOH 
ECU-
202-
G01-H-
00 
3,816,033.36 3,816,033.35 100.00 
Ecua
dor 
2 HIV/
AIDS 
CARE 
International 
CS/P
S: 
NGO 
ECU-
202-
G03-H-
00 
2,464,385.01 2,401,781.33 97.46 
Ecua
dor 
4 TB CARE 
International 
CS/P
S: 
ECU-
405-
6,755,366.02 6,755,366.00 100.00 
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NGO G02-T 
El 
Salv
ador 
2 HIV/
AIDS 
Ministry of 
Health El 
Salvador 
Gov: 
MOH 
SLV-
202-
G03-H-
00 
2,180,116.02 2,180,116.02 100.00 
El 
Salv
ador 
2 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
SLV-
202-
G01-H-
00 
5,176,615.04 5,176,615.04 100.00 
El 
Salv
ador 
2 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
SLV-
202-
G02-T-
00 
317,044.87 317,044.85 100.00 
El 
Salv
ador 
2 TB Ministry of 
Health El 
Salvador 
Gov: 
MOH 
SLV-
202-
G04-T-
00 
1,542,836.03 1,542,015.00 99.95 
Guat
emal
a 
3 HIV/
AIDS 
World Vision 
International 
CS/P
S: 
NGO 
GUA-
304-
G01-H 
32,671,218.4
0 
32,671,218.38 100.00 
Guat
emal
a 
4 Mala
ria 
World Vision 
International 
CS/P
S: 
NGO 
GUA-
405-
G02-M 
3,623,977.22 3,506,625.47 96.76 
Guy
ana 
4 TB The Ministry 
of Health of 
Guyana 
Gov: 
MOH 
GYA-
405-
G03-T 
406,616.01 403,355.08 99.20 
Haiti 1 HIV/
AIDS 
Fondation 
SOGEBANK 
CS/P
S: PS 
HTI-102-
G01-H-
00 
83,192,711.0
3 
83,192,711.03 100.00 
Haiti 3 Mala
ria 
Fondation 
SOGEBANK 
CS/P
S: PS 
HTI-304-
G03-M 
6,241,952.02 5,454,984.00 87.39 
Haiti 3 TB Fondation 
SOGEBANK 
CS/P
S: PS 
HTI-304-
G04-T 
5,902,829.02 5,551,065.17 94.04 
Hon
dura
s 
1 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
HND-
102-
G03-M-
00 
3,031,573.18 3,031,573.18 100.00 
Hon
dura
s 
1 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
HND-
102-
G02-T-
00 
2,319,173.02 2,304,400.09 99.36 
Hon
dura
s 
1 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
HND-
102-
G01-H-
00 
13,482,925.3
1 
13,482,925.26 100.00 
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Jama
ica 
3 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Jamaica 
Gov: 
MOH 
JAM-
304-
G01-H 
15,294,694.0
1 
15,294,694.00 100.00 
Nica
ragu
a 
2 HIV/
AIDS 
Federación 
Red 
NICASALUD 
CS/P
S: 
NGO 
NIC-
202-
G03-H-
00 
5,799,593.86 5,799,593.81 100.00 
Nica
ragu
a 
2 Mala
ria 
Federación 
Red 
NICASALUD 
CS/P
S: 
NGO 
NIC-
202-
G01-M-
00 
2,171,416.42 2,171,416.38 100.00 
Nica
ragu
a 
2 TB Federación 
Red 
NICASALUD 
CS/P
S: 
NGO 
NIC-
202-
G02-T-
00 
1,350,881.14 1,350,881.10 100.00 
Pana
ma 
1 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
PAN-
102-
G01-T-
00 
113,816.56 113,816.54 100.00 
Peru 2 HIV/
AIDS 
CARE 
International 
CS/P
S: 
NGO 
PER-
202-
G01-H-
00 
5,628,779.77 5,628,779.74 100.00 
Peru 2 TB CARE 
International 
CS/P
S: 
NGO 
PER-
202-
G02-T-
00 
4,873,364.26 4,873,364.22 100.00 
Peru 5 TB CARE 
International 
CS/P
S: 
NGO 
PER-
506-
G04-T 
16,068,299.0
1 
14,325,748.52 89.16 
Peru 5 HIV/
AIDS 
CARE 
International 
CS/P
S: 
NGO 
PER-
506-
G03-H 
4,806,023.01 3,941,268.84 82.01 
Suri
nam
e 
4 Mala
ria 
Medische 
Zending - 
Primary Health 
Care Suriname 
CS/P
S: 
NGO 
SUR-
404-
G02-M 
1,698,223.88 1,698,223.86 100.00 
Alge
ria 
3 HIV/
AIDS 
The Ministry 
of Health, 
Population 
and Hospital 
Reform of the 
Government 
of the People's 
Gov: 
MOH 
DZA-
304-
G01-H 
760,288.95 760,288.93 100.00 
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Democratic 
Republic of 
Algeria 
Chad 2 TB The Fonds de 
Soutien aux 
Activités en 
matière de 
Population(FO
SAP) 
Gov: 
Oth 
TCD-
202-
G01-T-
00 
1,775,358.01 1,116,522.26 62.89 
Chad 3 HIV/
AIDS 
The Fonds de 
Soutien aux 
Activités en 
matière de 
Population(FO
SAP) 
Gov: 
Oth 
TCD-
304-
G02-H 
10,403,188.0
1 
6,005,327.03 57.73 
Djib
outi 
4 HIV/
AIDS 
Executive 
secretariat for 
the fight 
against AIDS, 
Malaria and 
Tuberculosis 
Gov: 
MOH 
DJB-
404-
G01-H 
4,346,901.01 4,346,901.01 100.00 
Egyp
t 
2 TB National 
Tuberculosis 
Control 
Program, The 
Ministry of 
Health and 
Population of 
the 
Government 
of Egypt 
Gov: 
MOH 
EGY-
202-
G01-T-
00 
1,551,795.01 1,485,130.24 95.70 
Iraq 6 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
IRQ-
607-
G01-T 
5,001,595.02 5,001,595.00 100.00 
Jord
an 
2 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the 
Hashemite 
Kingdom of 
Jordan 
Gov: 
MOH 
JOR-
202-
G01-H-
00 
648,808.26 648,808.24 100.00 
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Jord
an 
5 TB Ministry of 
Health / 
National 
Tuberculosis 
Program 
Gov: 
MOH 
JOR-
506-
G02-T 
1,710,000.01 1,710,000.00 100.00 
Mali 1 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the 
Republic of 
Mali 
Gov: 
MOH 
MAL-
102-
G01-M-
00 
568,892.01 568,892.00 100.00 
Mali 4 TB The Ministry 
of Health of 
the 
Government 
of the 
Republic of 
Mali 
Gov: 
MOH 
MAL-
405-
G03-T 
4,183,842.01 2,509,531.97 59.98 
Mali 4 HIV/
AIDS 
The National 
High Council 
for HIV/AIDS 
control of the 
government of 
the Republic 
of Mali 
Gov: 
Oth 
MAL-
405-
G02-H 
28,857,202.0
1 
21,705,417.61 75.22 
Mau
ritan
ia 
2 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
MRT-
202-
G02-M-
00 
2,074,949.01 1,227,117.31 59.14 
Mau
ritan
ia 
2 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
MRT-
202-
G01-T-
00 
1,623,147.01 1,301,483.37 80.18 
Mau
ritan
ia 
5 HIV/
AIDS 
Sécretariat 
Exécutif, 
Comité 
National de 
Lutte Contre le 
SIDA 
Gov: 
Oth 
MRT-
506-
G03-H 
8,537,857.01 0.00 0.00 
Mor
occo 
1 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the 
Kingdom of 
Gov: 
MOH 
MOR-
102-
G01-H-
00 
4,491,855.61 4,491,855.59 100.00 
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Morocco 
Nige
r 
3 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
NGR-
306-
G06-M 
896,675.15 896,675.15 100.00 
Nige
r 
3 HIV/
AIDS 
The National 
Multi-sectorial 
Coordination 
Unit for the 
Fight Against 
HIV/AIDS/STI 
of the 
Government 
of the 
Republic of 
Niger 
Gov: 
Oth 
NGR-
304-
G01-H 
1,944,565.73 1,944,565.72 100.00 
Nige
r 
5 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
NGR-
506-
G05-T 
6,047,822.69 3,670,166.56 60.69 
Nige
r 
5 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
NGR-
506-
G04-M 
6,665,075.02 4,323,449.38 64.87 
Som
alia 
2 Mala
ria 
United 
Nations 
Children's 
Fund 
MO: 
Oth 
SOM-
202-
G01-M-
00 
3,995,916.01 3,995,916.00 100.00 
Som
alia 
3 TB World Vision 
International 
CS/P
S: 
NGO 
SOM-
304-
G02-T 
8,224,136.01 8,060,228.49 98.01 
Som
alia 
4 HIV/
AIDS 
United 
Nations 
Children's 
Fund 
MO: 
Oth 
SOM-
405-
G03-H 
14,917,363.0
1 
14,093,096.68 94.47 
Sout
h 
Suda
n 
2 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
SSD-
202-
G02-T-
00 
8,655,155.01 8,655,155.00 100.00 
Sout
h 
Suda
n 
2 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
SSD-
202-
G01-M-
00 
12,212,170.0
1 
12,212,170.00 100.00 
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Sout
h 
Suda
n 
4 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
SSD-
405-
G05-H 
18,118,195.0
1 
17,962,443.86 99.14 
Suda
n 
2 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
SUD-
202-
G03-M-
00 
18,840,189.3
3 
18,840,189.32 100.00 
Suda
n 
3 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
SUD-
305-
G04-H 
12,185,909.7
1 
12,185,909.70 100.00 
Suda
n 
5 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
SUD-
506-
G07-T 
4,854,904.02 4,854,904.00 100.00 
Yem
en 
2 Mala
ria 
The National 
Malaria 
Programme at 
the Ministry of 
Public Health 
and 
Population of 
the Republic 
of Yemen 
Gov: 
MOH 
YEM-
202-
G01-M-
00 
7,718,574.01 7,718,573.67 100.00 
Yem
en 
4 TB The National 
Tuberculosis 
Control 
Program 
Gov: 
MOH 
YEM-
405-
G04-T 
3,550,686.83 3,550,686.82 100.00 
Afgh
anist
an 
4 TB The Ministry 
of Public 
Health of the 
Islamic 
Republic of 
Afghanistan 
Gov: 
MOH 
AFG-
405-
G02-T 
2,678,960.64 2,678,960.64 100.00 
Afgh
anist
an 
5 Mala
ria 
HealthNet TPO CS/P
S: 
NGO 
AFG-
509-
G06-M 
7,171,871.31 7,171,871.31 100.00 
Afgh
anist
an 
5 Mala
ria 
The Ministry 
of Public 
Health of the 
Islamic 
Republic of 
Afghanistan 
Gov: 
MOH 
AFG-
506-
G03-M 
3,462,883.00 2,226,247.32 64.29 
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Bang
lade
sh 
2 HIV/
AIDS 
The Economic 
Relations 
Division, 
Ministry of 
Finance, The 
Government 
of the People's 
Republic of 
Bangladesh 
Gov: 
MOF 
BAN-
202-
G01-H-
00 
13,621,499.0
0 
13,621,499.00 100.00 
Bang
lade
sh 
3 TB BRAC 
(Bangladesh 
Rural 
Advancement 
Committee) 
CS/P
S: 
NGO 
BAN-
304-
G02-T 
15,570,300.0
0 
15,570,300.00 100.00 
Bang
lade
sh 
3 TB The Economic 
Relations 
Division, 
Ministry of 
Finance, The 
Government 
of the People's 
Republic of 
Bangladesh 
Gov: 
MOF 
BAN-
304-
G03-T 
4,715,139.58 4,715,139.29 100.00 
Bang
lade
sh 
5 TB BRAC 
(Bangladesh 
Rural 
Advancement 
Committee) 
CS/P
S: 
NGO 
BAN-
506-
G04-T 
18,414,927.0
0 
17,409,916.00 94.54 
Bang
lade
sh 
5 TB The Economic 
Relations 
Division, 
Ministry of 
Finance, The 
Government 
of the People's 
Republic of 
Bangladesh 
Gov: 
MOF 
BAN-
506-
G05-T 
14,760,034.0
0 
9,000,993.69 60.98 
Bang
lade
sh 
6 Mala
ria 
BRAC 
(Bangladesh 
Rural 
Advancement 
Committee) 
CS/P
S: 
NGO 
BAN-
607-
G06-M 
3,099,909.00 3,099,909.00 100.00 
Bhut
an 
4 TB Gross National 
Happiness 
(GNH) 
Commission, 
Gov: 
Oth 
BTN-
405-
G02-T 
433,730.00 372,402.21 85.86 
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Royal 
Government 
of Bhutan 
Bhut
an 
4 Mala
ria 
Gross National 
Happiness 
(GNH) 
Commission, 
Royal 
Government 
of Bhutan 
Gov: 
Oth 
BTN-
405-
G01-M 
342,240.81 342,240.81 100.00 
India 1 TB The 
Department of 
Economic 
Affairs, 
Ministry of 
Finance, 
Government 
of India 
Gov: 
Oth 
IDA-
102-
G01-T-
00 
2,599,422.02 2,599,422.00 100.00 
India 4 TB The 
Department of 
Economic 
Affairs, 
Ministry of 
Finance, 
Government 
of India 
Gov: 
Oth 
IDA-
405-
G08-T 
12,294,943.0
7 
12,294,943.05 100.00 
India 4 Mala
ria 
The 
Department of 
Economic 
Affairs, 
Ministry of 
Finance, 
Government 
of India 
Gov: 
MOF 
IDA-
405-
G07-M 
26,065,966.0
1 
26,065,966.00 100.00 
India 6 HIV/
AIDS 
The 
Population 
Foundation of 
India 
CS/P
S: 
NGO 
IDA-
607-
G10-H 
5,175,215.02 5,175,215.00 100.00 
India 6 HIV/
AIDS 
India HIV/AIDS 
Alliance 
CS/P
S: 
NGO 
IDA-
607-
G12-H 
9,124,294.01 8,452,016.00 92.63 
Iran 
(Isla
mic 
Rep
ublic
2 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
IRN-
202-
G01-H-
00 
10,224,855.0
1 
9,396,430.74 91.90 
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) 
Nep
al 
2 Mala
ria 
The Ministry 
of Health and 
Population of 
the 
Government 
of Nepal 
Gov: 
MOH 
NEP-
202-
G02-M-
00 
1,549,367.36 1,549,367.35 100.00 
Nep
al 
2 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
NEP-
202-
G05-H-
00 
4,551,995.45 4,551,995.45 100.00 
Nep
al 
2 HIV/
AIDS 
The Ministry 
of Health and 
Population of 
the 
Government 
of Nepal 
Gov: 
MOH 
NEP-
202-
G01-H-
00 
483,151.20 483,151.19 100.00 
Nep
al 
4 TB The Ministry 
of Health and 
Population of 
the 
Government 
of Nepal 
Gov: 
MOH 
NEP-
405-
G03-T 
3,825,482.21 3,825,482.19 100.00 
Nep
al 
7 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
NEP-
708-
G09-H 
5,597,346.00 2,310,178.20 41.27 
Pakis
tan 
2 TB The National 
AIDS Control 
Programme on 
the Behalf of 
the Ministry of 
Health of the 
Government 
of Pakistan 
Gov: 
MOH 
PKS-
202-
G03-T-
00 
1,794,100.01 1,652,637.00 92.12 
Pakis
tan 
2 HIV/
AIDS 
The National 
AIDS Control 
Programme on 
the Behalf of 
the Ministry of 
Health of the 
Government 
of Pakistan 
Gov: 
MOH 
PKS-
202-
G01-H-
00 
3,824,536.01 3,824,536.00 100.00 
    298 
Pakis
tan 
3 TB The National 
AIDS Control 
Programme on 
the Behalf of 
the Ministry of 
Health of the 
Government 
of Pakistan 
Gov: 
MOH 
PKS-
304-
G05-T 
2,767,529.27 2,767,529.26 100.00 
Sri 
Lank
a 
1 TB The Ministry 
of Healthcare, 
Nutrition and 
UVA Wellassa 
Development 
of the 
Government 
of Sri Lanka 
Gov: 
MOH 
SRL-
102-
G03-T-
00 
1,524,855.29 1,524,855.27 100.00 
Sri 
Lank
a 
1 Mala
ria 
Lanka Jatika 
Sarvodaya 
Shramadana 
Sangamaya 
CS/P
S: 
NGO 
SRL-
102-
G02-M-
00 
166,407.19 166,407.17 100.00 
Sri 
Lank
a 
1 Mala
ria 
The Ministry 
of Healthcare, 
Nutrition and 
UVA Wellassa 
Development 
of the 
Government 
of Sri Lanka 
Gov: 
MOH 
SRL-
102-
G01-M-
00 
1,347,083.01 1,347,083.00 100.00 
Sri 
Lank
a 
4 Mala
ria 
Lanka Jatika 
Sarvodaya 
Shramadana 
Sangamaya 
CS/P
S: 
NGO 
SRL-
405-
G06-M 
550,000.01 355,483.81 64.63 
Sri 
Lank
a 
4 Mala
ria 
The Ministry 
of Healthcare, 
Nutrition and 
UVA Wellassa 
Development 
of the 
Government 
of Sri Lanka 
Gov: 
MOH 
SRL-
405-
G05-M 
1,027,748.01 836,754.74 81.42 
Sri 
Lank
a 
6 HIV/
AIDS 
The Ministry 
of Healthcare, 
Nutrition and 
UVA Wellassa 
Development 
of the 
Gov: 
MOH 
SRL-
607-
G09-H 
291,223.01 291,223.00 100.00 
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Government 
of Sri Lanka 
Buru
ndi 
1 HIV/
AIDS 
The 
Permanent 
Executive 
Secretariat of 
the National 
Council for the 
Fight Against 
AIDS 
(SEP/CNLS) 
Gov: 
Oth 
BRN-
102-
G01-H-
00 
3,780,000.00 3,780,000.00 100.00 
Buru
ndi 
2 Mala
ria 
The Projet 
Sante et 
Population II 
of The 
Ministry of 
Public Health 
in the Republic 
of Burundi 
Gov: 
MOH 
BRN-
202-
G02-M-
00 
2,776,204.89 2,776,204.89 100.00 
Buru
ndi 
4 TB The 
Programme 
National Lèpre 
et 
Tuberculose(P
NLT) Govt of 
the Republic 
of Burundi 
Gov: 
MOH 
BRN-
405-
G03-T 
1,494,490.00 1,338,607.31 89.57 
Buru
ndi 
5 HIV/
AIDS 
The 
Permanent 
Executive 
Secretariat of 
the National 
Council for the 
Fight Against 
AIDS 
(SEP/CNLS) 
Gov: 
Oth 
BRN-
506-
G04-H 
17,647,943.2
1 
17,647,943.20 100.00 
Com
oros 
2 Mala
ria 
Association 
Comorienne 
pour le Bien-
Etre de la 
Famille 
(ASCOBEF) 
CS/P
S: 
NGO 
COM-
202-
G01-M-
00 
951,247.01 887,839.77 93.33 
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Com
oros 
3 HIV/
AIDS 
Association 
Comorienne 
pour le Bien-
Etre de la 
Famille 
(ASCOBEF) 
CS/P
S: 
NGO 
COM-
304-
G02-H 
452,988.02 449,625.67 99.26 
Cong
o 
(De
moc
ratic 
Rep
ublic
) 
2 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
ZAR-
202-
G01-T-
00 
1,217,032.01 1,081,890.00 88.90 
Cong
o 
(De
moc
ratic 
Rep
ublic
) 
3 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
ZAR-
304-
G03-M 
22,089,933.0
1 
22,089,932.32 100.00 
Cong
o 
(De
moc
ratic 
Rep
ublic
) 
3 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
ZAR-
304-
G02-H 
69,984,033.0
2 
69,916,426.56 99.90 
Cong
o 
(De
moc
ratic 
Rep
ublic
) 
5 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
ZAR-
506-
G04-T 
11,306,852.1
9 
8,403,674.73 74.32 
Eritr
ea 
2 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the State of 
Eritrea 
Gov: 
MOH 
ERT-
202-
G01-M-
00 
4,572,303.88 4,572,303.86 100.00 
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Eritr
ea 
3 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the State of 
Eritrea 
Gov: 
MOH 
ERT-
304-
G02-H 
8,567,246.02 8,567,246.00 100.00 
Eritr
ea 
5 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the State of 
Eritrea 
Gov: 
MOH 
ERT-
506-
G03-H 
15,519,155.0
1 
14,292,809.47 92.10 
Ethi
opia 
1 TB The Federal 
Ministry of 
Health of the 
Government 
of the Federal 
Democratic 
Republic of 
Ethiopia 
Gov: 
MOH 
ETH-
102-
G01-T-
00 
16,018,049.0
1 
16,018,049.00 100.00 
Ethi
opia 
2 Mala
ria 
The Federal 
Ministry of 
Health of the 
Government 
of the Federal 
Democratic 
Republic of 
Ethiopia 
Gov: 
MOH 
ETH-
202-
G02-M-
00 
35,960,200.0
1 
35,960,200.00 100.00 
Ethi
opia 
4 HIV/
AIDS 
The HIV/AIDS 
Prevention 
and Control 
Office 
Gov: 
Oth 
ETH-
405-
G04-H 
335,172,691.
31 
335,172,691.3
0 
100.00 
Ethi
opia 
5 Mala
ria 
The Federal 
Ministry of 
Health of the 
Government 
of the Federal 
Democratic 
Republic of 
Ethiopia 
Gov: 
MOH 
ETH-
506-
G05-M 
81,573,584.0
1 
73,176,937.54 89.71 
Ethi
opia 
7 HIV/
AIDS 
The HIV/AIDS 
Prevention 
and Control 
Office 
Gov: 
Oth 
ETH-
708-
G08-H 
1,310,862.00 0.00 0.00 
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Keny
a 
2 HIV/
AIDS 
The Ministry 
of Finance of 
the 
Government 
of the 
Republic of 
Kenya 
Gov: 
MOF 
KEN-
202-
G03-H-
00 
31,285,074.0
2 
31,285,074.00 100.00 
Mad
agas
car 
1 Mala
ria 
POPULATION 
SERVICES 
INTERNATION
AL 
CS/P
S: 
NGO 
MDG-
102-
G01-M-
00 
122,064.02 122,064.00 100.00 
Mad
agas
car 
2 HIV/
AIDS 
Pact CS/P
S: 
NGO 
MDG-
202-
G02-H-
00 
692,578.98 692,578.96 100.00 
Mad
agas
car 
2 HIV/
AIDS 
POPULATION 
SERVICES 
INTERNATION
AL 
CS/P
S: 
NGO 
MDG-
202-
G03-H-
00 
1,960,080.02 1,960,080.00 100.00 
Mad
agas
car 
3 HIV/
AIDS 
Sécrétariat 
Exécutif du 
Comité 
National de 
Lutte Contre le 
VIH/SIDA 
Gov: 
Oth 
MDG-
304-
G04-H 
904,993.37 904,993.36 100.00 
Mad
agas
car 
3 Mala
ria 
Unité de 
Gestion des 
Projets 
d'Appui au 
Secteur Santé 
Gov: 
MOH 
MDG-
304-
G05-M 
4,769,973.01 4,769,973.00 100.00 
Mad
agas
car 
4 Mala
ria 
Unité de 
Gestion des 
Projets 
d'Appui au 
Secteur Santé 
Gov: 
MOH 
MDG-
405-
G06-M 
11,404,267.1
1 
11,404,267.09 100.00 
Mad
agas
car 
4 TB Sécrétariat 
Exécutif du 
Comité 
National de 
Lutte Contre le 
VIH/SIDA 
Gov: 
Oth 
MDG-
404-
G08-T 
3,964,670.92 3,964,670.91 100.00 
Rwa
nda 
3 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Rwanda 
Gov: 
MOH 
RWN-
304-
G02-H 
41,785,724.5
1 
41,785,724.50 100.00 
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Rwa
nda 
4 TB The Ministry 
of Health of 
the 
Government 
of Rwanda 
Gov: 
MOH 
RWN-
404-
G04-T 
4,617,255.01 4,617,255.01 100.00 
Rwa
nda 
5 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of Rwanda 
Gov: 
MOH 
RWN-
506-
G06-M 
11,008,731.0
1 
11,008,731.00 100.00 
Rwa
nda 
6 TB The Ministry 
of Health of 
the 
Government 
of Rwanda 
Gov: 
MOH 
RWN-
606-
G07-T 
1,872,666.02 1,872,666.00 100.00 
Rwa
nda 
6 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of Rwanda 
Gov: 
MOH 
RWN-
607-
G08-H 
3,983,598.03 3,983,598.00 100.00 
Tanz
ania 
(Unit
ed 
Rep
ublic
) 
1 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the United 
Republic of 
Tanzania 
Gov: 
MOH 
TNZ-
102-
G01-M-
00 
11,037,104.0
1 
11,037,104.01 100.00 
Tanz
ania 
(Unit
ed 
Rep
ublic
) 
4 HIV/
AIDS 
Pact CS/P
S: 
NGO 
TNZ-
405-
G05-H 
35,027,544.7
3 
35,027,544.72 100.00 
Tanz
ania 
(Unit
ed 
Rep
ublic
) 
4 Mala
ria 
The Ministry 
of Finance of 
the 
Government 
of the United 
Republic of 
Tanzania 
Gov: 
MOF 
TNZ-
405-
G08-M 
20,884,977.0
1 
20,884,977.00 100.00 
Tanz
ania 
(Unit
ed 
Rep
4 HIV/
AIDS 
The Ministry 
of Finance of 
the 
Government 
of the United 
Gov: 
MOF 
TNZ-
405-
G04-H 
94,023,100.0
1 
94,023,100.00 100.00 
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ublic
) 
Republic of 
Tanzania 
Tanz
ania 
(Unit
ed 
Rep
ublic
) 
4 HIV/
AIDS 
African 
Medical and 
Research 
Foundation 
(AMREF) 
CS/P
S: 
NGO 
TNZ-
405-
G07-H 
8,290,885.01 8,290,885.00 100.00 
Uga
nda 
6 TB The Ministry 
of Finance, 
Planning and 
Economic 
Development 
of the 
Government 
of Uganda 
Gov: 
MOF 
UGD-
607-
G06-T 
1,127,523.00 0.00 0.00 
Zanz
ibar 
1 Mala
ria 
The Ministry 
of Health and 
Social Welfare 
of the 
Revolutionary 
Government 
of Zanzibar 
Gov: 
MOH 
ZAN-
102-
G01-M-
00 
371,860.01 371,860.00 100.00 
Zanz
ibar 
2 HIV/
AIDS 
Zanzibar AIDS 
Commission 
Gov: 
Oth 
ZAN-
202-
G02-H-
00 
316,274.51 316,274.50 100.00 
Zanz
ibar 
3 TB The Ministry 
of Health and 
Social Welfare 
of the 
Revolutionary 
Government 
of Zanzibar 
Gov: 
MOH 
ZAN-
304-
G03-T 
150,652.01 150,652.00 100.00 
Zanz
ibar 
4 Mala
ria 
The Ministry 
of Health and 
Social Welfare 
of the 
Revolutionary 
Government 
of Zanzibar 
Gov: 
MOH 
ZAN-
404-
G04-M 
3,349,427.01 3,349,427.00 100.00 
Ang
ola 
3 Mala
ria 
United 
Nations 
MO: 
UND
AGO-
305-
6,556,518.00 6,360,233.94 97.01 
    305 
Development 
Programme 
P G01-M 
Ang
ola 
4 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
AGO-
405-
G02-T 
2,968,098.87 2,968,098.87 100.00 
Bots
wan
a 
5 TB Ministry of 
Health of the 
Government 
of the 
Republic of 
Botswana 
Gov: 
MOH 
BOT-
506-
G02-T 
2,769,345.01 853,389.37 30.82 
Leso
tho 
2 TB The Ministry 
of Finance and 
Development 
Planning of 
the 
Government 
of the 
Kingdom of 
Lesotho 
Gov: 
MOF 
LSO-
202-
G02-T-
00 
3,000,000.01 1,325,670.45 44.19 
Leso
tho 
2 HIV/
AIDS 
The Ministry 
of Finance and 
Development 
Planning of 
the 
Government 
of the 
Kingdom of 
Lesotho 
Gov: 
MOF 
LSO-
202-
G01-H-
00 
18,755,000.0
1 
16,811,898.29 89.64 
Leso
tho 
5 HIV/
AIDS 
The Ministry 
of Finance and 
Development 
Planning of 
the 
Government 
of the 
Kingdom of 
Lesotho 
Gov: 
MOF 
LSO-
506-
G03-H 
5,768,188.96 5,768,188.94 100.00 
Mala
wi 
5 HIV/
AIDS 
The Registered 
Trustees of 
the National 
AIDS 
Commission 
Trust of the 
Republic of 
Gov: 
Oth 
MLW-
506-
G03-H 
9,881,107.01 5,306,582.00 53.70 
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Malawi 
Moz
ambi
que 
2 TB The Ministry 
of Health of 
the 
Government 
of 
Mozambique 
Gov: 
MOH 
MOZ-
202-
G04-T-
00 
1,302,060.19 1,302,060.18 100.00 
Moz
ambi
que 
2 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of 
Mozambique 
Gov: 
MOH 
MOZ-
202-
G03-M-
00 
14,566,933.3
3 
14,285,301.60 98.07 
Moz
ambi
que 
2 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of 
Mozambique 
Gov: 
MOH 
MOZ-
202-
G02-H-
00 
66,120,799.0
6 
65,832,503.16 99.56 
Moz
ambi
que 
2 HIV/
AIDS 
The National 
AIDS Council 
(CNCS) of 
Mozambique 
Gov: 
Oth 
MOZ-
202-
G01-H-
00 
0.00 0.00 0.00 
Moz
ambi
que 
6 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of 
Mozambique 
Gov: 
MOH 
MOZ-
607-
G06-M 
7,264,538.36 5,396,511.90 74.29 
Moz
ambi
que 
6 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of 
Mozambique 
Gov: 
MOH 
MOZ-
607-
G05-H 
34,253,874.9
0 
34,253,874.89 100.00 
Nam
ibia 
5 TB The Ministry 
of Health and 
Social Services 
of the 
Government 
of Namibia 
Gov: 
MOH 
NMB-
506-
G04-T 
9,981,773.01 5,370,166.80 53.80 
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Swaz
iland 
2 Mala
ria 
The National 
Emergency 
Response 
Council on 
HIV/AIDS 
(NERCHA) of 
the 
Government 
of the 
Kingdom of 
Swaziland 
Gov: 
Oth 
SWZ-
202-
G02-M-
00 
499,327.71 499,327.68 100.00 
Swaz
iland 
2 HIV/
AIDS 
The National 
Emergency 
Response 
Council on 
HIV/AIDS 
(NERCHA) of 
the 
Government 
of the 
Kingdom of 
Swaziland 
Gov: 
Oth 
SWZ-
202-
G01-H-
00 
18,244,865.7
3 
18,244,865.70 100.00 
Swaz
iland 
3 TB The National 
Emergency 
Response 
Council on 
HIV/AIDS 
(NERCHA) of 
the 
Government 
of the 
Kingdom of 
Swaziland 
Gov: 
Oth 
SWZ-
304-
G03-T 
1,157,600.01 1,104,755.82 95.44 
Swaz
iland 
4 HIV/
AIDS 
The National 
Emergency 
Response 
Council on 
HIV/AIDS 
(NERCHA) of 
the 
Government 
of the 
Kingdom of 
Swaziland 
Gov: 
Oth 
SWZ-
405-
G04-H 
2,913,369.47 2,913,369.45 100.00 
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Swaz
iland 
7 HIV/
AIDS 
The National 
Emergency 
Response 
Council on 
HIV/AIDS 
(NERCHA) of 
the 
Government 
of the 
Kingdom of 
Swaziland 
Gov: 
Oth 
SWZ-
708-
G05-H 
27,295,783.0
0 
0.00 0.00 
Zam
bia 
1 TB Zambia 
National AIDS 
Network 
CS/P
S: 
NGO 
ZAM-
102-
G15-T-
00 
1,164,676.00 1,164,676.00 100.00 
Zam
bia 
1 TB The Churches 
Health 
Association of 
Zambia 
CS/P
S: 
FBO 
ZAM-
102-
G06-T-
00 
8,056,728.01 8,056,728.00 100.00 
Zam
bia 
1 Mala
ria 
The Churches 
Health 
Association of 
Zambia 
CS/P
S: 
FBO 
ZAM-
102-
G05-M-
00 
2,529,900.01 2,529,891.40 100.00 
Zam
bia 
1 HIV/
AIDS 
Zambia 
National AIDS 
Network 
CS/P
S: 
NGO 
ZAM-
102-
G08-H-
00 
12,131,468.0
1 
12,131,468.00 100.00 
Zam
bia 
1 HIV/
AIDS 
The Churches 
Health 
Association of 
Zambia 
CS/P
S: 
FBO 
ZAM-
102-
G04-H-
00 
16,225,653.0
1 
16,225,653.00 100.00 
Zam
bia 
1 HIV/
AIDS 
Ministry of 
Health of the 
Government 
of the 
Republic of 
Zambia 
Gov: 
MOH 
ZAM-
102-
G01-H-
00 
15,043,020.3
8 
14,543,020.36 96.68 
Zam
bia 
1 Mala
ria 
Ministry of 
Health of the 
Government 
of the 
Republic of 
Zambia 
Gov: 
MOH 
ZAM-
102-
G02-M-
00 
18,452,099.8
2 
18,252,099.80 98.92 
Zam
bia 
1 TB Ministry of 
Health of the 
Government 
Gov: 
MOH 
ZAM-
102-
G03-T-
6,406,843.20 5,906,843.18 92.20 
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of the 
Republic of 
Zambia 
00 
Zam
bia 
4 HIV/
AIDS 
Zambia 
National AIDS 
Network 
CS/P
S: 
NGO 
ZAM-
405-
G11-H 
28,208,555.0
1 
16,202,591.64 57.44 
Zam
bia 
4 HIV/
AIDS 
The Churches 
Health 
Association of 
Zambia 
CS/P
S: 
FBO 
ZAM-
405-
G10-H 
57,264,052.7
9 
56,264,052.78 98.25 
Zam
bia 
4 HIV/
AIDS 
Ministry of 
Health of the 
Government 
of the 
Republic of 
Zambia 
Gov: 
MOH 
ZAM-
405-
G09-H 
38,536,277.7
2 
33,402,097.64 86.68 
Zam
bia 
4 HIV/
AIDS 
The Ministry 
of Finance and 
National 
Planning of 
the 
Government 
of Zambia 
Gov: 
MOF 
ZAM-
405-
G12-H 
5,694,580.15 5,194,580.14 91.22 
Zam
bia 
4 Mala
ria 
The Churches 
Health 
Association of 
Zambia 
CS/P
S: 
FBO 
ZAM-
405-
G14-M 
6,668,108.01 6,379,667.88 95.67 
Zam
bia 
4 Mala
ria 
Ministry of 
Health of the 
Government 
of the 
Republic of 
Zambia 
Gov: 
MOH 
ZAM-
405-
G13-M 
7,692,368.91 6,661,242.32 86.60 
Zimb
abw
e 
1 HIV/
AIDS 
National AIDS 
Council of 
Zimbabwe 
Gov: 
Oth 
ZIM-
102-
G07-H 
2,347,092.61 2,347,092.59 100.00 
Zimb
abw
e 
1 Mala
ria 
The Ministry 
of Health and 
Child Welfare 
of the 
Government 
of Zimbabwe 
Gov: 
MOH 
ZIM-
102-
G02-M-
00 
209,946.60 209,946.58 100.00 
Zimb
abw
e 
5 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
ZIM-
509-
G08-T 
1,437,752.98 1,437,752.97 100.00 
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Zimb
abw
e 
5 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
ZIM-
509-
G10-H 
21,033,988.1
3 
21,033,988.12 100.00 
Zimb
abw
e 
5 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
ZIM-
509-
G09-M 
3,658,648.86 3,658,648.85 100.00 
Beni
n 
1 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
BEN-
102-
G01-M-
00 
565,847.00 177,948.96 31.45 
Beni
n 
2 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
BEN-
202-
G03-H-
00 
5,381,576.78 3,928,162.78 72.99 
Beni
n 
2 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
BEN-
202-
G02-T-
00 
921,754.50 657,808.50 71.36 
Beni
n 
3 Mala
ria 
Africare CS/P
S: 
NGO 
BEN-
304-
G04-M 
1,072,999.00 1,059,783.85 98.77 
Beni
n 
5 HIV/
AIDS 
Ministry of 
Health of the 
Government 
of the 
Republic of 
Benin 
Gov: 
MOH 
BEN-
506-
G05-H 
10,715,495.0
9 
8,582,187.15 80.09 
Burk
ina 
Faso 
2 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
BUR-
202-
G02-H-
00 
1,658,609.67 1,658,609.67 100.00 
Burk
ina 
Faso 
2 HIV/
AIDS 
National 
Council for the 
Struggle 
against 
HIV/AIDS and 
STI (SP/CNLS-
IST) 
Gov: 
MOH 
BUR-
202-
G04-H-
00 
5,363,023.90 5,363,023.90 100.00 
Burk
ina 
Faso 
4 TB National 
Council for the 
Struggle 
against 
HIV/AIDS and 
STI (SP/CNLS-
Gov: 
MOH 
BUR-
407-
G05-T 
8,779,737.07 8,779,737.06 100.00 
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IST) 
Burk
ina 
Faso 
6 HIV/
AIDS 
National 
Council for the 
Struggle 
against 
HIV/AIDS and 
STI (SP/CNLS-
IST) 
Gov: 
Oth 
BUR-
607-
G06-H 
26,929,355.7
3 
19,188,396.31 71.25 
Cam
eroo
n 
3 TB The Ministry 
of Public 
Health of the 
Government 
of the 
Republic of 
Cameroon 
Gov: 
MOH 
CMR-
304-
G03-T 
2,818,741.01 2,492,598.95 88.43 
Cam
eroo
n 
3 HIV/
AIDS 
The Ministry 
of Public 
Health of the 
Government 
of the 
Republic of 
Cameroon 
Gov: 
MOH 
CMR-
304-
G01-H 
40,859,210.0
0 
40,859,209.86 100.00 
Cam
eroo
n 
3 HIV/
AIDS 
The Ministry 
of Public 
Health of the 
Government 
of the 
Republic of 
Cameroon 
Gov: 
MOH 
CMR-
304-
G01-H-e 
16,740,538.0
4 
12,395,802.09 74.05 
Cam
eroo
n 
3 Mala
ria 
The Ministry 
of Public 
Health of the 
Government 
of the 
Republic of 
Cameroon 
Gov: 
MOH 
CMR-
304-
G02-M 
14,842,393.0
1 
12,942,669.90 87.20 
Cam
eroo
n 
4 HIV/
AIDS 
CARE 
International 
CS/P
S: 
NGO 
CMR-
404-
G04-H 
9,846,793.01 9,568,161.91 97.17 
Cam
eroo
n 
5 HIV/
AIDS 
The Ministry 
of Public 
Health of the 
Government 
of the 
Gov: 
MOH 
CMR-
506-
G05-H 
7,975,540.30 5,397,342.98 67.67 
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Republic of 
Cameroon 
Cam
eroo
n 
5 Mala
ria 
The Ministry 
of Public 
Health of the 
Government 
of the 
Republic of 
Cameroon 
Gov: 
MOH 
CMR-
506-
G06-M 
440,803.45 0.00 0.00 
Cent
ral 
Afric
an 
Rep
ublic 
2 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
CAF-
202-
G01-H-
00 
14,857,770.8
2 
12,557,770.82 84.52 
Cent
ral 
Afric
an 
Rep
ublic 
4 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
CAF-
404-
G03-T 
1,351,759.06 1,351,759.04 100.00 
Cent
ral 
Afric
an 
Rep
ublic 
4 TB National 
Coordination 
of the National 
AIDS Control 
Committee of 
the 
Government 
of the Central 
African 
Republic 
Gov: 
MOH 
CAF-
409-
G07-T 
562,701.00 256,983.00 45.67 
Cent
ral 
Afric
an 
Rep
ublic 
4 HIV/
AIDS 
National 
Coordination 
of the National 
AIDS Control 
Committee of 
the 
Government 
of the Central 
African 
Republic 
Gov: 
MOH 
CAF-
409-
G06-H 
2,163,415.00 1,515,742.00 70.06 
Cent
ral 
Afric
an 
4 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
CAF-
404-
G02-H 
3,800,250.31 3,800,250.31 100.00 
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Rep
ublic 
Cent
ral 
Afric
an 
Rep
ublic 
4 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
CAF-
405-
G04-M 
6,071,081.00 3,040,819.71 50.09 
Côte 
d'Ivo
ire 
2 HIV/
AIDS 
CARE 
International 
CS/P
S: 
NGO 
CIV-202-
G05-H 
26,171,118.0
2 
22,799,434.92 87.12 
Côte 
d'Ivo
ire 
2 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
CIV-202-
G01-H-
00 
2,887,949.56 2,887,949.27 100.00 
Côte 
d'Ivo
ire 
3 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
CIV-304-
G03-T 
959,985.01 872,223.52 90.86 
Equa
toria
l 
Guin
ea 
4 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
GNQ-
405-
G01-H 
5,426,072.01 3,411,383.11 62.87 
Equa
toria
l 
Guin
ea 
5 Mala
ria 
Medical Care 
Development 
International 
CS/P
S: 
NGO 
GNQ-
506-
G02-M 
10,168,195.0
1 
10,100,216.25 99.33 
Gab
on 
3 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
GAB-
304-
G01-H-e 
1,797,515.62 1,797,515.62 100.00 
Gab
on 
3 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
GAB-
304-
G01-H 
1,938,467.00 1,938,467.00 100.00 
Gab
on 
4 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
GAB-
404-
G02-M 
1,196,698.02 1,196,698.00 100.00 
Gab
on 
5 Mala
ria 
Ministry of 
Health and 
Public Hygiene 
of the 
Governemnt 
Gov: 
MOH 
GAB-
509-
G04-M 
9,667,209.24 4,762,891.98 49.27 
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of the 
Gabonese 
Republic 
Gam
bia 
3 Mala
ria 
The 
Department of 
State for 
Health of the 
Republic of 
the Gambia 
Gov: 
MOH 
GMB-
304-
G02-M 
9,129,204.02 9,129,204.00 100.00 
Gam
bia 
3 HIV/
AIDS 
The National 
AIDS 
Secretariat of 
the Republic 
of the Gambia 
Gov: 
Oth 
GMB-
304-
G01-H 
8,322,164.30 8,322,164.29 100.00 
Gam
bia 
5 TB Ministry of 
Health and 
Social welfare 
of the 
Government 
of the 
Republic of 
the Gambia 
Gov: 
MOH 
GMB-
506-
G03-T 
2,471,602.01 2,339,403.55 94.65 
Gha
na 
1 TB The Ministry 
of Health of 
the Republic 
of Ghana 
Gov: 
MOH 
GHN-
102-
G02-T-
00 
3,348,552.56 3,348,552.55 100.00 
Gha
na 
1 HIV/
AIDS 
The Ministry 
of Health of 
the Republic 
of Ghana 
Gov: 
MOH 
GHN-
102-
G01-H-
00 
9,204,744.01 9,204,744.00 100.00 
Gha
na 
2 Mala
ria 
The Ministry 
of Health of 
the Republic 
of Ghana 
Gov: 
MOH 
GHN-
202-
G03-M-
00 
4,253,380.01 4,253,379.98 100.00 
Gha
na 
5 TB The Ministry 
of Health of 
the Republic 
of Ghana 
Gov: 
MOH 
GHN-
506-
G05-T 
16,924,238.0
1 
16,514,468.72 97.58 
Guin
ea 
2 HIV/
AIDS 
The Ministry 
of Public 
Health of the 
Government 
of the 
Republic of 
Guinea 
Gov: 
MOH 
GIN-
202-
G01-H-
00 
4,846,409.01 432,011.32 8.91 
    315 
Guin
ea-
Bissa
u 
3 TB The Ministry 
of Health of 
the 
Government 
of the 
Republic of 
Guinea-Bissau 
(CG/PNDS) 
Gov: 
MOH 
GNB-
309-
G06-T 
609,179.01 609,179.00 100.00 
Guin
ea-
Bissa
u 
3 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
GNB-
304-
G01-T 
423,481.41 423,481.39 100.00 
Guin
ea-
Bissa
u 
4 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
GNB-
404-
G03-M 
234,538.22 234,538.20 100.00 
Guin
ea-
Bissa
u 
4 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the 
Republic of 
Guinea-Bissau 
(CG/PNDS) 
Gov: 
MOH 
GNB-
409-
G08-M 
599,333.01 599,333.00 100.00 
Guin
ea-
Bissa
u 
4 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
GNB-
404-
G02-H 
754,641.86 754,641.84 100.00 
Guin
ea-
Bissa
u 
4 HIV/
AIDS 
The Ministry 
of Health of 
the 
Government 
of the 
Republic of 
Guinea-Bissau 
(CG/PNDS) 
Gov: 
MOH 
GNB-
409-
G07-H 
1,203,226.01 1,203,226.00 100.00 
Liber
ia 
6 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
LBR-
607-
G04-H 
66,025.01 66,025.00 100.00 
Liber
ia 
7 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
LBR-
708-
G05-M 
6,794,339.01 6,794,339.00 100.00 
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Nige
ria 
4 Mala
ria 
The Yakubu 
Gowon Center 
for National 
Unity and 
International 
Cooperation 
CS/P
S: 
NGO 
NGA-
404-
G05-M 
23,433,696.0
2 
18,014,706.64 76.88 
Nige
ria 
4 Mala
ria 
SOCIETY FOR 
FAMILY 
HEALTH 
CS/P
S: 
NGO 
NGA-
407-
G10-M 
30,641,591.0
1 
25,670,295.00 83.78 
Nige
ria 
5 HIV/
AIDS 
Association 
For 
Reproductive 
And Family 
Health (ARFH) 
CS/P
S: 
NGO 
NGA-
506-
G09-H 
6,643,707.02 6,643,707.00 100.00 
Nige
ria 
5 HIV/
AIDS 
SOCIETY FOR 
FAMILY 
HEALTH 
CS/P
S: 
NGO 
NGA-
506-
G08-H 
8,907,254.56 8,907,254.53 100.00 
Nige
ria 
5 HIV/
AIDS 
National 
Agency for the 
Control of 
AIDS 
Gov: 
Oth 
NGA-
506-
G07-H 
23,567,222.0
2 
23,567,222.00 100.00 
Sao 
Tom
e 
and 
Princ
ipe 
4 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
STP-
405-
G01-M 
1,469,439.01 1,469,439.01 100.00 
Sao 
Tom
e 
and 
Princ
ipe 
5 HIV/
AIDS 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
STP-
506-
G02-H 
864,202.02 769,956.31 89.09 
Sene
gal 
1 HIV/
AIDS 
Alliance 
Nationale 
Contre le SIDA 
CS/P
S: 
NGO 
SNG-
102-
G04-H-
00 
2,906,326.01 2,906,326.00 100.00 
Sene
gal 
1 HIV/
AIDS 
The National 
AIDS Council 
of Senegal 
Gov: 
Oth 
SNG-
102-
G01-H-
00 
2,748,914.92 2,748,914.91 100.00 
Sene
gal 
4 Mala
ria 
The Ministry 
of Health of 
the 
Government 
of the 
Gov: 
MOH 
SNG-
405-
G03-M 
7,327,690.01 2,723,410.70 37.17 
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Republic of 
Senegal 
Sene
gal 
7 TB The Ministry 
of Health and 
Medical 
Prevention 
(MSPM), 
Government 
of the 
Repbulic of 
Senegal 
Gov: 
MOH 
SNG-
708-
G08-T 
45,596.77 44,089.25 96.69 
Sierr
a 
Leon
e 
2 TB The Sierra 
Leone Red 
Cross Society 
CS/P
S: 
NGO 
SLE-202-
G01-T-
00 
2,461,733.90 2,461,733.88 100.00 
Sierr
a 
Leon
e 
4 HIV/
AIDS 
The Sierra 
Leone 
National 
HIV/AIDS 
Secretariat 
Gov: 
Oth 
SLE-405-
G02-H 
9,246,548.01 7,250,397.74 78.41 
Togo 3 TB United 
Nations 
Development 
Programme 
MO: 
UND
P 
TGO-
304-
G03-T 
48,906.22 0.00 0.00 
Togo 3 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
TGO-
304-
G02-M 
2,377,499.47 2,238,149.71 94.14 
Togo 4 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
TGO-
405-
G05-M 
4,628,947.01 4,601,050.98 99.40 
Togo 4 HIV/
AIDS 
POPULATION 
SERVICES 
INTERNATION
AL 
CS/P
S: 
NGO 
TGO-
405-
G04-H 
21,136,912.0
2 
19,243,729.87 91.04 
Togo 6 Mala
ria 
United 
Nations 
Development 
Programme 
MO: 
UND
P 
TGO-
607-
G06-M 
1,215,983.06 983,581.67 80.89 
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APPENDIX 4: GOVERNANCE, RISK AND TOTAL DISEASE BURDEN SCORES PER COUNTRY 
 
 
Country Governance and Risk  Total Burden  
Afghanistan 15 18 
Albania 8 12 
Algeria 11.4 16 
Angola 46.2 26 
Argentina 22.5 16 
Armenia 25 20 
Azerbaijan 30 24 
Bangladesh 54 18 
Belarus 30 22 
Belize 12 22 
Benin 42.75 20 
Bhutan 5 18 
Bolivia 30                                                                                                                         20
Bosnia and Herzegovina 30 14 
Botswana 4 26 
Brazil 20 22 
Bulgaria 20 20 
Burkina Faso 85.5 22 
Burundi 87 26 
Cambodia 85 26 
Cameroon 90 26 
Cape Verde 9.25 16 
Central African Republic 80 26 
Chad 98 26 
Chile 5 16 
Colombia 20 20 
Comoros 29 12 
Congo-Brazzaville 30.8 22 
Costa Rica 9.4 18 
Cote d'Ivoire 89 26 
Cuba 48 18 
D.P.R. Korea 36 18 
D.R. Congo 93 20 
Djibouti 97 26 
Dominican Republic 90 18 
Ecuador 24 16 
Egypt 13.25 14 
El Salvador 32 16 
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Equatorial Guinea 24 18 
Eritrea 48 20 
Ethiopia 60 20 
Fiji 12 10 
Gabon 40 26 
Gambia 26 26 
Georgia 32 22 
Ghana 22.2 24 
Guatemala 47 18 
Guinea 60 22 
Guina-Bissau 77 26 
Guyana 24 22 
Haiti 100 20 
Honduras 72 18 
India 32 26 
Indonesia 48 24 
Iran 96 14 
Iraq 30 14 
Jamaica 20 16 
Jordan 8 12 
Kazakhstan 30 20 
Kenya 58.4 26 
Kosovo 15 12 
Kyrgyzstan 60 22 
Lao P.D.R. 60 18 
Lesotho 22.2 20 
Liberia 32.25 14 
Macedonia 8 14 
Madagascar 45 18 
Malawi 32 26 
Malaysia 8 22 
Maldives 48 12 
Mali 96 24 
Mauritania 95 20 
Mauritius 5 16 
Mexico 12 18 
Moldova 30 10 
Mongolia 12 16 
Montenegro 8 12 
Morocco 8 14 
Mozambique 45.6 26 
Myanmar 84 24 
Namibia 22.2 28 
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Nepal 48 20 
Nicaragua 45 16 
Niger 67.5 22 
Nigeria 88 26 
Pakistan 49 22 
Panama 8 18 
Papua New Guinea 96 22 
Paraguay 16 18 
P.R. of China 32 20 
Peru 30 24 
Phillipes 96 18 
Romania 16 18 
Russian Federation 80 22 
Rwanda 43 24 
Sao tome and Principe 14.25 18 
Senegal 51 22 
Serbia 8 16 
Sierra Leone 54 24 
Solomon Islands 15 20 
Somalia 60 26 
South Africa 44.4 26 
Sri Lanka 45 16 
Sudan 94 24 
Suriname 15 22 
Swaziland 34.2 26 
Syrian Arab Republic 36 10 
Tajikistan 40 22 
Thailand 30 26 
Timor-Leste 18 20 
Togo 45 24 
Tunisia 9.25 14 
Turkey 10 16 
Turkmenistan 16 14 
U.R. Tanzania 92 26 
Uganda 91 26 
Ukraine 99 22 
Uruguay 4 18 
Uzbekistan 32 20 
Viet Nam 45 26 
West Bank and Gaza 15 10 
Yemen 80 16 
Zambia 87 26 
Zanzibar 17.1 26 
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Zimbabwe 86 26 
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APPENDIX 5: COUNTRY DISEASE SCORE PER COMPONENT 
 
 
Country Component Disease Score 
Afghanistan HIV 4 
Malaria 2 
TB 6 
Angola 
 
HIV 6 
Malaria 6 
TB 6 
Albania 
 
HIV 1 
Malaria 1 
TB 1 
Argentina 
 
HIV 4 
Malaria 1 
TB 1 
Armenia 
 
HIV 1 
Malaria 1 
TB 6 
Antigua and Barbuda 
 
HIV 1 
Malaria 1 
TB 1 
Azerbaijan 
 
HIV 4 
Malaria 2 
TB 6 
Bangladesh 
 
HIV 1 
Malaria 4 
TB 6 
Belize 
 
HIV 6 
Malaria 2 
TB 2 
Benin 
 
HIV 4 
Malaria 6 
TB 2 
Bosnia & Herzegovina HIV 1 
Bosnia & Herzegovina Malaria 1 
Bosnia & Herzegovina TB 2 
Belarus HIV 4 
Belarus Malaria 1 
Belarus TB 6 
Bolivia HIV 4 
Bolivia Malaria 2 
Bolivia TB 4 
Botswana HIV 8 
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Botswana Malaria 4 
Botswana TB 8 
Brazil HIV 4 
Brazil Malaria 2 
Brazil TB 4 
Burundi HIV 6 
Burundi Malaria 6 
Burundi TB 6 
Bhutan HIV 1 
Bhutan Malaria 4 
Bhutan TB 6 
Bulgaria HIV 4 
Bulgaria Malaria 1 
Bulgaria TB 4 
Burkina Faso HIV 4 
Burkina Faso Malaria 8 
Burkina Faso TB 4 
Central African Republic HIV 6 
Central African Republic Malaria 8 
Central African Republic TB 6 
Cambodia HIV 4 
Cambodia Malaria 6 
Cambodia TB 6 
Cape Verde HIV 2 
Cape Verde Malaria 2 
Cape Verde TB 4 
Chile HIV 4 
Chile Malaria 1 
Chile TB 1 
China HIV 4 
China Malaria 1 
China TB 6 
Côte d'Ivoire HIV 6 
Côte d'Ivoire Malaria 6 
Côte d'Ivoire TB 6 
Cameroon HIV 6 
Cameroon Malaria 6 
Cameroon TB 6 
Congo HIV 6 
Congo Malaria 6 
Congo TB 6 
Colombia HIV 2 
Colombia Malaria 4 
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Colombia TB 2 
Comoros HIV 1 
Comoros Malaria 4 
Comoros TB 1 
Costa Rica HIV 4 
Costa Rica Malaria 2 
Costa Rica TB 1 
Cuba HIV 1 
Cuba Malaria 1 
Cuba TB 1 
Djibouti HIV 6 
Djibouti Malaria 6 
Djibouti TB 8 
Dominica HIV 1 
Dominica Malaria 1 
Dominica TB 1 
Dominican Republic HIV 4 
Dominican Republic Malaria 1 
Dominican Republic TB 2 
Algeria HIV 1 
Algeria Malaria 1 
Algeria TB 4 
Ecuador HIV 1 
Ecuador Malaria 2 
Ecuador TB 2 
Egypt HIV 4 
Egypt Malaria 1 
Egypt TB 1 
Eritrea HIV 4 
Eritrea Malaria 2 
Eritrea TB 4 
Estonia HIV   
Estonia Malaria   
Estonia TB   
Ethiopia HIV 6 
Ethiopia Malaria 6 
Ethiopia TB 6 
Fiji HIV 1 
Fiji Malaria 1 
Fiji TB 1 
Micronesia HIV 1 
Micronesia Malaria 1 
Micronesia TB 6 
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Gabon HIV 6 
Gabon Malaria 4 
Gabon TB 6 
Georgia HIV 2 
Georgia Malaria 2 
Georgia TB 6 
Ghana HIV 4 
Ghana Malaria 6 
Ghana TB 6 
Guinea HIV 4 
Guinea Malaria 8 
Guinea TB 4 
Gambia HIV 6 
Gambia Malaria 6 
Gambia TB 6 
Guinea-Bissau HIV 6 
Guinea-Bissau Malaria 8 
Guinea-Bissau TB 6 
Equatorial Guinea HIV   
Equatorial Guinea Malaria   
Equatorial Guinea TB   
Grenada HIV 1 
Grenada Malaria 1 
Grenada TB 1 
Guatemala HIV 4 
Guatemala Malaria 2 
Guatemala TB 2 
Guyana HIV 4 
Guyana Malaria 4 
Guyana TB 6 
Honduras HIV 4 
Honduras Malaria 2 
Honduras TB 2 
Croatia HIV   
Croatia Malaria   
Croatia TB   
Haiti HIV 4 
Haiti Malaria 2 
Haiti TB 6 
India HIV 4 
India Malaria 8 
India TB 6 
Indonesia HIV 4 
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Indonesia Malaria 4 
Indonesia TB 6 
Iran (Islamic Republic of) HIV 1 
Iran (Islamic Republic of) Malaria 2 
Iran (Islamic Republic of) TB 1 
Iraq HIV 1 
Iraq Malaria 2 
Iraq TB 2 
Jamaica HIV 4 
Jamaica Malaria 1 
Jamaica TB 1 
Jordan HIV 1 
Jordan Malaria 1 
Jordan TB 1 
Kazakhstan HIV 2 
Kazakhstan Malaria 1 
Kazakhstan TB 6 
Kenya HIV 6 
Kenya Malaria 4 
Kenya TB 6 
Kyrgyzstan HIV 4 
Kyrgyzstan Malaria 2 
Kyrgyzstan TB 6 
Kiribati HIV 1 
Kiribati Malaria 1 
Kiribati TB 6 
Saint Kitts and Nevis HIV 1 
Saint Kitts and Nevis Malaria 1 
Saint Kitts and Nevis TB 1 
Kosovo HIV 1 
Kosovo Malaria 1 
Kosovo TB 1 
Lao People Democratic 
Republic 
HIV 1 
Lao People Democratic 
Republic 
Malaria 4 
Lao People Democratic 
Republic 
TB 4 
Lebanon HIV 1 
Lebanon Malaria 1 
Lebanon TB 1 
Liberia HIV 4 
Liberia Malaria 8 
Liberia TB 6 
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Libyan Arab Jamahiriya HIV 1 
Libyan Arab Jamahiriya Malaria 1 
Libyan Arab Jamahiriya TB 2 
St Lucia HIV 4 
St Lucia Malaria 1 
St Lucia TB 1 
Lesotho HIV 8 
Lesotho Malaria 1 
Lesotho TB 8 
Lithuania HIV 4 
Lithuania Malaria 1 
Lithuania TB 6 
Multicountry Americas 
(Andean) 
Malaria   
Multicountry Americas 
(CARICOM / PANCAP) 
HIV   
Multicountry Americas 
(OECS) 
HIV   
Multicountry Africa (RMCC) Malaria   
Mali HIV 4 
Mali Malaria 8 
Mali TB 6 
Multicountry Americas 
(Meso) 
HIV   
Multicountry Americas 
(CRN+) 
HIV   
Multicountry Americas 
(REDCA+) 
HIV   
Multicountry Africa (SADC) HIV   
Multicountry Americas 
(REDTRASEX) 
HIV   
Multicountry Africa (West 
Africa Corridor Program) 
HIV   
Multicountry Americas 
(COPRECOS) 
HIV   
Madagascar HIV 1 
Madagascar Malaria 4 
Madagascar TB 6 
Maldives HIV 1 
Maldives Malaria 1 
Maldives TB 2 
Multicountry East Asia And 
Pacific (APN+) 
HIV   
Multicountry East Asia And HIV   
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Pacific (ISEAN-HIVOS) 
Multicountry East Asia And 
Pacific (ISEAN-HIVOS) 
Malaria   
Multicountry East Asia And 
Pacific (ISEAN-HIVOS) 
TB   
Mexico HIV 4 
Mexico Malaria 2 
Mexico TB 1 
Marshall Islands HIV 1 
Marshall Islands Malaria 1 
Marshall Islands TB 6 
Macedonia HIV 1 
Macedonia Malaria 1 
Macedonia TB 2 
Malawi HIV 8 
Malawi Malaria 6 
Malawi TB 6 
Multicountry Middle East - 
North Africa (MENAHRA) 
HIV   
Montenegro HIV 1 
Montenegro Malaria 1 
Montenegro TB 1 
Republic of Moldova HIV 4 
Republic of Moldova Malaria 1 
Republic of Moldova TB 6 
Mongolia HIV 1 
Mongolia Malaria 1 
Mongolia TB 6 
Morocco HIV 1 
Morocco Malaria 1 
Morocco TB 4 
Mozambique HIV 8 
Mozambique Malaria 8 
Mozambique TB 6 
Mauritania HIV 4 
Mauritania Malaria 4 
Mauritania TB 4 
Multicountry South Asia HIV   
Mauritius HIV 4 
Mauritius Malaria 1 
Mauritius TB 1 
Multicountry Western Pacific HIV   
Multicountry Western Pacific Malaria   
Multicountry Western Pacific TB   
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Myanmar HIV 4 
Myanmar Malaria 6 
Myanmar TB 6 
Malaysia HIV 4 
Malaysia Malaria 2 
Malaysia TB 4 
Nepal HIV 4 
Nepal Malaria 2 
Nepal TB 6 
Nigeria HIV 6 
Nigeria Malaria 8 
Nigeria TB 6 
Niger HIV 4 
Niger Malaria 8 
Niger TB 4 
Nicaragua HIV 2 
Nicaragua Malaria 2 
Nicaragua TB 2 
Namibia HIV 8 
Namibia Malaria 6 
Namibia TB 8 
Panama HIV 2 
Panama Malaria 2 
Panama TB 2 
Peru HIV 4 
Peru Malaria 2 
Peru TB 6 
Philippines HIV 1 
Philippines Malaria 2 
Philippines TB 6 
Pakistan HIV 4 
Pakistan Malaria 2 
Pakistan TB 6 
Palau HIV 1 
Palau Malaria 1 
Palau TB 4 
Papua New Guinea HIV 4 
Papua New Guinea Malaria 4 
Papua New Guinea TB 6 
Democratic People Republic 
of Korea 
HIV 1 
Democratic People Republic 
of Korea 
Malaria 2 
Democratic People Republic TB 6 
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of Korea 
Paraguay HIV 4 
Paraguay Malaria 2 
Paraguay TB 2 
West Bank and Gaza HIV 1 
West Bank and Gaza Malaria 1 
West Bank and Gaza TB 1 
Romania HIV 2 
Romania Malaria 1 
Romania TB 4 
Russian Federation HIV 4 
Russian Federation Malaria 1 
Russian Federation TB 6 
Rwanda HIV 6 
Rwanda Malaria 4 
Rwanda TB 6 
South Africa HIV 8 
South Africa Malaria 4 
South Africa TB 8 
Solomon Islands HIV 1 
Solomon Islands Malaria 6 
Solomon Islands TB 4 
Sierra Leone HIV 4 
Sierra Leone Malaria 8 
Sierra Leone TB 6 
El Salvador HIV 4 
El Salvador Malaria 1 
El Salvador TB 2 
Senegal HIV 4 
Senegal Malaria 6 
Senegal TB 4 
Somalia HIV 4 
Somalia Malaria 6 
Somalia TB 6 
Serbia HIV 4 
Serbia Malaria 1 
Serbia TB 1 
Sri Lanka HIV 1 
Sri Lanka Malaria 4 
Sri Lanka TB 2 
Sao Tome & Principe HIV 4 
Sao Tome & Principe Malaria 8 
Sao Tome & Principe TB 2 
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Sudan North HIV 4 
Sudan North Malaria 4 
Sudan North TB 6 
Suriname HIV 4 
Suriname Malaria 6 
Suriname TB 2 
Sudan South HIV 4 
Sudan South Malaria 4 
Sudan South TB 6 
Swaziland HIV 8 
Swaziland Malaria 4 
Swaziland TB 8 
Seychelles HIV 1 
Seychelles Malaria 1 
Seychelles TB 1 
Syrian Arab Republic HIV 1 
Syrian Arab Republic Malaria 1 
Syrian Arab Republic TB 1 
Tajikistan HIV 4 
Tajikistan Malaria 2 
Tajikistan TB 6 
Chad HIV 6 
Chad Malaria 8 
Chad TB 6 
Togo HIV 6 
Togo Malaria 6 
Togo TB 4 
Thailand HIV 4 
Thailand Malaria 6 
Thailand TB 6 
Turkmenistan HIV 1 
Turkmenistan Malaria 1 
Turkmenistan TB 4 
Timor-Leste HIV 1 
Timor-Leste Malaria 4 
Timor-Leste TB 6 
United Republic of Tanzania HIV 6 
United Republic of Tanzania Malaria 8 
United Republic of Tanzania TB 6 
Tonga HIV 1 
Tonga Malaria 1 
Tonga TB 1 
Tunisia HIV 2 
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Tunisia Malaria 1 
Tunisia TB 2 
Turkey HIV 1 
Turkey Malaria 2 
Turkey TB 2 
Tuvalu HIV 1 
Tuvalu Malaria 1 
Tuvalu TB 6 
Uganda HIV 6 
Uganda Malaria 8 
Uganda TB 6 
Ukraine HIV 4 
Ukraine Malaria 1 
Ukraine TB 6 
Uruguay HIV 4 
Uruguay Malaria 1 
Uruguay TB 2 
Uzbekistan HIV 4 
Uzbekistan Malaria 1 
Uzbekistan TB 6 
St Vincent & Grenadines HIV 1 
St Vincent & Grenadines Malaria 1 
St Vincent & Grenadines TB 1 
Venezuela HIV 1 
Venezuela Malaria 2 
Venezuela TB 2 
Viet Nam HIV 4 
Viet Nam Malaria 6 
Viet Nam TB 6 
Vanuatu HIV 1 
Vanuatu Malaria 4 
Vanuatu TB 4 
Lutheran World Federation HIV   
Lutheran World Federation Malaria   
Lutheran World Federation TB   
Samoa HIV 1 
Samoa Malaria 1 
Samoa TB 1 
Yemen HIV 1 
Yemen Malaria 4 
Yemen TB 2 
Zambia HIV 8 
Zambia Malaria 6 
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Zambia TB 8 
Zanzibar HIV 6 
Zanzibar Malaria 8 
Zanzibar TB 6 
Democratic Republic of the 
Congo 
HIV 4 
Democratic Republic of the 
Congo 
Malaria 8 
Democratic Republic of the 
Congo 
TB 6 
Zimbabwe HIV 8 
Zimbabwe Malaria 6 
Zimbabwe TB 8 
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APPENDIX 6:  COUNTRY SCORE FOR DEVELOPMENT ASSISTANCE FOR HEALTH (DAH) 
 PER DISABILITY-ADJUSTED YEAR LIFE (DALY) 
 
 
Country 
DAH per DALY (in 
USD) 
Afghanistan 9.58 
Albania 36.46 
Algeria 0.50 
Angola 4.92 
Argentina 32.22 
Armenia 27.53 
Azerbaijan 6.44 
Bangladesh 4.48 
Belarus 3.08 
Belize 24.71 
Benin 14.26 
Bhutan 33.30 
Bolivia 24.29 
Bosnia and 
Herzegovina 
25.50 
Botswana 95.07 
Brazil 3.29 
Bulgaria 17.98 
Burkina Faso  
Burundi 7.98 
Cambodia 20.08 
Cameroon 5.98 
Cape Verde 99.26 
Central African 
Republic 
6.11 
Chad 4.28 
Chile 3.71 
Colombia 18.30 
Comoros 11.17 
Congo-Brazzaville 7.15 
Costa Rica 11.25 
Cote d'Ivoire 5.63 
Cuba 6.36 
D.P.R. Korea 0.51 
D.R. Congo 4.66 
Djibouti 38.46 
Dominican Republic 20.64 
Ecuador 18.43 
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Egypt 5.67 
El Salvador 29.30 
Equatorial Guinea 12.07 
Eritrea 16.11 
Ethiopia 8.93 
Fiji 33.62 
Gabon 17.45 
Gambia 21.37 
Georgia 32.33 
Ghana 22.15 
Guatemala 14.60 
Guinea 5.31 
Guina-Bissau 11.57 
Guyana 112.26 
Haiti 27.83 
Honduras 34.50 
India 1.76 
Indonesia 3.57 
Iran 0.99 
Iraq 11.71 
Jamaica 24.84 
Jordan 23.23 
Kazakhstan 3.03 
Kenya 19.99 
Kosovo 12.96 
Kyrgyzstan 22.19 
Lao P.D.R. 18.23 
Lesotho 24.37 
Liberia 11.15 
Macedonia 1.26 
Madagascar 9.21 
Malawi 21.35 
Malaysia 0.22 
Maldives 11.74 
Mali 10.33 
Mauritania 8.46 
Mauritius 1.91 
Mexico 3.21 
Moldova 19.53 
Mongolia 18.45 
Montenegro 12.96 
Morocco 8.57 
Mozambique 25.21 
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Myanmar 2.26 
Namibia 107.06 
Nepal 8.90 
Nicaragua 64.95 
Niger 4.92 
Nigeria 5.29 
Pakistan 5.18 
Panama 12.74 
Papua New Guinea 32.19 
Paraguay 13.38 
P.R. of China 1.07 
Peru 16.76 
Phillipes 6.27 
Romania 4.54 
Russian Federation 1.69 
Rwanda 25.78 
Sao tome and Principe 71.44 
Senegal 19.15 
Serbia 12.96 
Sierra Leone 6.21 
Solomon Islands 128.29 
Somalia 3.04 
South Africa 13.21 
Sri Lanka 4.23 
Sudan 5.06 
Suriname 86.35 
Swaziland 32.23 
Syrian Arab Republic 4.15 
Tajikistan 14.35 
Thailand 3.90 
Timor-Leste 44.71 
Togo 7.30 
Tunisia 8.10 
Turkey 3.92 
Turkmenistan 1.23 
U.R. Tanzania 19.10 
Uganda 19.92 
Ukraine 3.93 
Uruguay 15.07 
Uzbekistan 5.64 
Viet Nam 12.04 
West Bank and Gaza 4.15 
Yemen 4.83 
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Zambia 33.43 
Zanzibar 19.10 
Zimbabwe 11.52 
    338 
 
APPENDIX 7: DATAON ROUND OF FUNDING, DISEASE COMPONENT,  
TYPE OF IMPLEMENTER AND NUMBER OF GRANTS MANAGED  
 
 
Country Round Component PR Type Grant Number 
Number of Grants 
managed by the 
PR 
Cambodia 1 HIV/AIDS Gov: MOH CAM-102-G01-H-00 5 
Cambodia 2 HIV/AIDS Gov: MOH CAM-202-G02-H-00 5 
Cambodia 2 Malaria Gov: MOH CAM-202-G03-M-
00 
5 
Cambodia 2 TB Gov: MOH CAM-202-G04-T-00 5 
Cambodia 4 HIV/AIDS Gov: MOH CAM-405-G05-H 5 
Cambodia 4 Malaria Gov: MOH CAM-405-G06-M 5 
Cambodia 5 HIV/AIDS Gov: MOH CAM-506-G07-H 5 
Cambodia 5 TB Gov: MOH CAM-506-G09-T 5 
Cambodia 6 Malaria Gov: MOH CAM-607-G10-M 5 
Cambodia 7 HIV/AIDS Gov: Oth CAM-708-G11-H 1 
Cambodia 7 TB Gov: Oth CAM-708-G12-T 1 
China 1 TB Gov: Oth CHN-102-G01-T-00 5 
China 1 Malaria Gov: Oth CHN-102-G02-M-
00 
5 
China 3 HIV/AIDS Gov: Oth CHN-304-G03-H 5 
China 4 HIV/AIDS Gov: Oth CHN-405-G05-H 5 
China 4 TB Gov: Oth CHN-405-G04-T 5 
China 5 TB Gov: Oth CHN-506-G08-T 5 
China 5 Malaria Gov: Oth CHN-506-G07-M 5 
China 5 HIV/AIDS Gov: Oth CHN-506-G06-H 5 
China 6 Malaria Gov: Oth CHN-607-G09-M 5 
China 6 HIV/AIDS Gov: Oth CHN-607-G10-H 5 
China 7 TB Gov: Oth CHN-708-G11-T 5 
China 8 TB Gov: Oth CHN-809-G12-T 5 
Indonesia 1 TB Gov: MOH IND-102-G01-T-00 5 
Indonesia 1 HIV/AIDS Gov: MOH IND-102-G03-H-00 5 
Indonesia 1 Malaria Gov: MOH IND-102-G02-M-00 5 
Indonesia 4 HIV/AIDS Gov: MOH IND-405-G04-H 5 
Indonesia 5 TB Gov: MOH IND-506-G05-T 5 
Indonesia 6 Malaria Gov: MOH IND-607-G06-M 5 
Indonesia 8 TB CS/PS: NGO IND-809-G10-T 1 
Indonesia 8 HIV/AIDS Gov: MOH IND-809-G08-H 2 
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Indonesia 8 HIV/AIDS CS/PS: NGO IND-809-G09-H 1 
Indonesia 8 TB Gov: MOH IND-809-G11-T 2 
Indonesia 8 Malaria Gov: MOH IND-809-G14-M 1 
Indonesia 8 Malaria CS/PS: NGO IND-809-G13-M 1 
Indonesia 8 TB CS/PS: NGO IND-809-G12-T 1 
Indonesia 8 HIV/AIDS Gov: Oth IND-809-G07-H 1 
Lao (Peoples 
Democratic 
Republic) 
1 HIV/AIDS Gov: MOH LAO-102-G01-H-00 5 
Lao (Peoples 
Democratic 
Republic) 
1 Malaria Gov: MOH LAO-102-G02-M-00 5 
Lao (Peoples 
Democratic 
Republic) 
2 TB Gov: MOH LAO-202-G03-T-00 5 
Lao (Peoples 
Democratic 
Republic) 
4 HIV/AIDS Gov: MOH LAO-405-G04-H 5 
Lao (Peoples 
Democratic 
Republic) 
4 Malaria Gov: MOH LAO-405-G05-M 5 
Lao (Peoples 
Democratic 
Republic) 
4 TB Gov: MOH LAO-405-G06-T 5 
Lao (Peoples 
Democratic 
Republic) 
6 Malaria Gov: MOH LAO-607-G07-M 5 
Lao (Peoples 
Democratic 
Republic) 
6 HIV/AIDS Gov: MOH LAO-607-G08-H 5 
Lao (Peoples 
Democratic 
Republic) 
7 TB Gov: MOH LAO-708-G10-T 5 
Lao (Peoples 
Democratic 
Republic) 
7 Malaria Gov: MOH LAO-708-G09-M 5 
Lao (Peoples 
Democratic 
Republic) 
8 HIV/AIDS Gov: MOH LAO-809-G11-H 5 
Mongolia 1 TB Gov: MOH MON-102-G01-T-
00 
3 
Mongolia 2 HIV/AIDS Gov: MOH MON-202-G02-H-
00 
3 
Mongolia 4 TB Gov: MOH MON-405-G03-T 3 
Mongolia 5 HIV/AIDS Gov: MOH MON-506-G04-H 3 
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Mongolia 7 HIV/AIDS Gov: MOH MON-708-G05-H 3 
Multicountry 
Western 
Pacific 
2 TB Gov: Oth MWP-202-G03-T-
00 
5 
Myanmar 2 TB MO: UNDP MYN-202-G01-T-00 3 
Myanmar 3 Malaria MO: UNDP MYN-305-G03-M 3 
Myanmar 3 HIV/AIDS MO: UNDP MYN-305-G02-H 3 
Papua New 
Guinea 
3 Malaria Gov: MOH PNG-304-G01-M 3 
Papua New 
Guinea 
4 HIV/AIDS Gov: MOH PNG-405-G02-H 3 
Papua New 
Guinea 
6 TB Gov: MOH PNG-607-G03-T 1 
Papua New 
Guinea 
8 Malaria CS/PS: NGO PNG-809-G05-M 1 
Papua New 
Guinea 
8 Malaria Gov: MOH PNG-809-G04-M 3 
Papua New 
Guinea 
8 Malaria CS/PS: PS PNG-809-G06-M 1 
Philippines 2 TB CS/PS: PS PHL-202-G02-T-e 5 
Philippines 2 TB CS/PS: PS PHL-202-G02-T-00 5 
Philippines 2 Malaria CS/PS: PS PHL-202-G09-M 5 
Philippines 2 Malaria CS/PS: PS PHL-202-G01-M-00 5 
Philippines 3 HIV/AIDS CS/PS: PS PHL-304-G03-H 5 
Philippines 5 HIV/AIDS CS/PS: PS PHL-506-G04-H 5 
Philippines 5 TB CS/PS: PS PHL-506-G06-T 5 
Philippines 5 HIV/AIDS Gov: MOH PHL-509-G10-H 2 
Philippines 5 Malaria CS/PS: PS PHL-506-G05-M 1 
Philippines 6 HIV/AIDS Gov: MOH PHL-607-G08-H 2 
Thailand 1 HIV/AIDS Gov: MOH THA-102-G01-H-00 5 
Thailand 1 TB Gov: MOH THA-102-G02-T-00 5 
Thailand 2 Malaria Gov: MOH THA-202-G05-M-00 5 
Thailand 2 HIV/AIDS CS/PS: NGO THA-202-G03-H-00 2 
Thailand 2 HIV/AIDS Gov: MOH THA-202-G04-H-00 5 
Thailand 3 HIV/AIDS CS/PS: NGO THA-304-G06-H 2 
Thailand 6 TB CS/PS: NGO THA-607-G08-T 2 
Thailand 6 TB Gov: MOH THA-607-G07-T 5 
Thailand 7 Malaria Gov: MOH THA-708-G09-M 5 
Thailand 8 TB Gov: MOH THA-809-G13-T 5 
Thailand 8 HIV/AIDS CS/PS: NGO THA-809-G12-H 2 
Thailand 8 HIV/AIDS Gov: MOH THA-809-G10-H 5 
Thailand 8 HIV/AIDS CS/PS: NGO THA-809-G11-H 2 
    341 
Timor-Leste 2 Malaria Gov: MOH TMP-202-G01-M-
00 
3 
Timor-Leste 3 TB Gov: MOH TMP-304-G02-T 3 
Timor-Leste 5 HIV/AIDS Gov: MOH TMP-506-G03-H 3 
Timor-Leste 7 Malaria Gov: MOH TMP-709-G05-M 3 
Timor-Leste 7 TB Gov: MOH TMP-708-G04-T 3 
Viet Nam 1 HIV/AIDS Gov: MOH VTN-102-G01-H-00 2 
Viet Nam 1 TB Gov: MOH VTN-102-G02-T-00 2 
Viet Nam 3 Malaria Gov: MOH VTN-304-G03-M 1 
Viet Nam 6 TB Gov: MOH VTN-607-G05-T 1 
Viet Nam 6 HIV/AIDS Gov: MOH VTN-607-G04-H 1 
Viet Nam 7 Malaria Gov: MOH VTN-708-G06-M 1 
Albania 5 TB Gov: MOH ALB-506-G02-T 2 
Albania 5 HIV/AIDS Gov: MOH ALB-506-G01-H 2 
Armenia 2 HIV/AIDS CS/PS: NGO ARM-202-G01-H-00 1 
Armenia 5 TB Gov: MOH ARM-506-G02-T 2 
Armenia 8 TB Gov: MOH ARM-809-G03-T 2 
Azerbaijan 4 HIV/AIDS Gov: MOH AZE-405-G01-H 4 
Azerbaijan 5 TB Gov: MOH AZE-506-G02-T 4 
Azerbaijan 7 Malaria Gov: MOH AZE-708-G04-M 4 
Azerbaijan 7 TB Gov: MOH AZE-708-G03-T 4 
Belarus 3 HIV/AIDS MO: UNDP BLR-304-G01-H 4 
Belarus 6 TB MO: UNDP BLR-607-G02-T 4 
Belarus 8 HIV/AIDS MO: UNDP BLR-809-G03-H 4 
Bosnia and 
Herzegovina 
5 HIV/AIDS MO: UNDP BIH-506-G01-H 4 
Bosnia and 
Herzegovina 
6 TB MO: UNDP BIH-607-G02-T 4 
Bulgaria 2 HIV/AIDS Gov: MOH BUL-202-G01-H-00 1 
Bulgaria 6 TB Gov: MOH BUL-607-G02-T 1 
Georgia 2 HIV/AIDS Gov: Oth GEO-202-G01-H-00 5 
Georgia 3 Malaria Gov: Oth GEO-304-G02-M 5 
Georgia 4 TB Gov: Oth GEO-405-G03-T 5 
Georgia 6 TB Gov: Oth GEO-607-G05-T 5 
Georgia 6 HIV/AIDS Gov: Oth GEO-607-G06-H 5 
Georgia 6 Malaria Gov: Oth GEO-607-G04-M 5 
Georgia S HIV/AIDS Gov: Oth GEO-S10-G07-H 5 
Kazakhstan 2 HIV/AIDS Gov: Oth KAZ-202-G01-H-00 1 
Kazakhstan 6 TB Gov: MOH KAZ-607-G02-T 2 
Kazakhstan 7 HIV/AIDS Gov: Oth KAZ-708-G03-H 1 
Kazakhstan 8 TB Gov: MOH KAZ-809-G04-T 2 
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Kosovo 4 TB Gov: MOH KOS-405-G01-T 2 
Kosovo 7 HIV/AIDS Gov: MOH KOS-708-G02-H 2 
Kyrgyzstan 2 TB Gov: MOH KGZ-202-G02-T-00 2 
Kyrgyzstan 2 HIV/AIDS Gov: Oth KGZ-202-G01-H-00 1 
Kyrgyzstan 5 Malaria Gov: Oth KGZ-506-G03-M 2 
Kyrgyzstan 6 TB Gov: MOH KGZ-607-G04-T 2 
Kyrgyzstan 7 HIV/AIDS Gov: MOH KGZ-708-G05-H 1 
Kyrgyzstan 8 Malaria Gov: Oth KGZ-809-G06-M 2 
Macedonia 
(Former 
Yugoslav 
Republic) 
3 HIV/AIDS Gov: MOH MKD-304-G01-H 2 
Macedonia 
(Former 
Yugoslav 
Republic) 
5 TB Gov: MOH MKD-506-G02-T 2 
Macedonia 
(Former 
Yugoslav 
Republic) 
7 HIV/AIDS Gov: MOH MKD-708-G03-H 2 
Moldova 6 TB Gov: MOH MOL-607-G02-T 3 
Moldova 6 HIV/AIDS Gov: MOH MOL-607-G03-H 3 
Moldova 8 HIV/AIDS CS/PS: NGO MOL-809-G06-H 1 
Moldova 8 TB Gov: MOH MOL-809-G04-T 3 
Montenegro 5 HIV/AIDS MO: UNDP MNT-506-G01-H 2 
Montenegro 6 TB MO: UNDP MNT-607-G02-T 2 
Romania 2 HIV/AIDS Gov: MOH ROM-202-G01-H-
00 
2 
Romania 2 TB Gov: MOH ROM-202-G02-T-00 2 
Romania 6 HIV/AIDS CS/PS: NGO ROM-607-G03-H 2 
Romania 6 TB CS/PS: NGO ROM-607-G04-T 2 
Russian 
Federation 
3 TB CS/PS: NGO RUS-304-G02-T 1 
Russian 
Federation 
3 HIV/AIDS CS/PS: NGO RUS-304-G01-H 1 
Russian 
Federation 
4 TB CS/PS: NGO RUS-405-G04-T 2 
Russian 
Federation 
4 HIV/AIDS CS/PS: NGO RUS-405-G03-H 2 
Russian 
Federation 
5 HIV/AIDS CS/PS: NGO RUS-506-G05-H 1 
Serbia 1 HIV/AIDS CS/PS: PS SER-102-G01-H-00 1 
Serbia 3 TB Gov: MOH SER-304-G02-T 2 
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Serbia 6 HIV/AIDS Gov: MOH SER-607-G03-H 2 
Serbia 8 HIV/AIDS Gov: MOH SER-809-G04-H 3 
Serbia 8 HIV/AIDS CS/PS: NGO SER-809-G05-H 3 
Tajikistan 1 HIV/AIDS MO: UNDP TAJ-102-G01-H-00 1 
Tajikistan 3 TB CS/PS: NGO TAJ-304-G02-T 1 
Tajikistan 4 HIV/AIDS MO: UNDP TAJ-404-G03-H 5 
Tajikistan 5 Malaria MO: UNDP TAJ-506-G04-M 5 
Tajikistan 6 TB MO: UNDP TAJ-607-G06-T 5 
Tajikistan 6 HIV/AIDS MO: UNDP TAJ-607-G05-H 5 
Tajikistan 8 TB MO: UNDP TAJ-809-G09-T 5 
Tajikistan 8 Malaria MO: UNDP TAJ-809-G08-M 5 
Tajikistan 8 HIV/AIDS MO: UNDP TAJ-809-G07-H 5 
Turkey 4 HIV/AIDS Gov: MOH TUR-405-G01-H 1 
Ukraine 1 HIV/AIDS CS/PS: NGO UKR-102-G04-H-00 2 
Ukraine 1 HIV/AIDS Gov: MOH UKR-102-G02-H-00 1 
Ukraine 1 HIV/AIDS MO: UNDP UKR-102-G03-H-00 1 
Ukraine 1 HIV/AIDS Gov: Oth UKR-102-G01-H-00 1 
Ukraine 1 HIV/AIDS CS/PS: NGO UKR-102-A04-H-00 2 
Ukraine 6 HIV/AIDS CS/PS: NGO UKR-607-G06-H 1 
Ukraine 6 HIV/AIDS CS/PS: NGO UKR-607-G05-H 1 
Uzbekistan 3 HIV/AIDS Gov: MOH UZB-304-G01-H 1 
Uzbekistan 4 Malaria Gov: Oth UZB-405-G02-M 1 
Uzbekistan 4 TB Gov: MOH UZB-405-G03-T 2 
Uzbekistan 8 TB Gov: MOH UZB-809-G05-T 2 
Uzbekistan 8 Malaria Gov: Oth UZB-809-G04-M 1 
Argentina 1 HIV/AIDS MO: UNDP ARG-102-G01-H-00 1 
Argentina 1 HIV/AIDS CS/PS: PS ARG-102-G02-H-00 1 
Belize 3 HIV/AIDS CS/PS: NGO BEL-304-G01-H 1 
Bolivia 
(Plurinational 
State) 
3 HIV/AIDS MO: UNDP BOL-306-G04-H 3 
Bolivia 
(Plurinational 
State) 
3 HIV/AIDS CS/PS: NGO BOL-304-G01-H 3 
Bolivia 
(Plurinational 
State) 
3 TB CS/PS: NGO BOL-304-G03-T 3 
Bolivia 
(Plurinational 
State) 
3 HIV/AIDS CS/PS: NGO BOL-307-G07-H 1 
Bolivia 
(Plurinational 
3 TB MO: UNDP BOL-306-G06-T 3 
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State) 
Bolivia 
(Plurinational 
State) 
3 Malaria CS/PS: NGO BOL-304-G02-M 3 
Bolivia 
(Plurinational 
State) 
3 Malaria MO: UNDP BOL-306-G05-M 3 
Bolivia 
(Plurinational 
State) 
8 Malaria MO: UNDP BOL-809-G08-M 1 
Brazil 5 TB CS/PS: Oth BRA-506-G02-T 1 
Brazil 5 TB CS/PS: Oth BRA-506-G01-T 1 
Brazil 8 Malaria CS/PS: NGO BRA-809-G04-M 1 
Brazil 8 Malaria CS/PS: NGO BRA-809-G03-M 1 
Chile 1 HIV/AIDS CS/PS: PS CHL-102-G01-H-00 1 
Colombia 2 HIV/AIDS MO: Oth COL-202-G01-H-00 1 
Costa Rica 2 HIV/AIDS Gov: Oth COR-202-G01-H-00 1 
Costa Rica 2 HIV/AIDS CS/PS: NGO COR-202-G02-H-00 1 
Cuba 2 HIV/AIDS MO: UNDP CUB-202-G01-H-00 1 
Cuba 6 HIV/AIDS MO: UNDP CUB-607-G02-H 2 
Cuba 7 TB MO: UNDP CUB-708-G03-T 2 
Dominican 
Republic 
2 HIV/AIDS Gov: Oth DMR-202-G01-H-
00 
1 
Dominican 
Republic 
3 TB CS/PS: NGO DMR-304-G02-T 1 
Dominican 
Republic 
7 TB CS/PS: NGO DMR-708-G03-T 1 
Dominican 
Republic 
7 TB Gov: MOH DMR-708-G08-T 1 
Dominican 
Republic 
8 Malaria Gov: MOH DMR-809-G06-M 1 
Dominican 
Republic 
8 Malaria CS/PS: NGO DMR-809-G05-M 1 
Ecuador 2 HIV/AIDS Gov: MOH ECU-202-G01-H-00 3 
Ecuador 2 HIV/AIDS CS/PS: NGO ECU-202-G03-H-00 2 
Ecuador 4 TB CS/PS: NGO ECU-405-G02-T 2 
El Salvador 2 HIV/AIDS Gov: MOH SLV-202-G03-H-00 3 
El Salvador 2 HIV/AIDS MO: UNDP SLV-202-G01-H-00 2 
El Salvador 2 TB MO: UNDP SLV-202-G02-T-00 2 
El Salvador 2 TB Gov: MOH SLV-202-G04-T-00 3 
El Salvador 7 HIV/AIDS Gov: MOH SLV-708-G05-H 1 
El Salvador 7 HIV/AIDS MO: UNDP SLV-708-G06-H 1 
Guatemala 3 HIV/AIDS CS/PS: NGO GUA-304-G01-H 3 
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Guatemala 4 Malaria CS/PS: NGO GUA-405-G02-M 3 
Guatemala 6 TB CS/PS: NGO GUA-607-G03-T 3 
Guyana 3 Malaria Gov: MOH GYA-304-G02-M 4 
Guyana 3 HIV/AIDS Gov: MOH GYA-304-G01-H 4 
Guyana 4 TB Gov: MOH GYA-405-G03-T 4 
Guyana 7 Malaria Gov: MOH GYA-708-G04-M 4 
Haiti 1 HIV/AIDS CS/PS: PS HTI-102-G01-H-00 1 
Haiti 1 HIV/AIDS MO: UNDP HTI-102-G02-H-00 4 
Haiti 3 Malaria CS/PS: PS HTI-304-G03-M 3 
Haiti 3 TB CS/PS: PS HTI-304-G04-T 3 
Haiti 5 HIV/AIDS CS/PS: PS HTI-506-G05-H 3 
Haiti 7 HIV/AIDS CS/PS: PS HTI-708-G06-H 1 
Honduras 1 Malaria MO: UNDP HND-102-G03-M-
00 
4 
Honduras 1 Malaria CS/PS: Oth HND-102-G05-M-
00 
1 
Honduras 1 TB MO: UNDP HND-102-G02-T-00 4 
Honduras 1 HIV/AIDS MO: UNDP HND-102-G01-H-00 4 
Jamaica 3 HIV/AIDS Gov: MOH JAM-304-G01-H 1 
Jamaica 7 HIV/AIDS Gov: MOH JAM-708-G02-H 1 
Nicaragua 2 HIV/AIDS CS/PS: NGO NIC-202-G03-H-00 3 
Nicaragua 2 Malaria CS/PS: NGO NIC-202-G01-M-00 3 
Nicaragua 2 TB CS/PS: NGO NIC-202-G02-T-00 3 
Nicaragua 7 Malaria CS/PS: NGO NIC-708-G04-M 1 
Nicaragua 8 HIV/AIDS CS/PS: NGO NIC-809-G06-H 1 
Panama 1 TB MO: UNDP PAN-102-G01-T-00 1 
Paraguay 3 TB CS/PS: NGO PRY-304-G01-T 1 
Paraguay 6 HIV/AIDS CS/PS: NGO PRY-607-G02-H 1 
Paraguay 7 TB CS/PS: NGO PRY-708-G03-T 1 
Paraguay 8 HIV/AIDS CS/PS: NGO PRY-809-G04-H 1 
Peru 2 HIV/AIDS CS/PS: NGO PER-202-G01-H-00 5 
Peru 2 TB CS/PS: NGO PER-202-G02-T-00 5 
Peru 5 TB CS/PS: NGO PER-506-G04-T 5 
Peru 5 HIV/AIDS CS/PS: NGO PER-506-G03-H 5 
Peru 6 HIV/AIDS CS/PS: NGO PER-607-G05-H 5 
Suriname 3 HIV/AIDS Gov: MOH SUR-305-G01-H 2 
Suriname 4 Malaria CS/PS: NGO SUR-404-G02-M 1 
Suriname 5 HIV/AIDS Gov: MOH SUR-506-G03-H 2 
Suriname 7 Malaria Gov: MOH SUR-708-G04-M 1 
Algeria 3 HIV/AIDS Gov: MOH DZA-304-G01-H 1 
Chad 2 TB Gov: Oth TCD-202-G01-T-00 2 
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Chad 3 HIV/AIDS Gov: Oth TCD-304-G02-H 2 
Chad 7 Malaria MO: UNDP TCD-708-G03-M 1 
Chad 8 HIV/AIDS CS/PS: NGO TCD-810-G06-H 1 
Chad 8 HIV/AIDS CS/PS: NGO TCD-810-G04-H 2 
Chad 8 HIV/AIDS Gov: Oth TCD-810-G05-H 1 
Djibouti 4 HIV/AIDS Gov: MOH DJB-404-G01-H 4 
Djibouti 6 TB Gov: MOH DJB-607-G03-T 4 
Djibouti 6 Malaria Gov: MOH DJB-607-G02-M 4 
Djibouti 6 HIV/AIDS Gov: MOH DJB-607-G04-H 4 
Egypt 2 TB Gov: MOH EGY-202-G01-T-00 1 
Egypt 6 HIV/AIDS Gov: MOH EGY-608-G03-H 1 
Egypt 6 TB Gov: MOH EGY-607-G02-T 1 
Iraq 6 TB MO: UNDP IRQ-607-G01-T 1 
Jordan 2 HIV/AIDS Gov: MOH JOR-202-G01-H-00 1 
Jordan 5 TB Gov: MOH JOR-506-G02-T 1 
Jordan 6 HIV/AIDS Gov: MOH JOR-607-G03-H 1 
Mali 1 Malaria Gov: MOH MAL-102-G01-M-
00 
3 
Mali 4 TB Gov: MOH MAL-405-G03-T 3 
Mali 4 HIV/AIDS Gov: Oth MAL-405-G02-H 1 
Mali 6 Malaria CS/PS: NGO MAL-607-G05-M 2 
Mali 6 Malaria Gov: MOH MAL-607-G04-M 3 
Mali 7 TB Gov: MOH MAL-708-G06-T 3 
Mali 8 HIV/AIDS Gov: Oth MAL-809-G08-H 1 
Mali 8 HIV/AIDS CS/PS: NGO MAL-809-G07-H 2 
Mauritania 2 Malaria MO: UNDP MRT-202-G02-M-
00 
4 
Mauritania 2 TB MO: UNDP MRT-202-G01-T-00 4 
Mauritania 5 HIV/AIDS Gov: Oth MRT-506-G03-H 1 
Mauritania 6 TB MO: UNDP MRT-607-G05-T 4 
Mauritania 6 Malaria MO: UNDP MRT-607-G04-M 4 
Morocco 1 HIV/AIDS Gov: MOH MOR-102-G01-H-
00 
1 
Morocco 6 TB Gov: MOH MOR-607-G03-T 2 
Morocco 6 HIV/AIDS Gov: MOH MOR-607-G02-H 2 
Niger 3 Malaria MO: UNDP NGR-306-G06-M 3 
Niger 3 Malaria CS/PS: NGO NGR-304-G02-M 1 
Niger 3 HIV/AIDS Gov: Oth NGR-304-G01-H 1 
Niger 4 Malaria MO: Oth NGR-405-G03-M 1 
Niger 5 TB MO: UNDP NGR-506-G05-T 3 
Niger 5 Malaria MO: UNDP NGR-506-G04-M 3 
    347 
Niger 7 HIV/AIDS Gov: Oth NGR-708-G08-H 1 
Niger 7 Malaria CS/PS: FBO NGR-708-G07-M 1 
Somalia 2 Malaria MO: Oth SOM-202-G01-M-
00 
3 
Somalia 3 TB CS/PS: NGO SOM-304-G02-T 1 
Somalia 4 HIV/AIDS MO: Oth SOM-405-G03-H 3 
Somalia 6 Malaria MO: Oth SOM-607-G04-M 3 
Somalia 7 TB CS/PS: NGO SOM-708-G05-T 1 
Somalia 8 HIV/AIDS MO: Oth SOM-809-G06-H 2 
South Sudan 2 TB MO: UNDP SSD-202-G02-T-00 3 
South Sudan 2 Malaria MO: UNDP SSD-202-G01-M-00 3 
South Sudan 4 HIV/AIDS MO: UNDP SSD-405-G05-H 3 
South Sudan 5 TB MO: UNDP SSD-506-G06-T 3 
South Sudan 7 TB MO: UNDP SSD-708-G11-T 3 
South Sudan 7 Malaria CS/PS: NGO SSD-708-G09-M 1 
Sudan 2 Malaria MO: UNDP SUD-202-G03-M-00 4 
Sudan 3 HIV/AIDS MO: UNDP SUD-305-G04-H 4 
Sudan 5 HIV/AIDS MO: UNDP SUD-506-G08-H 4 
Sudan 5 TB MO: UNDP SUD-506-G07-T 4 
Sudan 7 Malaria MO: UNDP SUD-708-G10-M 4 
Sudan 8 TB MO: UNDP SUD-809-G12-T 4 
Syrian Arab 
Republic 
6 TB MO: UNDP SYR-607-G01-T 1 
Tunisia 6 HIV/AIDS Gov: MOH TUN-607-G01-H 1 
West Bank 
and Gaza 
7 HIV/AIDS MO: UNDP PSE-708-G01-H 2 
West Bank 
and Gaza 
8 TB MO: UNDP PSE-809-G02-T 2 
Yemen 2 Malaria Gov: MOH YEM-202-G01-M-
00 
1 
Yemen 3 HIV/AIDS Gov: MOH YEM-305-G03-H 1 
Yemen 3 HIV/AIDS Gov: MOH YEM-305-G02-H 1 
Yemen 3 HIV/AIDS MO: UNDP YEM-307-G05-H 1 
Yemen 4 TB Gov: MOH YEM-405-G04-T 1 
Yemen 7 Malaria Gov: MOH YEM-708-G06-M 1 
Afghanistan 4 TB Gov: MOH AFG-405-G02-T 2 
Afghanistan 5 Malaria CS/PS: NGO AFG-509-G06-M 1 
Afghanistan 5 Malaria Gov: MOH AFG-506-G03-M 2 
Afghanistan 7 HIV/AIDS Gov: Oth AFG-708-G05-H 1 
Afghanistan 7 HIV/AIDS Gov: MOH AFG-708-G04-H 2 
Afghanistan 8 TB CS/PS: NGO AFG-809-G07-T 1 
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Bangladesh 2 HIV/AIDS CS/PS: NGO BAN-202-G12-H-00 1 
Bangladesh 2 HIV/AIDS Gov: MOF BAN-202-G01-H-00 3 
Bangladesh 3 TB CS/PS: NGO BAN-304-G02-T 2 
Bangladesh 3 TB Gov: MOF BAN-304-G03-T 3 
Bangladesh 5 TB CS/PS: NGO BAN-506-G04-T 2 
Bangladesh 5 TB Gov: MOF BAN-506-G05-T 3 
Bangladesh 6 HIV/AIDS Gov: MOF BAN-607-G08-H 2 
Bangladesh 6 Malaria CS/PS: NGO BAN-607-G06-M 2 
Bangladesh 6 Malaria Gov: MOF BAN-607-G07-M 2 
Bangladesh 8 TB CS/PS: NGO BAN-809-G10-T 3 
Bhutan 4 TB Gov: Oth BTN-405-G02-T 5 
Bhutan 4 Malaria Gov: Oth BTN-405-G01-M 5 
Bhutan 6 TB Gov: Oth BTN-607-G04-T 5 
Bhutan 6 HIV/AIDS Gov: Oth BTN-607-G03-H 5 
Bhutan 7 Malaria Gov: Oth BTN-708-G05-M 5 
India 1 TB Gov: Oth IDA-102-G01-T-00 5 
India 2 HIV/AIDS Gov: Oth IDA-202-G02-H-00 5 
India 2 TB Gov: Oth IDA-202-G03-T-00 5 
India 4 HIV/AIDS Gov: Oth IDA-405-G06-H 5 
India 4 TB Gov: Oth IDA-405-G08-T 5 
India 4 HIV/AIDS CS/PS: NGO IDA-405-G05-H 5 
India 4 Malaria Gov: MOF IDA-405-G07-M 5 
India 6 TB Gov: Oth IDA-607-G09-T 5 
India 6 HIV/AIDS CS/PS: NGO IDA-607-G10-H 1 
India 6 HIV/AIDS CS/PS: NGO IDA-607-G12-H 1 
India 6 HIV/AIDS Gov: Oth IDA-607-G11-H 5 
India 7 HIV/AIDS Gov: Oth IDA-708-G13-H 5 
India 7 HIV/AIDS Gov: MOH IDA-708-G14-H 1 
India 7 HIV/AIDS CS/PS: Oth IDA-708-G15-H 1 
Iran (Islamic 
Republic) 
2 HIV/AIDS MO: UNDP IRN-202-G01-H-00 1 
Iran (Islamic 
Republic) 
7 TB MO: UNDP IRN-708-G03-T 2 
Iran (Islamic 
Republic) 
7 Malaria MO: UNDP IRN-708-G02-M 2 
Maldives 6 HIV/AIDS MO: UNDP MDV-607-G01-H 1 
Nepal 2 Malaria CS/PS: NGO NEP-202-G04-M-00 1 
Nepal 2 Malaria Gov: MOH NEP-202-G02-M-00 3 
Nepal 2 HIV/AIDS MO: UNDP NEP-202-G05-H-00 1 
Nepal 2 HIV/AIDS Gov: MOH NEP-202-G01-H-00 3 
Nepal 4 TB Gov: MOH NEP-405-G03-T 3 
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Nepal 7 HIV/AIDS CS/PS: NGO NEP-708-G11-H 1 
Nepal 7 Malaria Gov: MOH NEP-708-G07-M 3 
Nepal 7 Malaria CS/PS: NGO NEP-708-G06-M 1 
Nepal 7 HIV/AIDS CS/PS: NGO NEP-708-G10-H 1 
Nepal 7 HIV/AIDS MO: UNDP NEP-708-G09-H 1 
Nepal 7 TB Gov: MOH NEP-708-G08-T 3 
Pakistan 2 TB Gov: MOH PKS-202-G03-T-00 5 
Pakistan 2 Malaria Gov: MOH PKS-202-G02-M-00 5 
Pakistan 2 HIV/AIDS Gov: MOH PKS-202-G01-H-00 5 
Pakistan 3 TB Gov: MOH PKS-304-G05-T 5 
Pakistan 3 Malaria Gov: MOH PKS-304-G04-M 5 
Pakistan 6 TB CS/PS: NGO PKS-607-G06-T 1 
Pakistan 6 TB Gov: MOH PKS-607-G07-T 2 
Pakistan 7 Malaria Gov: MOH PKS-708-G08-M 1 
Pakistan 8 TB Gov: MOH PKS-809-G09-T 2 
Pakistan 8 TB CS/PS: PS PKS-809-G10-T 1 
Sri Lanka 1 TB CS/PS: NGO SRL-102-G04-T-00 3 
Sri Lanka 1 TB Gov: MOH SRL-102-G03-T-00 3 
Sri Lanka 1 Malaria CS/PS: NGO SRL-102-G02-M-00 3 
Sri Lanka 1 Malaria Gov: MOH SRL-102-G01-M-00 3 
Sri Lanka 4 Malaria CS/PS: NGO SRL-405-G06-M 3 
Sri Lanka 4 Malaria Gov: MOH SRL-405-G05-M 3 
Sri Lanka 6 HIV/AIDS Gov: MOH SRL-607-G09-H 3 
Sri Lanka 6 TB Gov: MOH SRL-607-G07-T 3 
Sri Lanka 6 TB CS/PS: NGO SRL-607-G08-T 3 
Sri Lanka 8 Malaria CS/PS: NGO SRL-809-G12-M 3 
Sri Lanka 8 Malaria CS/PS: NGO SRL-809-G11-M 1 
Sri Lanka 8 Malaria Gov: MOH SRL-809-G10-M 3 
Burundi 1 HIV/AIDS Gov: Oth BRN-102-G01-H-00 2 
Burundi 2 Malaria Gov: MOH BRN-202-G02-M-00 2 
Burundi 2 Malaria Gov: MOH BRN-202-G05-M-00 2 
Burundi 4 TB Gov: MOH BRN-405-G03-T 2 
Burundi 5 HIV/AIDS Gov: Oth BRN-506-G04-H 2 
Burundi 7 TB Gov: MOH BRN-708-G06-T 2 
Burundi 8 HIV/AIDS CS/PS: NGO BRN-809-G08-H 1 
Burundi 8 HIV/AIDS Gov: Oth BRN-809-G07-H 2 
Comoros 2 Malaria CS/PS: NGO COM-202-G01-M-
00 
2 
Comoros 3 HIV/AIDS CS/PS: NGO COM-304-G02-H 2 
Congo 
(Democratic 
2 TB MO: UNDP ZAR-202-G01-T-00 5 
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Republic) 
Congo 
(Democratic 
Republic) 
3 Malaria MO: UNDP ZAR-304-G03-M 5 
Congo 
(Democratic 
Republic) 
3 HIV/AIDS MO: UNDP ZAR-304-G02-H 5 
Congo 
(Democratic 
Republic) 
5 TB MO: UNDP ZAR-506-G04-T 5 
Congo 
(Democratic 
Republic) 
6 TB MO: UNDP ZAR-607-G05-T 5 
Congo 
(Democratic 
Republic) 
7 HIV/AIDS MO: UNDP ZAR-708-G06-H 5 
Congo 
(Democratic 
Republic) 
8 HIV/AIDS MO: UNDP ZAR-809-G10-H 5 
Congo 
(Democratic 
Republic) 
8 Malaria CS/PS: NGO ZAR-809-G07-M 1 
Congo 
(Democratic 
Republic) 
8 Malaria CS/PS: NGO ZAR-810-G08-M 1 
Eritrea 2 Malaria Gov: MOH ERT-202-G01-M-00 5 
Eritrea 3 HIV/AIDS Gov: MOH ERT-304-G02-H 5 
Eritrea 5 HIV/AIDS Gov: MOH ERT-506-G03-H 5 
Eritrea 6 TB Gov: MOH ERT-607-G04-T 5 
Eritrea 6 Malaria Gov: MOH ERT-607-G05-M 5 
Eritrea 8 HIV/AIDS Gov: MOH ERT-809-G06-H 4 
Ethiopia 1 TB Gov: MOH ETH-102-G01-T-00 4 
Ethiopia 2 HIV/AIDS Gov: Oth ETH-202-G03-H-00 2 
Ethiopia 2 Malaria Gov: MOH ETH-202-G02-M-00 4 
Ethiopia 4 HIV/AIDS Gov: Oth ETH-405-G04-H 2 
Ethiopia 5 Malaria Gov: MOH ETH-506-G05-M 4 
Ethiopia 6 TB Gov: MOH ETH-607-G06-T 4 
Ethiopia 7 HIV/AIDS CS/PS: FBO ETH-708-G09-H 1 
Ethiopia 7 HIV/AIDS CS/PS: NGO ETH-708-G07-H 1 
Ethiopia 7 HIV/AIDS Gov: Oth ETH-708-G08-H 1 
Ethiopia 8 Malaria Gov: MOH ETH-809-G10-M 2 
Kenya 1 HIV/AIDS CS/PS: NGO KEN-102-G02-H-00 1 
Kenya 1 HIV/AIDS CS/PS: NGO KEN-102-G01-H-00 1 
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Kenya 2 Malaria Gov: MOF KEN-202-G05-M-00 5 
Kenya 2 HIV/AIDS Gov: MOF KEN-202-G03-H-00 5 
Kenya 2 TB Gov: MOF KEN-202-G04-T-00 5 
Kenya 4 Malaria Gov: MOF KEN-405-G06-M 5 
Kenya 5 TB Gov: MOF KEN-506-G07-T 5 
Kenya 6 TB Gov: MOF KEN-607-G08-T 5 
Kenya 7 HIV/AIDS CS/PS: NGO KEN-708-G10-H 1 
Kenya 7 HIV/AIDS Gov: MOF KEN-708-G09-H 4 
Madagascar 1 Malaria CS/PS: NGO MDG-102-G01-M-
00 
2 
Madagascar 2 HIV/AIDS CS/PS: NGO MDG-202-G02-H-
00 
1 
Madagascar 2 HIV/AIDS CS/PS: NGO MDG-202-G03-H-
00 
2 
Madagascar 3 HIV/AIDS Gov: Oth MDG-304-G04-H 2 
Madagascar 3 Malaria Gov: MOH MDG-304-G05-M 2 
Madagascar 4 Malaria Gov: MOH MDG-405-G06-M 2 
Madagascar 4 Malaria CS/PS: NGO MDG-405-G07-M 3 
Madagascar 4 TB Gov: Oth MDG-404-G08-T 2 
Madagascar 7 Malaria CS/PS: NGO MDG-708-G10-M 3 
Madagascar 7 Malaria Gov: MOH MDG-708-G09-M 3 
Madagascar 8 HIV/AIDS Gov: Oth MDG-809-G11-H 3 
Madagascar 8 HIV/AIDS CS/PS: NGO MDG-809-G12-H 3 
Mauritius 8 HIV/AIDS CS/PS: NGO MUS-809-G02-H 1 
Mauritius 8 HIV/AIDS Gov: MOH MUS-809-G01-H 1 
Rwanda 3 Malaria Gov: MOH RWN-304-G03-M 4 
Rwanda 3 HIV/AIDS Gov: MOH RWN-304-G02-H 4 
Rwanda 4 TB Gov: MOH RWN-404-G04-T 4 
Rwanda 5 Malaria Gov: MOH RWN-506-G06-M 4 
Rwanda 6 TB Gov: MOH RWN-606-G07-T 5 
Rwanda 6 HIV/AIDS Gov: MOH RWN-607-G08-H 5 
Rwanda 7 HIV/AIDS Gov: MOH RWN-708-G09-H 5 
Rwanda 8 Malaria Gov: MOH RWN-809-G10-M 5 
Tanzania 
(United 
Republic) 
1 Malaria Gov: MOH TNZ-102-G01-M-00 5 
Tanzania 
(United 
Republic) 
1 HIV/AIDS Gov: MOF TNZ-102-G02-H-00 5 
Tanzania 
(United 
Republic) 
4 HIV/AIDS CS/PS: NGO TNZ-405-G05-H 1 
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Tanzania 
(United 
Republic) 
4 Malaria Gov: MOF TNZ-405-G08-M 5 
Tanzania 
(United 
Republic) 
4 HIV/AIDS Gov: MOF TNZ-405-G04-H 5 
Tanzania 
(United 
Republic) 
4 HIV/AIDS CS/PS: NGO TNZ-405-G06-H 1 
Tanzania 
(United 
Republic) 
4 HIV/AIDS CS/PS: NGO TNZ-405-G07-H 1 
Tanzania 
(United 
Republic) 
6 TB Gov: MOF TNZ-607-G09-T 5 
Tanzania 
(United 
Republic) 
7 Malaria Gov: MOF TNZ-708-G10-M 5 
Tanzania 
(United 
Republic) 
8 Malaria Gov: MOF TNZ-809-G11-M 5 
Tanzania 
(United 
Republic) 
8 HIV/AIDS CS/PS: NGO TNZ-809-G12-H 1 
Uganda 1 HIV/AIDS Gov: MOF UGD-102-G01-H-00 4 
Uganda 2 Malaria Gov: MOF UGD-202-G02-M-
00 
4 
Uganda 2 TB Gov: MOF UGD-202-G03-T-00 4 
Uganda 3 HIV/AIDS Gov: MOF UGD-304-G04-H 4 
Uganda 4 Malaria Gov: MOF UGD-405-G05-M 4 
Uganda 6 TB Gov: MOF UGD-607-G06-T 4 
Uganda 7 HIV/AIDS Gov: MOF UGD-708-G07-H 4 
Uganda 7 Malaria Gov: MOF UGD-708-G08-M 4 
Zanzibar 1 Malaria Gov: MOH ZAN-102-G01-M-00 4 
Zanzibar 2 HIV/AIDS Gov: Oth ZAN-202-G02-H-00 2 
Zanzibar 3 TB Gov: MOH ZAN-304-G03-T 4 
Zanzibar 4 Malaria Gov: MOH ZAN-404-G04-M 4 
Zanzibar 6 HIV/AIDS Gov: MOH ZAN-607-G05-H 4 
Zanzibar 6 HIV/AIDS Gov: Oth ZAN-607-G06-H 2 
Angola 3 Malaria MO: UNDP AGO-305-G01-M 3 
Angola 4 TB MO: UNDP AGO-405-G02-T 3 
Angola 4 HIV/AIDS MO: UNDP AGO-405-G03-H 3 
Angola 7 Malaria Gov: MOH AGO-708-G04-M 1 
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Botswana 2 HIV/AIDS Gov: MOH BOT-202-G01-H-00 2 
Botswana 5 TB Gov: MOH BOT-506-G02-T 2 
Lesotho 2 TB Gov: MOF LSO-202-G02-T-00 3 
Lesotho 2 HIV/AIDS Gov: MOF LSO-202-G01-H-00 3 
Lesotho 5 HIV/AIDS Gov: MOF LSO-506-G03-H 3 
Lesotho 6 TB Gov: MOF LSO-607-G04-T 4 
Lesotho 7 HIV/AIDS Gov: MOF LSO-708-G05-H 4 
Lesotho 8 HIV/AIDS Gov: MOF LSO-809-G06-H 4 
Malawi 1 HIV/AIDS Gov: Oth MLW-102-G01-H-
00 
1 
Malawi 2 Malaria Gov: MOH MLW-202-G02-M-
00 
1 
Malawi 5 HIV/AIDS Gov: Oth MLW-506-G03-H 2 
Malawi 7 TB Gov: MOH MLW-708-G06-T 2 
Malawi 7 HIV/AIDS Gov: Oth MLW-708-G07-H 2 
Malawi 7 Malaria Gov: Oth MLW-708-G05-M 2 
Mozambique 2 TB Gov: MOH MOZ-202-G04-T-00 5 
Mozambique 2 Malaria Gov: MOH MOZ-202-G03-M-
00 
5 
Mozambique 2 HIV/AIDS Gov: MOH MOZ-202-G02-H-00 5 
Mozambique 2 HIV/AIDS Gov: Oth MOZ-202-G01-H-00 1 
Mozambique 6 Malaria Gov: MOH MOZ-607-G06-M 5 
Mozambique 6 HIV/AIDS Gov: MOH MOZ-607-G05-H 5 
Mozambique 7 TB Gov: MOH MOZ-708-G07-T 5 
Namibia 2 HIV/AIDS Gov: MOH NMB-202-G01-H-
00 
4 
Namibia 2 TB Gov: MOH NMB-202-G02-T-00 4 
Namibia 2 Malaria Gov: MOH NMB-202-G03-M-
00 
4 
Namibia 5 TB Gov: MOH NMB-506-G04-T 4 
Namibia 6 Malaria Gov: MOH NMB-607-G06-M 4 
South Africa 3 HIV/AIDS Gov: MOH SAF-304-G04-H 1 
South Africa 6 HIV/AIDS Gov: MOH SAF-607-G06-H 2 
Swaziland 2 Malaria Gov: Oth SWZ-202-G02-M-
00 
4 
Swaziland 2 HIV/AIDS Gov: Oth SWZ-202-G01-H-00 4 
Swaziland 3 TB Gov: Oth SWZ-304-G03-T 4 
Swaziland 4 HIV/AIDS Gov: Oth SWZ-405-G04-H 4 
Swaziland 7 HIV/AIDS Gov: Oth SWZ-708-G05-H 4 
Swaziland 8 HIV/AIDS Gov: Oth SWZ-809-G08-S 4 
Swaziland 8 TB Gov: Oth SWZ-809-G07-T 4 
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Swaziland 8 Malaria Gov: Oth SWZ-809-G06-M 4 
Zambia 1 HIV/AIDS Gov: MOF ZAM-102-G07-H-00 1 
Zambia 1 TB CS/PS: NGO ZAM-102-G15-T-00 3 
Zambia 1 TB CS/PS: FBO ZAM-102-G06-T-00 3 
Zambia 1 Malaria CS/PS: FBO ZAM-102-G05-M-
00 
3 
Zambia 1 HIV/AIDS CS/PS: NGO ZAM-102-G08-H-00 3 
Zambia 1 HIV/AIDS CS/PS: FBO ZAM-102-G04-H-00 3 
Zambia 1 HIV/AIDS Gov: MOH ZAM-102-G01-H-00 3 
Zambia 1 Malaria Gov: MOH ZAM-102-G02-M-
00 
3 
Zambia 1 TB Gov: MOH ZAM-102-G03-T-00 3 
Zambia 4 HIV/AIDS CS/PS: NGO ZAM-405-G11-H 3 
Zambia 4 HIV/AIDS CS/PS: FBO ZAM-405-G10-H 5 
Zambia 4 HIV/AIDS Gov: MOH ZAM-405-G09-H 4 
Zambia 4 HIV/AIDS Gov: MOF ZAM-405-G12-H 1 
Zambia 4 Malaria CS/PS: FBO ZAM-405-G14-M 5 
Zambia 4 Malaria Gov: MOH ZAM-405-G13-M 4 
Zambia 7 Malaria Gov: MOH ZAM-708-G17-M 4 
Zambia 7 TB CS/PS: NGO ZAM-708-G20-T 3 
Zambia 7 TB CS/PS: FBO ZAM-708-G18-T 5 
Zambia 7 TB Gov: MOH ZAM-708-G16-T 4 
Zambia 7 Malaria CS/PS: FBO ZAM-708-G19-M 5 
Zambia 8 HIV/AIDS CS/PS: NGO ZAM-809-G22-H 3 
Zambia 8 HIV/AIDS Gov: MOF ZAM-809-G23-H 2 
Zambia 8 HIV/AIDS CS/PS: FBO ZAM-809-G21-H 5 
Zimbabwe 1 HIV/AIDS MO: UNDP ZIM-102-G01-H-00 1 
Zimbabwe 1 HIV/AIDS Gov: Oth ZIM-102-G07-H 1 
Zimbabwe 1 Malaria Gov: MOH ZIM-102-G02-M-00 1 
Zimbabwe 5 TB MO: UNDP ZIM-509-G08-T 5 
Zimbabwe 5 HIV/AIDS CS/PS: FBO ZIM-506-G04-H 2 
Zimbabwe 5 Malaria Gov: MOH ZIM-506-G06-M 1 
Zimbabwe 5 HIV/AIDS MO: UNDP ZIM-509-G10-H 5 
Zimbabwe 5 TB CS/PS: FBO ZIM-506-G05-T 2 
Zimbabwe 5 HIV/AIDS Gov: Oth ZIM-506-G03-H 1 
Zimbabwe 5 Malaria MO: UNDP ZIM-509-G09-M 5 
Zimbabwe 8 TB MO: UNDP ZIM-809-G12-T 5 
Zimbabwe 8 Malaria MO: UNDP ZIM-809-G14-S 5 
Zimbabwe 8 HIV/AIDS MO: UNDP ZIM-809-G11-H 5 
Zimbabwe 8 Malaria MO: UNDP ZIM-809-G13-M 5 
Benin 1 Malaria MO: UNDP BEN-102-G01-M-00 3 
    355 
Benin 2 HIV/AIDS MO: UNDP BEN-202-G03-H-00 3 
Benin 2 TB MO: UNDP BEN-202-G02-T-00 3 
Benin 3 Malaria CS/PS: NGO BEN-304-G04-M 1 
Benin 5 HIV/AIDS Gov: MOH BEN-506-G05-H 2 
Benin 6 TB Gov: MOH BEN-607-G06-T 2 
Benin 7 Malaria CS/PS: FBO BEN-708-G07-M 1 
Burkina Faso 2 Malaria MO: UNDP BUR-202-G01-M-00 3 
Burkina Faso 2 HIV/AIDS MO: UNDP BUR-202-G02-H-00 3 
Burkina Faso 2 HIV/AIDS Gov: MOH BUR-202-G04-H-00 3 
Burkina Faso 4 TB Gov: MOH BUR-407-G05-T 3 
Burkina Faso 4 TB MO: UNDP BUR-404-G03-T 3 
Burkina Faso 6 HIV/AIDS Gov: Oth BUR-607-G06-H 3 
Burkina Faso 7 Malaria Gov: Oth BUR-708-G07-M 2 
Burkina Faso 8 Malaria Gov: Oth BUR-809-G08-M 1 
Burkina Faso 8 Malaria CS/PS: NGO BUR-809-G09-M 1 
Cameroon 3 TB Gov: MOH CMR-304-G03-T 5 
Cameroon 3 HIV/AIDS Gov: MOH CMR-304-G01-H 5 
Cameroon 3 HIV/AIDS Gov: MOH CMR-304-G01-H-e 5 
Cameroon 3 Malaria Gov: MOH CMR-304-G02-M 5 
Cameroon 4 HIV/AIDS CS/PS: NGO CMR-404-G04-H 1 
Cameroon 5 HIV/AIDS Gov: MOH CMR-506-G05-H 5 
Cameroon 5 Malaria Gov: MOH CMR-506-G06-M 5 
Central 
African 
Republic 
2 HIV/AIDS MO: UNDP CAF-202-G01-H-00 4 
Central 
African 
Republic 
4 TB MO: UNDP CAF-404-G03-T 4 
Central 
African 
Republic 
4 TB Gov: MOH CAF-409-G07-T 3 
Central 
African 
Republic 
4 HIV/AIDS Gov: MOH CAF-409-G06-H 3 
Central 
African 
Republic 
4 HIV/AIDS MO: UNDP CAF-404-G02-H 4 
Central 
African 
Republic 
4 Malaria MO: UNDP CAF-405-G04-M 4 
Central 
African 
Republic 
7 HIV/AIDS Gov: MOH CAF-708-G05-H 3 
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Congo 5 HIV/AIDS Gov: Oth COG-506-G01-H 1 
Côte d'Ivoire 2 HIV/AIDS CS/PS: NGO CIV-202-G05-H 3 
Côte d'Ivoire 2 HIV/AIDS MO: UNDP CIV-202-G01-H-00 2 
Côte d'Ivoire 3 HIV/AIDS CS/PS: NGO CIV-304-G02-H 3 
Côte d'Ivoire 3 TB MO: UNDP CIV-304-G03-T 2 
Côte d'Ivoire 5 HIV/AIDS CS/PS: NGO CIV-506-G04-H 3 
Côte d'Ivoire 6 Malaria CS/PS: NGO CIV-607-G06-M 4 
Côte d'Ivoire 6 TB Gov: MOH CIV-607-G07-T 1 
Côte d'Ivoire 8 Malaria Gov: MOH CIV-809-G09-M 1 
Côte d'Ivoire 8 Malaria CS/PS: NGO CIV-809-G08-M 3 
Equatorial 
Guinea 
4 HIV/AIDS MO: UNDP GNQ-405-G01-H 2 
Equatorial 
Guinea 
5 Malaria CS/PS: NGO GNQ-506-G02-M 2 
Gabon 3 HIV/AIDS MO: UNDP GAB-304-G01-H-e 4 
Gabon 3 HIV/AIDS MO: UNDP GAB-304-G01-H 4 
Gabon 4 Malaria MO: UNDP GAB-404-G02-M 4 
Gabon 5 Malaria MO: UNDP GAB-506-G03-M 4 
Gabon 5 Malaria Gov: MOH GAB-509-G04-M 2 
Gabon 8 HIV/AIDS Gov: MOH GAB-809-G05-H 2 
Gambia 3 Malaria Gov: MOH GMB-304-G02-M 2 
Gambia 3 HIV/AIDS Gov: Oth GMB-304-G01-H 2 
Gambia 5 TB Gov: MOH GMB-506-G03-T 1 
Gambia 6 Malaria Gov: MOH GMB-607-G04-M 2 
Gambia 8 HIV/AIDS Gov: Oth GMB-809-G05-H 2 
Gambia 8 HIV/AIDS CS/PS: NGO GMB-809-G06-H 1 
Ghana 1 TB Gov: MOH GHN-102-G02-T-00 4 
Ghana 1 HIV/AIDS Gov: MOH GHN-102-G01-H-00 4 
Ghana 2 Malaria Gov: MOH GHN-202-G03-M-
00 
4 
Ghana 4 Malaria Gov: MOH GHN-405-G04-M 4 
Ghana 5 TB Gov: MOH GHN-506-G05-T 4 
Ghana 5 HIV/AIDS Gov: MOH GHN-506-G06-H 4 
Ghana 8 HIV/AIDS Gov: MOH GHN-809-G11-H 4 
Ghana 8 HIV/AIDS CS/PS: NGO GHN-809-G10-H 1 
Ghana 8 Malaria Gov: MOH GHN-809-G07-M 4 
Ghana 8 HIV/AIDS CS/PS: NGO GHN-809-G09-H 1 
Ghana 8 HIV/AIDS CS/PS: NGO GHN-809-G12-H 1 
Ghana 8 Malaria CS/PS: NGO GHN-809-G08-M 1 
Guinea 2 HIV/AIDS Gov: MOH GIN-202-G01-H-00 5 
Guinea 2 Malaria Gov: MOH GIN-202-G02-M-00 5 
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Guinea 5 TB Gov: MOH GIN-506-G03-T 5 
Guinea 6 Malaria Gov: MOH GIN-607-G05-M 5 
Guinea 6 HIV/AIDS Gov: MOH GIN-607-G04-H 5 
Guinea-
Bissau 
3 TB Gov: MOH GNB-309-G06-T 3 
Guinea-
Bissau 
3 TB MO: UNDP GNB-304-G01-T 3 
Guinea-
Bissau 
4 Malaria MO: UNDP GNB-404-G03-M 3 
Guinea-
Bissau 
4 Malaria Gov: MOH GNB-409-G08-M 3 
Guinea-
Bissau 
4 HIV/AIDS MO: UNDP GNB-404-G02-H 3 
Guinea-
Bissau 
4 HIV/AIDS Gov: MOH GNB-409-G07-H 3 
Guinea-
Bissau 
6 Malaria Gov: MOH GNB-607-G04-M 3 
Guinea-
Bissau 
7 HIV/AIDS Gov: Oth GNB-708-G05-H 1 
Liberia 2 HIV/AIDS MO: UNDP LBR-202-G01-H-00 4 
Liberia 2 TB MO: UNDP LBR-202-G02-T-00 4 
Liberia 3 Malaria MO: UNDP LBR-304-G03-M 4 
Liberia 6 HIV/AIDS MO: UNDP LBR-607-G04-H 4 
Liberia 7 TB MO: UNDP LBR-708-G06-T 5 
Liberia 7 Malaria MO: UNDP LBR-708-G05-M 5 
Nigeria 1 HIV/AIDS Gov: Oth NGA-102-G01-H-00 2 
Nigeria 1 HIV/AIDS CS/PS: NGO NGA-102-G02-H-00 3 
Nigeria 1 HIV/AIDS Gov: Oth NGA-102-G03-H-00 2 
Nigeria 2 Malaria CS/PS: NGO NGA-202-G04-M-
00 
3 
Nigeria 4 Malaria CS/PS: NGO NGA-404-G05-M 3 
Nigeria 4 Malaria CS/PS: NGO NGA-407-G10-M 2 
Nigeria 5 TB CS/PS: NGO NGA-509-G15-T 2 
Nigeria 5 HIV/AIDS CS/PS: NGO NGA-506-G09-H 2 
Nigeria 5 HIV/AIDS CS/PS: NGO NGA-506-G08-H 3 
Nigeria 5 HIV/AIDS Gov: Oth NGA-506-G07-H 2 
Nigeria 5 TB CS/PS: FBO NGA-506-G06-T 1 
Nigeria 8 HIV/AIDS Gov: Oth NGA-809-G12-S 2 
Nigeria 8 Malaria CS/PS: NGO NGA-809-G11-M 3 
Nigeria 8 Malaria Gov: MOH NGA-809-G14-M 1 
Nigeria 8 Malaria CS/PS: NGO NGA-809-G13-M 3 
Sao Tome 4 Malaria MO: UNDP STP-405-G01-M 3 
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and Principe 
Sao Tome 
and Principe 
5 HIV/AIDS MO: UNDP STP-506-G02-H 3 
Sao Tome 
and Principe 
7 Malaria MO: UNDP STP-708-G03-M 3 
Sao Tome 
and Principe 
8 TB MO: UNDP STP-809-G04-T 3 
Senegal 1 HIV/AIDS CS/PS: NGO SNG-102-G04-H-00 1 
Senegal 1 Malaria Gov: MOH SNG-102-G02-M-00 2 
Senegal 1 HIV/AIDS Gov: Oth SNG-102-G01-H-00 1 
Senegal 4 Malaria Gov: MOH SNG-405-G03-M 2 
Senegal 6 HIV/AIDS Gov: Oth SNG-607-G05-H 1 
Senegal 6 HIV/AIDS CS/PS: NGO SNG-607-G06-H 1 
Senegal 7 TB Gov: MOH SNG-708-G08-T 2 
Senegal 7 Malaria Gov: MOH SNG-708-G07-M 2 
Sierra Leone 2 TB CS/PS: NGO SLE-202-G01-T-00 2 
Sierra Leone 4 Malaria CS/PS: NGO SLE-405-G03-M 2 
Sierra Leone 4 HIV/AIDS Gov: Oth SLE-405-G02-H 2 
Sierra Leone 6 HIV/AIDS Gov: Oth SLE-607-G04-H 2 
Sierra Leone 7 Malaria Gov: MOH SLE-708-G05-M 2 
Sierra Leone 7 TB Gov: MOH SLE-708-G06-T 2 
Togo 2 HIV/AIDS MO: UNDP TGO-202-G01-H-00 5 
Togo 3 TB MO: UNDP TGO-304-G03-T 5 
Togo 3 Malaria MO: UNDP TGO-304-G02-M 5 
Togo 4 Malaria MO: UNDP TGO-405-G05-M 5 
Togo 4 HIV/AIDS CS/PS: NGO TGO-405-G04-H 2 
Togo 6 Malaria MO: UNDP TGO-607-G06-M 5 
Togo 6 TB MO: UNDP TGO-607-G07-T 5 
Togo 8 HIV/AIDS Gov: MOH TGO-809-G08-H 1 
Togo 8 HIV/AIDS CS/PS: NGO TGO-809-G09-H 2 
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Grant Number Country 
Rou
nd 
Compon
ent 
PRType 
N
o.  
Governa
nce and 
Risk 
Burd
en 
Assista
nce to 
Health 
Absorpt
ive 
Capacit
y 
CAM-102-G01-
H-00 
Cambodia 1 HIV/AID
S 
Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-202-G02-
H-00 
Cambodia 2 HIV/AID
S 
Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-202-G03-
M-00 
Cambodia 2 Malaria Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-202-G04-
T-00 
Cambodia 2 TB Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-405-G05-
H 
Cambodia 4 HIV/AID
S 
Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-405-G06-
M 
Cambodia 4 Malaria Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-506-G07-
H 
Cambodia 5 HIV/AID
S 
Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-506-G09-
T 
Cambodia 5 TB Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-607-G10-
M 
Cambodia 6 Malaria Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-708-G11-
H 
Cambodia 7 HIV/AID
S 
Gov: Oth 1 85 26 20.08 100.00 
CAM-708-G12-
T 
Cambodia 7 TB Gov: Oth 1 85 26 20.08 100.00 
CHN-102-G01-
T-00 
China 1 TB Gov: Oth 5 32 20 1.67 100.00 
CHN-102-G02-
M-00 
China 1 Malaria Gov: Oth 5 32 20 1.67 100.00 
CHN-304-G03-
H 
China 3 HIV/AID
S 
Gov: Oth 5 32 20 1.67 100.00 
CHN-405-G05-
H 
China 4 HIV/AID
S 
Gov: Oth 5 32 20 1.67 100.00 
CHN-405-G04-T China 4 TB Gov: Oth 5 32 20 1.67 100.00 
CHN-506-G08-T China 5 TB Gov: Oth 5 32 20 1.67 100.00 
CHN-506-G07-
M 
China 5 Malaria Gov: Oth 5 32 20 1.67 100.00 
CHN-506-G06-
H 
China 5 HIV/AID
S 
Gov: Oth 5 32 20 1.67 100.00 
CHN-607-G09-
M 
China 6 Malaria Gov: Oth 5 32 20 1.67 100.00 
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CHN-607-G10-
H 
China 6 HIV/AID
S 
Gov: Oth 5 32 20 1.67 100.00 
CHN-708-G11-T China 7 TB Gov: Oth 5 32 20 1.67 100.00 
CHN-809-G12-T China 8 TB Gov: Oth 5 32 20 1.67 100.00 
IND-102-G01-T-
00 
Indonesia 1 TB Gov: 
MOH 
5 48 24 3.57 100.00 
IND-102-G03-
H-00 
Indonesia 1 HIV/AID
S 
Gov: 
MOH 
5 48 24 3.57 100.00 
IND-102-G02-
M-00 
Indonesia 1 Malaria Gov: 
MOH 
5 48 24 3.57 100.00 
IND-405-G04-H Indonesia 4 HIV/AID
S 
Gov: 
MOH 
5 48 24 3.57 100.00 
IND-506-G05-T Indonesia 5 TB Gov: 
MOH 
5 48 24 3.57 100.00 
IND-607-G06-
M 
Indonesia 6 Malaria Gov: 
MOH 
5 48 24 3.57 100.00 
IND-809-G10-T Indonesia 8 TB CS/PS: 
NGO 
1 48 24 3.57 100.00 
IND-809-G08-H Indonesia 8 HIV/AID
S 
Gov: 
MOH 
2 48 24 3.57 100.00 
IND-809-G09-H Indonesia 8 HIV/AID
S 
CS/PS: 
NGO 
1 48 24 3.57 100.00 
IND-809-G11-T Indonesia 8 TB Gov: 
MOH 
2 48 24 3.57 100.00 
IND-809-G14-
M 
Indonesia 8 Malaria Gov: 
MOH 
1 48 24 3.57 98.50 
IND-809-G12-T Indonesia 8 TB CS/PS: 
NGO 
1 48 24 3.57 100.00 
IND-809-G07-H Indonesia 8 HIV/AID
S 
Gov: Oth 1 48 24 3.57 100.00 
LAO-102-G01-
H-00 
Lao 
(Peoples 
Democrat
ic 
Republic) 
1 HIV/AID
S 
Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-102-G02-
M-00 
Lao 
(Peoples 
Democrat
ic 
Republic) 
1 Malaria Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-202-G03-
T-00 
Lao 
(Peoples 
Democrat
ic 
Republic) 
2 TB Gov: 
MOH 
5 60 18 18.23 100.00 
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LAO-405-G04-H Lao 
(Peoples 
Democrat
ic 
Republic) 
4 HIV/AID
S 
Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-405-G05-
M 
Lao 
(Peoples 
Democrat
ic 
Republic) 
4 Malaria Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-405-G06-T Lao 
(Peoples 
Democrat
ic 
Republic) 
4 TB Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-607-G07-
M 
Lao 
(Peoples 
Democrat
ic 
Republic) 
6 Malaria Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-607-G08-H Lao 
(Peoples 
Democrat
ic 
Republic) 
6 HIV/AID
S 
Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-708-G10-T Lao 
(Peoples 
Democrat
ic 
Republic) 
7 TB Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-708-G09-
M 
Lao 
(Peoples 
Democrat
ic 
Republic) 
7 Malaria Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-809-G11-H Lao 
(Peoples 
Democrat
ic 
Republic) 
8 HIV/AID
S 
Gov: 
MOH 
5 60 18 18.23 100.00 
MON-102-G01-
T-00 
Mongolia 1 TB Gov: 
MOH 
3 12 16 18.45 100.00 
MON-202-G02-
H-00 
Mongolia 2 HIV/AID
S 
Gov: 
MOH 
3 12 16 18.45 100.00 
MON-405-G03-
T 
Mongolia 4 TB Gov: 
MOH 
3 12 16 18.45 100.00 
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MON-506-G04-
H 
Mongolia 5 HIV/AID
S 
Gov: 
MOH 
3 12 16 18.45 100.00 
MON-708-G05-
H 
Mongolia 7 HIV/AID
S 
Gov: 
MOH 
3 12 16 18.45 100.00 
MYN-202-G01-
T-00 
Myanmar 2 TB MO: 
UNDP 
3 84 24 2.26 100.00 
MYN-305-G03-
M 
Myanmar 3 Malaria MO: 
UNDP 
3 84 24 2.26 100.00 
MYN-305-G02-
H 
Myanmar 3 HIV/AID
S 
MO: 
UNDP 
3 84 24 2.26 100.00 
PNG-304-G01-
M 
Papua 
New 
Guinea 
3 Malaria Gov: 
MOH 
3 96 22 32.19 100.00 
PNG-405-G02-
H 
Papua 
New 
Guinea 
4 HIV/AID
S 
Gov: 
MOH 
3 96 22 32.19 100.00 
PNG-607-G03-T Papua 
New 
Guinea 
6 TB Gov: 
MOH 
1 96 22 32.19 100.00 
PNG-809-G04-
M 
Papua 
New 
Guinea 
8 Malaria Gov: 
MOH 
3 96 22 32.19 100.00 
PHL-202-G02-T-
00 
Philippine
s 
2 TB CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-202-G09-
M 
Philippine
s 
2 Malaria CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-202-G01-
M-00 
Philippine
s 
2 Malaria CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-304-G03-H Philippine
s 
3 HIV/AID
S 
CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-506-G04-H Philippine
s 
5 HIV/AID
S 
CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-506-G06-T Philippine
s 
5 TB CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-506-G05-
M 
Philippine
s 
5 Malaria CS/PS: 
PS 
2 96 18 6.27 100.00 
PHL-607-G08-H Philippine
s 
6 HIV/AID
S 
Gov: 
MOH 
2 96 18 6.27 100.00 
THA-102-G01-
H-00 
Thailand 1 HIV/AID
S 
Gov: 
MOH 
5 30 26 3.90 100.00 
THA-102-G02-
T-00 
Thailand 1 TB Gov: 
MOH 
5 30 26 3.90 100.00 
THA-202-G05-
M-00 
Thailand 2 Malaria Gov: 
MOH 
5 30 26 3.90 100.00 
THA-202-G03-
H-00 
Thailand 2 HIV/AID
S 
CS/PS: 
NGO 
2 30 26 3.90 100.00 
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THA-304-G06-H Thailand 3 HIV/AID
S 
CS/PS: 
NGO 
2 30 26 3.90 100.00 
THA-607-G08-T Thailand 6 TB CS/PS: 
NGO 
2 30 26 3.90 100.00 
THA-607-G07-T Thailand 6 TB Gov: 
MOH 
5 30 26 3.90 100.00 
THA-708-G09-
M 
Thailand 7 Malaria Gov: 
MOH 
5 30 26 3.90 100.00 
THA-809-G13-T Thailand 8 TB Gov: 
MOH 
5 30 26 3.90 100.00 
THA-809-G12-H Thailand 8 HIV/AID
S 
CS/PS: 
NGO 
2 30 26 3.90 100.00 
THA-809-G10-H Thailand 8 HIV/AID
S 
Gov: 
MOH 
5 30 26 3.90 100.00 
THA-809-G11-H Thailand 8 HIV/AID
S 
CS/PS: 
NGO 
2 30 26 3.90 100.00 
TMP-202-G01-
M-00 
Timor-
Leste 
2 Malaria Gov: 
MOH 
3 18 20 44.71 100.00 
TMP-304-G02-T Timor-
Leste 
3 TB Gov: 
MOH 
3 18 20 44.71 100.00 
TMP-506-G03-
H 
Timor-
Leste 
5 HIV/AID
S 
Gov: 
MOH 
3 18 20 44.71 100.00 
TMP-709-G05-
M 
Timor-
Leste 
7 Malaria Gov: 
MOH 
3 18 20 44.71 100.00 
TMP-708-G04-T Timor-
Leste 
7 TB Gov: 
MOH 
3 18 20 44.71 100.00 
VTN-102-G01-
H-00 
Viet Nam 1 HIV/AID
S 
Gov: 
MOH 
2 45 26 12.04 100.00 
VTN-102-G02-
T-00 
Viet Nam 1 TB Gov: 
MOH 
2 45 26 12.04 100.00 
VTN-304-G03-
M 
Viet Nam 3 Malaria Gov: 
MOH 
1 45 26 12.04 100.00 
VTN-607-G05-T Viet Nam 6 TB Gov: 
MOH 
1 45 26 12.04 100.00 
VTN-607-G04-H Viet Nam 6 HIV/AID
S 
Gov: 
MOH 
1 45 26 12.04 100.00 
VTN-708-G06-
M 
Viet Nam 7 Malaria Gov: 
MOH 
1 45 26 12.04 100.00 
ALB-506-G02-T Albania 5 TB Gov: 
MOH 
2 8 12 36.46 100.00 
ALB-506-G01-H Albania 5 HIV/AID
S 
Gov: 
MOH 
2 8 12 36.46 100.00 
ARM-202-G01-
H-00 
Armenia 2 HIV/AID
S 
CS/PS: 
NGO 
1 22.5 16 32.22 100.00 
ARM-809-G03- Armenia 8 TB Gov: 2 22.5 16 32.22 100.00 
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T MOH 
AZE-405-G01-H Azerbaija
n 
4 HIV/AID
S 
Gov: 
MOH 
4 30 24 6.44 100.00 
AZE-506-G02-T Azerbaija
n 
5 TB Gov: 
MOH 
4 30 24 6.44 100.00 
AZE-708-G04-
M 
Azerbaija
n 
7 Malaria Gov: 
MOH 
4 30 24 6.44 100.00 
AZE-708-G03-T Azerbaija
n 
7 TB Gov: 
MOH 
4 30 24 6.44 100.00 
BLR-304-G01-H Belarus 3 HIV/AID
S 
MO: 
UNDP 
4 30 22 3.08 100.00 
BLR-607-G02-T Belarus 6 TB MO: 
UNDP 
4 30 22 3.08 100.00 
BLR-809-G03-H Belarus 8 HIV/AID
S 
MO: 
UNDP 
4 30 22 3.08 100.00 
BIH-506-G01-H Bosnia 
and 
Herzegovi
na 
5 HIV/AID
S 
MO: 
UNDP 
4 30 14 25.50 100.00 
BIH-607-G02-T Bosnia 
and 
Herzegovi
na 
6 TB MO: 
UNDP 
4 30 14 25.50 100.00 
BUL-202-G01-
H-00 
Bulgaria 2 HIV/AID
S 
Gov: 
MOH 
1 20 20 17.98 100.00 
BUL-607-G02-T Bulgaria 6 TB Gov: 
MOH 
1 20 20 17.98 100.00 
GEO-202-G01-
H-00 
Georgia 2 HIV/AID
S 
Gov: Oth 5 32 22 32.33 100.00 
GEO-304-G02-
M 
Georgia 3 Malaria Gov: Oth 5 32 22 32.33 100.00 
GEO-405-G03-T Georgia 4 TB Gov: Oth 5 32 22 32.33 100.00 
GEO-607-G05-T Georgia 6 TB Gov: Oth 5 32 22 32.33 100.00 
GEO-607-G06-
H 
Georgia 6 HIV/AID
S 
Gov: Oth 5 32 22 32.33 100.00 
GEO-607-G04-
M 
Georgia 6 Malaria Gov: Oth 5 32 22 32.33 100.00 
KAZ-202-G01-
H-00 
Kazakhsta
n 
2 HIV/AID
S 
Gov: Oth 1 30 20 3.03 100.00 
KAZ-607-G02-T Kazakhsta
n 
6 TB Gov: 
MOH 
2 30 20 3.03 100.00 
KAZ-708-G03-H Kazakhsta
n 
7 HIV/AID
S 
Gov: Oth 1 30 20 3.03 100.00 
KAZ-809-G04-T Kazakhsta
n 
8 TB Gov: 
MOH 
2 30 20 3.03 99.72 
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KOS-405-G01-T Kosovo 4 TB Gov: 
MOH 
2 15 12 12.96 100.00 
KOS-708-G02-H Kosovo 7 HIV/AID
S 
Gov: 
MOH 
2 15 12 12.96 100.00 
KGZ-202-G02-
T-00 
Kyrgyzsta
n 
2 TB Gov: 
MOH 
2 60 22 22.19 100.00 
KGZ-202-G01-
H-00 
Kyrgyzsta
n 
2 HIV/AID
S 
Gov: Oth 1 60 22 22.19 100.00 
KGZ-506-G03-
M 
Kyrgyzsta
n 
5 Malaria Gov: Oth 2 60 22 22.19 100.00 
KGZ-607-G04-T Kyrgyzsta
n 
6 TB Gov: 
MOH 
2 60 22 22.19 100.00 
KGZ-708-G05-H Kyrgyzsta
n 
7 HIV/AID
S 
Gov: 
MOH 
1 60 22 22.19 100.00 
MKD-304-G01-
H 
Macedoni
a (Former 
Yugoslav 
Republic) 
3 HIV/AID
S 
Gov: 
MOH 
2 8 14 1.26 100.00 
MKD-506-G02-
T 
Macedoni
a (Former 
Yugoslav 
Republic) 
5 TB Gov: 
MOH 
2 8 14 1.26 100.00 
MKD-708-G03-
H 
Macedoni
a (Former 
Yugoslav 
Republic) 
7 HIV/AID
S 
Gov: 
MOH 
2 8 14 1.26 100.00 
MOL-607-G02-
T 
Moldova 6 TB Gov: 
MOH 
3 30 10 19.53 100.00 
MOL-607-G03-
H 
Moldova 6 HIV/AID
S 
Gov: 
MOH 
3 30 10 19.53 100.00 
MOL-809-G04-
T 
Moldova 8 TB Gov: 
MOH 
3 30 10 19.53 100.00 
MNT-506-G01-
H 
Montene
gro 
5 HIV/AID
S 
MO: 
UNDP 
2 8 12 12.96 100.00 
MNT-607-G02-
T 
Montene
gro 
6 TB MO: 
UNDP 
2 8 12 12.96 100.00 
ROM-202-G01-
H-00 
Romania 2 HIV/AID
S 
Gov: 
MOH 
2 16 18 4.54 100.00 
ROM-202-G02-
T-00 
Romania 2 TB Gov: 
MOH 
2 16 18 4.54 100.00 
ROM-607-G03-
H 
Romania 6 HIV/AID
S 
CS/PS: 
NGO 
2 16 18 4.54 100.00 
ROM-607-G04-
T 
Romania 6 TB CS/PS: 
NGO 
2 16 18 4.54 100.00 
RUS-304-G02-T Russian 
Federatio
3 TB CS/PS: 
NGO 
1 80 22 1.69 100.00 
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n 
RUS-304-G01-H Russian 
Federatio
n 
3 HIV/AID
S 
CS/PS: 
NGO 
1 80 22 1.69 100.00 
RUS-405-G04-T Russian 
Federatio
n 
4 TB CS/PS: 
NGO 
2 80 22 1.69 100.00 
RUS-405-G03-H Russian 
Federatio
n 
4 HIV/AID
S 
CS/PS: 
NGO 
2 80 22 1.69 100.00 
RUS-506-G05-H Russian 
Federatio
n 
5 HIV/AID
S 
CS/PS: 
NGO 
1 80 22 1.69 100.00 
SER-102-G01-
H-00 
Serbia 1 HIV/AID
S 
CS/PS: 
PS 
1 8 16 12.96 100.00 
SER-304-G02-T Serbia 3 TB Gov: 
MOH 
2 8 16 12.96 100.00 
SER-607-G03-H Serbia 6 HIV/AID
S 
Gov: 
MOH 
2 8 16 12.96 100.00 
SER-809-G04-H Serbia 8 HIV/AID
S 
Gov: 
MOH 
3 8 16 12.96 100.00 
SER-809-G05-H Serbia 8 HIV/AID
S 
CS/PS: 
NGO 
3 8 16 12.96 100.00 
TAJ-102-G01-H-
00 
Tajikistan 1 HIV/AID
S 
MO: 
UNDP 
1 40 22 14.35 100.00 
TAJ-304-G02-T Tajikistan 3 TB CS/PS: 
NGO 
1 40 22 14.35 100.00 
TAJ-404-G03-H Tajikistan 4 HIV/AID
S 
MO: 
UNDP 
5 40 22 14.35 100.00 
TAJ-506-G04-M Tajikistan 5 Malaria MO: 
UNDP 
5 40 22 14.35 100.00 
TAJ-607-G06-T Tajikistan 6 TB MO: 
UNDP 
5 40 22 14.35 100.00 
TAJ-607-G05-H Tajikistan 6 HIV/AID
S 
MO: 
UNDP 
5 40 22 14.35 100.00 
TAJ-809-G09-T Tajikistan 8 TB MO: 
UNDP 
5 40 22 14.35 100.00 
TAJ-809-G08-M Tajikistan 8 Malaria MO: 
UNDP 
5 40 22 14.35 100.00 
TAJ-809-G07-H Tajikistan 8 HIV/AID
S 
MO: 
UNDP 
5 40 22 14.35 100.00 
TUR-405-G01-H Turkey 4 HIV/AID
S 
Gov: 
MOH 
1 10 16 3.92 100.00 
UKR-102-G04-
H-00 
Ukraine 1 HIV/AID
S 
CS/PS: 
NGO 
2 99 22 3.93 100.00 
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UKR-102-G02-
H-00 
Ukraine 1 HIV/AID
S 
Gov: 
MOH 
1 99 22 3.93 100.00 
UKR-102-G03-
H-00 
Ukraine 1 HIV/AID
S 
MO: 
UNDP 
1 99 22 3.93 100.00 
UKR-102-G01-
H-00 
Ukraine 1 HIV/AID
S 
Gov: Oth 1 99 22 3.93 100.00 
UKR-102-A04-
H-00 
Ukraine 1 HIV/AID
S 
CS/PS: 
NGO 
2 99 22 3.93 100.00 
UKR-607-G06-H Ukraine 6 HIV/AID
S 
CS/PS: 
NGO 
1 99 22 3.93 100.00 
UKR-607-G05-H Ukraine 6 HIV/AID
S 
CS/PS: 
NGO 
1 99 22 3.93 100.00 
UZB-304-G01-H Uzbekista
n 
3 HIV/AID
S 
Gov: 
MOH 
1 32 20 5.64 100.00 
UZB-405-G02-
M 
Uzbekista
n 
4 Malaria Gov: Oth 1 32 20 5.64 100.00 
UZB-405-G03-T Uzbekista
n 
4 TB Gov: 
MOH 
2 32 20 5.64 100.00 
ARG-102-G01-
H-00 
Argentina 1 HIV/AID
S 
MO: 
UNDP 
1 22.5 16 32.22 100.00 
ARG-102-G02-
H-00 
Argentina 1 HIV/AID
S 
CS/PS: 
PS 
1 22.5 16 32.22 100.00 
BEL-304-G01-H Belize 3 HIV/AID
S 
CS/PS: 
NGO 
1 12 22 24.80 100.00 
BOL-306-G04-H Bolivia 
(Plurinati
onal 
State) 
3 HIV/AID
S 
MO: 
UNDP 
3 84 20 24.29 100.00 
BOL-304-G01-H Bolivia 
(Plurinati
onal 
State) 
3 HIV/AID
S 
CS/PS: 
NGO 
3 84 20 24.29 100.00 
BOL-304-G03-T Bolivia 
(Plurinati
onal 
State) 
3 TB CS/PS: 
NGO 
3 84 20 24.29 100.00 
BOL-307-G07-H Bolivia 
(Plurinati
onal 
State) 
3 HIV/AID
S 
CS/PS: 
NGO 
1 84 20 24.29 100.00 
BOL-306-G06-T Bolivia 
(Plurinati
onal 
State) 
3 TB MO: 
UNDP 
3 84 20 24.29 100.00 
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BOL-304-G02-
M 
Bolivia 
(Plurinati
onal 
State) 
3 Malaria CS/PS: 
NGO 
3 84 20 24.29 100.00 
BOL-306-G05-
M 
Bolivia 
(Plurinati
onal 
State) 
3 Malaria MO: 
UNDP 
3 84 20 24.29 100.00 
BOL-809-G08-
M 
Bolivia 
(Plurinati
onal 
State) 
8 Malaria MO: 
UNDP 
1 84 20 24.29 100.00 
BRA-506-G02-T Brazil 5 TB CS/PS: 
Oth 
1 20 22 3.29 100.00 
BRA-506-G01-T Brazil 5 TB CS/PS: 
Oth 
1 20 22 3.29 100.00 
CHL-102-G01-
H-00 
Chile 1 HIV/AID
S 
CS/PS: 
PS 
1 5 16 3.71 100.00 
COL-202-G01-
H-00 
Colombia 2 HIV/AID
S 
MO: Oth 1 20 20 18.30 100.00 
COR-202-G01-
H-00 
Costa Rica 2 HIV/AID
S 
Gov: Oth 1 9.4 18 11.25 100.00 
COR-202-G02-
H-00 
Costa Rica 2 HIV/AID
S 
CS/PS: 
NGO 
1 9.4 18 11.25 100.00 
CUB-202-G01-
H-00 
Cuba 2 HIV/AID
S 
MO: 
UNDP 
1 48 18 6.36 100.00 
CUB-607-G02-H Cuba 6 HIV/AID
S 
MO: 
UNDP 
2 48 18 6.36 100.00 
CUB-708-G03-T Cuba 7 TB MO: 
UNDP 
2 48 18 6.36 100.00 
DMR-202-G01-
H-00 
Dominica
n 
Republic 
2 HIV/AID
S 
Gov: Oth 1 90 18 20.64 100.00 
DMR-304-G02-
T 
Dominica
n 
Republic 
3 TB CS/PS: 
NGO 
1 90 18 20.64 100.00 
DMR-708-G03-
T 
Dominica
n 
Republic 
7 TB CS/PS: 
NGO 
1 90 18 20.64 100.00 
DMR-809-G06-
M 
Dominica
n 
Republic 
8 Malaria Gov: 
MOH 
1 90 18 20.64 100.00 
DMR-809-G05-
M 
Dominica
n 
Republic 
8 Malaria CS/PS: 
NGO 
1 90 18 20.64 100.00 
ECU-202-G01- Ecuador 2 HIV/AID Gov: 3 24 16 18.43 100.00 
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ECU-202-G03-
H-00 
Ecuador 2 HIV/AID
S 
CS/PS: 
NGO 
2 24 16 18.43 100.00 
ECU-405-G02-T Ecuador 4 TB CS/PS: 
NGO 
3 24 16 18.43 100.00 
SLV-202-G01-
H-00 
El 
Salvador 
2 HIV/AID
S 
MO: 
UNDP 
3 32 16 29.30 100.00 
SLV-202-G02-T-
00 
El 
Salvador 
2 TB MO: 
UNDP 
2 32 16 29.30 100.00 
SLV-708-G05-H El 
Salvador 
7 HIV/AID
S 
Gov: 
MOH 
1 32 16 29.30 100.00 
SLV-708-G06-H El 
Salvador 
7 HIV/AID
S 
MO: 
UNDP 
1 32 16 29.30 100.00 
GUA-304-G01-
H 
Guatemal
a 
3 HIV/AID
S 
CS/PS: 
NGO 
3 47 18 14.60 100.00 
GUA-405-G02-
M 
Guatemal
a 
4 Malaria CS/PS: 
NGO 
3 47 18 14.60 100.00 
GUA-607-G03-T Guatemal
a 
6 TB CS/PS: 
NGO 
3 24 22 14.60 100.00 
GYA-304-G02-
M 
Guyana 3 Malaria Gov: 
MOH 
4 24 22 112.26 100.00 
GYA-304-G01-H Guyana 3 HIV/AID
S 
Gov: 
MOH 
4 24 22 112.26 100.00 
GYA-405-G03-T Guyana 4 TB Gov: 
MOH 
4 24 22 112.26 100.00 
GYA-708-G04-
M 
Guyana 7 Malaria Gov: 
MOH 
4 24 22 112.26 100.00 
HTI-102-G01-H-
00 
Haiti 1 HIV/AID
S 
CS/PS: 
PS 
1 100 20 27.83 100.00 
HTI-102-G02-H-
00 
Haiti 1 HIV/AID
S 
MO: 
UNDP 
4 100 20 27.83 100.00 
HTI-304-G03-M Haiti 3 Malaria CS/PS: 
PS 
3 100 20 27.83 100.00 
HTI-304-G04-T Haiti 3 TB CS/PS: 
PS 
3 100 20 27.83 100.00 
HTI-506-G05-H Haiti 5 HIV/AID
S 
CS/PS: 
PS 
3 100 20 27.83 100.00 
HND-102-G03-
M-00 
Honduras 1 Malaria MO: 
UNDP 
4 72 18 34.50 100.00 
HND-102-G02-
T-00 
Honduras 1 TB MO: 
UNDP 
4 72 18 34.50 100.00 
HND-102-G01-
H-00 
Honduras 1 HIV/AID
S 
MO: 
UNDP 
4 72 18 34.50 100.00 
JAM-304-G01-
H 
Jamaica 3 HIV/AID
S 
Gov: 
MOH 
1 20 16 24.84 100.00 
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JAM-708-G02-
H 
Jamaica 7 HIV/AID
S 
Gov: 
MOH 
1 20 16 24.84 100.00 
NIC-202-G03-H-
00 
Nicaragua 2 HIV/AID
S 
CS/PS: 
NGO 
3 45 16 64.95 100.00 
NIC-202-G01-
M-00 
Nicaragua 2 Malaria CS/PS: 
NGO 
3 45 16 64.95 100.00 
NIC-202-G02-T-
00 
Nicaragua 2 TB CS/PS: 
NGO 
3 45 16 64.95 100.00 
NIC-708-G04-M Nicaragua 7 Malaria CS/PS: 
NGO 
1 45 16 64.95 100.00 
PAN-102-G01-
T-00 
Panama 1 TB MO: 
UNDP 
1 8 18 12.74 100.00 
PRY-304-G01-T Paraguay 3 TB CS/PS: 
NGO 
1 16 18 13.38 100.00 
PRY-607-G02-H Paraguay 6 HIV/AID
S 
CS/PS: 
NGO 
1 16 18 13.38 100.00 
PRY-708-G03-T Paraguay 7 TB CS/PS: 
NGO 
1 16 18 13.38 100.00 
PRY-809-G04-H Paraguay 8 HIV/AID
S 
CS/PS: 
NGO 
1 16 18 13.38 100.00 
PER-202-G01-
H-00 
Peru 2 HIV/AID
S 
CS/PS: 
NGO 
5 30 24 16.76 100.00 
PER-202-G02-T-
00 
Peru 2 TB CS/PS: 
NGO 
5 30 24 16.76 100.00 
PER-506-G04-T Peru 5 TB CS/PS: 
NGO 
5 30 24 16.76 100.00 
PER-506-G03-H Peru 5 HIV/AID
S 
CS/PS: 
NGO 
5 30 24 16.76 100.00 
PER-607-G05-H Peru 6 HIV/AID
S 
CS/PS: 
NGO 
5 30 24 16.76 100.00 
SUR-305-G01-H Suriname 3 HIV/AID
S 
Gov: 
MOH 
2 15 22 86.35 100.00 
SUR-404-G02-
M 
Suriname 4 Malaria CS/PS: 
NGO 
1 15 22 86.35 100.00 
SUR-506-G03-H Suriname 5 HIV/AID
S 
Gov: 
MOH 
2 15 22 86.35 100.00 
SUR-708-G04-
M 
Suriname 7 Malaria Gov: 
MOH 
1 15 22 86.35 100.00 
DZA-304-G01-H Algeria 3 HIV/AID
S 
Gov: 
MOH 
1 11.4 16 0.50 100.00 
TCD-202-G01-
T-00 
Chad 2 TB Gov: Oth 2 98 26 4.28 100.00 
TCD-304-G02-H Chad 3 HIV/AID
S 
Gov: Oth 2 98 26 4.28 100.00 
DJB-404-G01-H Djibouti 4 HIV/AID Gov: 4 97 26 38.46 100.00 
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EGY-202-G01-
T-00 
Egypt 2 TB Gov: 
MOH 
1 13.25 14 5.67 100.00 
EGY-608-G03-H Egypt 6 HIV/AID
S 
Gov: 
MOH 
1 13.25 14 5.67 100.00 
EGY-607-G02-T Egypt 6 TB Gov: 
MOH 
1 13.25 14 5.67 100.00 
IRQ-607-G01-T Iraq 6 TB MO: 
UNDP 
1 30 14 11.71 100.00 
JOR-202-G01-
H-00 
Jordan 2 HIV/AID
S 
Gov: 
MOH 
1 8 12 23.23 100.00 
JOR-506-G02-T Jordan 5 TB Gov: 
MOH 
1 8 12 23.23 100.00 
JOR-607-G03-H Jordan 6 HIV/AID
S 
Gov: 
MOH 
1 8 12 23.23 100.00 
MAL-102-G01-
M-00 
Mali 1 Malaria Gov: 
MOH 
3 96 24 10.33 100.00 
MAL-405-G03-T Mali 4 TB Gov: 
MOH 
3 96 24 10.33 100.00 
MAL-405-G02-
H 
Mali 4 HIV/AID
S 
Gov: Oth 1 96 24 10.33 100.00 
MAL-607-G05-
M 
Mali 6 Malaria CS/PS: 
NGO 
2 96 24 10.33 100.00 
MRT-202-G02-
M-00 
Mauritani
a 
2 Malaria MO: 
UNDP 
4 95 20 8.46 100.00 
MRT-202-G01-
T-00 
Mauritani
a 
2 TB MO: 
UNDP 
4 95 20 8.46 100.00 
MOR-102-G01-
H-00 
Morocco 1 HIV/AID
S 
Gov: 
MOH 
1 8 14 8.57 100.00 
MOR-607-G03-
T 
Morocco 6 TB Gov: 
MOH 
2 8 14 8.57 100.00 
MOR-607-G02-
H 
Morocco 6 HIV/AID
S 
Gov: 
MOH 
2 8 14 8.57 100.00 
NGR-306-G06-
M 
Niger 3 Malaria MO: 
UNDP 
3 67.5 22 4.92 100.00 
NGR-304-G02-
M 
Niger 3 Malaria CS/PS: 
NGO 
1 67.5 22 4.92 100.00 
NGR-304-G01-
H 
Niger 3 HIV/AID
S 
Gov: Oth 1 67.5 22 4.92 100.00 
NGR-405-G03-
M 
Niger 4 Malaria MO: Oth 1 67.5 22 4.92 100.00 
NGR-506-G05-T Niger 5 TB MO: 
UNDP 
3 67.5 22 4.92 100.00 
NGR-506-G04-
M 
Niger 5 Malaria MO: 
UNDP 
3 67.5 22 4.92 100.00 
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NGR-708-G08-
H 
Niger 7 HIV/AID
S 
Gov: Oth 1 67.5 22 4.92 100.00 
NGR-708-G07-
M 
Niger 7 Malaria CS/PS: 
FBO 
1 67.5 22 4.92 99.11 
SOM-202-G01-
M-00 
Somalia 2 Malaria MO: Oth 3 60 26 3.04 100.00 
SOM-304-G02-
T 
Somalia 3 TB CS/PS: 
NGO 
1 60 26 3.04 100.00 
SOM-405-G03-
H 
Somalia 4 HIV/AID
S 
MO: Oth 3 60 26 3.04 100.00 
SOM-607-G04-
M 
Somalia 6 Malaria MO: Oth 3 60 26 3.04 100.00 
SOM-708-G05-
T 
Somalia 7 TB CS/PS: 
NGO 
1 60 26 3.04 100.00 
SSD-202-G02-T-
00 
South 
Sudan 
2 TB MO: 
UNDP 
3 94 24 5.09 100.00 
SSD-202-G01-
M-00 
South 
Sudan 
2 Malaria MO: 
UNDP 
3 94 24 5.09 100.00 
SSD-405-G05-H South 
Sudan 
4 HIV/AID
S 
MO: 
UNDP 
3 94 24 5.09 100.00 
SSD-506-G06-T South 
Sudan 
5 TB MO: 
UNDP 
3 94 24 5.09 100.00 
SSD-708-G11-T South 
Sudan 
7 TB MO: 
UNDP 
3 94 24 5.09 100.00 
SSD-708-G09-
M 
South 
Sudan 
7 Malaria CS/PS: 
NGO 
1 94 24 5.09 100.00 
SUD-202-G03-
M-00 
Sudan 2 Malaria MO: 
UNDP 
4 94 24 5.09 100.00 
SUD-305-G04-H Sudan 3 HIV/AID
S 
MO: 
UNDP 
4 94 24 5.09 100.00 
SUD-506-G08-H Sudan 5 HIV/AID
S 
MO: 
UNDP 
4 94 24 5.09 100.00 
SUD-506-G07-T Sudan 5 TB MO: 
UNDP 
4 94 24 5.09 100.00 
SUD-708-G10-
M 
Sudan 7 Malaria MO: 
UNDP 
4 94 24 5.09 100.00 
SUD-809-G12-T Sudan 8 TB MO: 
UNDP 
4 94 24 5.09 100.00 
SYR-607-G01-T Syrian 
Arab 
Republic 
6 TB MO: 
UNDP 
1 36 10 4.15 100.00 
TUN-607-G01-
H 
Tunisia 6 HIV/AID
S 
Gov: 
MOH 
1 9.25 14 8.10 100.00 
YEM-202-G01-
M-00 
Yemen 2 Malaria Gov: 
MOH 
1 80 16 4.83 100.00 
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YEM-305-G03-
H 
Yemen 3 HIV/AID
S 
Gov: 
MOH 
1 80 16 4.83 100.00 
YEM-305-G02-
H 
Yemen 3 HIV/AID
S 
Gov: 
MOH 
1 80 16 4.83 100.00 
YEM-307-G05-
H 
Yemen 3 HIV/AID
S 
MO: 
UNDP 
1 80 16 4.83 100.00 
YEM-405-G04-T Yemen 4 TB Gov: 
MOH 
1 80 16 4.83 100.00 
AFG-506-G03-
M 
Afghanist
an 
5 Malaria Gov: 
MOH 
2 15 18 9.58 100.00 
AFG-708-G05-H Afghanist
an 
7 HIV/AID
S 
Gov: Oth 1 15 18 9.58 100.00 
BAN-202-G01-
H-00 
Banglades
h 
2 HIV/AID
S 
Gov: 
MOF 
3 54 18 4.48 100.00 
BAN-304-G02-T Banglades
h 
3 TB CS/PS: 
NGO 
3 54 18 4.48 100.00 
BAN-304-G03-T Banglades
h 
3 TB Gov: 
MOF 
3 54 18 4.48 100.00 
BAN-506-G04-T Banglades
h 
5 TB CS/PS: 
NGO 
2 54 18 4.48 100.00 
BAN-506-G05-T Banglades
h 
5 TB Gov: 
MOF 
3 54 18 4.48 100.00 
BAN-607-G08-
H 
Banglades
h 
6 HIV/AID
S 
Gov: 
MOF 
2 54 18 4.48 100.00 
BAN-607-G06-
M 
Banglades
h 
6 Malaria CS/PS: 
NGO 
2 54 18 4.48 100.00 
BAN-607-G07-
M 
Banglades
h 
6 Malaria Gov: 
MOF 
2 54 18 4.48 100.00 
BAN-809-G10-T Banglades
h 
8 TB CS/PS: 
NGO 
3 54 18 4.48 100.00 
BTN-405-G02-T Bhutan 4 TB Gov: Oth 5 5 18 33.30 100.00 
BTN-405-G01-
M 
Bhutan 4 Malaria Gov: Oth 5 5 18 33.30 100.00 
BTN-607-G04-T Bhutan 6 TB Gov: Oth 5 5 18 33.30 100.00 
BTN-607-G03-H Bhutan 6 HIV/AID
S 
Gov: Oth 5 5 18 33.30 100.00 
BTN-708-G05-
M 
Bhutan 7 Malaria Gov: Oth 5 5 18 33.30 100.00 
IDA-102-G01-T-
00 
India 1 TB Gov: Oth 5 32 26 1.76 100.00 
IDA-202-G02-
H-00 
India 2 HIV/AID
S 
Gov: Oth 5 32 26 1.76 100.00 
IDA-202-G03-T-
00 
India 2 TB Gov: Oth 5 32 26 1.76 100.00 
IDA-405-G06-H India 4 HIV/AID Gov: Oth 5 32 26 1.76 100.00 
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IDA-405-G08-T India 4 TB Gov: Oth 5 32 26 1.76 100.00 
IDA-405-G05-H India 4 HIV/AID
S 
CS/PS: 
NGO 
5 32 26 1.76 100.00 
IDA-405-G07-M India 4 Malaria Gov: 
MOF 
5 32 26 1.76 100.00 
IDA-607-G09-T India 6 TB Gov: Oth 5 32 26 1.76 100.00 
IDA-607-G10-H India 6 HIV/AID
S 
CS/PS: 
NGO 
1 32 26 1.76 100.00 
IDA-607-G12-H India 6 HIV/AID
S 
CS/PS: 
NGO 
1 32 26 1.76 100.00 
IDA-607-G11-H India 6 HIV/AID
S 
Gov: Oth 5 32 26 1.76 100.00 
IDA-708-G13-H India 7 HIV/AID
S 
Gov: Oth 5 32 26 1.76 100.00 
IDA-708-G14-H India 7 HIV/AID
S 
Gov: 
MOH 
1 32 26 1.76 100.00 
IDA-708-G15-H India 7 HIV/AID
S 
CS/PS: 
Oth 
1 32 26 1.76 100.00 
IRN-202-G01-
H-00 
Iran 
(Islamic 
Republic) 
2 HIV/AID
S 
MO: 
UNDP 
1 96 14 0.99 100.00 
IRN-708-G03-T Iran 
(Islamic 
Republic) 
7 TB MO: 
UNDP 
2 96 14 0.99 100.00 
IRN-708-G02-M Iran 
(Islamic 
Republic) 
7 Malaria MO: 
UNDP 
2 96 14 0.99 100.00 
MDV-607-G01-
H 
Maldives 6 HIV/AID
S 
MO: 
UNDP 
1 48 12 11.74 100.00 
NEP-202-G04-
M-00 
Nepal 2 Malaria CS/PS: 
NGO 
1 48 20 8.90 100.00 
NEP-202-G02-
M-00 
Nepal 2 Malaria Gov: 
MOH 
3 48 20 8.90 100.00 
NEP-202-G01-
H-00 
Nepal 2 HIV/AID
S 
Gov: 
MOH 
3 48 20 8.90 100.00 
NEP-405-G03-T Nepal 4 TB Gov: 
MOH 
  48 20 8.90 100.00 
NEP-708-G11-H Nepal 7 HIV/AID
S 
CS/PS: 
NGO 
3 48 20 8.90 100.00 
NEP-708-G07-
M 
Nepal 7 Malaria Gov: 
MOH 
3 48 20 8.90 100.00 
NEP-708-G10-H Nepal 7 HIV/AID
S 
CS/PS: 
NGO 
1 48 20 8.90 100.00 
NEP-708-G09-H Nepal 7 HIV/AID MO: 1 48 20 8.90 100.00 
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NEP-708-G08-T Nepal 7 TB Gov: 
MOH 
3 48 20 8.90 100.00 
PKS-202-G03-T-
00 
Pakistan 2 TB Gov: 
MOH 
5 49 22 5.18 100.00 
PKS-202-G02-
M-00 
Pakistan 2 Malaria Gov: 
MOH 
5 49 22 5.18 100.00 
PKS-202-G01-
H-00 
Pakistan 2 HIV/AID
S 
Gov: 
MOH 
5 49 22 5.18 100.00 
PKS-304-G05-T Pakistan 3 TB Gov: 
MOH 
5 49 22 5.18 100.00 
PKS-607-G06-T Pakistan 6 TB CS/PS: 
NGO 
1 49 22 5.18 100.00 
PKS-607-G07-T Pakistan 6 TB Gov: 
MOH 
1 49 22 5.18 100.00 
SRL-102-G03-T-
00 
Sri Lanka 1 TB Gov: 
MOH 
3 45 16 4.23 100.00 
SRL-102-G02-
M-00 
Sri Lanka 1 Malaria CS/PS: 
NGO 
3 45 16 4.23 100.00 
SRL-102-G01-
M-00 
Sri Lanka 1 Malaria Gov: 
MOH 
3 45 16 4.23 100.00 
SRL-405-G06-M Sri Lanka 4 Malaria CS/PS: 
NGO 
3 45 16 4.23 100.00 
SRL-405-G05-M Sri Lanka 4 Malaria Gov: 
MOH 
3 45 16 4.23 100.00 
SRL-607-G09-H Sri Lanka 6 HIV/AID
S 
Gov: 
MOH 
3 45 16 4.23 100.00 
SRL-607-G07-T Sri Lanka 6 TB Gov: 
MOH 
3 45 16 4.23 100.00 
BRN-102-G01-
H-00 
Burundi 1 HIV/AID
S 
Gov: Oth 2 87 26 7.98 100.00 
BRN-202-G02-
M-00 
Burundi 2 Malaria Gov: 
MOH 
2 87 26 7.98 100.00 
BRN-405-G03-T Burundi 4 TB Gov: 
MOH 
2 87 26 7.98 100.00 
BRN-506-G04-H Burundi 5 HIV/AID
S 
Gov: Oth 2 87 26 7.98 100.00 
BRN-708-G06-T Burundi 7 TB Gov: 
MOH 
2 87 26 7.98 100.00 
COM-202-G01-
M-00 
Comoros 2 Malaria CS/PS: 
NGO 
2 29 12 11.17 100.00 
COM-304-G02-
H 
Comoros 3 HIV/AID
S 
CS/PS: 
NGO 
2 29 12 11.17 100.00 
ZAR-202-G01-
T-00 
Congo 
(Democra
2 TB MO: 
UNDP 
5 93 20 4.66 100.00 
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tic 
Republic) 
ZAR-304-G03-
M 
Congo 
(Democra
tic 
Republic) 
3 Malaria MO: 
UNDP 
5 93 20 4.66 100.00 
ZAR-304-G02-H Congo 
(Democra
tic 
Republic) 
3 HIV/AID
S 
MO: 
UNDP 
5 93 20 4.66 100.00 
ZAR-506-G04-T Congo 
(Democra
tic 
Republic) 
5 TB MO: 
UNDP 
5 93 20 4.66 100.00 
ZAR-607-G05-T Congo 
(Democra
tic 
Republic) 
6 TB MO: 
UNDP 
5 93 20 4.66 100.00 
ZAR-708-G06-H Congo 
(Democra
tic 
Republic) 
7 HIV/AID
S 
MO: 
UNDP 
5 93 20 4.66 100.00 
ZAR-810-G08-
M 
Congo 
(Democra
tic 
Republic) 
8 Malaria CS/PS: 
NGO 
1 93 20 4.66 100.00 
ERT-202-G01-
M-00 
Eritrea 2 Malaria Gov: 
MOH 
5 48 20 16.11 100.00 
ERT-304-G02-H Eritrea 3 HIV/AID
S 
Gov: 
MOH 
5 48 20 16.11 100.00 
ERT-506-G03-H Eritrea 5 HIV/AID
S 
Gov: 
MOH 
5 48 20 16.11 100.00 
ERT-607-G04-T Eritrea 6 TB Gov: 
MOH 
5 48 20 16.11 100.00 
ERT-607-G05-
M 
Eritrea 6 Malaria Gov: 
MOH 
5 48 20 16.11 100.00 
ETH-102-G01-
T-00 
Ethiopia 1 TB Gov: 
MOH 
4 60 20 8.93 100.00 
ETH-202-G03-
H-00 
Ethiopia 2 HIV/AID
S 
Gov: Oth 2 60 20 8.93 100.00 
ETH-202-G02-
M-00 
Ethiopia 2 Malaria Gov: 
MOH 
4 60 20 8.93 100.00 
ETH-405-G04-H Ethiopia 4 HIV/AID
S 
Gov: Oth 2 60 20 8.93 100.00 
ETH-506-G05- Ethiopia 5 Malaria Gov: 4 60 20 8.93 100.00 
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M MOH 
ETH-607-G06-T Ethiopia 6 TB Gov: 
MOH 
4 60 20 8.93 100.00 
ETH-708-G09-H Ethiopia 7 HIV/AID
S 
CS/PS: 
FBO 
1 60 20 8.93 100.00 
ETH-708-G07-H Ethiopia 7 HIV/AID
S 
CS/PS: 
NGO 
1 60 20 8.93 100.00 
KEN-102-G02-
H-00 
Kenya 1 HIV/AID
S 
CS/PS: 
NGO 
1 58.4 26 19.99 100.00 
KEN-102-G01-
H-00 
Kenya 1 HIV/AID
S 
CS/PS: 
NGO 
1 58.4 26 19.99 100.00 
KEN-202-G05-
M-00 
Kenya 2 Malaria Gov: 
MOF 
5 58.4 26 19.99 100.00 
KEN-202-G03-
H-00 
Kenya 2 HIV/AID
S 
Gov: 
MOF 
5 58.4 26 19.99 100.00 
KEN-202-G04-
T-00 
Kenya 2 TB Gov: 
MOF 
5 58.4 26 19.99 100.00 
KEN-405-G06-
M 
Kenya 4 Malaria Gov: 
MOF 
5 58.4 26 19.99 100.00 
KEN-506-G07-T Kenya 5 TB Gov: 
MOF 
5 58.4 26 19.99 100.00 
KEN-607-G08-T Kenya 6 TB Gov: 
MOF 
5 58.4 26 19.99 100.00 
KEN-708-G10-H Kenya 7 HIV/AID
S 
CS/PS: 
NGO 
1 58.4 26 19.99 100.00 
KEN-708-G09-H Kenya 7 HIV/AID
S 
Gov: 
MOF 
4 58.4 26 19.99 100.00 
MDG-102-G01-
M-00 
Madagasc
ar 
1 Malaria CS/PS: 
NGO 
2 45 18 9.21 100.00 
MDG-202-G02-
H-00 
Madagasc
ar 
2 HIV/AID
S 
CS/PS: 
NGO 
1 45 18 9.21 100.00 
MDG-202-G03-
H-00 
Madagasc
ar 
2 HIV/AID
S 
CS/PS: 
NGO 
2 45 18 9.21 100.00 
MDG-304-G04-
H 
Madagasc
ar 
3 HIV/AID
S 
Gov: Oth 2 45 18 9.21 100.00 
MDG-304-G05-
M 
Madagasc
ar 
3 Malaria Gov: 
MOH 
2 45 18 9.21 100.00 
MDG-405-G06-
M 
Madagasc
ar 
4 Malaria Gov: 
MOH 
2 45 18 9.21 100.00 
MDG-405-G07-
M 
Madagasc
ar 
4 Malaria CS/PS: 
NGO 
3 45 18 9.21 100.00 
MDG-404-G08-
T 
Madagasc
ar 
4 TB Gov: Oth 2 45 18 9.21 100.00 
MDG-708-G10-
M 
Madagasc
ar 
7 Malaria CS/PS: 
NGO 
3 45 18 9.21 100.00 
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MDG-708-G09-
M 
Madagasc
ar 
7 Malaria Gov: 
MOH 
3 45 18 9.21 100.00 
MUS-809-G02-
H 
Mauritius 8 HIV/AID
S 
CS/PS: 
NGO 
1 5 16 1.91 100.00 
RWN-304-G03-
M 
Rwanda 3 Malaria Gov: 
MOH 
4 43 24 25.78 100.00 
RWN-304-G02-
H 
Rwanda 3 HIV/AID
S 
Gov: 
MOH 
4 43 24 25.78 100.00 
RWN-404-G04-
T 
Rwanda 4 TB Gov: 
MOH 
4 43 24 25.78 100.00 
RWN-506-G06-
M 
Rwanda 5 Malaria Gov: 
MOH 
4 43 24 25.78 100.00 
RWN-606-G07-
T 
Rwanda 6 TB Gov: 
MOH 
5 43 24 25.78 100.00 
RWN-607-G08-
H 
Rwanda 6 HIV/AID
S 
Gov: 
MOH 
5 43 24 25.78 100.00 
RWN-708-G09-
H 
Rwanda 7 HIV/AID
S 
Gov: 
MOH 
5 43 24 25.78 99.22 
RWN-809-G10-
M 
Rwanda 8 Malaria Gov: 
MOH 
5 43 24 25.78 100.00 
TNZ-102-G01-
M-00 
Tanzania 
(United 
Republic) 
1 Malaria Gov: 
MOH 
5 92 26 19.10 100.00 
TNZ-102-G02-
H-00 
Tanzania 
(United 
Republic) 
1 HIV/AID
S 
Gov: 
MOF 
5 92 26 19.10 100.00 
TNZ-405-G05-H Tanzania 
(United 
Republic) 
4 HIV/AID
S 
CS/PS: 
NGO 
1 92 26 19.10 100.00 
TNZ-405-G08-
M 
Tanzania 
(United 
Republic) 
4 Malaria Gov: 
MOF 
5 92 26 19.10 100.00 
TNZ-405-G04-H Tanzania 
(United 
Republic) 
4 HIV/AID
S 
Gov: 
MOF 
5 92 26 19.10 100.00 
TNZ-405-G06-H Tanzania 
(United 
Republic) 
4 HIV/AID
S 
CS/PS: 
NGO 
1 92 26 19.10 100.00 
TNZ-405-G07-H Tanzania 
(United 
Republic) 
4 HIV/AID
S 
CS/PS: 
NGO 
1 92 26 19.10 100.00 
TNZ-607-G09-T Tanzania 
(United 
Republic) 
6 TB Gov: 
MOF 
5 92 26 19.10 100.00 
    379 
TNZ-708-G10-
M 
Tanzania 
(United 
Republic) 
7 Malaria Gov: 
MOF 
5 92 26 19.10 100.00 
UGD-102-G01-
H-00 
Uganda 1 HIV/AID
S 
Gov: 
MOF 
4 91 26 19.92 100.00 
UGD-202-G02-
M-00 
Uganda 2 Malaria Gov: 
MOF 
4 91 26 19.92 100.00 
UGD-202-G03-
T-00 
Uganda 2 TB Gov: 
MOF 
4 91 26 19.92 98.03 
UGD-304-G04-
H 
Uganda 3 HIV/AID
S 
Gov: 
MOF 
4 91 26 19.92 100.00 
UGD-405-G05-
M 
Uganda 4 Malaria Gov: 
MOF 
4 91 26 19.92 100.00 
UGD-708-G08-
M 
Uganda 7 Malaria Gov: 
MOF 
4 91 26 19.92 99.56 
ZAN-102-G01-
M-00 
Zanzibar 1 Malaria Gov: 
MOH 
2 17.1 26 19.10 100.00 
ZAN-202-G02-
H-00 
Zanzibar 2 HIV/AID
S 
Gov: Oth 2 17.1 26 19.10 100.00 
ZAN-304-G03-T Zanzibar 3 TB Gov: 
MOH 
4 17.1 26 19.10 100.00 
ZAN-404-G04-
M 
Zanzibar 4 Malaria Gov: 
MOH 
4 17.1 26 19.10 100.00 
ZAN-607-G06-H Zanzibar 6 HIV/AID
S 
Gov: Oth 2 17.1 26 19.10 100.00 
AGO-305-G01-
M 
Angola 3 Malaria MO: 
UNDP 
3 46.2 26 4.92 100.00 
AGO-405-G02-T Angola 4 TB MO: 
UNDP 
3 46.2 26 4.92 100.00 
AGO-405-G03-
H 
Angola 4 HIV/AID
S 
MO: 
UNDP 
3 46.2 26 4.92 100.00 
BOT-506-G02-T Botswana 5 TB Gov: 
MOH 
2 4 26 95.07 100.00 
LSO-202-G02-T-
00 
Lesotho 2 TB Gov: 
MOF 
3 22.2 20 24.37 100.00 
LSO-202-G01-
H-00 
Lesotho 2 HIV/AID
S 
Gov: 
MOF 
3 22.2 20 24.37 100.00 
LSO-506-G03-H Lesotho 5 HIV/AID
S 
Gov: 
MOF 
3 22.2 20 24.37 100.00 
LSO-607-G04-T Lesotho 6 TB Gov: 
MOF 
4 22.2 20 24.37 100.00 
LSO-708-G05-H Lesotho 7 HIV/AID
S 
Gov: 
MOF 
4 22.2 20 24.37 100.00 
MLW-102-G01-
H-00 
Malawi 1 HIV/AID
S 
Gov: Oth 1 32 26 21.35 100.00 
    380 
MLW-202-G02-
M-00 
Malawi 2 Malaria Gov: 
MOH 
1 32 26 21.35 100.00 
MLW-506-G03-
H 
Malawi 5 HIV/AID
S 
Gov: Oth 2 32 26 21.35 100.00 
MLW-708-G07-
H 
Malawi 7 HIV/AID
S 
Gov: Oth 2 32 26 21.35 100.00 
MLW-708-G05-
M 
Malawi 7 Malaria Gov: Oth 2 32 26 21.35 100.00 
MOZ-202-G04-
T-00 
Mozambi
que 
2 TB Gov: 
MOH 
5 45.6 26 25.21 100.00 
MOZ-202-G03-
M-00 
Mozambi
que 
2 Malaria Gov: 
MOH 
5 45.6 26 25.21 100.00 
MOZ-202-G02-
H-00 
Mozambi
que 
2 HIV/AID
S 
Gov: 
MOH 
5 45.6 26 25.21 100.00 
MOZ-607-G06-
M 
Mozambi
que 
6 Malaria Gov: 
MOH 
5 45.6 26 25.21 100.00 
MOZ-607-G05-
H 
Mozambi
que 
6 HIV/AID
S 
Gov: 
MOH 
5 45.6 26 25.21 100.00 
NMB-202-G01-
H-00 
Namibia 2 HIV/AID
S 
Gov: 
MOH 
4 22.2 28 107.06 100.00 
NMB-202-G02-
T-00 
Namibia 2 TB Gov: 
MOH 
4 22.2 28 107.06 100.00 
NMB-202-G03-
M-00 
Namibia 2 Malaria Gov: 
MOH 
4 22.2 28 107.06 100.00 
NMB-506-G04-
T 
Namibia 5 TB Gov: 
MOH 
4 22.2 28 107.06 100.00 
NMB-607-G06-
M 
Namibia 6 Malaria Gov: 
MOH 
4 22.2 28 107.06 100.00 
SAF-304-G04-H South 
Africa 
3 HIV/AID
S 
Gov: 
MOH 
1 44.4 26 13.21 100.00 
SAF-607-G06-H South 
Africa 
6 HIV/AID
S 
Gov: 
MOH 
2 44.4 26 13.21 100.00 
SWZ-202-G02-
M-00 
Swaziland 2 Malaria Gov: Oth 4 34.2 26 32.23 100.00 
SWZ-202-G01-
H-00 
Swaziland 2 HIV/AID
S 
Gov: Oth 4 34.2 26 32.23 100.00 
SWZ-304-G03-T Swaziland 3 TB Gov: Oth 4 34.2 26 32.23 100.00 
SWZ-405-G04-
H 
Swaziland 4 HIV/AID
S 
Gov: Oth 4 34.2 26 32.23 100.00 
ZAM-102-G06-
T-00 
Zambia 1 TB CS/PS: 
FBO 
3 87 26 33.43 100.00 
ZAM-102-G05-
M-00 
Zambia 1 Malaria CS/PS: 
FBO 
3 87 26 33.43 100.00 
ZAM-102-G08-
H-00 
Zambia 1 HIV/AID
S 
CS/PS: 
NGO 
3 87 26 33.43 100.00 
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ZAM-102-G04-
H-00 
Zambia 1 HIV/AID
S 
CS/PS: 
FBO 
3 87 26 33.43 100.00 
ZAM-102-G01-
H-00 
Zambia 1 HIV/AID
S 
Gov: 
MOH 
3 87 26 33.43 100.00 
ZAM-102-G02-
M-00 
Zambia 1 Malaria Gov: 
MOH 
3 87 26 33.43 100.00 
ZAM-102-G03-
T-00 
Zambia 1 TB Gov: 
MOH 
3 87 26 33.43 100.00 
ZAM-405-G11-
H 
Zambia 4 HIV/AID
S 
CS/PS: 
NGO 
3 87 26 33.43 100.00 
ZAM-405-G10-
H 
Zambia 4 HIV/AID
S 
CS/PS: 
FBO 
5 87 26 33.43 100.00 
ZAM-405-G09-
H 
Zambia 4 HIV/AID
S 
Gov: 
MOH 
4 87 26 33.43 100.00 
ZAM-405-G12-
H 
Zambia 4 HIV/AID
S 
Gov: 
MOF 
1 87 26 33.43 100.00 
ZAM-405-G14-
M 
Zambia 4 Malaria CS/PS: 
FBO 
5 87 26 33.43 100.00 
ZAM-405-G13-
M 
Zambia 4 Malaria Gov: 
MOH 
4 87 26 33.43 100.00 
ZAM-708-G18-
T 
Zambia 7 TB CS/PS: 
FBO 
5 87 26 33.43 100.00 
ZAM-708-G16-
T 
Zambia 7 TB Gov: 
MOH 
4 87 26 33.43 100.00 
ZAM-708-G19-
M 
Zambia 7 Malaria CS/PS: 
FBO 
5 87 26 33.43 100.00 
ZIM-102-G01-
H-00 
Zimbabw
e 
1 HIV/AID
S 
MO: 
UNDP 
1 86 26 11.52 100.00 
ZIM-102-G07-H Zimbabw
e 
1 HIV/AID
S 
Gov: Oth 1 86 26 11.52 100.00 
ZIM-102-G02-
M-00 
Zimbabw
e 
1 Malaria Gov: 
MOH 
1 86 26 11.52 100.00 
ZIM-509-G08-T Zimbabw
e 
5 TB MO: 
UNDP 
5 86 26 11.52 100.00 
ZIM-506-G04-H Zimbabw
e 
5 HIV/AID
S 
CS/PS: 
FBO 
2 86 26 11.52 100.00 
ZIM-509-G10-H Zimbabw
e 
5 HIV/AID
S 
MO: 
UNDP 
5 86 26 11.52 100.00 
ZIM-506-G05-T Zimbabw
e 
5 TB CS/PS: 
FBO 
2 86 26 11.52 100.00 
ZIM-506-G03-H Zimbabw
e 
5 HIV/AID
S 
Gov: Oth 1 86 26 11.52 100.00 
ZIM-509-G09-
M 
Zimbabw
e 
5 Malaria MO: 
UNDP 
5 86 26 11.52 100.00 
BEN-102-G01- Benin 1 Malaria MO: 3 42.75 20 14.26 100.00 
    382 
M-00 UNDP 
BEN-202-G03-
H-00 
Benin 2 HIV/AID
S 
MO: 
UNDP 
3 42.75 20 14.26 100.00 
BEN-202-G02-
T-00 
Benin 2 TB MO: 
UNDP 
3 42.75 20 14.26 100.00 
BEN-304-G04-
M 
Benin 3 Malaria CS/PS: 
NGO 
1 42.75 20 14.26 100.00 
BEN-506-G05-H Benin 5 HIV/AID
S 
Gov: 
MOH 
3 42.75 20 14.26 100.00 
BEN-607-G06-T Benin 6 TB Gov: 
MOH 
3 42.75 20 14.26 100.00 
BEN-708-G07-
M 
Benin 7 Malaria CS/PS: 
FBO 
3 42.75 20 14.26 100.00 
BUR-202-G01-
M-00 
Burkina 
Faso 
2 Malaria MO: 
UNDP 
3 85.5 22 9.42 100.00 
BUR-202-G02-
H-00 
Burkina 
Faso 
2 HIV/AID
S 
MO: 
UNDP 
3 85.5 22 9.42 100.00 
BUR-407-G05-T Burkina 
Faso 
4 TB Gov: 
MOH 
3 85.5 22 9.42 100.00 
BUR-404-G03-T Burkina 
Faso 
4 TB MO: 
UNDP 
3 85.5 22 9.42 100.00 
BUR-607-G06-H Burkina 
Faso 
6 HIV/AID
S 
Gov: Oth 3 85.5 22 9.42 100.00 
BUR-708-G07-
M 
Burkina 
Faso 
7 Malaria Gov: Oth 2 85.5 22 9.42 100.00 
BUR-809-G08-
M 
Burkina 
Faso 
8 Malaria Gov: Oth 1 85.5 22 9.42 99.45 
BUR-809-G09-
M 
Burkina 
Faso 
8 Malaria CS/PS: 
NGO 
1 85.5 22 9.42 98.55 
CMR-304-G03-
T 
Cameroo
n 
3 TB Gov: 
MOH 
5 90 26 5.98 100.00 
CMR-304-G01-
H 
Cameroo
n 
3 HIV/AID
S 
Gov: 
MOH 
5 90 26 5.98 100.00 
CMR-304-G02-
M 
Cameroo
n 
3 Malaria Gov: 
MOH 
5 90 26 5.98 100.00 
CMR-404-G04-
H 
Cameroo
n 
4 HIV/AID
S 
CS/PS: 
NGO 
1 90 26 5.98 100.00 
CMR-506-G05-
H 
Cameroo
n 
5 HIV/AID
S 
Gov: 
MOH 
5 90 26 5.98 100.00 
CAF-202-G01-
H-00 
Central 
African 
Republic 
2 HIV/AID
S 
MO: 
UNDP 
4 80 26 6.11 100.00 
CAF-404-G03-T Central 
African 
Republic 
4 TB MO: 
UNDP 
3 80 26 6.11 100.00 
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CAF-404-G02-H Central 
African 
Republic 
4 HIV/AID
S 
MO: 
UNDP 
4 80 26 6.11 100.00 
CAF-405-G04-
M 
Central 
African 
Republic 
4 Malaria MO: 
UNDP 
4 80 26 6.11 100.00 
CIV-202-G01-H-
00 
Côte 
d'Ivoire 
2 HIV/AID
S 
MO: 
UNDP 
3 89 26 5.63 100.00 
CIV-304-G02-H Côte 
d'Ivoire 
3 HIV/AID
S 
CS/PS: 
NGO 
3 89 26 5.63 100.00 
CIV-304-G03-T Côte 
d'Ivoire 
3 TB MO: 
UNDP 
2 89 26 5.63 100.00 
CIV-506-G04-H Côte 
d'Ivoire 
5 HIV/AID
S 
CS/PS: 
NGO 
3 89 26 5.63 99.91 
CIV-607-G07-T Côte 
d'Ivoire 
6 TB Gov: 
MOH 
1 89 26 5.63 100.00 
GNQ-405-G01-
H 
Equatorial 
Guinea 
4 HIV/AID
S 
MO: 
UNDP 
2 24 18 12.07 100.00 
GNQ-506-G02-
M 
Equatorial 
Guinea 
5 Malaria CS/PS: 
NGO 
2 24 18 12.07 100.00 
GAB-304-G01-
H 
Gabon 3 HIV/AID
S 
MO: 
UNDP 
4 40 26 17.45 100.00 
GAB-404-G02-
M 
Gabon 4 Malaria MO: 
UNDP 
4 40 26 17.45 100.00 
GAB-506-G03-
M 
Gabon 5 Malaria MO: 
UNDP 
4 40 26 17.45 100.00 
GMB-304-G02-
M 
Gambia 3 Malaria Gov: 
MOH 
4 26 26 21.37 100.00 
GMB-304-G01-
H 
Gambia 3 HIV/AID
S 
Gov: Oth 4 26 26 21.37 100.00 
GMB-506-G03-
T 
Gambia 5 TB Gov: 
MOH 
4 26 26 21.37 100.00 
GMB-607-G04-
M 
Gambia 6 Malaria Gov: 
MOH 
2 26 26 21.37 100.00 
GHN-102-G02-
T-00 
Ghana 1 TB Gov: 
MOH 
4 22.2 24 22.15 100.00 
GHN-102-G01-
H-00 
Ghana 1 HIV/AID
S 
Gov: 
MOH 
4 22.2 24 22.15 100.00 
GHN-202-G03-
M-00 
Ghana 2 Malaria Gov: 
MOH 
4 22.2 24 22.15 100.00 
GHN-405-G04-
M 
Ghana 4 Malaria Gov: 
MOH 
4 22.2 24 22.15 100.00 
GHN-506-G05-
T 
Ghana 5 TB Gov: 
MOH 
4 22.2 24 22.15 100.00 
GHN-506-G06- Ghana 5 HIV/AID Gov: 4 22.2 24 22.15 100.00 
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H S MOH 
GHN-809-G07-
M 
Ghana 8 Malaria Gov: 
MOH 
4 22.2 24 22.15 100.00 
GIN-202-G01-
H-00 
Guinea 2 HIV/AID
S 
Gov: 
MOH 
5 60 22 5.31 100.00 
GIN-202-G02-
M-00 
Guinea 2 Malaria Gov: 
MOH 
5 60 22 5.31 100.00 
GIN-506-G03-T Guinea 5 TB Gov: 
MOH 
5 60 22 5.31 100.00 
GIN-607-G04-H Guinea 6 HIV/AID
S 
Gov: 
MOH 
5 60 22 5.31 100.00 
GNB-304-G01-T Guinea-
Bissau 
3 TB MO: 
UNDP 
3 77 26 11.57 100.00 
GNB-404-G03-
M 
Guinea-
Bissau 
4 Malaria MO: 
UNDP 
3 77 26 11.57 100.00 
GNB-404-G02-
H 
Guinea-
Bissau 
4 HIV/AID
S 
MO: 
UNDP 
3 77 26 11.57 100.00 
GNB-607-G04-
M 
Guinea-
Bissau 
6 Malaria Gov: 
MOH 
3 77 26 11.57 100.00 
GNB-708-G05-
H 
Guinea-
Bissau 
7 HIV/AID
S 
Gov: Oth 1 77 26 11.57 100.00 
LBR-202-G01-
H-00 
Liberia 2 HIV/AID
S 
MO: 
UNDP 
4 32.25 14 11.15 100.00 
LBR-202-G02-T-
00 
Liberia 2 TB MO: 
UNDP 
4 32.25 14 11.15 100.00 
LBR-304-G03-
M 
Liberia 3 Malaria MO: 
UNDP 
4 32.25 14 11.15 100.00 
LBR-607-G04-H Liberia 6 HIV/AID
S 
MO: 
UNDP 
4 32.25 14 11.15 100.00 
LBR-708-G06-T Liberia 7 TB MO: 
UNDP 
5 32.25 14 11.15 100.00 
LBR-708-G05-
M 
Liberia 7 Malaria MO: 
UNDP 
5 32.25 14 11.15 100.00 
NGA-102-G01-
H-00 
Nigeria 1 HIV/AID
S 
Gov: Oth 1 88 26 5.29 100.00 
NGA-102-G02-
H-00 
Nigeria 1 HIV/AID
S 
CS/PS: 
NGO 
3 88 26 5.29 100.00 
NGA-102-G03-
H-00 
Nigeria 1 HIV/AID
S 
Gov: Oth 2 88 26 5.29 100.00 
NGA-202-G04-
M-00 
Nigeria 2 Malaria CS/PS: 
NGO 
3 88 26 5.29 100.00 
NGA-404-G05-
M 
Nigeria 4 Malaria CS/PS: 
NGO 
3 88 26 5.29 100.00 
NGA-509-G15-T Nigeria 5 TB CS/PS: 
NGO 
2 88 26 5.29 100.00 
    385 
NGA-506-G09-
H 
Nigeria 5 HIV/AID
S 
CS/PS: 
NGO 
2 88 26 5.29 100.00 
NGA-506-G08-
H 
Nigeria 5 HIV/AID
S 
CS/PS: 
NGO 
3 88 26 5.29 100.00 
NGA-506-G07-
H 
Nigeria 5 HIV/AID
S 
Gov: Oth 2 88 26 5.29 100.00 
NGA-506-G06-T Nigeria 5 TB CS/PS: 
FBO 
1 88 26 5.29 100.00 
STP-405-G01-M Sao Tome 
and 
Principe 
4 Malaria MO: 
UNDP 
3 14.25 18 71.44 100.00 
STP-506-G02-H Sao Tome 
and 
Principe 
5 HIV/AID
S 
MO: 
UNDP 
3 14.25 18 71.44 100.00 
STP-708-G03-M Sao Tome 
and 
Principe 
7 Malaria MO: 
UNDP 
3 14.25 18 71.44 100.00 
SNG-102-G02-
M-00 
Senegal 1 Malaria Gov: 
MOH 
2 51 22 19.15 100.00 
SNG-102-G01-
H-00 
Senegal 1 HIV/AID
S 
Gov: Oth 1 51 22 19.15 100.00 
SNG-405-G03-
M 
Senegal 4 Malaria Gov: 
MOH 
2 51 22 19.15 100.00 
SNG-607-G05-H Senegal 6 HIV/AID
S 
Gov: Oth 1 51 22 19.15 100.00 
SNG-607-G06-H Senegal 6 HIV/AID
S 
CS/PS: 
NGO 
1 51 22 19.15 100.00 
SNG-708-G08-T Senegal 7 TB Gov: 
MOH 
2 51 22 19.15 100.00 
SLE-202-G01-T-
00 
Sierra 
Leone 
2 TB CS/PS: 
NGO 
2 54 24 6.21 100.00 
SLE-405-G03-M Sierra 
Leone 
4 Malaria CS/PS: 
NGO 
2 54 24 6.21 100.00 
SLE-405-G02-H Sierra 
Leone 
4 HIV/AID
S 
Gov: Oth 2 54 24 6.21 100.00 
SLE-607-G04-H Sierra 
Leone 
6 HIV/AID
S 
Gov: Oth 2 54 24 6.21 100.00 
SLE-708-G05-M Sierra 
Leone 
7 Malaria Gov: 
MOH 
2 54 24 6.21 100.00 
SLE-708-G06-T Sierra 
Leone 
7 TB Gov: 
MOH 
2 54 24 6.21 100.00 
TGO-202-G01-
H-00 
Togo 2 HIV/AID
S 
MO: 
UNDP 
5 45 24 7.30 100.00 
TGO-304-G02-
M 
Togo 3 Malaria MO: 
UNDP 
5 45 24 7.30 100.00 
    386 
TGO-405-G05-
M 
Togo 4 Malaria MO: 
UNDP 
5 45 24 7.30 100.00 
TGO-405-G04-
H 
Togo 4 HIV/AID
S 
CS/PS: 
NGO 
2 45 24 7.30 100.00 
TGO-607-G06-
M 
Togo 6 Malaria MO: 
UNDP 
5 45 24 7.30 100.00 
TGO-607-G07-T Togo 6 TB MO: 
UNDP 
5 45 24 7.30 100.00 
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Grant Number Country 
Rou
nd 
Compon
ent 
PR Type 
No. 
of 
Gran
ts 
Governa
nce and 
Risk 
Burd
en 
Assista
nce to 
Health 
Absorpt
ive 
Capacit
y 
CAM-102-G01-
H-00 
Cambodi
a 
1 HIV/AID
S 
Gov: 
MOH 
5 85 26 20.08 100.00 
CAM-202-G02-
H-00 
Cambodi
a 
2 HIV/AID
S 
Gov: 
MOH 
5 85 26 20.08 98.06 
CAM-202-G03-
M-00 
Cambodi
a 
2 Malaria Gov: 
MOH 
5 85 26 20.08 99.01 
CAM-202-G04-
T-00 
Cambodi
a 
2 TB Gov: 
MOH 
5 85 26 20.08 100.00 
CHN-102-G01-
T-00 
China 1 TB Gov: 
Oth 
5 5 32 1.67 100.00 
CHN-102-G02-
M-00 
China 1 Malaria Gov: 
Oth 
5 5 32 1.67 100.00 
CHN-405-G05-
H 
China 4 HIV/AID
S 
Gov: 
Oth 
5 5 32 1.67 100.00 
CHN-405-G04-
T 
China 4 TB Gov: 
Oth 
5 5 32 1.67 100.00 
CHN-506-G08-
T 
China 5 TB Gov: 
Oth 
5 5 32 1.67 100.00 
CHN-506-G08-
T-e 
China 5 TB Gov: 
Oth 
5 5 32 1.67 100.00 
CHN-506-G07-
M 
China 5 Malaria Gov: 
Oth 
5 5 32 1.67 98.53 
CHN-506-G06-
H 
China 5 HIV/AID
S 
Gov: 
Oth 
5 5 32 1.67 100.00 
IND-102-G01-
T-00 
Indonesia 1 TB Gov: 
MOH 
5 48 24 3.57 100.00 
IND-102-G02-
M-00 
Indonesia 1 Malaria Gov: 
MOH 
5 48 24 3.57 100.00 
LAO-102-G01-
H-00 
Lao 
(Peoples 
Democrat
ic 
Republic) 
1 HIV/AID
S 
Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-102-G02-
M-00 
Lao 
(Peoples 
Democrat
ic 
Republic) 
1 Malaria Gov: 
MOH 
5 60 18 18.23 100.00 
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LAO-202-G03-
T-00 
Lao 
(Peoples 
Democrat
ic 
Republic) 
2 TB Gov: 
MOH 
5 60 18 18.23 100.00 
LAO-405-G04-
H 
Lao 
(Peoples 
Democrat
ic 
Republic) 
4 HIV/AID
S 
Gov: 
MOH 
5 60 18 18.23 100.00 
MON-102-
G01-T-00 
Mongolia 1 TB Gov: 
MOH 
3 12 16 18.45 100.00 
MON-202-
G02-H-00 
Mongolia 2 HIV/AID
S 
Gov: 
MOH 
3 12 16 18.45 100.00 
PNG-304-G01-
M 
Papua 
New 
Guinea 
3 Malaria Gov: 
MOH 
3 96 22 32.19 100.00 
PHL-202-G02-
T-e 
Philippine
s 
2 TB CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-202-G02-
T-00 
Philippine
s 
2 TB CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-202-G01-
M-00 
Philippine
s 
2 Malaria CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-304-G03-
H 
Philippine
s 
3 HIV/AID
S 
CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-506-G04-
H 
Philippine
s 
5 HIV/AID
S 
CS/PS: 
PS 
5 96 18 6.27 100.00 
PHL-509-G10-
H 
Philippine
s 
5 HIV/AID
S 
Gov: 
MOH 
5 96 18 6.27 100.00 
THA-102-G01-
H-00 
Thailand 1 HIV/AID
S 
Gov: 
MOH 
5 30 26 3.90 100.00 
THA-202-G05-
M-00 
Thailand 2 Malaria Gov: 
MOH 
5 30 26 3.90 99.41 
THA-304-G06-
H 
Thailand 3 HIV/AID
S 
CS/PS: 
NGO 
3 30 26 3.90 100.00 
TMP-202-G01-
M-00 
Timor-
Leste 
2 Malaria Gov: 
MOH 
3 18 20 44.71 100.00 
VTN-102-G01-
H-00 
Viet Nam 1 HIV/AID
S 
Gov: 
MOH 
2 45 26 12.04 100.00 
VTN-102-G02-
T-00 
Viet Nam 1 TB Gov: 
MOH 
2 45 26 12.04 100.00 
VTN-304-G03-
M 
Viet Nam 3 Malaria Gov: 
MOH 
1 45 26 12.04 100.00 
ARM-202-G01-
H-00 
Armenia 2 HIV/AID
S 
CS/PS: 
NGO 
1 22.5 16 32.22 100.00 
AZE-405-G01- Azerbaija 4 HIV/AID Gov: 4 30 24 6.44 99.73 
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BLR-607-G02-T Belarus 6 TB MO: 
UNDP 
4 30 22 3.08 100.00 
BIH-506-G01-H Bosnia 
and 
Herzegovi
na 
5 HIV/AID
S 
MO: 
UNDP 
4 30 14 25.50 99.19 
BUL-202-G01-
H-00 
Bulgaria 2 HIV/AID
S 
Gov: 
MOH 
1 20 20 17.98 100.00 
GEO-202-G01-
H-00 
Georgia 2 HIV/AID
S 
Gov: 
Oth 
5 32 22 32.33 100.00 
GEO-304-G02-
M 
Georgia 3 Malaria Gov: 
Oth 
5 32 22 32.33 100.00 
GEO-405-G03-
T 
Georgia 4 TB Gov: 
Oth 
5 32 22 32.33 100.00 
GEO-607-G06-
H 
Georgia 6 HIV/AID
S 
Gov: 
Oth 
5 32 22 32.33 100.00 
GEO-607-G04-
M 
Georgia 6 Malaria Gov: 
Oth 
5 32 22 32.33 100.00 
KAZ-202-G01-
H-00 
Kazakhsta
n 
2 HIV/AID
S 
Gov: 
Oth 
1 30 20 3.03 100.00 
KOS-708-G02-
H 
Kosovo 7 HIV/AID
S 
Gov: 
MOH 
2 15 12 12.96 100.00 
KGZ-202-G02-
T-00 
Kyrgyzsta
n 
2 TB Gov: 
MOH 
2 60 22 22.19 100.00 
KGZ-202-G01-
H-00 
Kyrgyzsta
n 
2 HIV/AID
S 
Gov: 
Oth 
1 60 22 22.19 100.00 
MNT-506-G01-
H 
Montene
gro 
5 HIV/AID
S 
MO: 
UNDP 
2 8 12 12.96 100.00 
ROM-202-G01-
H-00 
Romania 2 HIV/AID
S 
Gov: 
MOH 
2 16 18 4.54 100.00 
ROM-607-G03-
H 
Romania 6 HIV/AID
S 
CS/PS: 
NGO 
2 16 18 4.54 100.00 
RUS-304-G02-T Russian 
Federatio
n 
3 TB CS/PS: 
NGO 
1 80 22 1.69 100.00 
RUS-304-G01-
H 
Russian 
Federatio
n 
3 HIV/AID
S 
CS/PS: 
NGO 
1 80 22 1.69 99.33 
RUS-405-G04-T Russian 
Federatio
n 
4 TB CS/PS: 
NGO 
2 80 22 1.69 99.20 
RUS-405-G03-
H 
Russian 
Federatio
n 
4 HIV/AID
S 
CS/PS: 
NGO 
2 80 22 1.69 100.00 
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RUS-506-G05-
H 
Russian 
Federatio
n 
5 HIV/AID
S 
CS/PS: 
NGO 
1 80 22 1.69 99.51 
SER-102-G01-
H-00 
Serbia 1 HIV/AID
S 
CS/PS: 
PS 
1 8 16 12.96 100.00 
SER-304-G02-T Serbia 3 TB Gov: 
MOH 
2 8 16 12.96 100.00 
TAJ-102-G01-
H-00 
Tajikistan 1 HIV/AID
S 
MO: 
UNDP 
1 40 22 14.35 100.00 
TAJ-404-G03-H Tajikistan 4 HIV/AID
S 
MO: 
UNDP 
5 40 22 14.35 99.74 
TAJ-506-G04-
M 
Tajikistan 5 Malaria MO: 
UNDP 
5 40 22 14.35 98.88 
UZB-304-G01-
H 
Uzbekista
n 
3 HIV/AID
S 
Gov: 
MOH 
1 32 20 5.64 100.00 
UZB-405-G02-
M 
Uzbekista
n 
4 Malaria Gov: 
Oth 
1 32 20 5.64 100.00 
UZB-405-G03-
T 
Uzbekista
n 
4 TB Gov: 
MOH 
2 32 20 5.64 100.00 
ARG-102-G02-
H-00 
Argentina 1 HIV/AID
S 
CS/PS: 
PS 
1 22.5 16 32.22 100.00 
BOL-307-G07-
H 
Bolivia 
(Plurinati
onal 
State) 
3 HIV/AID
S 
CS/PS: 
NGO 
1 84 20 24.29 100.00 
BOL-306-G06-T Bolivia 
(Plurinati
onal 
State) 
3 TB MO: 
UNDP 
3 84 20 24.29 100.00 
CHL-102-G01-
H-00 
Chile 1 HIV/AID
S 
CS/PS: 
PS 
1 5 16 3.71 100.00 
COL-202-G01-
H-00 
Colombia 2 HIV/AID
S 
MO: Oth 1 20 20 18.30 100.00 
COR-202-G02-
H-00 
Costa 
Rica 
2 HIV/AID
S 
CS/PS: 
NGO 
1 9.4 18 11.25 100.00 
DMR-304-G02-
T 
Dominica
n 
Republic 
3 TB CS/PS: 
NGO 
1 90 18 20.64 100.00 
ECU-202-G01-
H-00 
Ecuador 2 HIV/AID
S 
Gov: 
MOH 
3 24 16 18.43 100.00 
ECU-405-G02-
T 
Ecuador 4 TB CS/PS: 
NGO 
2 24 16 18.43 100.00 
SLV-202-G03-
H-00 
El 
Salvador 
2 HIV/AID
S 
Gov: 
MOH 
3 32 16 29.30 100.00 
SLV-202-G01-
H-00 
El 
Salvador 
2 HIV/AID
S 
MO: 
UNDP 
2 32 16 29.30 100.00 
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SLV-202-G02-
T-00 
El 
Salvador 
2 TB MO: 
UNDP 
2 32 16 29.30 100.00 
SLV-202-G04-
T-00 
El 
Salvador 
2 TB Gov: 
MOH 
3 32 16 29.30 99.95 
GUA-304-G01-
H 
Guatemal
a 
3 HIV/AID
S 
CS/PS: 
NGO 
3 47 18 14.60 100.00 
GYA-405-G03-
T 
Guyana 4 TB Gov: 
MOH 
3 24 22 112.26 99.20 
HTI-102-G01-
H-00 
Haiti 1 HIV/AID
S 
CS/PS: 
PS 
1 100 20 27.83 100.00 
HND-102-G03-
M-00 
Honduras 1 Malaria MO: 
UNDP 
4 72 18 34.50 100.00 
HND-102-G02-
T-00 
Honduras 1 TB MO: 
UNDP 
4 72 18 34.50 99.36 
HND-102-G01-
H-00 
Honduras 1 HIV/AID
S 
MO: 
UNDP 
4 72 18 34.50 100.00 
JAM-304-G01-
H 
Jamaica 3 HIV/AID
S 
Gov: 
MOH 
1 20 16 24.84 100.00 
NIC-202-G03-
H-00 
Nicaragu
a 
2 HIV/AID
S 
CS/PS: 
NGO 
3 45 16 64.95 100.00 
NIC-202-G01-
M-00 
Nicaragu
a 
2 Malaria CS/PS: 
NGO 
3 45 16 64.95 100.00 
NIC-202-G02-
T-00 
Nicaragu
a 
2 TB CS/PS: 
NGO 
3 45 16 64.95 100.00 
PAN-102-G01-
T-00 
Panama 1 TB MO: 
UNDP 
1 8 18 12.74 100.00 
PER-202-G01-
H-00 
Peru 2 HIV/AID
S 
CS/PS: 
NGO 
5 30 24 16.76 100.00 
PER-202-G02-
T-00 
Peru 2 TB CS/PS: 
NGO 
5 30 24 16.76 100.00 
SUR-404-G02-
M 
Suriname 4 Malaria CS/PS: 
NGO 
1 15 22 86.35 100.00 
DZA-304-G01-
H 
Algeria 3 HIV/AID
S 
Gov: 
MOH 
1 11.4 16 0.50 100.00 
DJB-404-G01-H Djibouti 4 HIV/AID
S 
Gov: 
MOH 
4 97 26 38.46 100.00 
IRQ-607-G01-T Iraq 6 TB MO: 
UNDP 
1 30 14 11.71 100.00 
JOR-202-G01-
H-00 
Jordan 2 HIV/AID
S 
Gov: 
MOH 
1 8 12 23.23 100.00 
JOR-506-G02-T Jordan 5 TB Gov: 
MOH 
1 8 12 23.23 100.00 
MAL-102-G01-
M-00 
Mali 1 Malaria Gov: 
MOH 
3 96 24 10.33 100.00 
MOR-102-G01- Morocco 1 HIV/AID Gov: 1 8 14 8.57 100.00 
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NGR-306-G06-
M 
Niger 3 Malaria MO: 
UNDP 
3 67.5 22 4.92 100.00 
NGR-304-G01-
H 
Niger 3 HIV/AID
S 
Gov: 
Oth 
1 67.5 22 4.92 100.00 
SOM-202-G01-
M-00 
Somalia 2 Malaria MO: Oth 3 60 26 3.04 100.00 
SOM-304-G02-
T 
Somalia 3 TB CS/PS: 
NGO 
1 60 26 3.04 98.01 
SSD-202-G02-
T-00 
South 
Sudan 
2 TB MO: 
UNDP 
3 94 24 5.09 100.00 
SSD-202-G01-
M-00 
South 
Sudan 
2 Malaria MO: 
UNDP 
3 94 24 5.09 100.00 
SSD-405-G05-
H 
South 
Sudan 
4 HIV/AID
S 
MO: 
UNDP 
3 94 24 5.09 99.14 
SUD-202-G03-
M-00 
Sudan 2 Malaria MO: 
UNDP 
3 94 24 5.09 100.00 
SUD-305-G04-
H 
Sudan 3 HIV/AID
S 
MO: 
UNDP 
4 94 24 5.09 100.00 
SUD-506-G07-
T 
Sudan 5 TB MO: 
UNDP 
4 94 24 5.09 100.00 
YEM-202-G01-
M-00 
Yemen 2 Malaria Gov: 
MOH 
1 80 16 4.83 100.00 
YEM-405-G04-
T 
Yemen 4 TB Gov: 
MOH 
1 80 16 4.83 100.00 
AFG-405-G02-
T 
Afghanist
an 
4 TB Gov: 
MOH 
2 15 18 9.58 100.00 
AFG-509-G06-
M 
Afghanist
an 
5 Malaria CS/PS: 
NGO 
1 15 18 9.58 100.00 
BAN-202-G01-
H-00 
Banglade
sh 
2 HIV/AID
S 
Gov: 
MOF 
3 54 18 4.48 100.00 
BAN-304-G02-
T 
Banglade
sh 
3 TB CS/PS: 
NGO 
2 54 18 4.48 100.00 
BAN-304-G03-
T 
Banglade
sh 
3 TB Gov: 
MOF 
3 54 18 4.48 100.00 
BAN-607-G06-
M 
Banglade
sh 
6 Malaria CS/PS: 
NGO 
2 54 18 4.48 100.00 
BTN-405-G01-
M 
Bhutan 4 Malaria Gov: 
Oth 
5 5 18 33.30 100.00 
IDA-102-G01-
T-00 
India 1 TB Gov: 
Oth 
5 32 26 1.76 100.00 
IDA-405-G08-T India 4 TB Gov: 
Oth 
5 32 26 1.76 100.00 
IDA-405-G07-
M 
India 4 Malaria Gov: 
MOF 
5 32 26 1.76 100.00 
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IDA-607-G10-H India 6 HIV/AID
S 
CS/PS: 
NGO 
1 32 26 1.76 100.00 
NEP-202-G02-
M-00 
Nepal 2 Malaria Gov: 
MOH 
1 48 20 8.90 100.00 
NEP-202-G05-
H-00 
Nepal 2 HIV/AID
S 
MO: 
UNDP 
1 48 20 8.90 100.00 
NEP-202-G01-
H-00 
Nepal 2 HIV/AID
S 
Gov: 
MOH 
1 48 20 8.90 100.00 
NEP-405-G03-T Nepal 4 TB Gov: 
MOH 
3 48 20 8.90 100.00 
PKS-202-G01-
H-00 
Pakistan 2 HIV/AID
S 
Gov: 
MOH 
5 49 22 5.18 100.00 
PKS-304-G05-T Pakistan 3 TB Gov: 
MOH 
5 49 22 5.18 100.00 
SRL-102-G03-
T-00 
Sri Lanka 1 TB Gov: 
MOH 
3 45 16 4.23 100.00 
SRL-102-G02-
M-00 
Sri Lanka 1 Malaria CS/PS: 
NGO 
3 45 16 4.23 100.00 
SRL-102-G01-
M-00 
Sri Lanka 1 Malaria Gov: 
MOH 
3 45 16 4.23 100.00 
SRL-607-G09-H Sri Lanka 6 HIV/AID
S 
Gov: 
MOH 
3 45 16 4.23 100.00 
BRN-102-G01-
H-00 
Burundi 1 HIV/AID
S 
Gov: 
Oth 
2 87 26 7.98 100.00 
BRN-202-G02-
M-00 
Burundi 2 Malaria Gov: 
MOH 
2 87 26 7.98 100.00 
BRN-506-G04-
H 
Burundi 5 HIV/AID
S 
Gov: 
Oth 
2 87 26 7.98 100.00 
COM-304-G02-
H 
Comoros 3 HIV/AID
S 
CS/PS: 
NGO 
2 29 12 11.17 99.26 
ZAR-304-G03-
M 
Congo 
(Democra
tic 
Republic) 
3 Malaria MO: 
UNDP 
5 93 20 4.66 100.00 
ZAR-304-G02-
H 
Congo 
(Democra
tic 
Republic) 
3 HIV/AID
S 
MO: 
UNDP 
5 93 20 4.66 99.90 
ERT-202-G01-
M-00 
Eritrea 2 Malaria Gov: 
MOH 
5 48 20 16.11 100.00 
ERT-304-G02-
H 
Eritrea 3 HIV/AID
S 
Gov: 
MOH 
5 48 20 16.11 100.00 
ETH-102-G01-
T-00 
Ethiopia 1 TB Gov: 
MOH 
4 60 20 8.93 100.00 
ETH-202-G02-
M-00 
Ethiopia 2 Malaria Gov: 
MOH 
4 60 20 8.93 100.00 
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ETH-405-G04-
H 
Ethiopia 4 HIV/AID
S 
Gov: 
Oth 
2 60 20 8.93 100.00 
KEN-202-G03-
H-00 
Kenya 2 HIV/AID
S 
Gov: 
MOF 
5 58.4 26 19.99 100.00 
MDG-102-G01-
M-00 
Madagas
car 
1 Malaria CS/PS: 
NGO 
2 45 18 9.21 100.00 
MDG-202-G02-
H-00 
Madagas
car 
2 HIV/AID
S 
CS/PS: 
NGO 
1 45 18 9.21 100.00 
MDG-202-G03-
H-00 
Madagas
car 
2 HIV/AID
S 
CS/PS: 
NGO 
2 45 18 9.21 100.00 
MDG-304-G04-
H 
Madagas
car 
3 HIV/AID
S 
Gov: 
Oth 
2 45 18 9.21 100.00 
MDG-304-G05-
M 
Madagas
car 
3 Malaria Gov: 
MOH 
2 45 18 9.21 100.00 
MDG-405-G06-
M 
Madagas
car 
4 Malaria Gov: 
MOH 
2 45 18 9.21 100.00 
MDG-404-G08-
T 
Madagas
car 
4 TB Gov: 
Oth 
2 45 18 9.21 100.00 
RWN-304-G02-
H 
Rwanda 3 HIV/AID
S 
Gov: 
MOH 
4 43 24 25.78 100.00 
RWN-404-G04-
T 
Rwanda 4 TB Gov: 
MOH 
4 43 24 25.78 100.00 
RWN-506-G06-
M 
Rwanda 5 Malaria Gov: 
MOH 
4 43 24 25.78 100.00 
RWN-606-G07-
T 
Rwanda 6 TB Gov: 
MOH 
5 43 24 25.78 100.00 
RWN-607-G08-
H 
Rwanda 6 HIV/AID
S 
Gov: 
MOH 
5 43 24 25.78 100.00 
TNZ-102-G01-
M-00 
Tanzania 
(United 
Republic) 
1 Malaria Gov: 
MOH 
5 92 26 19.10 100.00 
TNZ-405-G05-
H 
Tanzania 
(United 
Republic) 
4 HIV/AID
S 
CS/PS: 
NGO 
1 92 26 19.10 100.00 
TNZ-405-G08-
M 
Tanzania 
(United 
Republic) 
4 Malaria Gov: 
MOF 
5 92 26 19.10 100.00 
TNZ-405-G04-
H 
Tanzania 
(United 
Republic) 
4 HIV/AID
S 
Gov: 
MOF 
5 92 26 19.10 100.00 
TNZ-405-G07-
H 
Tanzania 
(United 
Republic) 
4 HIV/AID
S 
CS/PS: 
NGO 
1 92 26 19.10 100.00 
ZAN-102-G01-
M-00 
Zanzibar 1 Malaria Gov: 
MOH 
4 17.1 26 19.10 100.00 
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ZAN-202-G02-
H-00 
Zanzibar 2 HIV/AID
S 
Gov: 
Oth 
2 17.1 26 19.10 100.00 
ZAN-304-G03-
T 
Zanzibar 3 TB Gov: 
MOH 
4 17.1 26 19.10 100.00 
ZAN-404-G04-
M 
Zanzibar 4 Malaria Gov: 
MOH 
4 17.1 26 19.10 100.00 
AGO-405-G02-
T 
Angola 4 TB MO: 
UNDP 
3 46.2 26 4.92 100.00 
LSO-506-G03-
H 
Lesotho 5 HIV/AID
S 
Gov: 
MOF 
3 22.2 20 24.37 100.00 
MOZ-202-G04-
T-00 
Mozambi
que 
2 TB Gov: 
MOH 
5 45.6 26 25.21 100.00 
MOZ-202-G03-
M-00 
Mozambi
que 
2 Malaria Gov: 
MOH 
5 45.6 26 25.21 98.07 
MOZ-202-G02-
H-00 
Mozambi
que 
2 HIV/AID
S 
Gov: 
MOH 
5 45.6 26 25.21 99.56 
MOZ-607-G05-
H 
Mozambi
que 
6 HIV/AID
S 
Gov: 
MOH 
5 45.6 26 25.21 100.00 
SWZ-202-G02-
M-00 
Swaziland 2 Malaria Gov: 
Oth 
4 34.2 26 32.23 100.00 
SWZ-202-G01-
H-00 
Swaziland 2 HIV/AID
S 
Gov: 
Oth 
4 34.2 26 32.23 100.00 
SWZ-405-G04-
H 
Swaziland 4 HIV/AID
S 
Gov: 
Oth 
4 34.2 26 32.23 100.00 
ZAM-102-G15-
T-00 
Zambia 1 TB CS/PS: 
NGO 
3 87 26 33.43 100.00 
ZAM-102-G06-
T-00 
Zambia 1 TB CS/PS: 
FBO 
3 87 26 33.43 100.00 
ZAM-102-G05-
M-00 
Zambia 1 Malaria CS/PS: 
FBO 
3 87 26 33.43 100.00 
ZAM-102-G08-
H-00 
Zambia 1 HIV/AID
S 
CS/PS: 
NGO 
3 87 26 33.43 100.00 
ZAM-102-G04-
H-00 
Zambia 1 HIV/AID
S 
CS/PS: 
FBO 
3 87 26 33.43 100.00 
ZAM-102-G02-
M-00 
Zambia 1 Malaria Gov: 
MOH 
3 87 26 33.43 98.92 
ZAM-405-G10-
H 
Zambia 4 HIV/AID
S 
CS/PS: 
FBO 
5 87 26 33.43 98.25 
ZIM-102-G07-
H 
Zimbabw
e 
1 HIV/AID
S 
Gov: 
Oth 
1 86 26 11.52 100.00 
ZIM-102-G02-
M-00 
Zimbabw
e 
1 Malaria Gov: 
MOH 
1 86 26 11.52 100.00 
ZIM-509-G08-T Zimbabw
e 
5 TB MO: 
UNDP 
5 86 26 11.52 100.00 
ZIM-509-G10- Zimbabw 5 HIV/AID MO: 5 86 26 11.52 100.00 
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ZIM-509-G09-
M 
Zimbabw
e 
5 Malaria MO: 
UNDP 
5 86 26 11.52 100.00 
BEN-304-G04-
M 
Benin 3 Malaria CS/PS: 
NGO 
1 42.75 20 14.26 98.77 
BUR-202-G02-
H-00 
Burkina 
Faso 
2 HIV/AID
S 
MO: 
UNDP 
3 85.5 22 9.42 100.00 
BUR-202-G04-
H-00 
Burkina 
Faso 
2 HIV/AID
S 
Gov: 
MOH 
3 85.5 22 9.42 100.00 
BUR-407-G05-
T 
Burkina 
Faso 
4 TB Gov: 
MOH 
3 85.5 22 9.42 100.00 
CMR-304-G01-
H 
Cameroo
n 
3 HIV/AID
S 
Gov: 
MOH 
5 90 26 5.98 100.00 
CAF-404-G03-T Central 
African 
Republic 
4 TB MO: 
UNDP 
4 80 26 6.11 100.00 
CAF-404-G02-
H 
Central 
African 
Republic 
4 HIV/AID
S 
MO: 
UNDP 
4 80 26 6.11 100.00 
CIV-202-G01-
H-00 
Côte 
d'Ivoire 
2 HIV/AID
S 
MO: 
UNDP 
2 89 26 5.63 100.00 
GNQ-506-G02-
M 
Equatoria
l Guinea 
5 Malaria CS/PS: 
NGO 
2 24 18 12.07 99.33 
GAB-304-G01-
H-e 
Gabon 3 HIV/AID
S 
MO: 
UNDP 
4 40 26 17.45 100.00 
GAB-304-G01-
H 
Gabon 3 HIV/AID
S 
MO: 
UNDP 
4 40 26 17.45 100.00 
GAB-404-G02-
M 
Gabon 4 Malaria MO: 
UNDP 
4 40 26 17.45 100.00 
GMB-304-G02-
M 
Gambia 3 Malaria Gov: 
MOH 
2 26 26 21.37 100.00 
GMB-304-G01-
H 
Gambia 3 HIV/AID
S 
Gov: 
Oth 
2 26 26 21.37 100.00 
GHN-102-G02-
T-00 
Ghana 1 TB Gov: 
MOH 
4 22.2 24 22.15 100.00 
GHN-102-G01-
H-00 
Ghana 1 HIV/AID
S 
Gov: 
MOH 
4 22.2 24 22.15 100.00 
GHN-202-G03-
M-00 
Ghana 2 Malaria Gov: 
MOH 
4 22.2 24 22.15 100.00 
GNB-309-G06-
T 
Guinea-
Bissau 
3 TB Gov: 
MOH 
3 77 26 11.57 100.00 
GNB-304-G01-
T 
Guinea-
Bissau 
3 TB MO: 
UNDP 
3 77 26 11.57 100.00 
GNB-404-G03-
M 
Guinea-
Bissau 
4 Malaria MO: 
UNDP 
3 77 26 11.57 100.00 
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GNB-409-G08-
M 
Guinea-
Bissau 
4 Malaria Gov: 
MOH 
3 77 26 11.57 100.00 
GNB-404-G02-
H 
Guinea-
Bissau 
4 HIV/AID
S 
MO: 
UNDP 
3 77 26 11.57 100.00 
GNB-409-G07-
H 
Guinea-
Bissau 
4 HIV/AID
S 
Gov: 
MOH 
3 77 26 11.57 100.00 
LBR-607-G04-H Liberia 6 HIV/AID
S 
MO: 
UNDP 
4 32.25 14 11.15 100.00 
LBR-708-G05-
M 
Liberia 7 Malaria MO: 
UNDP 
5 32.25 14 11.15 100.00 
NGA-506-G09-
H 
Nigeria 5 HIV/AID
S 
CS/PS: 
NGO 
2 88 26 5.29 100.00 
NGA-506-G08-
H 
Nigeria 5 HIV/AID
S 
CS/PS: 
NGO 
3 88 26 5.29 100.00 
NGA-506-G07-
H 
Nigeria 5 HIV/AID
S 
Gov: 
Oth 
2 88 26 5.29 100.00 
STP-405-G01-
M 
Sao Tome 
and 
Principe 
4 Malaria MO: 
UNDP 
3 14.25 18 71.44 100.00 
SNG-102-G04-
H-00 
Senegal 1 HIV/AID
S 
CS/PS: 
NGO 
1 51 22 19.15 100.00 
SNG-102-G01-
H-00 
Senegal 1 HIV/AID
S 
Gov: 
Oth 
1 51 22 19.15 100.00 
SLE-202-G01-
T-00 
Sierra 
Leone 
2 TB CS/PS: 
NGO 
2 54 24 6.21 100.00 
TGO-405-G05-
M 
Togo 4 Malaria MO: 
UNDP 
5 45 24 7.30 99.40 
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APPENDIX 10: MEMBERSHIP VALUES ADOPTED FOR FUZZY-SET ANALYSIS 
Main Outcome: Low Absorptive Capacity 
 
Variables 1 
(membership 
value) 
0.5 (membership 
value) 
0 (membership 
value) 
Absorptive 
Capacity 
0 to 90% 91% to 97% 98% and up 
Governance and 
Risk 
50 and up 21 to 49 20 and less 
Burden of 
Diseases 
25 and up 16 to 24 14 and less 
Assistance to 
Health 
15 and less 16 to 24 25 and up 
Number of Grants 4 and up 3 1 to 2 
    
Alternative Outcome: High Absorptive Capacity 
Variables 1 
(membership 
value)  
0.5 (membership 
value) 
0 (membership 
value) 
Absorptive 
Capacity 
98% and up 91% to 97% 0 to 90% 
Governance and 
Risk 
20 and less 21 to 49 50 and up 
Burden of 
Diseases 
14 and less 16 to 24 25 and up 
Assistance to 
Health 
25 and up 16 to 24 15 and less 
Number of Grants 1 to 2 3 4 and up 
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APPENDIX 11: DATA USED FOR COMPARATIVE ANALYSIS 
Phase 1     
  All Phase I Grants Phase 1 Grants with Low Absorptive 
Capacity 
Total Number 664 77 
      
Grant Type     
HIV 291  (43.8%) 37 (48%) 
TB 186 (28%) 16 (20.7%) 
Malaria 187 (28.1%) 24 (31%) 
      
Principal Recipient     
Government 374 (56.3%) 34 (44%) 
Civil Society 167 (25.1%) 29 (37.6%) 
International 
Organization 
123 (18.5%) 9 (11.6%) 
      
Funding Round     
Round 1 65 (9.7%) 1 (1.2%) 
Round 2 96 (14.45%) 2 (2.5%) 
Round 3 73 (10.9%) 1 (1.2%) 
Round 4 80 (12%) 0 
Round 5 71 (10.6%) 2 (2.5%) 
Round 6 95 (14.3%) 9 (11.6%) 
Round 7 87 (13.1%) 13 (16.8%) 
Round 8 97 (14.6%) 49 (63.6%) 
   
   
Phase 2     
  Phase 2 grants 
included in the study 
Phase 2 grants with low absorptive 
capacity 
Total number 321 41 
HIV 144 (44.8%) 17 (41.41%) 
TB 92 (28.6%) 14 (34.1%) 
Malaria 85 (26.4%) 10 (2.4%) 
Government PR 184 (57.3%) 27 (65.8%) 
Civil Society PR 72 (22.4%) 3 (7.3%) 
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International 
Organization PR 
65 (20.2%) 11 (26.8%) 
Round 1 48 (14.95) 1 (2.4%) 
Round 2 75 (23.3%) 7 (17%) 
Round 3 51 (15.8%) 4 (9.7%) 
Round 4 72 (22.4%) 9 (21.9%) 
Round 5 50 (15.5%) 13 (31.7%) 
Round 6 19 (5.9%) 4 (9.7%) 
Round 7 6 (1.8%) 3 (7.3%) 
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APPENDIX 12: EXAMPLE OF TRUTH TABLE 
 
Truth Table for all Phase 1 grants 
Assisthealt
hcal 
burden
cal 
govandrisk
cal 
nogrants
cal 
numb
er 
absorcapa
cal 
raw 
consist. 
PRI 
consist. 
SYM 
consist 
1 1 1 0 145  0.181376 0.05343
1 
0.572989 
0 1 1 1 124  0.175937 0.02900
4 
0.537607 
1 1 1 1 109  0.159219 0.02272
7 
0.53271 
0 1 1 0 52  0.222005 0.04562
3 
0.54571 
1 1 0 0 19  0.241447 0.02651
2 
0.522347 
1 0 0 0 16  0.24308 0.00485
3 
0.503825 
0 1 0 0 13  0.238006 0.03400
4 
0.529857 
0 1 0 1 8  0.238441 0.01954
7 
0.516442 
1 0 1 0 8  0.264296 0.02104
8 
0.515424 
1 0 1 1 6  0.28701 0.01801 0.511656 
0 0 0 0 5  0.24413 0.00306
3 
0.50239 
0 0 1 1 2  0.291118 0.00069
2 
0.500422 
0 0 1 0 1  0.278004 0.00694 0.504579 
0 0 0 1 0  0.316962 0.00374
8 
0.502035 
1 0 0 1 0  0.337176 0 0.5 
1 1 0 1 0  0.257746 0 0.5 
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Appendix 13: Example of FSCQA SOFTWARE OUTPUT 
 
 
Software output for all Phase 1 grants: 
            
*TRUTH TABLE ANALYSIS*           
         
**********************             
File:  C:/Users/Lilian Pedrosa/Documents/UNC-Dissertation/Data Analysis/Phase 1 data/All Phase 1 
Data/Phase1calibration.csv           
         
Model: absorptivecapac = f(assisthealthcal, burdencal, govandriskcal, nograntscal)     
          
         
 Rows:       7           
         
    Algorithm: Quine-McCluskey           
         
      True: 1           
                
         
--- COMPLEX SOLUTION ---          
         
frequency cutoff: 15.000000          
         
consistency cutoff: 0.155231          
         
             
                                                raw       unique                      
  
         
                                              coverage    coverage   consistency        
   
         
                                             ----------  ----------  ----------          
  
   
       
burdencal*govandriskcal*~nograntscal         0.659685    0.256085    0.170942     
     
         
~assisthealthcal*burdencal*govandriskcal     0.598615    0.195015    0.169578     
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solution coverage: 0.854700          
solution consistency: 0.153700           
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